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Abstract
Abstract
Sleep problems inerease with age and this may be, in part, due to a reduction in 
environmental and perceived light levels and the impact these have on the circadian 
system and daytime functioning. This study investigated the effeets of daytime light 
exposure delivered as a skeleton photoperiod on subjective and actigraphic sleep,
daytime mood and alertness, circadian activity rhythms and melatonin production and 
timing in healthy older people (>60 years) with self-reported sleep problems 
(Pittsburgh Sleep Quality Index >5). Two polychromatic light sources with different 
spectral compositions were compared, a blue-enriched (17000 K) and a control (4000 
K) white light condition, at two different irradianees.
Participants (66.5 ± 4.7 years; 23F, lOM) completed an at-home study o f 11 
consecutive weeks: 1 week baseline followed by 3 weeks daily light exposure (2 h in 
the morning and 2 h evening) and 2 weeks o f washout for each light condition 
(randomised, crossover design). Twelve participants received low irradiance lights 
(-3.6x10*'* photons/cm^/sec, -400 lux) and 21 participants received high irradiance 
lights (-9.1x10*^* photons/cm^/sec, -1100 lux). Participants completed daily sleep 
diaries, mood and alertness scales, and wore an aetivity monitor continuously. The 
urinary metabolite of melatonin, 6-sulphatoxymelatonin, was measured before and at 
the end of each light exposure period (sequential urine collection over a 39 h period).
Timed light exposure showed some beneficial effects on subjective and aetigraphic 
sleep, mood, alertness, activity and the melatonin rhythm. Results were shown to be 
irradiance- and period-dependent. Blue-enriched light significantly delayed subjective 
and aetigraphic sleep time compared to control light. Light administration produced 
few effects, possibly due to insufficient strength of the photic signal (irradiance, 
duration) as well as the confounding effects of a real world-life environment (natural 
photoperiod, social commitments). Future work should focus on refining and 
optimising light treatment for older community-dwelling individuals with sleep 
problems.
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CHAPTER ONE 
INTRODUCTION
____________________________________________________________________Chapter 1
1 Introduction
Most living organisms are exposed to a rhythmically changing environment as a result 
of the earth rotating around its axis and around the sun, the tilt of the earth and also 
from the moon revolving around our planet. Whereas the inclination of the earth's 
axis drives the change of seasons and the motion of the moon causes tides, the most 
prominent of these environmental cycles, generated by autorotation of the earth, is the 
daily 24 h light-dark cycle.
Mammals and other organisms have adapted to the rhythmically changing 
environment through the development of biological clocks, linking their biological 
rhythms to the 24 h light-dark cycle. Similar to 'normal' clocks (from French 'c/oc/ze' 
and Latin 'c/occa' meaning bell), which signal the external time, biological clocks 
provide a measure of internal time to the body. Thus they ensure that the body's 
behaviour and physiology are in appropriate phase with the outside world (Sweeney, 
1977; Thor and Fietze, 2001). As the period of most circadian (from Latin czrca' 
about and day) clocks deviates slightly flom the 24 h light-dark cycle, these
clocks need to be reset/synchronised by environmental signals ('ze%e6er% German 
for 'time giver') on a daily basis to oscillate with a period of 24 hours; a process of 
stable synchronisation is called entrainment. The most potent zeitgeber to entrain the 
human body clock to the environment is the light-dark cycle. The photic signal is 
detected in the eye and transmitted via the retinohypothalamic tract to the 
suprachiasmatic nuclei in the brain. The SCN is the main pacemaker or master clock 
of the human body. This clock serves to drive rhythmieity and orchestrates all other 
clocks in the periphery in each cell, tissue and organ. Examples of circadian rhythms 
in humans are the sleep-wake cycle and core body temperature rhythm.
Based on their periodicity three other biological rhythms are of further importance, 
however, they should only briefly be mentioned here: (i) ultradian rhythms with a 
periodicity of less than 24 hours as for example heart beat or nerves firing, (ii) 
inffadian rhythms with cycles longer than 24 hours as the human menstrual cycle and 
(iii) cirannual rhythms which extend over one year, e.g. hibernation, migration or 
seasonal reproduction in animals.
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A first step to understand the mammalian circadian system is to illustrate it consisting 
of three interacting elements with (1) the input pathway for the perception and 
transmission of time cue information, (2) the circadian clock or pacemaker and (3) the 
output pathways, i.e. the overt biological rhythms (Goldman, 1999). If one of these 
elements fails, the whole system alters and there is potential risk of mal-entrainment 
and of losing physiological homeostasis. Details of these mechanisms/elements are 
presented in the following sections.
1.1 Circadian rhythms
One of the earliest descriptions of circadian rhythmic behaviour comes from the 
French astronomer de Mairan who reported that the leaf movement of 
followed a 24 h pattern even under constant darkness (de Mairan, 1729). Circadian 
rhythmieity is observable in many physiological processes in many organisms as 
exemplified by the eclosion of insects, movements of certain plant parts or the 
rhythmic bioluminescence of a sea-dwelling protozoan (reviewed in Dunlap, 1999). 
Experiments keeping animals, including humans, under constant environmental 
conditions have shown that the circadian rhythmieity of many physiological and 
behavioural functions do persist but "free-run" showing oscillations that have an 
intrinsic period length (raw, r) slightly different from 24 hours (Aschoff and Pohl, 
1978; Middleton et al, 1996) which is genetically determined (Liu et ai, 1997a). All 
these rhythms need to be entrained or synchronised to the solar 24 h day (T-cycle) and 
any changes in entrainment will lead to alterations in their rhythmieity and alignment 
(section 1.6.1). Circadian rhythms can therefore be defined by three criteria: (1) 
persistence of the rhythm's approximately 24 h period under constant conditions in the 
absence of a zeitgeber, (2) stability of r over a range of temperatures, i.e. temperature- 
compensation, and (3) entrainment of the rhythm by an external stimulus (zeitgeber) 
such as light (Aschoff, 1960; Pittendrigh, 1960; reviewed in Vitatema er a/., 2001). 
Responsible for generating circadian rhythms and for synchronisation with the 24 h 
light-dark cycle (timekeeping) is the endogenous pacemaker (the master circadian 
clock) situated in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus 
(Ralph era/., 1990) (section 1.2.1).
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1.1.1 Circadian rhythm profile
A circadian rhythm as illustrated in Figure 1.1 can be described in physical terms with 
the mesur being the mean value of the fitted curve, the aerophase being the time of the 
peak value and the nadir being the trough of the oscillation. The difference between 
peak and nadir is referred to as amplitude. The phase is the timing of a set reference 
point or marker, e.g. aerophase o f melatonin levels, relative to the start of a fixed 
external phase, e.g. lights-off/nighttime (reviewed in Vitatema e/ a/., 2001). The 
period of the rhythm is the time interval between two successive reference points, e.g. 
two acrophases.
4k. Amplitude
Period
(mean value)
Phase
TimeAerophase 
(time of peak) Nadir
(timeofminimum)
Daytime Nighttime
Figure 1.1: Representative circadian rhythm (adapted from Middleton, unpublished).
1.1.2 Photoentrainment
Photoentrainment is the resetting or shifting o f the endogenous clock via light to match 
the 24 hour light-dark cycle (Czeisler a/., 1981; reviewed in Czeisler, 1995; 
Middleton gr a/., 1996; reviewed in Roenneberg and Foster, 1997). The 24 h light- 
dark cycle is the most potent zeitgeber to entrain the circadian clock in humans 
(reviewed in Reppert and Weaver, 1997; Czeisler and Wright, 1999; Roenneberg er a/., 
2007). Depending on whether r is longer or shorter than 24 hours the circadian clock 
needs to be shifted forward (advanced) or backwards (delayed) in order to be 
synchronised. However, the extent to which other non-photie events such as 
temperature changes, feeding times or social cues can act as zeitgebers for entrainment 
in humans remains elusive (Duffy a/., 1996; Mistlberger and Skene, 2005).
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Onee the circadian clock is entrained, a fixed phase relationship to the environmental 
cycle is established (reviewed in Roenneberg and Foster, 1997). The relationship 
between r and T is referred to as the phase angle (T) of entrainment (Pittendrigh and 
Daan, 1976a).
1.1.3 Models of photoentrainment
Two models have been developed to explain how light can reset the circadian timing 
system, called the continuous model and the discrete model (reviewed in Johnson,
1999). These will be discussed in the following two sections.
1.1.3.1 Continuous model
The continuous or parametric model states that entrainment is achieved by simply 
altering the speed of the clock thereby adapting r of the endogenous rhythm to the 
external environment. Light is continuously perceived and changes in the pacing of 
the clock are proportional to the gradual changes o f the light intensity (Aschoff^ 1963;
Aschoff, 1965; Johnson et al, 2004). This model is also referred to as the parametric 
or tonic model.
1.1.3.2 Discrete model
By contrast, the discrete or non-parametric model suggests that photic entrainment is a 
result of short light pulses or abrupt changes in light intensity correcting the phase ((p) 
of the clock (Pittendrigh and Daan, 1976a; Daan, 2000). Light pulses provide discrete 
time cues which function as a more abrupt correction mechanism for resetting the 
phase. Under natural conditions, these discrete time cues are exemplified by dusk and 
dawn (Pittendrigh, 1965). To achieve entrainment the circadian system must vary in 
its response to light (of different irradiance and spectral composition) over the course 
of its cycle, i.e. depending on the internal phase. The phase response curve (PRC) is a 
useful tool to (graphically) describe the phase-dependency of the system's response 
and to predict the behaviour of the clock (section 1.1.4.1).
Although the discrete model has been more accepted it appears that it may be a 
combination of both models which leads to the optimal photoentrainment of the 
endogenous clock (Aschoff, 1963; reviewed in Johnson, 1999) especially in diurnal
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species experiencing complete/fhll photoperiods. Another important factor influencing 
the behaviour o f the clock is the previous light history which can have after-effects on 
T (Pittendriglr and Daan, 1976a).
1.1.4 The phase response curve
Depending on the phase of the clock its response to a light signal differs causing 
different responses or phase shifts as described by the non-parametrie model (section 
1.1.3.2). Phase response curves (PRCs) offer a reliable method to study the 
physiology of the circadian system (Daan, 2000) allowing calculation of the magnitude 
of the phase shift in response to the light stimulus (e.g. light pulse).
1.1.4.1 Construction of a phase response curve
The direction and magnitude of a phase shift of the circadian clock varies depending 
on the actual internal time or phase that the light pulse/signal is presented as well as 
the duration and intensity o f the light (Honma e/ a/., 1987; Kennaway a/., 1987; 
Dawson and Campbell, 1991; reviewed in Czeisler, 1995). The experimental 
conditions (amount of background light) (Czeisler a/., 1989; Jewett et ai/., 1997) and
the organism's photoperiodic history prior to the experiment (Pittendrigh and Daan, 
1976a; Pittendrigh, 1981) also play a role. To assess phase shifts short single light 
signals are given at different times during the 24 hour period to an organism which is 
kept in the laboratory under constant conditions (constant dark [DD]) for the 
endogenous clock to free-run. The induced and circadian time-dependent phase shifts 
of a circadian rhythm (e.g. melatonin rhythm) are plotted against circadian time of the 
light signal showing the size and direction of the light-induced phase shift (Minors e/ 
a/., 1991; Khalsa e/a /., 2003) (Figure 1.2).
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Figure 1.2: Phase response curve (PRC) to a light stimulus. The melatonin aerophase times
(filled and unfilled circles) are used as the circadian phase maker (Khalsa et al, 2003). 
Ordinate: Magnitude of the phase shift: positive values are phase advances, negative values are 
phase delays. Abscissa: Circadian time (CT) when the light pulse is given.
On the abscissa the free-running eireadian phase is divided into 24 circadian time units 
(CT) with each unit of a duration of x/24. For diurnal species CTO is the time point of 
activity onset (subjective day) and CT12 the time point of activity offset (subjective 
night). Light in the late subjective night/early subjective morning results in a phase 
advance (earlier; positive phase shiA in Figure 1.2) and light in the early subjective 
night causes a phase delay (later; negative phase shift in Figure 1.2) (reviewed in 
Takahashi and Zatz, 1982; Honma and Honma, 1988; Czeisler g/ a/., 1989). What 
remains controversial is the effect light has on shifting the clock when given during the 
middle of the subjective day. Studies showing no or only a small effect o f light 
administered during midday suggest a 'dead zone' (Czeisler er a/., 1989; Dumont and 
Carrier, 1997; reviewed in Johnson, 1999) whereas others report light having an 
entraining effect even during the subjective day (Jewett er a/., 1997; Khalsa a/.,
2003). The greatest phase shifts (delays) induced by light are seen during the night.
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1.1.4.2 Skeleton photoperiod
Studies have shown that two short light pulses given at lights-on and lights-off o f a 
photoperiod have sufficient zeitgeber strength to simulate a complete photoperiod 
(PPc) of a 12:12 light-dark cycle and entrain the circadian system of an organism 
(Pittendrigh, 1964; Pittendrigh and Minis, 1964; Wehr er a/., 2001). The two light 
pulses resemble a skeleton photoperiod or “2-pulse entrainment” and the resulting 
entrainment is the net effect of both pulses on the circadian system (Pittendrigh, 1964; 
reviewed in Johnson e/ a/., 2003). Entrainment to a skeleton photoperiod using two 
light pulses leads to a more stable phase angle of entrainment than using one light 
pulse (reviewed in Johnson er a/., 2003). Both, advancing and delaying phase shiAs 
may counterbalance each other thereby stabilising entrainment.
This observed effectiveness of a skeleton photoperiod on the clock can be explained in 
relation to the photic entrainment mechanism of the circadian pacemaker. An 
experimental skeleton photoperiod resembles the circadian clock's most potent 
indicator of time-of-day, the light transition at twilight times (reviewed in Roenneberg 
and Foster, 1997). The dual oscillatory model (Pittendrigh and Daan, 1976b; Illnerova 
and Vanecek, 1982) postulates that the circadian clock is composed of two separate 
oscillators, both situated within the SCN: a Morning (M) oscillator, entrained to dawn 
(lights-on), and an Evening (E) oscillator, entrained to dusk (lights-off) (Wehr er a/., 
2001). Since the cell groups of the M and E oscillators are differently entrained they 
shift in opposite direction in response to light. This enables the SCN to set the start 
and end times of diurnal and nocturnal periods for the circadian rhythm of various 
outputs (Wehr er a/., 2001).
1.2 Circadian system
The mammalian circadian master clock or pacemaker resides within the SCN of the 
hypothalamus (Moore and Eichler 1972; Stephan and Zucker, 1972; KJein 1991) 
(section 1.3.1). The SCN, entrained by environmental time cues (zeitgebers) via a 
specific signalling pathway (section 1.2.1.2), shows self-sustained oscillations of clock 
gene expression (section 1.2.3) driving various physiological and behavioural output 
rhythms (section 1.2.1.3) and synchronising other oscillators in peripheral tissues 
(section 1.2.2).
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1.2.1 The SCN
Several studies have confirmed that the SCN acts as the primary pacemaker of 
circadian oscillations in mammals (Moore and Eichler 1972; Klein e/ a/., 1991; Welsh 
e/ a/., 1995), with a peak firing rate o f its neurons during daytime (Inouye and 
Kawamura, 1979). Lesion and ablation of the SCN leads to a disruption o f circadian 
behaviour within the organism (Stephan and Zucker, 1972; Stetson and Watson- 
Whitmyre, 1976). 7» vftm isolation of SCN neurons showed a sustained rhythmic 
firing rate over several days with rhythmic transcription, translation and neuropeptide 
secretion in these cells (Inouye und Kawamura, 1979; Gillette, 1986; Gillette and 
Reppert, 1987; Maywood er a/., 2006). Transplantation of SCN tissue Aom fetal 
mutant hamsters (exhibiting a short intrinsic x) into the brains of adult arrhythmic 
hamsters with ablated SCN restored circadian rhythmieity in these adult hamsters 
(Ralph, 1990). The period displayed was that of the donor (/aw-mutant) hamsters. 
This was the final proof of the role of the SCN as the major pacemaker in mammals.
1.2.1.1 Neuroanatomy of the SCN
The human SCN is composed of two clusters of neurons (approximately 20000 in 
total) and is located in the anterior hypothalamus above the optic chiasm surrounding 
the third ventricle (and hence it is called suprachiasmatic nucleus) (Van den Pol, 1980; 
Ralph et al, 1990). On a cellular level the mammalian circadian pacemaker is a 
heterogeneous structure (Antle er a/., 2007) and can be subdivided into two divisions: 
the ventrolateral shell region and the dorsomedial core region, both with different 
functions, cells types and innervations (Leak and Moore, 2001; Moore er a/., 2002; 
reviewed in Antle and Silver, 2005). Above and adjacent the optic chiasm lay the 
neurons of the core which produce mainly either vasoactive intestinal polypeptide 
(VIP) or gastrin-releasing peptide and y-aminobutric acid (GABA). The core receives 
primary and secondary visual input. The shell, surrounding the core, contains neurons 
producing GABA and arginine-vasopressin (VP) and to a lesser extent neurons which 
produce calretinin. It receives afferents Aom non-visual cortical and subcortical 
regions. VP and VIP play crucial roles in cAcadian time-keeping (Harmar e/ a/., 
2002).
The SCN consists of non-rhythmic, gate cells (core region) and rhythmic, oscillator 
cells (shell region). The latter contain the entire molecular clockwork machinery for
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entraining to a signal and generating and conveying circadian rhythm information to 
peripheral oscillators, and each cell oscillates with its own phase and period (Antle er 
a/., 2003; Antle cr a/., 2007). The gate cells receive photic input and relay this 
resetting information to the oscillator cells. Thereby, a synchronised rhythmic output 
is generated and transmitted (Antle er a/., 2007). GABA is the m^or neurotransmitter 
for synchronising/coupling of both cell groups/subdivisions (Liu and Reppert, 2000; 
Albus er a/., 2005). This communication is asymmetrical, the core exerts an excitatory 
signal whereas the shell (dorsal area) exerts an inhibitory signal on the ventral side 
(Albus er a/., 2005).
1.2.1.2 Input
Three major input pathways to the SCN have been identified. (1) The 
retinohypothalamic tract (RHT) provides the primary photic input Aom the retina. (2) 
The intergeniculate leaflet (IGL) provides non-photie as well as indirect photic input 
via the geniculohypothalamic tract (GHT) (Moore and Lenn, 1972; Rusack et a/., 
1989; Thankaehan and Rusak, 2005). Lesion studies of the IGL have been shown to 
alter the phase shiAing capacity and the phase angle of entrainment, rate o f re- 
entrainment, and response to skeleton photoperiods of the clock. (3) Further non- 
photic input is received Aom the serotonergic raphe nuclei (RN) (Moore gr a/., 1978; 
Meyer-Bemstein and Morin, 1996). The RN might modulate both RHT and IGL input 
(pathways) thereby participating in non-photic entrainment (Meyer-Bemstein and 
Morin, 1996). In addition, the SCN has intra-neuronal connections to provide 
entrainment as well as integration and consolidation of its output signals (Albus et al., 
2005; reviewed in Aton and Herzog, 2005)
The RHT is the most important input pathway to the SCN, and will be discussed in 
more detail in section 1.2.1.2.2. However, the origin of the photic signal transmitted 
by the RHT starts in the eye which will therefore be briefly described first (section 
1.2 . 1.2 . 1).
1.2.1.2.1 The eye
Eyes are very complex organs which are able to perceive light thereby enabling the 
organism to detect visual information Aom the environment. In order for this to
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happen light must pass through several layers of eells and two fluid-filled 
eompartments within the eye. After entering via the eomea light erosses the anterior 
ehamber, tilled with watery material (aqueous humor) produeed by the eiliary body. 
Light then passes through the pupil eontinuing through the lens. Both the pupil and 
lens are adjustable in size sueh that the amount of light reaehing the baek of the eye 
(retinal photoreeeptors) ean be eontrolled. The surfaees of the cornea and lens bend 
the entering light by inverting it. Onee through the posterior chamber (vitreous 
humour), light reaches the retina, the photosensitive layer of the eye (Figure 1.3). The 
retina is a sensory tissue containing photoreeeptors. Light elicits a chemical reaction 
which is converted into a neuronal signal and then transmitted via ganglion eells and 
the optic nerve to different brain areas.
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Figure 1.3: Anatomy of the mammalian eye (taken from Randall et al, 1997).
The eye detects light for two reasons: visual perception of the environment (section 
1.5.1) and measurement of environmental irradiance for non-visual responses sueh as 
photoentrainment of the eireadian clock (section 1.5.2).
1.2.1.2.2 The retinohypothalamic tract (RHT)
The light signal for entrainment of the clock is detected by type III retinal ganglion 
cells (RGCs) which are diffusely distributed in the inner retina (Pickard, 1980; Moore
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et a l, 1995). The integrated photie information is mediated via the monosynaptic 
retinohypothalamic tract (RTH) (Moore and Lenn, 1972; Moore et a l, 1995) primarily 
to the ventrolateral region of the SCN.
Other brain areas which receive innervations from the RHT are the IGL (Pickard, 
1985; Takatsuji et a l, 1991) and olivary pretectal nucleus (OPN) both important for 
irradiance detection (Foster, 2002; Hattar et a l, 2006) (Figure 1.4). Other brain areas 
include the ventrolateral preoptic nucleus (VLPO), involved in sleep-wake regulation 
(section 1.3.2.2), and the subparaventricular zone (sPVZ) of the hypothalamus (Hattar 
et a l, 2002; Gooley et a l, 2003; Hannibal and Fahrenkrug, 2004; Hattar et a l, 2006) 
which also contributes to light-induced (eireadian) responses (Gooley et al., 2003).
OPN
IGL
SCG
PVN
IML
CG
Figure 1.4: Schematic representation of central targets of ipRGCs in the brain (taken from 
Berson, 2003). SCN, suprachiasmatic nucleus; PVN, paraventricular nucleus of the 
hypothalamus; LGNv, ventral division of the intergeniculate nueleus; IGL, intergenieulate 
leaflet; OPN, olivary pretectal nucleus; P, pineal; SCG, superior eervieal ganglion; IML, 
intermediolateral nueleus; EW, Edinger-Westfal nueleus; CG, eiliary ganglion. Dark blue 
pathway: RHT innervating its major targets; orange pathway: regulation of melatonin release; 
light blue: pupillary reflex.
The two primary neurotransmitters in the RHT involved in light-induced resetting of 
the clock are glutamate and neuropeptide pituitary adenylate cyclase-activating 
polypeptide (PACAP) (Liou et a l, 1986; Hannibal et a l, 2000; Hannibal et a l, 2001). 
A marker for sueh light-induced neuronal activity in the SCN is c-fos which belongs to
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the family of immediate-early genes (lEG) (Sheng er a/., 1990; reviewed in 
Komhauser e/ aA, 1996).
1.2.1.3 Output pathways
The SCN imposes circadian rhythmieity on many physiological and behavioural 
functions such as the sleep-wake cycle, core body temperature (CBT), hormone 
secretion (e.g. melatonin and corticosterone) and alertness. These overt output 
rhythms are generated via hormonal (Silver et 6z/., 1996; Kramer et a/., 2001; Cheng et 
a/., 2002; Tousson and Meissl, 2004) and neuronal (firing rate and neural connections) 
(Ueyama et a/., 1999; de La Iglesia et a/., 2000; Guo et a/., 2005) output pathways and 
their different peak activity times (Hastings et a/., 1999; Yan et a/., 1999) The 
hormonal output pathway uses an assembly of different neuropeptides such as VP, 
tumor necrosis factor-a and prokineticin-2 which are produced in the SCN (Kramer et 
a/., 2001; Cheng et a/., 2002; Tousson and Meissl, 2004). The humoral and neuronal 
outputs from the SCN are mainly focused on areas within the (anterior) hypothalamus, 
e.g. the paraventricular nucleus (PVN), the sPVZ, the medial preoptic area (MPA), the 
dorsomedial hypothalamic nucleus (DMH), and other brain areas including the IGL, 
RN, nuclei of the locus coeruleus (LC), basal fbrebrain and retrochiasmatic area 
(RCA) (Morin et a/., 1994). All o f these targets function as relay areas (nuclei) which 
disperse the imposed circadian signal widely across an organism (Tousson and Meissl,
2004).
The PVN, an important centre for regulation of many neuroendocrine and autonomic 
processes (reviewed in Swanson and Sawchenko, 1980; Tousson and Meissl, 2004), is 
the relay nucleus between the SCN and the pineal gland (Klein er a;/., 1983; 
Teclemariam-Mesbah et al, 1999). The MPA and DMH are intermediate nuclei for 
conveying the SCN signal to the VLPO which is involved in sleep-wake regulation.
1.2.2 Peripheral clocks
The mammalian circadian system is a hierarchical multioseillatory system with the 
SCN as the self-sustaining master oscillator orchestrating various downstream 
oscillators (Yamazaki er a/., 2000; Yoo a/., 2004) via individual output pathways 
(Balsalobre a/., 2000 Resetting; Le Minh er a/., 2001; section 1.2.1.3) (Figure 1.5).
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Peripheral clocks in turn drive physiological and behavioural output rhythms in 
respective target cells, tissues and organs. The oscillatory clock gene expression in 
these peripheral clocks is similar to that in the SCN (Balsalobre e/ a/., 1998), however, 
they display a different phase to the SCN (Yoo er <3/., 2004). In culture these cells 
maintain their intrinsic firing rate for up to 20 days (Y00 e/ a/., 2004) until the rhythms 
dampen and synchrony is lost (Yamazaki g/ a/., 2000).
i Q r RHT
Neural / humoral
Relay nuclei
V /
Peripheral oscillators
Feeding rhythm s
Activity
O vert biological rhythm s
Humoral / autonomic nervous system
Figure 1.5: Mammalian circadian organization. The entraining light signal is perceived by the 
eye and transmitted primarily via the RHT to the SCN. The synchronised SCN, the central 
clock, generates output signals in a circadian fashion. This time-coded information is spread 
via relay nuclei in other brain areas to peripheral oscillators (clocks) using humoral or neural 
signals. The outputs of the peripheral oscillators are overt biological (behavioural and 
physiological) rhythms. In addition, feeding times and activity can influence peripheral clocks 
independently of the SCN.
There is evidence that peripheral clocks may also entrain to non-photic cues (i.e. 
feeding time and rest/activity [Damiola er a/., 2000; Stokkan a/., 2001]). Non- 
photic entrainment is discussed in section 1.6.6. The molecular characteristics, i.e.
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signalling pathway(s) for resetting peripheral clocks remains to be precisely
elucidated.
1.2.3 The circadian molecular clock in mammals
The circadian molecular clock of mammals possesses similar features to those found in 
other organisms (i.e. clock components, feedback loops) (reviewed in Panda g/ a/., 
2002a; reviewed in Yu and Hardin, 2006; reviewed in Takahashi et ai, 2008). The 
mammalian oscillator is composed of a series of interconnected 
transcriptional/translational feedback loops (Shearman et al. 2000; reviewed in 
Reppert and Weaver, 2002). Core members of the positive limb of the loop include 
proteins encoded by circadian output cycle kaput (C/ocA:) and brain and muscle amt- 
like protein 1 (^/Ma/f). Key members of the negative limb include proteins encoded 
by three period genes (Per7, and fe r j) , and two cryptochrome genes (C^yf and 
Cyy2) (Tei e/ a/., 1997; Zylka e/ a/., 1998; Shearman a/., 2000). The retinoic acid 
receptor-related orphan receptor a (Rora) and reverse erythroblastic leukaemia virus a 
(Rev-gr6a) are components o f a secondary loop.
During the subjective day the transcription factors CLOCK and BMALl form a 
heterodimer, bind to the E-Box in the promoter regions o f and C^7/2, and
activate their transcription (Lee et al, 2001). During midday and in the early evening 
PER and CRY proteins accumulate in the cytosol where they form PER/PER 
homodimers or CRY/PER heterodimers. These dimers form large multimers with 
casein kinases (CKI). In the early subjective night the CRY/PER/CKl complex enters 
the nucleus where it binds to and inhibits the CLOCK/BMALl transcriptional activity. 
While CRY proteins act as potent inhibitors, PER proteins have a mild inhibiting 
offset (Griffin er a/., 1999; Kume gr a/., 1999). Following post-translational 
modification, PER and CRY are degraded during the night, removing the inhibitory 
effect on the CLOCKiBMALl heterodimers so that a new transcriptional cycle may 
begin.
The molecular oscillator secondary loop includes the constitutive expression of Rora, 
and the CLOCK/BMALl-mediated transcription of Rev-er6a during the subjective 
night. RORa and REV-ERBa compete for the binding site in the promoter region of 
REV-ERBa represses (Preitner er a/., 2002), and RORa activates
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transcription (Sato et a l, 2004). Thus, when REV-ERBa levels are elevated, Bmall 
expression is reduced. Indeed, CRY increases Bmall mRNA levels by repressing Rev- 
erba expression, whereas PER (PER2) stimulates Bmall expression (Shearmann et a l,
2000). These interconnected feedback loops result in rhythmical expression of Bmall, 
which peaks at night and 12 h out of phase with the Per and Cry mRNAs.
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Figure 1.6: The mammalian molecular clock. In the primary loop, through heterodimerisation 
of CLOCK (light beige) and BMALl (light brown) transcription of Per 1/2, Cry 1/2 and Rev- 
erba is initiated. CRY (dusky pink) and PER (blue) form a complex. This is phosphorylated 
(P, orange circle) and bound by CKle/CKlô (green) enabling the complex to enter the 
nucleus; here CRY and PER inhibit their own transcription. In the secondary loop, the 
promoter of Bmall is bound by REV-ERBa (lilac) repressing Bmall expression. Bmall 
expression is stimulated by RORa binding to ROR response elements (RRE, grey). The 
expression of clock-controlled genes (CCG) is under the control of CLOCK:BMALl. 
Degradation of CRY and PER is mediated by ubiquitin ligase and F-Box protein complexes. 
(Adapted from Takahashi et al, 2008.)
Casein kinase 1 delta (CKlô) and epsilon (CK ls) both play an essential role in the 
machinery of the circadian clock. Through phosphorylation of clock proteins, the 
kinases influence the subcellular localisation of the protein, function as transcriptional 
inhibitors, and influence the speed of degradation (Etchegaray et a l, 2009; Lee et a l, 
2009). Ubiquitin ligase and F-Box protein complexes have been associated with
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degradation o f PER and CRY (Eide e/ ùi/., 2005; Bnsino e/ a/., 2007; reviewed in 
Takahashi e/ a/., 2008).
Entrainment to light is accomplished through indirect light-induced activation of f  erf 
and Per2 (Travnickova-Bendova e/ a/., 2002). Through several signalling pathways 
involving kinase cascades, cAMP responsive element binding protein (CREB) is 
finally activated and binds to the promoter regions of f  erf and f  er2 (and other light- 
responsive genes) stimulating gene expression (Travnickova-Bendova e/ a/., 2002).
The rhythmic expression of clock-controlled genes (CCGs) is under the regulation of
the CLOCK/BMALl limb. The CCGs are the direct output of the SCN clockwork and 
are involved in downstream pathways.
1.3 Human circadian rhythms
In humans circadian rhythms include changes in hormone levels (e.g. melatonin,
cortisol), CBT, performance, metabolism and the sleep-wake cycle. Using the 
constant routine protocol (constant wake, constant semi-recumbent posture, constant 
caloric food intake, constant light) where subjects were scheduled to different -  24 h 
days, Wright et al. (2001) could show that the r of the human circadian pacemaker in 
sighted humans is near but different from 24 hours. Therefore the circadian clock has 
to be adjusted everyday to be in synchrony with the light-dark cycle and enable correct 
behavioural and physiological functioning o f the human body.
1.3.1 Pineal gland and melatonin rhythm
The pineal gland, situated in the centre of the brain, behind the third ventricle, is the 
most directly linked output/target of the SCN. This endocrine gland is composed of  
two cell types, the neuroglia cells and the pinealocytes. The latter produce the 
indoleamine melatonin (N-acetyl-5-methoxytryptamine), the primary neurohormone of 
the pineal gland, during the dark phase of 24 h light-dark cycle (Arendt, 1995). The 
SCN utilises GABA (Hermes et a/., 1996; Kalsbeek et a/., 1999) to regulate the 
rhythmic production (output) of melatonin in a multi-synaptic pathway: Photic 
information is relayed from the SCN to the PVN and &om there sequentially to the 
superior cervical ganglion (SCG) and finally to the pineal gland (Klein et a/., 1983;
1-16
___________________________________________________________________ Chapter 1
Larsen g/ a/., 1998; Teclemariam-Mesbah a/., 1999). Through the SCN the 
melatonin rhythm is entrained to the natural light-dark cycle (Arendt, 1995). Light is 
therefore the main zeitgeber for the rhythmic (circadian) production o f melatonin.
1.3.1.1 Melatonin synthesis
The pathway of pineal melatonin synthesis is depicted in Figure 1.7. The pinealocytes 
take up L-tryptophan from the blood and convert it by tryptophan hydroxylase to 5- 
hydroxytryptophan. This is then decarboxylated to serotonin (5-hydroxytryptamine, 5- 
HT) during the light phase of light-dark cycle. 5-HT is converted to N-acetylserotonin 
(NAS) by serotonin-N-acetyltransferase (AA-NAT) which is the rate limiting step of 
the melatonin synthesis and shows a remarkable increase during nighttime. NAS is 
then converted by hydroxyindole-O-methyltransferase to melatonin (Klein, 1985; 
Arendt, 1995) which is immediately released into the cerebrospinal fluid and blood (as 
a direct response to the clock's signal); as such the tiny, lipophilic melatonin can 
theoretically access every cell in the body.
Melatonin is metabolised to 6-hydroxymelatonin by CYFlA2-mediated 6- 
hydroxylation in the liver (Facciola et a l, 2001; Skene et a l, 2001) followed by 
sulphate conjugation resulting in 6-sulphatoxymelatonin (aMT6s). The end product, 
aMT6s, together with a number o f minor metabolites, including the glucuronide 
conjugate, is excreted in the urine (Kopin er 6f/., 1961; Arendt a/., 1985). Melatonin 
clearance rate can be altered by certain pathologies, e.g. liver and kidney diseases 
(Iguchi er a/., 1982; Steindl c/ a/., 1997; Montagnese a/., 2009). Melatonin 
metabolism is rapid with a short half life (10 min) in plasma and circulating melatonin 
levels are therefore highly representative of its pineal production (Arendt, 1995; 
reviewed in von Gall, 2002).
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Figure 1.7: Melatonin synthesis (Arendt, 1995).
1.3.1.2 The melatonin rhythm
Melatonin production follows a robust and reproducible rhythm (within an individual) 
(Arendt, 1978; reviewed in Arendt, 1988; Klerman et a l, 2002a). Figure 1.8 shows a 
diagram of the rhythmic production o f melatonin with different markers to characterise 
the rhythm. The onset o f melatonin synthesis starts in the early evening with the peak 
or acrophase time during the night (plasma melatonin: between 02:00 and 04:00 h 
[reviewed in Zawilska er a/., 2009]). The secretion of melatonin ceases in the morning 
hours (offset) remaining at very low levels during daytime, the light phase o f the 24 h 
photoperiod (Arendt, 1993). Both, the amplitude (not indicated, difference between 
the peak and median) and the median provide information of the amount of melatonin 
produced.
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Figure 1.8: Plasma melatonin profile. Markers to characterise the rhythm of plasma, saliva, 
and urinary 6-sulphatoxymelatonin (aMT6s) are indicated (adapted from Arendt and Skene,
2005).
Under the control o f light (Broadway er a/., 1987; Shanahan and Czeisler, 1991; 
Deacon and Arendt, 1994a), the characteristics of the melatonin rhythm (amplitude, 
duration and acrophase time) signal photie information (e.g. seasonal changes in 
photoperiod length and day length) to the organism (reviewed in Bartness and 
Goldman, 1989; reviewed in Wehr, 1997; 2001). In humans for instance, seasonal 
photoperiod variations seem to be mediated by changes in melatonin acrophase time 
(Illnerova e/ a/., 1985; Kennaway and Royles, 1986; Bojkowski and Arendt, 1988) and 
duration of secretion at nighttime (depending on latitude) (Kauppila a/., 1987; 
Bojkowski and Arendt, 1988). To date, the main physiological role of melatonin in 
humans still remains inconclusive. It seems, however, that daily melatonin production 
is involved in entrainment of the clock (via a feedback mechanism) (Lewy e/ a/., 1992; 
Sumova and Illnerova, 1996; McArthur e/ a/., 1997) and has sleep-promoting 
(Waldhauser er a/., 1990; reviewed in Dawson and Encel, 1993; Zhdanova et a/., 
1996) and sleep-wake regulatory effects (reviewed in Dawson and Encel, 1993; Dijk 
and C^ochen, 1997; reviewed in Lavie, 1997; Krauchi e/ a/., 2000; reviewed in 
Krauchi and Wirz-Justice, 2001; reviewed in Lavie, 2001; reviewed in C^ochen er a/..
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2003) and sleep structure/architecture (Dijk g/ a/., 1995). This might be achieved 
through a temporal relationship between the rhythms o f sleep propensity and 
melatonin secretion (Dijk and C^ochen, 1997).
An inverse relationship exists between the melatonin rhythm and CBT (another marker 
of the circadian clock). The decline in CBT is temporally correlated to the rise of 
melatonin levels in the early subjective evening (Cagnacci ef a/., 1992). The 
temperature nadir around ~ 03:00 h is opposite to the peak in melatonin synthesis and 
the subsequent decline in melatonin levels is associated with a simultaneous increase 
in CBT. Evidence exists linking the lowering of the CBT with a subsequent increase 
in distal skin temperature to the eireadian regulation of sleep and sleepiness in the 
evening (section 1.3.2.1.2). This lowering o f the CBT (Krauchi gr a/., 2000; reviewed 
in Krauchi et al, 2006) has been linked to melatonin’s soporific effects.
A dual oscillator model has been proposed to explain how photoperiod might be 
measured (section 1.1.4.2). Both, the M and E oscillator, are thought to be involved, 
amongst other rhythmic events, in generating the melatonin rhythm (Illnerova and 
Vanecek, 1982, 1988). The E oscillator determines the rise (onset) of nocturnal 
melatonin production whereas the M oscillator controls the offset of the melatonin 
secretion (Wehr g/ a/., 2001).
1.3.1.3 Marker of the circadian phase
Melatonin, direetly measured in plasma or saliva, and its major urinary metabolite 
aMT6s, is considered the best marker of the phase o f the circadian clock (Arendt gt a/., 
1985; Klerman et al, 2002a). This is due to melatonin’s direct responsiveness to 
signals from the SCN (Lewy g/ a/., 1999), its sensitivity to light (section 1.3.1.5) and 
its robustness to most masking factors, although, changes in posture have been shown 
to affect plasma and saliva melatonin levels (Deacon and Arendt, 1994b; Nathan g/ a/., 
1998). The timing of the melatonin rhythm reflects the phase position of the circadian 
clock (internal, circadian time in relation to external time). Assessment o f the clock’s 
phase using melatonin in plasma, saliva and the urinary metabolite, aMT6s, has 
revealed a good correlation between the three phase markers (Arendt g^  a/., 1985; 
Bojkowski g^  a/., 1987a; Ross g/ a/., 1995). The least invasive and most employable 
sampling method for field studies is measurement of aMT6s levels via timed urine
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collections. The disadvantages are the reduced resolution due to longer integration 
times (longer duration of urine collection bins compared to blood sampling) and 
possible participant errors during sampling. The aMT6s rhythm is usually delayed by 
-  2 h and its morning decline by 3 -  4 h compared to the plasma melatonin rhythm 
(reviewed in Arendt, 1988; reviewed in Zawilska g7 a/., 2009); sleep oceurs 1 -  2 h 
after plasma melatonin onset and ends 1 -  2 h before melatonin offset (reviewed in 
Skene and Arendt, 2006).
1.3.1.4 Melatonin receptors
Three melatonin receptors have been identified. The first two types, MTi and MT], 
have a high affinity to melatonin and are G protein-coupled receptors situated in the 
retina, brain and peripheral tissues (Reppert g/ a/., 1994; Reppert g/ a/., 1995; reviewed 
in Duboeovieh and Markowska 2005). The third type, MT3, belongs to the family of 
the quinone reductases (Nosjean g^  a/., 2000; reviewed in Duboeovieh g^  a/., 2003). 
The SCN expresses MTi and MT% receptors and uses endogenous melatonin as a 
feedback mechanism thereby regulating neuronal activity and timing o f circadian 
rhythms (Liu et al, 1997b; reviewed in Gillette and Mitchell, 2002).
1.3.1.5 Effects of light on the melatonin rhythm
Light has two effects on the melatonin rhythm. (I) Entrained to the light-dark cycle 
melatonin production is almost exclusively confined to the nighttime (dark period) in 
both diurnal and nocturnal vertebrates. Exposure to light at night will acutely suppress 
melatonin production but synthesis will be resumed once the light has stopped 
(Wurtman g^  a/., 1964; Lewy g/ a/., 1980; Bojkowski g/ a/., 1987b; Kennaway g/ a/., 
1987). (II) Light has the ability to phase shift the melatonin rhythm (in accordance 
with the PRC) (section 1.1.4.1) providing a reliable marker for (light-induced) phase 
shifting of the circadian clock (Van Cauter et al, 1994; Boivin and James, 2002; 
Revell et al, 2005).
1.3.1.6 Melatonin and light history
Melatonin production and light-induced melatonin suppression show great inter-
individual variation. The latter may be due to differences in light sensitivity between
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individuals. In addition, previous light exposure, e.g. the amount of light perceived 
during the day, can modulate the light sensitivity of different parts of the circadian 
system (Reiter gr a/., 1983; Herbert g/ a/., 2002; Smith g^  a/., 2004). In a counter­
balanced cross-over design study from Herbert g/ a/. (2002) participants completed 5 
days in a bright light or dim light environment followed by two nights in the 
laboratory. On night seven participants were exposed to light and melatonin 
suppression was measured. Melatonin levels were less suppressed if the previous 
week had been the bright light condition compared to values from the dim light week. 
Jasser g^  <3/. (2006) showed a dampened melatonin suppression to a monochromatic 
light (460 nm) stimulus when participants were dim white light adapted compared to 
when participants were dark adapted. The influence of the seasonal change in 
photoperiod length may also alter light sensitivity in humans with a decrease in 
sensitivity in summer and an increasing in winter (Eastman, 1990; Cole gr a/., 1995; 
Herbert g7 a/., 1998).
It may be speculated that other parts of the circadian system or functions under its 
control respond differently to experimental light exposure depending on photic history. 
This possibility should be taken into consideration when interpreting the results of 
light exposure trials (if direct measurement of the environmental light exposure of an
individual is not possible).
1.3.2 Sleep
During sleep consciousness is reduced and many diverse physiological changes in the 
brain and body take place (Tononi and Cirelli, 2006). The purpose of sleep is not yet 
fully understood; it has been hypothesised that it allows both brain and body to 
replenish and restore as well as consolidate memory (reviewed in Stickgold and 
Walker, 2005; Tobler, 2005; reviewed in Tononi and Cirelli, 2006). Lack of sleep by 
eontrast has detrimental effects on many functions such as physical and mental health, 
memory, general well-being and alertness (Newman gf a/., 1997; reviewed in 
Rajaratnam and Arendt, 2001; reviewed in Carskadon, 2004; Ensrud g/ a/., 2009).
Sleep, as well as wakefulness, shows dynamie changes in brain activity with 
characteristic patterns measured by the electroeneephalogram (EEC). The EEC 
illustrates neuronal activity from the cortex (Berger, 1929) and differs between sleep
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and wake. Based on the brain's activity pattern (brain waves) sleep can be broadly 
divided into two states: rapid eye movement (REM) sleep, hirther characterised by 
muscle atonia, and non-sleep rapid eye movement (NREM) sleep (Dement and 
Kleitman, 1957). NREM sleep can be subdivided in three stages:
# Stage I: light sleep, transition from wake to sleep (alpha and theta waves)
# Stage II: sleep, but easy to awaken (theta waves, spindles and K-complexes)
# Stage III and IV: deep sleep (theta and mainly delta waves)
The NREM and REM sleep-stage sequence cycles several times across the night. The 
graphic representation of this ultradian sleep-stage sequence cycling is called a 
hypnogram (Figure 1.9) (Dement and Kleitman, 1957). Each cycle takes about 100
min with the proportion of REM slowly increasing across the night.
Wake
REM-Sleep
Sleep Stage I
Sleep Stage II
Sleep Stage III
Sleep Stage IV
T T TI
0 1 2 3 4 5 6 7
Time (hours since begin of sleep)
Figure 1.9: Hypnogram of a normal nighttime sleep (taken from Kantermann, 2008 
adapted from Roenneberg, 2006).
Sleep, its duration, distribution of NREM and REM states, and depth, changes with 
advancing age. Infants show the longest sleep duration and highest proportion of 
REM whereas later on in life these are reduced. Recent research has shown that the 
m^ority of these changes already occur between the ages of 19 to 60 years (Carrier e/ 
a/., 2001; 2002; Ohayon e/ a/., 2004). However, taking into account comorbidities of 
the ageing process, sleep changes are even more exacerbated later on in life (reviewed
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in Vitiello, 2006). Many older people complain about problems such as earlier bed- 
and wake-np times, less consolidated sleep due to frequent nocturnal awakenings and 
lighter sleep (reviewed in Dijk e/ a/., 2000). Section 1.7.2 will discuss age-related 
changes of sleep in more detail.
1.3.2.1 Sleep-wake cycle: The two process model
A two-process model for the regulation of the rhythmic alteration of sleep and wake 
has been conceptualised (Borbely, 1982; Daan a/., 1984; Achermann and Borbely, 
1990). Regulation is achieved through the interaction of two processes (Borbely, 
1982; Daan a/., 1984): a mechanism that measures time awake and sleep pressure, 
the sleep homeostat (process S), and a circadian oscillator, the circadian pacemaker 
(process C), generating signals for sleep propensity, duration and structure. 
Interlinked is the ultradian cycle of the REM and NREM sleep sequence (Figure 1.10) 
(Borbely and Achermann, 1992; reviewed in Borbely and Achermann, 1999).
1.3.2.1.1 Process S
The sleep homeostat represents the need to sleep which is determined by the temporal 
sequence of behavioural states of rest/activity and sleep/wake. Sleep pressure rises 
during wakefulness and dissipates during sleep. The physiological correlate of process 
S is the slow wave activity (SWA) (delta waves in the &equency range 0.75 -  4.0 Hz) 
(Daan a/., 1984; Dijk e/ a/., 1999) measured via polysomnography (PSG). SWA is 
proportional to the time being awake and used as a marker of sleep intensity. The time 
course of process S and sleep intensity can be derived by dynamic changes in SWA; 
this exponential time course shows an upper and lower threshold which are both 
influenced by Process C (Figure 1.10) (reviewed in Beersma and Gordijn, 2007).
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Figure 1.10: Time course of the two process model of sleep regulation.
A) Homeostatic drive (top), circadian drive (middle), ultradian sleep cycle (bottom) (taken 
from Borbely and Achermann, 1992). B) Interaction of process S (solid line) and process C 
(dashed line); vertical dashed line represents time of sleep onset in the evening (taken from 
Moore, 2007).
S: sleep; W: wake.
1.3.2.1.2 Process C
The circadian process C is controlled by the SCN and therefore not under the influence 
of behavioural states; this process is responsible for the timing and duration of sleep 
and wake (reviewed in Beersma and Gordijn, 2007). Thus the circadian oscillator 
regulates the ability to sleep as well as not to sleep at certain phases during the 24 h 
light-dark cycle (Dijk and Czeisler, 1994). This maintains the separation of sleep and 
wake into two different episodes (one during the day and the other at night).
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In an entrained state, the circadian drive for sleep (propensity) peaks in the early 
morning hours and coincides with the nadir of the CBT (Dijk and Czeisler, 1995). The 
trough of this drive is in the early evening (Strogatz er a/., 1987; Dijk and Czeisler, 
1995) coinciding with the rise in melatonin (Lavie, 1986) and distal body temperature 
(Krauchi er <3/., 2000). Thereby, the circadian drive for wakefulness counters process 
S and increases over the course o f the day and peaks in the evening, a time point which 
has been termed the 'wake-maintenance zone' (Strogatz g/ a/., 1987) close to habitual 
bedtime (Strogatz e/ a/., 1987; Dijk and Czeisler, 1994). The opposing actions of the 
two processes might be explained through a paradoxical characteristic o f the circadian 
system. As the homeostatic need for sleep increases during the day, the circadian drive 
for wakefulness increases, too. At the end of a day, homeostatic sleep pressure will 
reach its highest point when in turn the strongest wake-promoting signal is needed to 
counteract physiological and mental decrements. During the subjective night the two 
processes reverse the direction of their promoting signals. While process S dissipates 
and aims towards wakefulness. Process C now promotes sleep necessary for sleep 
consolidation and prevention of early wakening (Edgar er a/., 1993; Dijk and Czeisler, 
1994; 1995). Thereby process C sets the upper and lower threshold of process S 
(Figure 1.11).
P rocessS TTTTTTTT
SLEEP LOAD
11
WAKE
alertness.
ALERTING
SIGNAL SLEEPProcessC
9 a.m. day-active 9 p.m. night-asleep 9 a.m.
Figure 1.11: Representation of the opposing interaction of Process S and Process C (adapted 
from Dyk and Edgar, 1999). Their interaction results in the alternation of sleep and wake. 
The solid line depicts the course of alertness (wake).
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1.3.2.2 Neuronal aspects of sleep-wake regulation
The SCN is involved in the interaction of sleep-promoting and wake-promoting brain 
areas (Steriade and McCarley, 1990; reviewed in Saper er a/., 2005; reviewed in Fuller 
g/ <3/., 2006, reviewed in C^ochen, 2007). These feed back to the SCN possibly 
adjusting its phase (Deboer cz/., 2003). Centres which are all highly active during 
wakefulness and involved in arousal are, amongst others, hypothalamic areas including 
the serotonergic RN, the histaminergie tuberomammilary nuclei (TMN), areas o f the 
basal forebrain and the noradrenergic LC (reviewed in Saper e/ a/., 2001). 
Furthermore hypocretin/orexin hypothalamic neurons are believed to have a 
wakefulness-promoting effect (reviewed in Saper e/ a/., 2005; Moore, 2007). Together 
these centres form the ascending arousal system innervating the cortex and thereby 
stimulating wakefulness (reviewed in Saper et al, 2005).
An important sleep-promoting area is the GABAergic VLPO (Szymusiak et al, 1998; 
reviewed in Saper et al, 2001). The VLPO receives direct projections from the RHT 
and indirect innervations from the SCN via the relay nuclei MPA and DMH 
(Deurveilher er a/., 2002) and to a lesser extend via the sPVZ (Deurveilher a/.,
2002). It is believed that during sleep the VLPO inhibits activation of the arousal 
centres via GABAergic innervations.
The wake- and sleep-promoting components interact by mutual inhibition of each 
other. This model is referred to as the flip-flop switch (reviewed in Saper et al, 2001;
2005). Due to the switching properties, a result of the mutual inhibition, intermediate 
states are prevented and only wake or sleep can occur. Light and dark influence this 
switch or rather its components in an opposing maimer. The arousal system is 
activated by light whereas darkness mediates activation of the VLPO. During 
wakefulness the components o f the arousal system inhibit the sleep-promoting VLPO 
whereas during sleep the VLPO inhibits neuronal activation o f the arousal system 
(Saper e/ a/., 2005).
1.3.2.3 Sleep assessment
The most reliable method and the 'golden standard' to assess sleep and sleep structure 
is via PSG. However, though practical for clinical and laboratory-based 
investigations, PSG is less practical for field studies as it is expensive and intrusive.
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Therefore, two alternative methods may be employed: subjective and
objeclive/actigraphic assessment (Lockley et a/., 1999).
The first alternative is the use o f sleep logs (diaries) for daily subjective sleep 
measurement. The shortcoming o f this approach is that this measure relies entirely on 
the individual to provide accurate information and participants often have difficulties 
estimating their sleep. The resulting error can be minimised by each participant 
serving as his/her own control, e.g. in intervention studies. Despite the wide 
application of sleep diaries their validity and reliability has not been fully established 
and results should be considered with caution (Rogers a/., 1993; Usui e/ a/., 1998).
The second alternative is actigraphy; motor activity data is gathered via wrist-worn 
monitors identifying and quantifying rest (‘sleep’) and activity ( ‘wake’). The use of 
actigraphy has been validated in several studies (Mullaney a/., 1980; Sadeh a/., 
1994; Van Someren et aZ., 1996; Ancoli-lsrael et a/., 1997a; Van Someren, 1997; 
Lockley et a/., 1999; Kushida et a/., 2001). Thereby, one can also assess variability of 
individual rest-activity rhythms and quantify rhythm disturbances. This might provide 
some knowledge on the capability and functionality of the circadian pacemaker itself 
(Van Someren, 1997). Limitations of actigraphic assessment might arise from the 
interpretation of activity levels. Inactivity due to sleep cannot be distinguished from 
inactivity whilst awake.
To overcome the shortcomings of both methods their simultaneous use is 
recommended (Kushida et al., 2001; Van den Berg et al, 2008). This allows for a 
more adequate assessment o f (a) relative values o f sleep and (b) relative changes of 
sleep parameters (Lockley a/., 1999).
1.3.3 Psychological circadian rhythms
The diurnal rhythms o f alermess, mood and performance (psychological rhythms) 
(Monk et a/., 1992a) are under the influence of four processes: circadian, behavioural, 
physiological and light. The psychological rhythms show circadian variation and 
parallel the rhythm of the CBT (Àkerstedt er <3/., 1979; Monk, 1987; Johnson eZ a/., 
1992; Monk eZ a/., 1997a). The trough o f these rhythms is late at night/in the very 
early morning about one hour after the melatonin acrophase; the peak times occurring 
during the daytime hours (Figure 1.12). The rhythms of CBT and the psychological
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parameters are all controlled by the SCN (Johnson eZ a/., 1992; Monk eZ a/., 1997a), 
however, it appears that CBT can additionally affect these psychological rhythms 
(Wright eZ <3/., 2002). An experiment by Wright and co-workers (2002) has shown that 
an increase of CBT (regardless o f internal time) can lead to improvements in 
psychological rhythms.
In addition to the circadian timing system the rhythms of alertness, mood and 
performance are also under the influence o f (prior) wakefulness and thus sleep 
(Brendel eZ a/., 1990; Johnson eZ a/., 1992; Monk eZ a/., 1992a; Birchler-Pedross eZ a/., 
2009). The wake-dependent deterioration of these neuro-behavioural parameters is 
opposed by the circadian arousal signal during the day and in the evening (Dijk eZ a/., 
1992; Johnson eZ o/., 1992; Dijk and Czeisler, 1994; Boivin gZ a/., 1997; section 
1.3.2.1.2). In other words, when properly entrained to the light-dark cycle the 
circadian pacemaker counteracts the decline in alertness, mood and performance 
resulting from sustained wakefulness and build-up of sleep need across the day 
(C^ochen eZ a/., 1999; Lockley eZ a/., 2008). At nighttime the circadian system 
promotes sleep resulting in a decline of these psychological variables. The rapid 
decline in alertness seen near to habitual bedtime coincides with an increase in sleep 
propensity, referred to as ‘the opening o f the sleep gate’ (Lavie, 1986) and with the 
rise o f melatonin (reviewed in Lavie, 1997, section 1.3.1.2).
A third component influencing rhythms of alertness, mood and performance is sleep 
inertia or process W. Sleep inertia is a state o f low arousal upon awakening in the 
morning causing impairment of the psychological rhythms. Due to inter-individual 
differences and prior sleep duration process W can last for up to 4 hours (Jewett eZ a/., 
1999; reviewed in C^ochen, 2007); after a fast increase of alertness in the first hour 
after awakening, levels begin to settle (Jewett gZ a/., 1999).
1-29
Chapter 1
A)
D)
■S
I  .eg o
B)
C)
5 -  - VC  r - J
l i t
y
H
3
Li
>  03 C;
60  1
40  -
20  -
0
37.1 -I
36.9 -
36.7  -
36.5  J
n  I I
60
40
20
I  s
-l 1------------ 1
H (U
U c
A .9
I I
1.8 -,
1.6  -
1.4
1.2 J
10  14 18 22  02  06  10  14
Clock time (h)
Figure 1.12: Circadian rhythms of plasma melatonin, core body temperature, alertness and 
performance (obtained under constant routine). Dotted line: peak in melatonin rhythm. 
(Adapted from R^aratnam and Arendt, 2001).
Light can acutely affect alertness, mood and performance (section 1.6.2). The 
neuronal basis for light-induced effects involves, apart from the SCN, mainly the LC
and VLPO, both part of the sleep-wake flip-flop switch (reviewed in Saper et al,
2005). Whereas the LC is involved in promoting wakefulness and depends on light 
input (Gonzalez and Aston-Jones, 2006), the sleep-promoting activity of the VLPO, 
innervating wake-promoting centres (reviewed in Saper er a/., 2001, 2005), is inhibited 
by light as has been shown in mice (Lupi a/., 2008). The interaction of these two
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centres modulated by light results in the eireadian rhythm of the psychological 
variables (reviewed in Cajoehen, 2007).
1.4 Light characteristics relevant for photoreception
Light is energy in the form of photons and it forms part of the electromagnetic 
spectrum. It can either behave like a wave or a particle (photon), known as the wave- 
partiele duality (reviewed in Foster and Lucas, 2000). Each photon has a distinct 
amount of energy associated with it (Halliday et a l, 1992). The energy of a photon is 
reciprocal to its wavelength; for instance high frequency short wavelength light will 
have a greater amount of energy than long wavelength light. This can be calculated 
using the following equation:
E = hn
(E = energy, h = Planck’s constant, n= frequency of the wave)
Visible light covers the portion of the electromagnetic spectrum from 400 to 700 nm 
and can be subdivided into different colours (Figure 1.13), each o f which is 
characterised by its intrinsic wavelength, frequency and energy. Each colour can also 
be measured in Degree Kelvin (K) which refers to the correlated colour temperature 
(CCT); this is the temperature of a theoretical black body that radiates light of 
comparable colour to that light source. Similar to photon energy, light of a higher 
CCT contains more shorter wavelengths whereas light of a low CCT contains more 
longer wavelengths.
Gamma 
rays X rays
Ultra­
violet Infrared
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radio waves
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Figure 1.13: Visible spectrum of electromagnetic radiation (taken from Randall et al, 1997).
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White light, such as we use in work and home settings, is composed of many different 
wavelengths of light covering the visual spectrum. The spectral power distribution 
(SPD) of a white (polychromatic) light source describes the power/energy emitted by 
each wavelength contained in the light (Wandell, 1995).
1.4.1 ‘Biological’ light measurement
Light can be described using radiant or photometric measurements with further 
subdivisions (reviewed in Foster and Lucas, 2000).
1) Radiometry measures all electromagnetic energy and detectors show the same 
sensitivity to all wavelengths.
2) Photometry only measures light o f the visible spectrum (only evaluating the human 
visual responses to light) and describes the brightness of a light as it would appear to 
the human eye. Photometric detectors do not measure all light present; they exhibit the
same sensitivity as the photopie system.
Both radiometric and photometric measures are further subdivided into;
a) Irradianee/Illuminanee: radiant energy from all directions over a 180® field 
of view.
b) Radiance/Luminance: radiant energy viewed from a specific direction in 
space.
Circadian experiments should use irradiance measurements (pW/cm^) for two reasons:
(1) Photometric measures assess only visible light perceived by a human. Aiming to 
mimic the sensitivity of the human eye, photometric detectors do not consider all 
wavelengths equally (reviewed in Peirson e/ a/., 2005). (2) Circadian responses to 
light are primarily mediated by a novel photopigment called melanopsin (section
1.5.2.1) and only to a lesser extent by the classical photoreceptors of the visual system.
Photopigments count the number but not the energy o f photons emitted by a light 
source. The number of photons absorbed will depend on the wavelength of the photon 
and the spectral sensitivity o f the photopigment. Thus all energy should further be 
converted into photon flux (photons/cm^/sec). It is also important to keep the total 
number of photons similar to compare the biological effectiveness of different lights.
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1.4.2 Light stimuli
Depending on the experimental question the spectral composition of a light source 
needs to be considered in circadian experiments. Broadly, three categories of light 
sourees can be differentiated: monochromatie light, polychromatic white light and 
enriched polychromatic white light. In an enriched polychromatic white light 
condition a specific wavelength area (colour) within the light source is enriched. As it 
is important to keep the overall amount of photon flux similar, if different light sources 
are compared (see above), the amount of photons contained in the other wavelengths 
(non-enriehed area) will be less.
1.5 Photoreception
After having passed through the different layers and compartments of the eye (section 
1.2.1.2.1) light reaches the light detecting cells, the photoreceptors, in the retina. The 
classical photoreceptors, the rods and cones, are primarily responsible for visual
photoreception (section 1.5.1); a third photoreceptor type (section 1.5.2.1) appears to 
be predominantly involved in eireadian, non-visual photoreception (section 1.5.2).
1.5.1 Visual photoreception
Light reaching the mammalian retina is perceived by rods and cones which are 
photosensitive cells expressing opsin-based photopigments. The opsin protein of these 
photopigments is coupled to a Vitamin A-retinaldehyde, usually 11-cM-retinal, which 
acts as the light absorbing chromophore (Wandell, 1995). The conversion of the light 
signal/photons into an electrical signal is called phototransduction and is very similar 
in both photoreceptor types: the detection o f a photon causes a conformational change 
of the 11 -cfr-retinal to the all-fr"aM.y-retinal form. This in turn triggers an enzymatic 
(G-protein) cascade changing the membrane potential (hyperpolarisation) o f the 
photoreceptor cell leading to the release of the activating neurotransmitter glutamate 
onto postsynaptic bipolar and horizontal cells. The bipolar cells relay this information 
onto the retinal ganglion cells (RGCs) (Figure 1.14). From there the electrical signal 
travels along the optic nerve via the lateral geniculate nucleus (LGN) to the primary 
visual cortex for processing of form and colour. This signal is the visual output signal 
from the retina.
1-33
Chapter 1
E X z c RPE
Photoreceptors
S'
pRGC
Output
z>
Figure 1.14: The basic cell types of the retina and the way light travels through it (adapted 
from Hankins et al, 2008).
R: rods, C: cones, G: ganglion cells, H; horizontal cells, B: bipolar cells. A: amacrine cells, 
pRGC: photosensitive (melanopsin containing) retinal ganglion cells.
The probability of the photopigment catching photons (Wandell, 1995) is dependent 
on the opsin’s wavelength sensitivity or absorption spectrum. This in turn determines 
the interaction between the opsin and the chromophore and the photopigment’s 
maximum wavelength sensitivity (l^ax) (reviewed in Foster and Hankins, 2002). 
Although each opsin has their own specific absorption spectrum or profile with a 
specific A.max all opsin-based photopigments display the same absorption shape called 
Dartnall nomogram (Dartnall, 1953) (Figure 1.15).
There are, however, some substantial differences between rods and cones. Rods and 
cones show an uneven distribution across the retina, with rods prevailing at the 
periphery whereas the cones are mainly found in the fovea (area of highest vision) 
(Curcio et a l, 1990) with a 1:1 ratio projection to the RGCs (via the bipolar cells). 
The rods are involved in seotopic vision and are sensitive to low levels of light, e.g. 
light at night, whereas the cones are capable of distinguishing between the different
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wavelengths o f a light source and are therefore responsible for photopic (colour) vision 
(Wehner and Gehring, 1995).
An important difference between the rods and cones is their spectral absorption (Figure 
1.15). Humans have three types of cones referred to as short- (S), middle- (M) and 
long-wavelength (L) cones. Their spectral responsiveness covers the entire visible 
spectrum with S-cones peaking at ~ 420 nm, M-cones at ~ 534 nm, and L-cones at ~ 
564 nm, in vitro, but broad overlaps occur (Bowmaker and Dartnell, 1980; Stockman 
et a l, 1999). In vitro the rods have a single peak absorbance at ~ 498 nm. In vivo the 
Imax are shifted to longer wavelengths: S-cones peak at ~ 440 nm, M-cones at ~ 545 
nm, and L-cones at ~ 565 nm (Sharpe et a l, 1999), and rods at ~ 505 nm (Commission 
internationale de l'éclairage, 1951).
420 498 534 564
1 0 0 -
400 500 600 700
Violet Blue Cyan Green Yellow Red 
Wavelength (nm)
Figure 1.15: Spectral absorption curves of the short (S), medium (M) and long (L) wavelength 
pigments in human cone and rod (R) cells (commons.wikimedia.org, adapted from Bowmaker 
and Dartnall, 1980). All curves are in shape of the Dartnall nomogram.
Colour is not perceived by the amount of photons a photopigment absorbs, instead the 
information is encoded by which, and how many, cells are signalling -  in the same 
way as the binary coding system works (Livingstone, 2002). Thereby the contribution 
of the different cells firing is integrated and produces the colour signal.
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Until just over 10 years ago it was believed that the classical photoreceptors were 
mediating photic input to the clock. Studies by Freedman and colleagues (1999) and 
Lucas er a/. (1999) showed that transgenic mice lacking rods and cones still exhibited 
circadian and melatonin suppression responses to light despite having lost all visual 
responsiveness. Similar observations were reported in studies on visually blind 
humans (Czeisler er a/., 1995a; Klerman a/., 2002b). Together, these findings 
demonstrated that rods and cones are not required for the elicitation o f circadian 
responses to light. Instead, the existence o f a third photoreceptor system containing a 
novel photopigment was postulated (Provencio er (r/., 1998a) which could mediate 
non-visual light processes. However, a contribution from the classical photoreceptors 
cannot be excluded.
1.5.2 Non-visual photoreception
It has been postulated that entrainment of the circadian system to the environmental 
light-dark cycle occurs mainly through gross changes in the amount of light namely 
changes in irradiance occurring at the beginning and end of the photoperiod. Photic 
information for the non-visual or non-image forming (NIF) pathway is detected in the 
eyes as demonstrated by the fact that in mammals removal of the eyes abolishes light 
entrainment o f the clock (Foster er a/., 1991). This photic information is perceived 
through photoreceptors in the retina and passed on to the SCN via the RHT.
1.5.2.1 Melanopsin and intrinsically photosensitive RGCs
Provencio and colleagues (1998a) first identified the novel opsin-based photopigment,
melanopsin, in &og dermal cells where the photopigment was redistributed in response
to light. Subsequently, melanopsin was identified in the mammalian, including
human, inner retina (Provencio et al, 2000). More specifically, it is almost
exclusively expressed in a subset of RGCs (Gooley er a/., 2001; Hannibal a/., 2002;
Hattar e/ a/., 2002; Provencio e/ a/., 2002; Dacey e/ a/., 2005).
The melanopsin-expressing RGCs of the inner mammalian retina were demonstrated 
to have intrinsic photosensitivity and be maximally sensitive to short wavelength blue 
light (Berson er a/., 2002). Subsequently, these intrinsically photosensitive retinal 
ganglion cells (ipRGCs) were proposed to be the third photoreceptor class (Gooley e/
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al., 2001; Berson et a l, 2002; Hannibal et a l, 2002; Hattar et a l, 2002; Provencio et 
a/., 2002; Dacey a/., 2005). Their morphology resembles that of type HI RGCs 
(Berson e/ a/., 2002; Hattar e/ a/., 2002). The ipRGCs make-up the RHT (Provencio er 
a/., 1998b; Hattar a/., 2002) that projects to the areas of the brain involved in non- 
visnal responses including the SCN, IGL and OPN (Hattar er a/., 2006) and other brain 
areas (Hattar a/., 2002; Gooley a/., 2003; Hannibal and Fahrenkrug, 2004) (e.g. 
involved in sleep-wake regulation). Opposite to the classical rod and cone 
photoreceptors the ipRCGs depolarise in response to light and express PACAP 
(Berson e/ a/., 2002; Hannibal er a/., 2001). The absorbance spectra of the 
melanopsin-ipRGCs resembles a Dartnall nomogram, similar to other retinaldehyde- 
based pigments (section 1.5.1), with a Imax 482 -  484 nm (Berson er a/., 2002; Dacey 
a/., 2005). The depolarising response of the ipRGCs is slow and sustained (Dacey 
e/ a/., 2005).
Gene ablation studies provided evidence that melanopsin is essential for the 
transduction o f a photic signal in ipRGCs. Mice lacking the melanopsin gene showed 
reduced light-induced non-visual responses, including phase shiAing and pupil 
constriction (pupillary light rcAex, PLR), compared to wild type mice (Panda er a/., 
2002b; Ruby a/., 2002; Lucas er a/., 2003). Studies in mice lacking functional rods 
and cones demonstrated action spectra that fit a single opsin/vitamin A-based 
photopigment with a Imax ^ 480 nm for both the PLR and phase shiAing responses 
(Lucas e/ a/., 2001; Hattar e/ a/., 2003). These action spectra match the absorbance 
specAa of the ipRGCs, strongly implicating melanopsin as the non-visual 
photopigment involved in theses light responses. The subsequent demonsAation that 
mice lacking rods, cones and melanopsin failed to produce any non-visual responses 
showed that all three photoreceptors are needed for non-visual responses (Hattar e/ a/.,
2003). Yet, the ultimate proof of melanopsin's functionality was still missing as it 
remained possible for melanopsin to function as a photoisomerase rather than as a 
photopigment. However, an m study by Newman er a/. (2003) demonstrated that 
melanopsin can form a functional photopigment through G-protein activation and is 
most effectively excited by short wavelength blue light (420 -  440 nm).
Three cellular studies Anally conArmed melanopsin's function as a photopigment with 
short wavelength blue light sensitivity (Melyan er a/., 2005; Panda e/ <3/., 2005; Qiu e/ 
a/., 2005). By heterologous expression melanopsin photosensitivity was conferred
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onto non-photosensitive cells. The action spectra provided by Qiu e/ a/. (2005) and 
Panda er a/. (2005) showed a Imax ^  480 nm and matched those for the ipRGCs. Dacey 
er a/. (2005) also reported a photosensitivity of Imax = 482 nm for melanopsin- 
expressing ganglion cells in macaques. However, there are discrepancies in m^ax with 
the study by Melyan and colleagues (2005). They reported a ^ 420 -  430 nm 
which is more in agreement with Newman e/ a/. (2003). These discrepancies may be 
due to the experimental settings and the environment of the photopigment, i.e. the 
responsiveness of melanopsin might differ between m vzfm and m vzvo conditions. 
The results proved that melanopsin is the long sought-aAer photopigment required for 
the photosensitivity of the ipRGCs.
1.5.2.2 Light response characteristics of melanopsin
Melanopsin-driven photoresponses display four crucial characteristics which 
differentiates them Aom classical photoreceptors responses. (1) A high threshold for 
activation with irradiances > lO’^photons/cm^/s (Berson et al, 2002; Tail et al, 2010).
(2) A sluggish/slow response to lights-on. (3) The response is sustained and provides 
an integrated measure; it outlasts the stimulus exposure (Dacey er a/., 2005) indicating 
resistance to bleaching (Berson g /  <3/., 2002; Sekaran a / . ,  2003; Mure <3/., 2007). 
(4) Finally, a short wavelength blue peak photosensitivity exists (section 1.6.4.1).
The four features might be explained with respect to melanopsin’s function in the 
circadian system. A high threshold Alters out unreliable (light) information about 
time-of-day, e.g. sudden light changes. Furthermore, the longer integration time 
minimises the inAuence of sudden, local Auctuations of the environmental light 
(Roenneberg and Foster, 1997). It has been hypothesised that this might also 
contribute to how the circadian system keeps track of previous light history (Takahashi 
g/ a/., 1984; Dacey <3/., 2005). Gross changes in light at dusk and dawn are 
accompanied by a certain spectral composition o f light and shoAer wavelengths of 
light are the most prominent ones at these times (Munz and McFarland, 1977).
1.5.2.3 Invertebrate homologies of melanopsin
Interestingly, melanopsin which belongs to the class of G-protein-coupled receptors, 
shares a greater homology with inveAebrate (rhabdomenc) opsins than veAebrate
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opsins (Provencio e/ a/., 2000) and a signiAcant sequence homology exists (Provencio 
et a/., 1998a). In addition, several studies have suggested that melanopsin may be a 
bistable photopigment, another propeAy of rhabdomenc but not veAebrate 
photopigments, and have both photosensitivity and photoisomerase functions (Fu et 
a/., 2005 ipRGC; Meylan et a/, 2005; Panda et a/, 2005; Qui et a/, 2005; reviewed in 
Lucas, 2006; reviewed in Berson, 2007). Therefore, apaA Aom acting as a 
photopigment (driving phototransduction), it might in addition function as a 
photoisomerase conveAing its own chromophore using long wavelength light (Mure et 
a/, 2007; Mure et a/, 2009). Furthermore, the phototransduction cascade used by 
melanopsin resembles that of inveAebrates (reviewed in PeAson and Foster, 2006). It 
involves the activation of a heteromenc Gq-type G-protein through melanopsin, 
leading to release of calcium ions inside the ganglion cells (Sekaran et a/., 2003). 
Graham and colleagues (2008) showed that more than one G-protein of the Gq-family 
can bind to melanopsin and thereby provide further evidence that the mammalian 
phototransduction cascade displays a high similarity with the rhabdomcric system.
1.5.3 Rod and cone photoreceptors involvement in non-visual responses 
To understand the inAuence of the characteristics of light (exposure) on the magnitude 
of non-visual responses it is crucial to know which photoreceptor system(s) are 
involved in circadian photoreception. Melanopsin knock-out mice with intact rod and 
cone signalling pathways are still capable of non-visual responses such as 
photocntrainment, melatonin suppression and PLR (Ruby et al, 2002; Panda et al, 
2002b). Tnple knock-out mice, however, do not show any non-visual responses to 
light (Hattar gr a/., 2003). Together, this provides evidence that rods and cones are 
also contributing in some way to the regulation of non-visual responses (in mice) (also 
section 1.5.2.1). In humans, evidence for a role of rods and/or cones in mediating 
circadian photoreception is only just emerging (Revell and Skene, 2007; Gooley er a/., 
2010).
Rods and cones appear to supply photic information to the circadian clock also via the 
ipRGCs (Guler a/., 2008). Through indirect innervations o f ipRGCs, involving 
bipolar and amacrine cells, rods and cones are able to modulate the photic signal 
elicited by melanopsin in animals (Belenky er a/., 2003; Dacey e/ a/., 2005; Dkhissi- 
Benyahya e/ a/., 2006; Perez-Leon gr a/., 2006; Dkhissi-Benyahya e/ a/., 2007; Wong
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a/., 2007). To what extent each of the classical photoreceptors contributes and how 
all three photoreceptors complement each other in regulating the different non-visual 
light responses needs fiiAher investigation, though.
1.6 Non-visual effects of light in humans
In humans, photic stimuli, perceived mainly by melanopsin, cause and regulate non- 
visual responses. These non-visual responses can be acute, i.e. (neuro-)endocrine, 
(neuro-)physiological, (neuro-)behavioural, and/or circadian (phase 
shiAing/photoentrainment). Circadian and acute responses to light and the magnitude 
of these responses are highly dependent on circadian time and the internal phase the 
light is administered as well as on the intensity/irradiance, wavelength and duration of 
the light exposure (reviewed in Czeisler, 1995; reviewed in Johnson et a/., 2003; 
section 1.6.4).
1.6.1 Circadian effects: photocntrainment and the phase response curve
The human circadian clock has an intrinsic free-running t which deviates from 24 h 
and is proposed to be close to 24.18 h (Middleton et 6%/., 1996; Czeisler et a/., 1999; 
Wright et <3/., 2001). Entrainment to the 24 h light-dark cycle depends on a changing 
sensitivity to light stimuli across the 24 h day (section 1.1.2). This differential effect 
o f light is described by the PRC where the direction and size of a phase shift is plotted 
against the circadian time that the stimulus is presented (section 1.1.4.1).
1.6.2 Acute effects of light
Light can acutely affect various endocrine, physiological and behavioural parameters. 
At night, light has been shown to suppress plasma melatonin (Lewy e/ a/., 1980; 
Bojkowski et a/., 1987b; Brainard et a/., 1988; Zeitzer et a/., 2000), reduce plasma 
coAisol levels (Jung et a/., 2010), and increase CBT (Badia et a:/., 1991; Cajoehen et 
<3/., 2005) and heaA rate (Scheer et a/., 2004; C^ochen et <3/., 2005; Rueger et a/.,
2006). The pupil will constrict in response to light (PLR) (Lucas et a/., 2003) due to 
innervations the OPN receives Aom the RHT. Additionally, light can immediately 
affect psychological parameters such as increasing aleAness (Cajoehen et <3/., 2000), 
brain activity and cognition (Vandewalle et a/., 2007a, b). Several studies
1-40
___________________________________________________________________ Chapter 1
investigating the acute effects of bright light on subjects showed an increase in mental 
performance and alertness at night (Campbell and Dawson, 1990; Badia et a/., 1991) 
suggesting a reciprocal relationship between melatonin suppression and increasing 
alertness (Myers and Badia, 1993). However, a study carried out by Phipps-Nelson et 
al (2003) looking at the effects of daytime bright light exposure on neuronal- 
behaviour performance found that light can also improve aleAness and decrease 
sleepiness during the day when no endogenous melatonin is present. Rueger and co­
workers (2006) showed similar results for psychological variables (sleepiness, fatigue 
and energy) which changed during light exposure independently Aom time of 
day/night. HeaA rate and CBT however, only increased when light was given at 
nighttime (Rüger et a/., 2006).
1.6.3 Light and sleep
Light plays a signiAcant role in the regulation o f the sleep-wake cycle in mammals. 
Data Aom rodent studies show that light is potent to induce sleep and to suppress 
activity (Borbely, 1976; Deboer er a/., 2007; Lupi et a/., 2008) whereas in diurnal 
animals, including humans, it increases alertness.
Light can excA its inAuence on sleep directly through entrainment o f the pacemaker. 
Additionally, in rodents direct projections from ipRGCs to the VLPO have been found 
(Gooley et al, 2003; Hattar et al, 2006). This suggests that light can directly 
inAuence the sleep-wake cycle through activation of VLPO-neurons (which in turn 
have an inhibitory inAuence on arousal centres; section 1.3.2.2). Altimus and 
colleagues (2008) have repoAed that both the classical and the melanopsin 
photoreceptor systems are needed for light to be able to inAuence the sleep-wake cycle 
in mice. This is achieved through differential signalling of light and dark through the 
interaction of these three photoreceptor systems. Lack o f one of these systems will 
result in a reduced acute, light-dependent sleep response. Mice are nocturnal whereas 
humans are diurnal and light will therefore affect sleep in these species in the opposite 
way. However, results by Altimus e/ a/. (2008) suggest that both retinal pathways are 
important for mediating the light signal and its effect on sleep in mice and humans.
The role o f melanopsin in this interaction has been fuAher elucidated in a recent study 
by Tsai (2009) working with melanopsin-deAcient mice. The authors have
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provided the first evidence for direct light-induced activation of GABAergic VLPO- 
neurons. Furthermore, Tsai and colleagues (2009) reported that melanopsin's 
contribution or ability to elicit non-visual effects is modulated in a time-of-day 
fashion. This 'circadian gating' includes melanopsin's influence on inducing sleep 
and sleep duration. The finding of Tsai and colleagues (2009) that melanopsin’s 
sensitivity to short wavelength blue light changes over the 24 hour light-dark cycle 
could have profound implications for the therapeutic use of light exposure. 
Additionally, photic input of the rods and cones may also vary over the circadian cycle 
as results from murine studies suggest.
In humans it has been shown that light can affect sleep physiology through SCN- 
innervations of sleep- and wake-promoting brain areas (Munch et al, 2006). Munch et 
al (2006) assessed the effects of short wavelength blue light (460 nm) on sleep 
architecture compared to 550 nm green light in human subjects. Blue light did not 
only alter the time course of SWA but additionally reduced the duration o f REM sleep 
significantly compared to a green light condition. These effects might be due to a 
delay of the circadian phase and a sustained/continued 'alerting' effect (after lights- 
off), which affected the sleep structure. The authors therefore concluded that non­
visual responses are involved in the architecture of sleep and that these effects are 
short wavelength dependent.
1.6.4 Light characteristics affecting non-visual responses
Non-visual light responses are elicited primarily by melanopsin and therefore
influenced and modulated by the same light characteristics as melanopsin. The 
magnitude o f non-visual responses therefore not only depends on the irradiance,
duration and timing of light but also on the wavelength(s) of light.
1.6.4.1 Wavelength
Several action spectra and wavelength studies o f circadian responses in humans have 
been conducted to try to define the spectral sensitivity of non-visual responses in 
humans. Two seminal action spectra studies by Brainard et al (2001) and Thapan et 
a/. (2001) demonstrated a short wavelength sensitivity (ranging between 446 -  477 
nm) of light-induced melatonin suppression in humans. Both action spectra fit a
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single, short (blue) wavelength sensitive novel opsin-based photopigment, different 
&om the known absorption spectra for rods and cones (section 1.5.1), with 464 
and 459 nm, respectively. Several other action spectra in monkeys and rodents (Hattar 
er a/., 2002; Hattar er a/., 2003; Dacey er a/., 2005; Gamlin er a/., 2007) have been 
obtained since, all showing a short wavelength sensitivity of non-visual responses.
Subsequently, other light wavelength studies looking at different non-visual responses 
like phase shifting (Wright and Lack, 2001; Lockley er a/., 2003; Revell a/., 2005), 
CBT (Cajochen er a/., 2005) and alertness (Cajochen a/., 2005; Lockley e/ a/., 2006; 
Revell er a/., 2006) have confirmed this short wavelength blue light sensitivity (460 -  
480 > 555 nm [Lockley e/ a/., 2003]). In these studies light was administered during 
the late subjective evening (Lockley g/ a/., 2003; C^ochen er a/., 2005; Lockley g/ a/.,
2006) or during the subjective morning (Revell et al, 2005; 2006); the light duration 
varied between 2 and 6.5 h.
1.6.4.2 Irradiance
Irradiance is o f crucial importance for non-visual responses (Boivin er 6z/., 1996; 
Zeitzer et al., 2000). Zeitzer and colleagues (2000) administered a 6.5 h white light 
stimulus of different intensities (3 to 9100 lux) at the beginning o f the early biological 
night and assessed the sensitivity of the circadian pacemaker. They demonstrated that 
a logistic dose-response curve exists and that the pacemaker and acute non-visual 
responses are sensitive to low intensities of light. However, it should be noted that the 
participants o f this study were dim light-adapted and therefore may have shown 
heightened light sensitivity (effect of prior light history, section 1.6.5). This might be 
partially explained by cones preferentially contributing to the circadian photoreception 
at low irradiance levels (Gooley a/., 2010). Gooley and co-workers (2010) have 
recently shown that cones contribute to circadian photoreception with light exposures 
of low irradiance or short duration. These findings are in agreement with the known 
response characteristics of melanopsin to a light stimulus (section 1.5.2.2).
1.6.4.3 Timing
The effects of light exposure on non-visual responses are time-of-day dependent. The
direction of phase shifts can be predicted from the PRC (sections 1.1.4.1 and 1.6.1).
1-43
____________________________________________________________________Chapter 1
For humans, the magnitude of most psychological and physiological responses is 
greater if light exposure occurs during the subjective night.
1.6.4.4 Duration
The duration and pattern of light are other temporal characteristics besides the timing 
of light exposure. A study by Comas and colleagues (2006) measured the phase 
shifting response of mice (kept in constant dark [DD]) each exposed to a single light 
pulse o f different durations. Their results indicate a slight predominance of the first 
part of the light pulse and a reduced effectiveness of the following part. The authors 
suggested that a combination of the two models o f entrainment (sections 1.1.3.1 and
1.1.3.2) might explain the effects of the light stimulus. The authors further confirmed 
this in a second study investigating the responses to double light pulses administered to 
mice at all circadian phases (Comas e/ a/., 2007). The pattern of light, i.e. continuous 
vj. intermittent illumination, can also affect non-visual responses. Under normal 
settings humans encounter brief exposures to light during the daytime and at nighttime. 
Studies where subjects were exposed to either intermittent light pulses with 
intervening darkness (Rimmer er a/., 2000; Gronfier er a/., 2004) or continuous light 
exposure showed that the magnitude of melatonin suppression with intermittent light 
was nearly as big as that observed under continuous light. These results agree with the 
findings from Comas er a/. (2006; 2007) in mice suggesting that the beginning o f a 
light signal is most important for eliciting non-visual responses. Similar experiments 
need to be done in humans to support (the hypothesis) that a non-linear relationship for 
dose-dependency exists as this has been proposed in a model by Kronauer g/ a/. 
(1999).
1.6.5 Light history affecting non-visual responses
Previous light history can modulate the amplitude of non-visual responses to 
subsequent light (Wong e/ a/., 2005; Comas er a/., 2007) as this has already been
discussed for the light-induced melatonin suppression (section 1.3.1.6).
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1.6.6 Non-photic entrainment
Light is the most potent zeitgeber for entrainment of the human circadian system 
(Wever e/ a/., 1983; Czeisler e/ a/., 1989). However, non-photic stimuli, e.g. social 
interaction, exercise and meal times might also influence the circadian clock and overt 
circadian rhythms.
Many human daily activities and events are determined by social interactions. It may 
be that these provide some input for entrainment of the clock per .ye. This could be 
direct or indirect by influencing the time of exposure to light (reviewed in Mistlberger 
and Skene, 2004; 2005). Studies in blind people suggest that for some of them social 
stimuli can maintain entrainment (Klerman et al, 1998), although the mechanisms and 
pathways involved remain to be discovered (reviewed in Mistlberger and Skene,
2004). However, the fact that totally blind people exhibit free-running circadian 
rhythms despite living in a 24 h society show the importance of light as a zeitgeber 
(reviewed in Skene and Arendt, 2006). It becomes apparent, that further studies 
investigating the effectiveness of social cues on the circadian system are needed.
Meal times have entraining effects on circadian rhythms in several mammalian and 
non-mammalian species (Damiola er a/., 2000; Stokkan e/ a/., 2001). In humans a 
similar entraining effect is believed to exist and the first data has been published in 
support of this hypothesis (Bogdan e/ a/., 2001; Krauchi er <3/., 2002).
1.7 Ageing
Ageing, healthy and pathological, is accompanied by various physiological and 
behavioural changes. These are, amongst others, reflected in alterations of sleep and 
the sleep-wake cycle as well as o f other circadian rhythms such as hormone level and 
CBT (Dijk er a/., 1999; reviewed in Dijk er a/., 2000). The reasons for age-related 
sleep problems are likely diverse and rather than being caused by individual age- 
related changes it appears that these changes are interlinked with each other forming a 
causal relationship. Some of the more significant age-related changes possibly 
influencing the sleep-wake rhythm are discussed in the following sections.
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1.7.1 Ageing and the circadian system
Circadian alterations as observed in older adults (e.g. reviewed in Bliwise, 1993; 
reviewed in Van Someren e/ a/., 1993; reviewed in Campbell er a/., 1995) might be 
caused by an impaired perception o f and/or exposure to the entraining light signal. A 
weakening of the entraining photic signal due to changes in the eye or in 
environmental light exposure may change the phase of entrainment and subsequently 
change the output rhythms. Alterations in the circadian system/pacemaker and/or a 
failure in transducing the circadian signal from the SCN to the overt biological 
rhythms might account at least partly for circadian rhythm disturbances. Additionally, 
changes in the overt biological rhythms, e.g. the melatonin rhythm (section 1.7.1.3), 
might further contribute to the observed sleep problems in older people.
1.7.1.1 Ageing and light perception
Physiological changes in the eye (section 1.7.1.1.1) are part of the healthy ageing 
process. Furthermore, older people have been shown to experience reduced exposure 
to environmental light (section 1.7.1.1.2).
1.7.1.1.1 Age-related changes o f the eye
The two most crucial age-related changes in the human eye are reduced pupil size and 
increased lens density, both o f which ultimately reduce the amount o f light reaching 
the retina (Figure 1.16). The result o f these changes would be a weaker photic signal 
to the circadian clock. A reduction in pupil size (Birren er a/., 1950; Verrist, 1971) 
with age can result in a twofold decrease in retinal illumination by the age of 70 years 
(reviewed in Charman, 2003). The change in pupil size is further accompanied by less 
pupil ac^ustment to changing light conditions resulting in glare and discomfort.
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Figure 1.16: Age-related changes of lens transmittance at 460 nm (-•-) (after Weale, 1985) 
and pupil size (-) (after Verrist, 1971) (both taken from Charman, 2003).
Transmission of light through the lens is not uniform aeross the visible light speetrum
and changes with age (Figure 1.17). The increase in lens density seen during ageing
(Pokomey et a l, 1987) is due to an accumulation of crystalline aggregates and yellow
ehromophores (Lerman et a l, 1976; reviewed in Lerman, 1987; Dillon and Atherton,
1990). As a result both the quantity and quality of light passing through the lens are
reduced and especially short wavelength light is filtered out (Said and Weale, 1959;
Pokomey et a l, 1987; Weale, 1988; Brainard et a l, 1997). Significantly less light is
being transmitted through lenses from humans aged 60 -  69 years than through lenses
from humans aged 20 -  29 years (Brainard a/., 1997) (Figure 1.17).
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Figure 1.17: Mean lenticular transmission aeross age (Brainard et a l, 1997).
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Since short wavelength blue light has been shown to be the most potent wavelength at 
suppressing nocturnal melatonin levels and phase shiAing the clock (section 1.6.4.1), a 
reduction in the transmission of blue light in older people could explain the observed 
reduction in sensitivity to short wavelength light observed (Herljevic e/ a/., 2005). 
The impaired wavelength-dependent non-visual responses could partially account for 
reported phase changes (Duffy er a/., 1998; 2002). These findings thus have important 
implications on the design o f light devices in light therapy for older people.
Animal studies have shown no reduction in RHT projections to the SCN (Zhang a/.,
1998). This finding suggests that other more influential changes, e.g. photoreceptor 
sensitivity and/or number as well as SCN physiology, might be responsible for the 
reduced light sensitivity of the circadian pacemaker. Studies in aged mice have shown 
that the number o f melanopsin-containing ganglion cells decline (Semo a/., 2003). 
In humans the sensitivity and populations o f S-cones (Haegerstrom-Portnoy, 1988) and 
ganglion cells decrease (Curcio and Drucker, 1993; Curcio er a/., 1993). The 
reduction of these two photoreceptors would further attenuate the photic signal but 
might affect acute and circadian responses differently through differences in 
photoreceptor contribution.
Laboratory studies have assessed whether age can affect non-visual responses to short 
wavelength light (Herljevic, e/ a/., 2005; Sletten er a/., 2009). The Andings show a
reduced melatonin suppression response and reduced alertness to short wavelength 
light in older people. However, the phase advancing responses to blue light seemed to 
be retained in older people (Sletten a/., 2009). The reasons for the differential 
effects of light on non-visual response are not clear.
1.7.1.1.2 Light exposure in older people
Light exposure is changed in older people and has been linked to poor nighttime sleep 
(Campbell a/., 1988; Ancoli-Israel a/., 1997b). Studies have shown a positive 
association between daily light exposure and nighttime sleep as well as the rest-
activity rhythm (Hood et a l, 2004; Van Someren et a l, 1996).
Daily exposure to natural and artiAcial light is oAen reduced in community-dwelling 
and even more in institutionalised older people (Savides e/ a/., 1986; Campbell e/ 6%/., 
1988; Espiritu a/., 1992; Shochat er (%/., 2000; Mishima er a/., 2001; Aarts and
1-48
____________________________________________________________________Chapter 1
Westerlaken, 2005). Apart Aom physiological changes of the eye (section 1.7.1.1.1) 
the reduction in exposure to natural sunlight can be related to changes in lifestyle, e.g. 
more constrained mobility and more time spent indoors. Indoor illumination levels are 
rather low and do not compensate for the loss of natural light (Aarts and Westerlaken,
2005). Furthermore, the proAle o f light exposure has been shown to differ between 
old and young adults (Kawinska er a/., 2005). Whereas young people receive more 
nighttime light, older people have been reported to experience higher illumination 
levels in the morning (Kawinska et al, 2005).
Interestingly, in a recent study by Seheuermaier et al. (2010) contradictory findings 
have been observed. The authors reported that older adults were exposed to
significantly higher light levels during the waking day compared to younger adults.
1.7.1.2 The aged SCN
Age-related sleep problems have been partially linked to changes of the circadian 
clock (Duffy and Czeisler, 2002). Neuronal degeneration of the SCN in healthy 
senescence (Hofinan er a/., 1988) and demented patients has been observed and linked
to deterioration of the circadian timing system (Swaab et al, 1985; reviewed in 
Hofinan and Swaab, 2006). Some evidence for this association stems from studies on 
dementia patients. Demented older people suffer fiom an irregular rest-activity (and 
sleep-wake) rhythm with an increase in nocturnal restlessness and more daytime 
inactivity and sleep (Bliwise et al, 1992; reviewed in Bliwise et al, 1993; Van 
Someren a/., 1996). These changes in the activity rhythm and/or its amplitude 
might be attributable to loss or inactivity o f specific cell groups within the SCN 
(Swaab et al, 1985; Liu et al, 2000; Harper et al, 2008). A similar neuronal 
degeneration of the SCN has been observed as part o f healthy senescence. The 
amplitude of circadian rhythms of electrical activity shows a reduction with age 
(Watanabe et al, 1995). A decrease in the overall cell number especially in VP- 
expressing cells (Swaab er a/., 1985) and to a lesser extent in VIP-containing cells 
(Zhou et al., 1995), resulting in impaired circadian time-keeping and a more 
fragmented rest-activity rhythm (Harper er a/., 2008), has been reported. In addition, 
the rhythmic day-night cycle of VP-expressing cells seems to be reduced and shifted 
(Hofinan and Swaab, 1994; Aiyard er a/., 2006). Research has shown that the age- and 
dementia-related neuronal degeneration of the SCN can be improved through enhanced 
neuronal stimulation (reviewed in Swaab, 1991). Increased stimulation of the SCN
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through, for example, light exposure may be effective to improve circadian 
rhythmicity in these patients as the results from light intervention studies suggest 
(Mishima er a/., 1994; Van Someren e/ a/., 1997a; reviewed in Van Someren a/., 
2002). It may also be possible that social interactions as well as physical and mental 
exercise provide stimulating effects. Okawa e/ a/. (1991a) have shown that increased 
contact with nursing staff improved sleep-wake disturbances in demented older people. 
In a study by Van Someren and colleagues (1997b) older male engaged in a fitness 
programme for 3 months (3 times per week) resulting in reduced fragmentation of the 
rest-activity rhythm. The authors suggested that increased physical activity might 
improve age-related SCN degeneration.
The neuronal changes in the SCN were, however, most pronounced only during the 
later part of ageing whereas changes in sleep and the circadian system start to appear 
from the middle years of life (Carrier e/ a/., 2001; 2002). It thus seems that, rather 
than an abrupt deterioration, subtle and gradual changes within the SCN are involved 
in circadian malfunctioning including sleep problems (reviewed in Hofinan and 
Swaab, 2006).
Further changes in the SCN might occur on a molecular level. In aged rodents a 
reduced light-induced expression of has been reported (Kolker a/., 2003; 
Davidson a/., 2008). These findings suggest that the light sensitivity of the aged 
pacemaker within the SCN might also be reduced.
1.7.1.3 Ageing and the melatonin rhythm
Evidence for an association between the rhythms of melatonin and the sleep-wake 
cycle exist (section 1.3.1.2). Three major changes of the melatonin rhythm occur with 
age and have been hypothesised to be causally related to sleep disturbances (reviewed 
in Dawson and Encel, 1993; Haimov et a l, 1994).
(1) Studies by Sack er a/. (1986) and Kennaway and colleagues (1999) investigated 
melatonin production across a wide range o f ages (20 -  80+ years). They showed that 
whereas melatonin levels are indeed decreased in older adults, this decline starts to 
occur early in life (between the ages of 20 -  30 years). Numerous studies have
furthermore demonstrated alterations in the levels of melatonin in plasma (Touitou et 
a/., 1981; Iguchi e/ a/., 1982; Nair a/., 1986; Waldhauser g/ 1988; Sharma g/ a/.,
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1989), saliva (Knoblauch g/ a/., 2005; Munch g^  a/., 2005) and urine aMT6s (Sack g/ 
a/. 1986; Bojkowski and Arendt, 1990; Skene gr a/., 1990; Herljevic g^  a/., 2005) in 
ageing adults compared to young adults. The amplitude of the melatonin rhythm has 
been reported to decline -  30% in older people compared to young adults (reviewed in 
C^ochen g^  a/., 2006). Animal data show a similar age-related reduction in melatonin 
production in rodents (Reiter g/ a/., 1980; Reiter gr a/., 1981).
Contrary to these findings of an age-related decline in melatonin secretion are results 
from Zeitzer g/ a/. (1999) and Fourtillan g^  a/. (2001). Both studies failed to detect a 
difference in melatonin production between older and young adults. However, the 
authors suggested this discrepancy could be due, in part, to the stringent exclusion 
criteria applied in their studies.
Gender differences in melatonin excretion were observed in some (Zeitzer gr a/., 2007) 
but not in most other studies (Touitou et al, 1981; Bojkowski and Arendt, 1990). In 
the study by Zeitzer and colleagues (2007) older men had lower melatonin levels at 
night than older women; the authors suggested that these gender differences might be 
due to differences in sleep physiology in ageing adults. Possible gender effects might 
further explain the discrepancies found for the levels of melatonin production with age.
(2) The circadian rhythms o f older people are generally phase-advanced compared to 
younger adults as can be seen, for example, in the earlier timing of sleep (Lieberman gr
al, 1989; Monk et al, 1992a; Duffy et al, 2002). The melatonin rhythm of older 
people shows a -  1 hour advance compared to younger adults (Dijk gr a/., 1999).
Duffy et al (2002) reported peak plasma melatonin times and wake-up times of 03:14 
±01:01 h and 06:54 ± 00:53 h in older adults whereas these were 04:04 ± 01:15 h and 
08:17 ± 00:46 h for young people, respectively.
(3) In addition, many studies have found that with age habitual wake-up time is also 
advanced with respect to the melatonin peak. This results in a changed phase 
relationship (phase angle) between the sleep-wake cycle and the melatonin rhythm 
(Van Coevorden gr a/., 1991; Duffy gr a/., 1998; Dijk g^  ar/., 1999; Klerman g/ a/., 
2001; Duffy g/ a/., 2002). Older adults therefore awaken at an earlier internal phase, 
that is, their wake-up time occurs when levels of melatonin are still high (Duffy et al, 
2002) (Figure 1.18). Thereby the phase angle between melatonin acrophase time and 
wake-up time becomes reduced.
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Figure 1.18: Phase relationship between time of melatonin peak (Mel peak) and habitual 
wake-up time in older and younger people (adapted from Dijk and Lockley, 2002).
The mechanism(s) which leads to changes in the characteristics of the melatonin 
rhythm are not yet fully understood. It seems natural to assume that these age-related 
changes in the melatonin rhythm are attributable to alterations of pineal processes.
Although some studies have shown an increase in pineal calcification (Gusek, 1983; 
Kloeden et al, 1990) this does not seem to affect the secretion melatonin (Bojkowski 
and Arendt, 1990) or the activity of the pinealoeytes (Wurtman et al, 1964). 
(However, other studies have provided evidence challenging this view. Findings by 
Kunz and co-workers [1998; 1999] suggested that a decreased melatonin production is 
a result of an increased pineal calcification.) It appears that pathomorphologieal 
processes such as innervations from the SCN and/or changes in the SCN (section
1.7.1.2) and its input pathways including reduced environmental light exposure 
(section 1.7.1.1) can be accountable for a declining melatonin rhythm with age.
Changes in components o f the circadian system and/or o f the whole circadian timing 
system will result in a weaker circadian signal involved in the regulation o f the sleep- 
wake cycle. Different aspects of the homeostatic drive for sleep and wakefulness 
might also deteriorate. Age-related sleep disturbances might therefore be due to an 
altered interaction of the two regulating processes.
1.7.2 Ageing and sleep
Subjective and objective sleep changes and its quality declines with age (Bixler a/., 
1979; reviewed in Miles and Dement, 1980; Bixler e/ a/., 1984; Monk g/ a/., 1992b; 
reviewed in Bliwise, 1993; reviewed in Prinz, 1995). Several studies have shown that 
more than -  40% of the older generation over 60 years endure sleep disturbances
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(Buysse er a/., 1991; Campbell g/ a/., 1993; Foley e/ a/., 1995; Maggi er a/., 1998; 
Ancoli-Israel and Roth, 1999). These figures might actually be underestimated since 
some ageing adults consider sleep problems as part of the 'normal' ageing process and 
do not report on them. Common sleep complaints in older people include earlier sleep 
onset and offset times, a less consolidated sleep, i.e. more frequent awakenings and 
shallower sleep, and an inability to stay asleep for a desired duration (reviewed in 
Miles and Dement, 1980; reviewed in Bliwise, 1993; reviewed in Prinz, 1995; Duffy 
a/., 1998; Dijk e/ a:/., 1999; Dijk a/., 2001; Duffy and Czeisler, 2002; Klerman e/ a/., 
2004). For some ageing adults possible consequences of poor nocturnal sleep are 
compromised daily functioning, impaired cognition (Jelicic aA, 2002; Blackwell er 
a/., 2006; Oosterman er a/., 2009) and increased daytime sleepiness (Carskadon er a/., 
1982). As mentioned before, deterioration o f sleep already starts to occur in the 
middle years of life (Carrier a/., 2001; 2002). Changes within the sleep-wake 
regulatory system, i.e. process C and/or process S, are most likely responsible for 
causing some of these problems. The relative contribution of both these processes can 
be assessed through sleep deprivation and satiations experiments as well as in forced 
desynchrony experiments aiming to desynchronise the sleep-wake rhythm. Lack of 
social interactions may also play a role in the occurrence of sleep problems as they 
may have some effect as zeitgebers (section 1.6.6). Furthermore, social interactions 
may positively affect SCN (reactivation of) neurons (section 1.7.1.2)
Sleep disturbances are very common in demented older people who might also 
experience little light exposure (reviewed in Bliwise, 1993; Ancoli-Israel er a/., 
1997b). Several studies have found a positive correlation between the level of 
cognitive impairment and disruption of the sleep-wake/rest-activity cycle (Jacobs er 
a/., 1989; reviewed in Vitiello and Prinz, 1989; Witting a/., 1990; reviewed in 
Vitiello et al, 1992). An overall neuronal degeneration including the SCN has been 
observed in demented older people (section 1.7.1.2) making the SCN and the circadian 
system a possible target area to treat sleep problems.
i .  7.2.1.1 Changes o f  the circadian signal
The age-related changes in sleep timing, structure and consolidation have largely been 
associated to changes o f the circadian system. These might be related to: (i) alterations
(phase advance) of the circadian rhythms of the CBT, melatonin and the sleep-wake
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cycle, resulting in a change in the phase angle o f entrainment, and/or (ii) dampening of 
the circadian amplitude (Czeisler, a/., 1992; Duffy gr a/., 1998; reviewed in Weinert, 
2000) and/or (iii) a shorter endogenous period. Whereas data supporting both 
misalignment and reduction in amplitude exist, although these are not consistent 
(Carrier g/ a/., 1999; Zeitzer g^  a/., 1999; Fourtillan g^  a/., 2001; Kripke g^  a/., 2005; 
reviewed in Monk, 2005), a shortening o f r in humans with ageing has not been 
confirmed (Czeisler g/ a/., 1995b; Duffy g/ aA, 1998). On the circadian side it 
therefore seems that a reduction o f the amplitude/strength o f the circadian signal can 
account for the observed disruption of the sleep-wake cycle. The result could be a 
weaker circadian drive for wakefulness (during the day and/or at night) and/or for 
sleep (at night) (Dijk g7 aA, 1999).
The advanced sleep-wake cycle observed in older people shows an altered phase 
relationship with the melatonin rhythm (section 1.7.1.3). A study by Duffy and 
colleagues (1998) observed earlier wake-up times which were shortly after the CBT 
trough coinciding with the rising limb of the CBT cycle of older people (when the 
circadian drive for wakefulness becomes stronger). The authors further reported that 
the timing of the endogenous CBT rhythm was later in older people. This finding 
shows that ageing adults not only wake-up at an earlier clock hour but also at an earlier 
internal phase of the temperature rhythm (Duffy g/ aA, 1998; Dijk g/ aA, 1999; 
reviewed in Dijk and Duffy, 1999; Duffy gr aA, 2002).
From these and similar findings several hypotheses can be made. Klerman and 
colleagues (2004) postulated that an impairment o f sleep consolidation in older people 
is due to an inability of the circadian system to sustain sleep at night. Duffy and 
colleagues' findings (1998) showing even greater difficulties in staying asleep shortly 
afier the CBT nadir suggested that the circadian sleep-promoting signal is reduced 
especially in the morning hours (at a time when under normal conditions it is at its 
strongest [Dijk and Czeisler, 1995]). Aged adults are therefore more susceptible to 
arousal at this time of the circadian cycle. The resultant earlier wake-up times will 
lead to earlier light exposure (Kawinska g/ aA, 2005) which, in addition, occurs at a 
circadian phase during which the circadian pacemaker is very sensitive to the phase 
advancing effects of light (Czeisler g/ aA, 1989). Light exposure in the early morning 
would thereby act to reinforce the phase advance of older people.
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The weakening of the circadian drive for sleep might be related to the altered 
relationship with the CBT rhythm and/or changes related to the SCN. Diminished 
output signals from the SCN to sleep-wake regulating centres like the VLPO and/or 
hypothalamic neurons producing orexin/hypocretin could result in changes in sleep 
such as nocturnal arousals (reviewed in Saper a/., 2005; reviewed in C^ochen g7 a/.,
2006).
Sleep propensity, another marker of the circadian process, has been reported to be 
modulated in older people. Munch g7 a/. (2005) reported that the circadian wake- 
promoting signal is weaker close to habitual bedtime leading to more sleep during the 
wake maintenance zone. The reduced arousal signal (in the evening) constitutes less
opposition for the homeostatic drive of sleep and sleep can occur. The reduced levels 
of melatonin might reflect this decline of the circadian drive for wakefulness.
A reduction of the circadian waking signal during the day, however, has not been 
found (Dijk et a l, 1999). Studies have investigated daytime sleep propensity 
(Reynolds g^  a/., 1991) and propensity to initiate sleep (Buysse g^  a/., 1993; Dijk g7 a/.,
1999) in older people. These studies failed to provide unambiguous evidence of an 
increase in daytime sleep propensity with age. Reynolds and colleagues (1991) even 
suggested that older adults have reduced daytime sleepiness levels compared to young 
adults. Studies by Haimov and Lavie (1997) and Dijk et a l (1999) have reported that 
sleep latencies were longer during the day compared to those in the evening in older 
people. These studies further confirm that the strength of the circadian signal for 
wakefulness is not attenuated with ageing. A recent study by Dijk gf a/. (2010) 
compared daytime sleep propensity across three different age groups (young, middle- 
aged and old). The authors did not find an increase in daytime sleepiness in the middle 
aged and older groups despite these groups reporting more sleep problems.
A 'strategy' to compensate for this deterioration of the circadian timing system might 
be adherence to a more regular lifestyle as observed for many older people. Better 
sleep quality has been linked to a greater lifestyle regularity (Monk gr a/., 2003). A 
structured lifestyle with (regular) daily activities like socialising, performing leisure 
activities and taking meals provides the circadian clock with two things: sensory 
stimulation by non-photic time cues and varying exposure to different light conditions. 
Monk and colleagues (1992b; 1997b; 2003; 2006) reported less day-to-day variability
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of events and activities in older compared to younger adults (assessed with the Social 
Rhythm Metric [SRM]). The findings from the studies by Monk er a/. (1992b; 1997b; 
2003; 2006) explain the link between sleep (problems) and lifestyle regularity as an 
adaptive response to the consequences of a weaker circadian system. In short, a highly 
regular lifestyle might provide ageing adults with a more coherent set o f zeitgebers 
(light and other stimuli, e.g. social interaction) necessary to achieve entrainment of the 
clock. In turn, lack o f a regular lifestyle and less social interactions may contribute to 
sleep disturbances in older adults.
1.7.2.2 Age-related changes of Process S
The interaction of the circadian and homeostatic processes regulates the timing and 
consolidation o f sleep. It therefore seems that an altered sleep homeostatic mechanism 
also plays a role in the aetiology of sleep problems in the elderly (Dijk et al, 1999; 
reviewed in Dijk g/ a/., 2000; reviewed in Monk, 2005). SWA is used as a marker for 
the homeostatic need/drive for sleep (Daan gr a/., 1984; section 1.3.2.1.1). To assess 
age-related changes of sleep homeostasis, studies have investigated the time course 
and amount of SWA of older and younger adults. These studies have reported an 
overall reduction in SWA (Ehlers and Kupfer, 1989; Carrier g^  a/., 2001; reviewed in 
C^ochen g7 a/., 2006) with a shallower decline (Munch g^  a/., 2004) in older adults. 
The pattern of REM sleep is also altered with age (flattened) (Dijk et al, 1999; Munch 
et al., 2005) which might be in response to changes in SWA. As older people are 
more likely to wake up from NREM sleep (compared to young adults) they might also 
be more susceptible to the effects of sleep inertia (Silva and Duffy, 2008).
Two hypotheses exist to explain the observed reduction in SWA with age. One 
hypothesis assumes that the reduction of SWA reflects a decreased homeostatic drive 
for sleep (reduced sleep need and depth). Consequently, other sleep changes (e.g. 
sleep consolidation, timing and even circadian misalignment) might then be a result of 
the reduced need for sleep and lighter sleep. Furthermore, daytime sleepiness should 
not be increased under such conditions. On the other hand, less SWA might be due to 
an impaired ability to dissipate sleep pressure efficiently (Dijk g^  a/., 2010). Sleep 
pressure would already by high in the morning after waking up and daytime sleep 
propensity would be increased. The findings obtained by Dijk and colleagues (2010) 
that older and middle-aged adults do not suffer from an increase o f daytime sleepiness
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provide evidence for the first explanation. According to their data the decline in SWA, 
sleep consolidation and depth are due to a slower build-up of the sleep need (smaller 
increase in sleep debt) during wakefulness in older people.
It can be concluded that although the deterioration of the sleep-wake regulation is due 
to changes in both the homeostatic and circadian drive for sleep, the latter appears to 
be more prone to alterations. This, in turn, might provide an opportunity to alleviate 
age-related sleep problems as it is possible to manipulate the circadian system through 
light exposure (reviewed in Van Someren, 2000; reviewed in C^ochen <3/., 2006). 
Timed administration of light has been reported to have some beneficial effects on 
sleep and daytime alertness in (mainly institutionalised) older people (see following 
sections).
1.7.3 Bright light administration in older people
Age-related sleep problems have been partially linked to an altered circadian timing 
system (Duffy and Czeisler, 2002; section 1.7.1 and 1.7.2.1.1). Poor nighttime sleep 
has also been associated with poor light exposure (section 1.7.1.1.2). The 
administration of (bright) light as a therapeutic strategy to treat age-related sleep 
problems is based on three physiological observations: (I) Enhanced (photic)
stimulation can improve SCN degeneration and restore rhythmic output (Van Someren 
et al, 1997a). (II) Light can reset the circadian system and affect other acute non­
visual responses (sections 1.6). (Ill) The efficacy of light administration to alleviate 
circadian rhythm disorders, SAD, and general sleep disturbances has been generally 
shown to be successful (reviewed in Terman g^  a/., 1995). Studies have also been 
conducted to optimise light intervention (irradiance, timing, duration) for situations of 
circadian misalignment (shiA work [Campbell, 1995; Eastman g^  a/., 1995; reviewed 
in Burgess gr aiA, 2002], advanced and delayed sleep phase syndromes [Rosenthal g/ 
a/., 1990; reviewed in Terman g/ a/., 1995] and jet lag [reviewed in Revell and 
Eastman, 2005]).
Furthermore, the therapeutic use o f light might offer an alternative or supplement to 
pharmacological (drug) treatment of age-related sleep disorders. Prescription of 
hypnotics is currently the most common strategy to treat these sleep disorders 
(reviewed in Gottlieb, 1990; reviewed in Conn and Madan, 2006). Despite some
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improvements in pharmacological sleep treatment (reviewed in Wagner and Wagner,
2000) these drugs do not treat the cause, merely the symptoms, of the problem and, 
while not always effective, they have the risk o f adverse effects (Nelson and 
Chouinard, 1999; reviewed in Bain, 2006; Gray at a/., 2006) including tolerance 
towards the treatment (reviewed in Monane, 1992). Some studies have shown that 
daytime alertness might actually be impaired due to intake o f sleep medication 
(reviewed in Fry 1987; Bensimon aA, 1990; reviewed in Gottlieb, 1990; reviewed in 
Glass 2005). If sleep problems are due to disruptions and alterations of the circadian 
system, light therapy might offer a less invasive and safer form of treatment. Possible 
side effects of bright light exposure include, amongst others, eye strain, seeing spots, 
problems with glare, eye burning or irritation, eye redness and headache (Levitt er aA, 
1993). However, their occurrence is rare and short-term as has been shown in studies 
of SAD patients treated with light (Labbate g/aA, 1994; Kogan and Guildford, 1998).
1.7.3.1 Bright light studies in older people
Most, but not all, previous studies administering light to older people have mainly 
focussed on older demented inpatients in care-home facilities when assessing the 
effects of daytime bright light administration on sleep and behavioural disturbances 
(section 1.7.3.1.1). Few of these studies have, in addition, aimed to assess changes in 
mood and performance in response to light administration (section 1.7.3.1.2).
1.7.3.1.1 Effect on sleep and activity
The results o f previous studies (Table 1.1) substantiate the effectiveness o f enhanced 
timed light exposure on sleep, maybe through resynchronisation of the circadian clock, 
while other studies (Suhner g^  aA, 2002; Dowling g^  aA, 2005; 2008) failed to 
demonstrate improvements in sleep. Overall, findings are heterogeneous and it 
remains unclear whether the observed improvements during or immediately aAer light 
administration persist. Fetveit and Bjorvatn (2004; 2005) have reported that 
improvements were maintained up to 12 weeks after the light exposure. Table 1.1 
presents a brief summary o f the major bright light studies conducted in older people 
and mainly focuses on the differences in the duration, timing and intensity of the lights 
used.
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____________________________________________________________________Chapter 1
Different protocols have been applied mainly varying in the length o f the light 
intervention period, light exposure duration (between 30 min and all-day) and timing 
(morning and/or evening or all-day). Studies administering light in the morning have 
observed improvements in nocturnal sleep and daytime wakefulness, a more 
consolidated rest-activity rhythm and/or better cognitive functioning (Van Someren g/ 
u;/., 1997a; Mishima g/ a/., 1998; Sakakibara g/ a/., 1999; Yamadera g/ <3/., 2000; 
Ancoli-Israel et al, 2002; 2003; Fetveit et al, 2003; Fetveit and Bjorvatn, 2004; 
2005). Evening light exposure has been shown to reduce nighttime agitation in 
demented patients (Satlin g/ a/., 1992; Ancoli-Israel gr a/., 2003). Campbell and 
Dawson (1991), Campbell et al (1993) and a review by Campbell et al (1995) stated 
that evening light can phase delay the circadian sleep-wake cycle in older people. All­
day exposure has been shown to increase actigraphic sleep efficiency and stabilise the 
rest-activity rhythm (Van Someren gr <3/., 1997a), improve cognition (light exposure) 
and increase actigraphic sleep efficiency (light exposure combined with evening 
melatonin [2.5 mg] administration) (Riemersma-van der Lek gr a/., 2008). In a cluster- 
unit cross-over design Sloane and colleagues (2007) exposed older patients with 
different levels of dementia to either bright light (2500 lux) in the morning, evening or 
all-day compared to a light condition exceeding industry standard levels (500 lux). 
The overall results are mixed; morning and all-day exposure caused a small but 
significant increase in nocturnal sleep duration and advanced the peak time o f the 
activity rhythm whereas evening light exposure delayed the peak of the activity 
rhythm. The authors concluded that bright light treatment can have a modest but 
measurable positive effect on sleep in demented people. One study has applied white 
light in the morning and evening intending to provide dawn and dusk stimulation and 
mimicking twilight conditions by gradual changes in light (0.001 -  200 lux) (Fontana 
Gasio gr a/., 2003). The study population consisted of nine demented female 
inpatients (mean + SD age: 86.8 + 4.5 years) receiving the active treatment (dawn and 
dusk light) and four (one male) inpatients (mean ± SD age: 83.0 ± 5 .2  years) receiving 
a dim control light. A small, but statistically significant, advance of the rest-activity 
rhythm (assessed via actigraphy) with the active treatment was observed. 
Additionally, some actigraphic sleep parameters showed a slight, yet not significant, 
improvement during the active treatment (but not in the fbllow-up): sleep latency and 
duration improved and immobility at night were diminished. The control dim light 
condition showed worsening of some actigraphic sleep parameters.
1-63
____________________________________________________________________Chapter 1
The light intensity (irradiance) used in these intervention studies varied to a rather 
small extent (contrary to light duration); most experiments used bright light (2500 -  
3000 lux [Youngstedt g/ a/., 2001]) or very bright light (> 10000 lux [reviewed in 
Montgomery and Dennis, 2002]) (1000 lux is considered to be moderately bright light 
[Kohsaka g^  a/., 1999]).
A shortcoming of the previous studies is that, despite the knowledge of the short- 
wavelength sensitivity o f the circadian system, to date only polychromatic light has 
been used for bright light therapy in older people (and some studies have used a dim, 
red light control condition) (for references see Table 1.1). More recently, few studies 
have tried to test the hypothesis that monochromatic blue or blue-enriched 
polychromatic light may act superiorly over traditional white light in alleviating sleep 
problems (Van Hoof et al, 2009a; Van Hoof et al, 2009b). Van Hoof and colleagues 
(2009a) have compared the effects of all-day exposure to either blueish (6500 K), 
yellowish (2700 K) or control dim lighting on rest-activity behaviour in 
institutionalised demented people. The authors reported a reduction of restlessness 
(staff ratings) following all-day exposure to blueish (6500 K, 1750 -  1810 lux) light 
whereas no change was seen following yellowish (2700 K, 1750-1810  lux) or control 
dim (200 lux) light exposure. Furthermore, the range o f the participants' tympanic 
temperature was increased following 6500 K light exposure, possibly suggestive of 
strengthening the circadian amplitude. Another study by Van Hoof g/ a/. (2009b) 
compared all-day exposure to either 17000 K or 2700 K light, both of low 
irradiance/intensity ( -  500 lux), in older dementia patients. Behaviour and circadian 
rhythmicity in these patients did not improve following either light condition. The 
authors suggested that this might be due to the low light intensity used and/or the short 
exposure duration (few hours per day). An interesting point raised is the possible 
'modification' o f the experimental light scenario due to interaction with environmental 
light and this potentially leading to a change in the physiological perception by the eye 
(i.e. photoreceptor stimulation). Moreover, the psychological (colour) perception of 
the lights by an individual may have caused alterations in the feeling of comfort.
1.73.1.2 Effect on mood and alertness
Studies of SAD patients reported an attenuation of depressive symptoms in response to 
daytime light treatment or increased natural light (Lewy gr a/., 1998; Terman gr oA,
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2001; aan het Rot g/ a/., 2008). Data on changes in mood (depression) in response to 
increased light exposure have been mainly obtained for older demented people 
although these data are inconsistent. Genhardt g/ a/. (1993) reported an adverse effect 
of light on mood in non-depressed community-living older women in response to light 
exposure. Similarly, Lyketsos g^  a/. (1999) did not see an improvement in agitated 
behaviour o f demented patients during light administration. Furthermore, in a study 
by Fontana Gasio and colleagues (2003) no improvement in mood and depression was 
seen with dawn and dusk stimulation when assessing depression in demented older 
people.
Other light studies, however, reported amelioration of mood and depression. Positive, 
though small, effects on mood and depression were observed in a study by Dowling 
and colleagues (2007) following light exposure. Studies by Sumaya g/ a/. (2001), 
investigating demented, depressed older people, and Tsai g/ <3/. (2004), assessing non- 
demented depressed older people, also reported amelioration of depressive symptoms 
following light exposure. A study by Riemersma-van der Lek et al. (2008) showed 
improvement in mood (depressive symptoms) following long-term light exposure in 
demented older inpatients with minor depression.
The reasons for the discrepancies between the light studies are not clear. They might 
be related to differences in the light intervention period (short-term vj. long-term light 
exposure) and/or level of dementia and disturbances o f sleep and mood in the study 
participants.
Rarely has research aimed to assess changes in alertness in response to light exposure 
in ageing non-demented adults living in the community. Studies in the care-home 
environment mainly relie on staff ratings and subjective alertness of an older resident 
can therefore not be assessed. Using an in-laboratory protocol Sletten and colleagues 
(2009) assessed the effect of monochromatic blue light exposure on subjective 
alertness of older men compared to young men during the early morning hours. They 
showed that subjective alertness was significantly diminished in the older group 
compared to the younger group. In addition, the effectiveness of monochromatic green 
light exposure on subjective alertness was assessed. During green light exposure, both 
groups did not differ in their ratings of subjective alertness. The authors explained 
their findings by a reduced sensitivity to the acute effects of short wavelength blue
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light in the older men which supported earlier work Aom the group (Herljevic e/ a/., 
2005).
1.7.3.2 Application of blue-enriched light
The human circadian system is short wavelength blue sensitive (section 1.6.4.1) and 
blue light exposure therefore produces greater non-visual responses compared to 
longer wavelength green light (section 1.6.4.1). Laboratory and Aeld studies have 
been conducted investigating how this sensitivity might be used in practical study 
protocols and 'real world' settings to optimise light exposure to (i) treat circadian 
disruptions and (ii) enhance well-being and performance.
Laboratory studies by Smith er a/. (2009) and Smith and Eastman (2009) aimed to 
compare the effectiveness and efficiency o f blue-enriched white light (17000 K) and a 
traditional control white light (4100 K) condition to phase shiA the circadian system in 
young adults with undilated pupils. Both light conditions were o f equal photon density 
and of light levels used for therapeutic applications but they differed in the amount of 
short wavelength blue light. In their phase-advance study (Smith er aA, 2009) and 
phase-delay study (Smith and Eastman, 2009) the authors did not find larger phase 
shifting responses with the blue-enriched polychromatic light (17000 K) compared to 
the lower colour temperature light condition (4000 K). Smith and co-workers (2009) 
suggested that this may be due to the high intensities used and/or that blue-enriched 
light exposure may not be effective in circadian phase shiAing.
By contrast, studies in office settings have shown positive effects of blue-enriched 
polychromatic white light exposure on subjective alertness, performance, sleep quality 
and well-being compared to control white light (Mills e/ aA, 2007; Viola aA, 2008). 
In a small, parallel design study (13 weeks plus 1 week o f baseline) Mills e/ aA (2007)
compared a 2900 K light (control condition, office standard light) and a 17000 K white 
light (condition) installed on two separate floors. The authors reported beneficial 
effects of all-day 17000 K light exposure on performance, alertness, functioning and 
well-being amongst the study participants compared to the control light condition (this 
study did not assess sleep quality). Viola and colleagues (2008) using a cross-over 
design study (8 weeks) compared all-day exposure to a 4000 K light (control 
condition, 4 weeks) with a 17000 K white light (condition, 4 weeks); both conditions
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were newly installed. The authors also showed improvements in well-being,
performance, alertness and quality and duration of nocturnal sleep compared to the 
control light condition.
Despite these encouraging findings by Mills e/ üf/. (2007) and Viola er a/. (2008) their 
studies have several shortcomings, including sample size, participants' expectations 
and the use of solely subjective rating scales. Blue-enriched light exposure is a new 
field of research and future studies should aim to replicate these results in occupational 
settings and investigate the practicability and effectiveness of blue-enriched light in 
other 'real world' situations including different age groups.
1.8 Rationale for the study
With ageing sleep problems become more severe and this might be partly attributable 
to a decreased sensitivity to light in older people or reduced environmental light 
exposure. Despite the recent discovery that short wavelength blue light is most 
effective in phase shifting the circadian system (Lockley er a/., 2003; Warman gr a/.,
2003; Revell et al, 2005; Gooley et al, 2010), to date only bright white light therapy 
has been used (occasionally compared against a dim control light) to try to improve 
sleep in older sleep-disturbed, mainly demented, people.
Little attention has been paid to studying rest-aetivity patterns and the effect of light 
on sleep in healthy, community-dwelling older people (Cooke er a/., 1998; Fukuda e/ 
a/., 1998; Kohsaka er a/., 1998; Kobayashi e/ a/., 1999; Kohsaka er a/., 1999; 
Sakakibara e/ a/., 1999; Kohsaka e/ a/., 2000). Even fewer studies have investigated 
the effect of light exposure on daytime mood or alertness in community-living older 
people as an additional parameter (Kobayashi er a/., 1999; Kohsaka gr a/., 1999). 
Conducting light intervention studies aimed to improve sleep in this population are of 
great importance for mainly two reasons: (i) the overall number and proportion of 
older people in society are increasing and (ii) deterioration of an older person's sleep 
with increased nighttime agitation often leads to institutionalisation of the older person 
(Poliak and Perlick, 1991; reviewed in Van Someren, 1997). Improvement of sleep 
problems will improve the older person's quality of life and prevent or delay 
institutionalisation as well as the burden on the care-giver. The practicability of light 
administration .ye and the use of short wavelength blue light or blue-enriehed
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polychromatic white light in a normal everyday environment requires further 
assessment in field studies to optimise its therapeutic value. The results fiom Vaii 
Hoof e/ a/. (2009b) (section 1.7.3.1.1) and the interpretation they offer underline this 
need for studies in healthy, older community-dwelling people with self-reported sleep 
problems. Instead of using monochromatic blue light, which would be expensive and 
difficult to administer, it was decided to use polychromatic blue-enriched white light 
(high colour temperature) in the present study. Apart from potentially stimulating the 
melanopsin signalling pathway, a blue-enriehed white light source would also 
stimulate the visual system which is important in a practical field study so that visual 
acuity remains unaffected. This would thereby enable the study participants to 
perform their daily activities (e.g. reading) without any impairment.
To avoid a placebo effect due to the participants’ expectations and for a better 
comparison a control light condition should be included in the investigation. The 
outcome of the present study may help to optimise light devices and schedules for 
administration of light to older people living at home.
1.9 Aims
For the current study it was planned to compare the effectiveness of blue-enriched 
white light (17000 K) with control white light (4000 K) to reduce sleep fiagmentation
and improve sleep, daytime functioning and circadian amplitude in healthy, older 
adults. Older community-dwelling people will be exposed to these two different light 
conditions over a period of time (three weeks) and their subjective and aetigraphie 
sleep and daytime mood, alertness and performance will be assessed. The light 
conditions will be photon-matched and designed to mimic a skeleton photoperiod thus 
providing a stronger lights-on and lights-off signal to the clock in order to align it with 
the 24 h light-dark cycle. The study aims to prove current scientific hypotheses and to 
test the practicability of daily light administration in older community-dwelling adults.
The irradiance levels of the blue-enriehed and control white light condition will be 
lower than has been used in previous field studies. These low irradiance(s) were 
chosen to test the effieieney of light exposure. Due to the blue light sensitivity of the 
circadian system lower irradiance levels o f blue light should be needed to elicit the 
same magnitude o f response compared to traditional white lights used in therapeutic
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applications. In addition, it was hoped to minimise glare and any feeling o f discomfort 
that some older people experience in bright light enviromnents.
1.10 Hypotheses
At two different light irradiances, the aims of the study were to assess and compare the 
effectiveness of blue-enriched and control white light on sleep and daytime 
functioning as well as on circadian amplitude in healthy older community-dwelling 
people (> 60 years) with self-reported sleep problems (PSQI > 5).
The working hypotheses of this study are:
Hypothesis]: Blue-enriched white and control white light at both irradiances will 
improve subjective and aetigraphie sleep, activity, daytime mood and alertness,
cognitive performance and circadian amplitude compared to the no light conditions 
(baseline and washout).
Hypothesis]: The magnitude of the responses elicited by the blue-enriehed white light 
will be greater than that of the control white light condition despite being photon- 
matched.
Hypothesis]: The magnitude o f the responses elicited by the two high irradiance light
conditions will be greater than those elicited by the low irradiance light conditions.
Hypothesis4: The magnitude of the responses will be greatest with the blue-enriehed 
white light at the higher irradiance.
The total photon density o f both lights was kept similar and as such, the blue-enriehed 
light had an increased number of photons in the short wavelength range. Comparison 
of the two light sources would thereby reveal whether the total photon density or the 
blue photon content o f the light was important in determining the magnitude of the 
non-visual responses.
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2 General Methodology
2.1 Recruitment
Partieipants were recruited by advertisement in the local newspapers. Those aged > 60 
years and with selfireported sleep problems completed a range of questionnaires 
(section 2.3) to determine their eligibility for the study. All potential participants 
received both oral and written explanations of the study requirements. Written 
informed consent was obtained before commencement of the study and participants 
were permitted to withdraw from the study at any point without stating a reason. 
Partieipants were reimbursed for their time and inconvenience on completion o f the 
study. Those who did not complete the full study received payment m/a. All 
participant information was coded alphanumerically (e.g. HLSOll) and stored in 
strictest confidence in compliance with the Da/a Pm/ec/ioM yfc/ (1998).
2.1.1 Inclusion criteria
In order to take part in the study partieipants were required to:
a) be > 60 years of age
b) be able and willing to give informed oral and written consent
c) complete and meet the defined criteria of the pre-study questionnaires (section 2.3)
d) have self-reported sleep complaints as identified by a Pittsburgh Sleep Quality 
Index (PSQI) score greater than 5 (section 2.3).
2.1.2 Exclusion criteria
Participants were excluded if they:
a) were taking regular medication known to influence sleep and the melatonin rhythm: 
barbiturates, benzodiazepines, p-bloekers, and/or antidepressants (including selective 
serotonin reuptake inhibitors, monoamine oxidase inhibitors)
b) had a history o f psychiatric or neurological disease
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c) had significant visual problems as assessed by an ophthalmic examination and/or 
were colour blind assessed with the Ishihara Colour Blindness Test (carried out by an 
optician)
d) had travelled across more than 2 time zones within 2 weeks of commencement of 
the study.
2.2 Participants
In total, 36 community-dwelling older people (25 females and 11 males; age range of 
60 -  76 years, mean age ± SD 66.5 ± 4.4 years), who met all inclusion and exclusion 
criteria and satisfied the pre-study screening requirements, were studied. Participants’ 
demographics, pre-screening results, data on eye conditions and the self-reported 
intake of medication, alcohol and nicotine are presented in chapter 3 (low irradiance 
light group) and chapter 4 (high irradiance light group).
2.3 Pre-study measurements
For the pre-screening measurements the following six validated questionnaires were 
used (Appendices A -  F):
1) General Health Questionnaire for general demographics (Appendix A)
2) Pittsburgh Sleep Quality Index (PSQI) (Buysse et al, 1989) (Appendix B)
The General Health Questionnaire and the PSQI were the principal questionnaires used 
to determine eligibility for study inclusion. The PSQI is an assessment of sleep quality 
(and sleep pattern) of the past four weeks based on 19 questions concerning the 
participant’s sleep including usual bedtime and get-up time. These 19 questions 
produce seven component scores, each score ranging between 0 and 3 (higher scores 
are indicative o f poorer sleep):
1) subjective sleep quality
2) sleep latency
3) sleep duration
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4) habitual sleep effieieney
5) sleep disturbances
6) use o f sleeping medication
7) daytime functioning
The global PSQI score (maximum of 21) is generated by summation of the seven 
component scores. A global score of 5 or higher is considered to indicate a sleep 
problem (Buysse e/ a/., 1989).
Questionnaires 3 - 6  were used for descriptive measures only.
3) General Sleep Questionnaire (Appendix C)
4) Home-Ostberg Momingness Eveningness Questionnaire (MEQ) (Home and 
Qstberg, 1976) (Appendix D)
5) Beck Depression Inventory (Beck e/ a/., 1961) (Appendix E)
6) Epworth Sleepiness Scale (Johns, 1991) (Appendix F)
The MEQ (Home and Qstberg, 1976) assesses diurnal preference and categorises 
individuals into the following groups based on their score: 
definitely morning type 70 -  86
moderately morning type 59 -  69
neither type 4 2 - 5 8
moderately evening type 3 1 - 4 1
definitely evening type 1 6 - 3 0
The Beck Depression Inventory (BDI) is used to detect depression in the normal 
population (Beck et al, 1961). The recommended cut-off scores for a population not 
clinically diagnosed as depressed are: 0 - 1 3  minimal range, 1 4 - 1 9  mild, 20 -  28 
moderate and 29 -  63 severely depressed.
The Epworth Sleepiness Seale (Johns, 1991) is a tool to assess daytime sleepiness with 
a recommended cut-off score for normal sleepiness of < 10. A score higher than 10 
indicates the possibility of suffering from daytime sleepiness.
In addition, all participants were asked to undergo an ophthalmic examination, 
performed by a registered and independent optician, which included an assessment of
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pupil size and the Ishihara Colour Blindness Test. No participant had to be excluded 
based on the ophthalmic examination results. Participants were allowed to take sleep 
medication during the study but were asked to keep it to a bare minimum and report it. 
These nights were excluded fi-om the subjective and actigraphy sleep analysis.
2.4 Study design
The study was carried out in the participants’ own homes. It was a randomised, cross- 
over light exposuie trial including two different light conditions administered via light 
boxes; a blue-enriched white light (colour temperature 17000 K) and control white 
light (4000 K) (section 2.5.2).
The cross-over design comprised two sequence groups: exposed to blue light first and 
exposed to control light first. Details on the light administration and light equipment 
are described in sections 2.5.1 and 2.5.2, respectively. The study lasted for 11 
consecutive weeks with baseline (BA; week 1 and week 6), light exposure either blue- 
enriehed or control white light (LI, L2, L3; weeks 2 to 4 and 7 to 9, respectively) and 
washout (W Al, WA2; weeks 5 to 6 and 10 to 11, respectively). Week 6 also served as 
baseline for the second light administration episode. The protocol overview is shown 
in Table 2.1:
Table 2.1: Protocol overview
Study Week Study phase (duration)
1 Baseline (BA): 1 week
2 - 4 Light exposure A or B (L1-L3): 3 weeks
5 - 6 Washout period (W Al, WA2): 2 weeks
7 - 9 Light exposure A or B (L1-L3): 3 weeks
1 0 - 1 1 Washout period (W Al, WA2): 2 weeks
Week 1 provided baseline measurements o f the participants’ normal sleep, activity and 
light environment at home. Each light condition was administered for 2 h in the 
morning and 2 h in the evening for three weeks. The study was single-blind with 
participants being unaware as to which light condition they were being exposed to.
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During the washout periods (weeks 5 to 6 and weeks 10 to 11) participants were not 
required to sit down for 2 h in the morning and evening as required during the light 
exposure.
Participants were visited on approximately a weekly basis to collect data and deliver 
diaries and questionnaires. Part of the visits during weeks 1, 4, 6, 9 and 11 a 
researcher conducted the Mini Mental State Exam (MMSE) (section 2.12) and a semi­
structured interview (section 2.14). During weeks 1, 4, 6, 9 and 11 the participants 
were asked to complete the Social Rhythm Metric (SRM) (section 2.13) which 
stretched over a complete week. Participants gave four 36 -  39 h urine collections 
(section 2.15) at the end of study weeks 1, 4, 6 and 9. Due to the participants’ 
schedule the weekly visits sometimes occurred on different days in the requested 
week. Figures 2.1 and 2.2 provide a detailed overview of the study protocol (separated 
for weekly and daily tasks).
Baseline
Light exposure ;
Washout period • <
Light exposure
Washout period
W eek 1
Urine sampling <^PSQ I (g)Interview & MMSE a  SRM Test | | □
W eek 2
W eek 3
W eek 4 0 © *
(Q
0)a
3
W eek 5
W eek 6
W eek?
W eek s
Week 9
W eek 10
Week 11 ©
o
3
(D
T3
Oa(D
(Q
3
B)a
3
o
3
<D■D
8
&
Light exposure
Figure 2.1: Detailed protocol overview. The week before each light exposure (period) began 
(baseline week), the three weeks of light exposure and the 2-week washout period are referred 
to as light administration episodes. Each horizontal block represents a study week.
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Daily program m e for baseline and washout periods
wake-up be(|time
Daily program m e for light exposure periods
wake-up afternoon
e n d  b e fo r e  1100 h
A ctivities Diary 
A ctiw atch-L
S le e p  Diary (p rev iou s nigtit)
bedtime
2h 2h
e n d  b e fo r e  2200 h
A ler tn ess , M ood & C ognition  T est
A p p etite  S c a le
Light e x p o su r e  s e s s io n
Figure 2.2: Daily programme during baseline and washout periods, and light exposure 
periods. Horizontal blocks represent example study days.
The following terms were used to describe the different time segments when analysing 
the data:
Light administration episode (six weeks): baseline week, three weeks of light 
exposure and two weeks of washout
Light exposure: three weeks of light exposure (blue-enriched or control light) 
Period: three weeks of light exposure (irrespective o f the light condition) 
Sequence: order in which the light conditions were received, i.e. blue-enriehed 
light followed by control light exposure or vice versa
2.5 Light
The following sections present details about the methods of light administration 
(section 2.5.1), the light equipment (section 2.5.2) and the spectral composition of the 
lights (section 2.5.4.1). Section 2.5.4.2 furthermore explains how the photon density 
of a light source is calculated; the photon density used in the low irradiance light study 
(chapter 3) is taken as an example. The irradiances used in the high irradiance light 
study are detailed in chapter 4.
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2.5.1 Light administration
During each three week light exposure period, light was administered as a skeleton 
photoperiod daily for 2 h in the morning, ending before 11:00 h and for 2 h in the 
evening, ending before 22:00 h. Participants were not required to have fixed start 
times; instead they were fiee to choose these times depending on their individual daily 
schedule. They were told not to get up earlier than normal in order to complete the 
light session in the morning. In the evening it was recommended to start the evening 
light exposure after dusk. Breaks from the lights were allowed, and breaks greater 
than 5 min were defined as being absent. The participants were asked to add this 
missing time onto the end of the session in order to ensure a total of two hours of light 
exposure. Participants completed a light time table (Appendix G) stating the times for 
start/break/end of each light exposure session as well as if  any session was missed. 
From this, the total exposure time/session for each participant was calculated. The 
importance of each light session was emphasised but at the same time participants 
were reassured that missing a light session would not lead to exclusion from the study.
To achieve the correct light intensity (section 2.5.4.2.5 and Table 2.3) and ocular 
exposure while the participant was seated in fiont of the light box, it was placed on a 
table so that the midpoint of the light box was at eye level and at a distance of 60 cm. 
The angle o f the light box to the participants’ face/head varied between 0 -  60°. The 
simultaneous use of other room lights was permitted. The participants were allowed to 
read, eat, watch television, do cross-words, etc during the light exposure and were 
instructed not to stare directly but occasionally look at the lights. Before the start of 
the light exposure period participants were instructed on how to set-up the light box 
and were provided with a 60 cm stick/pole. It was therefore possible for them to 
remove the light box in between light exposure sessions. Throughout the study 
participants were encouraged to report any side effects or discomfort to the 
investigators immediately.
2.5.2 Light equipment
The light boxes (57 x 16 x 33 cm) (Figure 2.3) contained 17000 K fluorescent bulbs 
(Master PL-L 36W/840/4F) for the blue-enriehed white light condition (Figure 2.3A) 
and 4000 K fluorescent bulbs (Master PL-L 36/865/4P) for the control white light
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eondition (Figure 2.3B). The cover of the box was made of polymethylmethacrylate, 
filtering out the UV part of the spectrum almost completely. The dimmer and time 
knobs on the light boxes were both disenabled leaving only the on/off knob working. 
The light equipment was provided by Philips Lighting (Eindhoven, The Netherlands).
Figure 2.3: Light boxes used in the study: A) blue-enriched white light box (17000 K) and B) 
control white light box (4000 K).
Irradiance and lux level of the light boxes were measured in the participants’ homes 
with the cover on using a calibrated radiometer (Macam Photometries Ltd, 
Livingstone, Scotland) before and after their use in the study. The spectral 
composition or spectral power distribution (SPD) of each light box (section 2.5.4.1 and 
Figure 2.4) was measured prior to the study with a spectroradiometer (Ocean Optics, 
BV, Florida, USA).
The lamps used in this study met UV and blue light hazard safety standards (standard 
ICNIRP 7/99 and CIE S 009/E: 2002). The blue light weighted radiance (Lb) was far 
below the safety limit of 100.
2.5.3 Light monitoring
Baseline ambient light irradiance (pW/em^) and illuminance (lux) in the participants’ 
room where the majority of the light administration was to be carried out was 
measured with a radiometer and luxmeter.
To measure the participants’ ambulatory light exposure an Aetiwateh-L (AWL) 
(Cambridge Neuroteehnology Ltd., UK) was worn by all partieipants around their neck
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as a medallion on a daily basis from get-np time until bedtime (participants completed 
a time table [Appendix H-I] stating the on/off times o f the neck-worn AWL). This 
approach was assumed to gain more realistic light data than fiom the additional AWL 
worn on the wrist. None of the light data recorded via the AWL (wrist and neck) has 
been analysed.
Environmental light levels were continuously monitored by an additional light sensor
(HOBO, Tempcon Instrumentation Ltd., UK) throughout the 11-week study. A 
HOBO was placed beside each light box or in the position of the light box during the 
washout weeks. HOBO data has not been used in the current data analysis.
2.5.4 Spectral composition and intensity of the light sources
The following sections will first describe the spectral composition of the lights sources 
used (section 2.5.4.1). Secondly, the calculations needed to set a light source to a 
specific photon density are explained (section 2.5.4.2).
2.5.4.1 Spectral composition
The study aim was to compare the biological effectiveness o f two polychromatic white 
light sources differing in their spectral composition (distribution). The m^or 
difference between the light sources was the amount of photons contained within the
short wavelength blue region (Figure 2.4). The blue-enriched light 17000 K light was 
enriched over the shorter wavelength blue range and should thereby achieve maximum 
melanopsin stimulation whereas the control light 4000 K light contained more of the 
longer wavelength (> 550 nm) photons (Figure 2.7 and Table 2.3). Apart from these 
differences, the lights had similar spectral compositions both exhibiting peaks around 
545 nm, 580 nm and 620 nm.
In order to compare the biological effectiveness of the light sources they were matched 
for total photon content (section 2.5.4.2.5 and Figure 2.7). In that way comparison of
the two light sources would reveal whether the differences in the spectral composition 
were important in determining the magnitude of the responses.
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Figure 2.4: Spectral power distribution of the blue-enriched white light (—) (17000 K) and 
control white light (—) (4000 K).
2.S.4.2 Photon density
2.5.4.2.1 General calculation o f photon flux
The energy of a light souree is measured as irradianee (pW/cm^) and can be converted 
into photon flux (photons/em^/see) with equation (Eq. 1):
Photons/emVsee = irradianee (pW/em^) / energy of 1 photon of a specific wavelength 
To calculate the amount of energy in one photon (E) at a specific wavelength the 
following equation can be used (Eq. 2) (Halliday et al, 1992):
E = hn
h = Planck’s constant (6.626 x 10'^ '^  W/see^) (W = Watts)
n = frequency of the wave (n = dX, where c = speed of light in a vacuum 3 x lO’  ^
nm/see and X = light wavelength in nm)
2.5.4.2.2 Calculation ofphoton density for a polychromatic light source
The total photon content in a polychromatic light souree at a specific irradianee can be 
calculated by integrating the spectral distribution of the light souree (section 2.5.4.1) 
and the known photon energies (Table 2.2, column B) at each wavelength (Table 2.2, 
column A). From this, the irradianee and hence the photon flux at each wavelength 
can be determined (Table 2.2 column H) and summed to give the total photon density. 
Thus, the total photon density which reaches the cornea for any given irradianee at any
2 - 1 0
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given distance from the light source can be calculated. It is possible to account for 
changes in ocular physiology and photopigment spectral sensitivity in predicting the 
number of photons reaching the retina and inducing a response via specific 
photopigments. Correction factors can be applied to account for age-related pupil size 
and spectral variation in lens transmission, and the absorbance spectrum of opsin- 
based photopigments e.g. rods, cones or melanopsin (following sections) before setting 
the light to the desired irradianee for the study.
2.S.4.2.3 Correcting for age-related lens transmission and pupil size 
The transmission of light through the lens varies with wavelength with a reduction in 
the transmission of shorter wavelengths. Age-related changes in lens composition 
(section 1.7.1.1.1) mean that even less light, especially o f the short wavelength blue 
light can pass through (Figure 2.5A). Applying a correction factor as shown in Figure 
2.5B (between 0.22 and 1.02) to each wavelength (Table 2.2, column F and I) it can 
then be estimated how many photons at each wavelength will pass through the lens of 
a person of a specific age group.
80-,
60-
o  §  20-
400 450 500 550 600 650 700
1.2 -,
1.0 -
.«S
0.6 -
oi 0.4-
&  0 .2 -
400 450 500 550 600 650 700
W aveleng th  (nm) W aveleng th  (nm)
Figure 2.5: Age-related lens transmission at different wavelengths: A) percentage of lens 
transmission 60 -  69 years and B) lens transmission ratio 60 -  69 years/20 -  29 years.
As mentioned previously the age-related reduction in pupil size decreases the amount 
of photons reaching the retina (section 2.5.4.2.2; section 1.7.1.1.1). Therefore, an age- 
related correction factor (1.25 x 1.25) (Verriest, 1971) should be applied to the (final) 
irradianee. This is done in the photon flux calculation in Figure 2.7.
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2.5.4.2.4 Calculation o f melanopsin stimulating photons
The absorbance spectrum of a photopigment describes the possibility o f the 
photopigment absorbing a photon at a certain wavelength (section 1.4.1). It is thus 
possible to predict how many photons are being absorbed by a photopigment at each 
wavelength. The number o f photons within a certain wavelength range contained in 
the light source can be adjusted to stimulate a specific photopigment. For example, the 
amount of melanopsin stimulating photons in a light source can be calculated using the 
Dartnall nomogram with 480 nm (Figure 2.6 and Table 2.2, column E).
450 500 550
Wavelength (nm)
Figure 2.6: Melanopsin nomogram template with a 480 nm derived from the Dartnall 
nomogram for opsin-based photopigments (Dartnall, 1953).
2.5.4.2.5 Calculation ofphoton flux for the light sources o f the pilot study 
In order to be able to compare the light sources it was necessary to ensure that the 
irradiances used for the lights would be sufficient to induce a measurable response. 
Previous controlled studies in our laboratory (Thapan et al, 2001; Revell et al, 2005; 
Sletten g/ a/., 2009) have shown that monochromatic blue light (X^ ax 456 nm), of  
approximately 6 x 10^  ^ photon/cm^/see at the level of the cornea, is able to 
significantly suppress melatonin production and phase shift the timing of the melatonin 
rhythm in young males that are pupil dilated. Thus, this was used as a starting point to 
determine the irradianee necessary to elicit a response with the 17000 K blue-enriched 
white light source; the control light (4000 K) was then matched to this in terms of total 
photon content.
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To deliver approximately 6 x 10^  ^ photon/em^/sec melanopsin stimulating photons to 
the retina of older individuals, at a recommended distance of 60 cm, it was necessary
to account for age-related changes in lens transmission, the melanopsin nomogram and 
age-related changes in pupil size. In Figure 2.7 the steps to calculate the total photon 
content and the number of melanopsin stimulating photons for the 17000 K light, 
applied in the low irradianee light study (chapter 3), are shown on the left:
17000 K light
Total photon density -
2.29 X 10^ '* photon/cmVsec
4000 K light
Total melanopsin photons = 
6.36 X 10'  ^photon/cm^/sec
Lens tranmission ratio 
old/young (^correction factor)
Accounting for age-related 
pupil size reduction (*1.25 )^
3.59 X 10'"* photon/cm^/sec 
= 141 pW/cm^
Matched 3.65 X 10'  ^photon/cmVsec 
-  133 pW/cm^
9.97 X 10*3 photon/cmVsec
melanopsin stimulating photons
6.29 X  10*3 photon/cm^/sec 
melanopsin stimulating photons
Figure 2.7: Stepwise photon flux calculation of the 17000 K light (left) and 4000 K light 
(right). Starting with a total photon density of 6.36 x lO'  ^ photon/cmVsec, correction factors 
for lens transmission and pupil size were applied to the 17000 K light and the resultant total 
photon density was calculated (3.59 x lO’'* photon/cm^/sec). The total photon density of the 
4000 K light (3.65 x 10''*photon/cm /^sec) was matched as precisley as possible to the 17000 K 
light source.
The same steps were then applied to the control white light (4000 K) (Figure 2.7, right) 
to achieve matching total photon densities (applied in the low irradianee light study, 
chapter 3). For both light sources the total number o f photons administered and the 
photon content contained in the different wavelength regions are detailed in Table 2.3.
2-14
Chapter 2
Table 2.3: Administered photon densities, irradiances and lux levels of the two light sources
Blue-enriched
light Control light
Colour temperature (K) 17000 4000
Total photons (photon/cmVsec) 3.59 X 10^ ^ 3.65 X 10"
Total photons (photon/cmVsec) corrected 
for age-related lens transmission
2.60 X 10^ ^ 3.08 X 10"
‘Blue’ photons: 400-490 nm 
(photon/cmVsec)
1.77 X 10*^ 8.87 X 10"
Blue’ photons
(400-490 nm) (photon/cmVsec) 
corrected for lens transmission
9.08 X 10" 4.53 X 10"
Melanopsin stimulating photons 
(photon/cmVsec)
9.97 X 10" 6.29 X 10"
Photons: 491-700 nm (photon/cmVsec) 1.81 X 10" 2.77 X 10"
‘Green’ photons
(500-570 nm) (photon/cm^/sec)
5.90 X 10" 7.00 X 10"
Photons: 570-650 nm (photon/cmVsec) 9.96 X 10" 1.76 X 10"
Irradianee (pW/cm^) 141 133
Lux 325 450
The blue-enriched light (17000 K) delivered approximately double the amount of blue 
photons (400 -  490 nm) compared to the control light (4000 K). In terms of 
melanopsin stimulating photons reaching the retina, the blue-enriched light delivered 
approximately 1.5-fold more short wavelength photons (400 -  490 nm) than the 
control light.
The photon densities used for the high irradianee light group will be discussed in 
section 4.3.2.
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2.6 Assessment of sleep
Sleep was assessed both subjectively, via daily sleep logs (Appendix I) (section 2.6.1), 
and objectively via actigraphy (AWL) (section 2.6.2). Decimal hours (dec.h ± SEM) 
are reported for all clock times, durations and changes in timing for any parameter 
measured.
2.6.1 Subjective sleep
Partieipants completed daily sleep diaries throughout the entire study period upon
awakening in the morning with reference to the previous night’s sleep. The sleep logs 
comprised eight sleep parameters (Loekley e/ a/., 1999). From these, a further three 
parameters (sleep latency, actual sleep duration, and sleep efficiency) were calculated 
resulting in a total of 11 subjective sleep parameters (Table 2.4).
Table 2.4: Subjective sleep parameters_____
Sleep parameter
Bedtime (dec. h)
Time trying to sleep (dee. h)
Sleep latency (min)
Sleep onset time (dec. h)
Number o f night awakenings/night 
Duration of night awakenings/night (min) 
Wake-up time (dee. h)
Get-up time (dec. h)
Sleep duration (dec. h)
Sleep efficiency (%)
Sleep quality (l=best sleep, 9=worst sleep)
Sleep onset: /zAMg rAymg ro WgMcy.
Sleep duration:
o then: /o/aZ a/Ze/Mpre^ Z .yZe^ /z/?ze -  (^Zeep Za/ezzcy + (Zwrarzozz zzzgZz/
awakenings). This yielded the sleep duration in hours.
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# Sleep efficiency: q/"r/ze .y/ggq (Zwm/zoM z^vz^ Zeal 6y .y/aqq pgno^Z (Zo/a/ 
<3//e/Mqrg6Z.y/gep fr/zzq).
# Sleep quality was assessed using a numeric scale from 1 to 9; 1 being the best 
sleep ever and 9 being the worst sleep ever.
Nights for which use of sleep medication was reported were excluded from data 
analysis. The corresponding nights of aetigraphie sleep recording were also excluded.
2.6.2 Aetigraphie sleep measurement
For aetigraphie sleep assessment participants wore an additional Aetiwatch-L (AWL) 
continuously on their non-dominant wrist (participants completed a time table
[Appendix H-II] stating the on/off times of the neck-worn AWL). This watch-like 
monitor records movement of the wrist and is indicative of the overall amount of body 
activity. From this the propriety software uses an algorithm to classify each epoch as 
sleep or wake. The recorded activity was logged in one-minute epochs. The data were 
downloaded in regular intervals during the study.
The actigraphy data were analysed using the Cambridge Neuroteehnology software
package (Sleep Analysis 7, version 7.23). For each day the subjective ‘time trying to 
sleep’ and ‘wake-up time’, obtained from the individual daily sleep diaries, were 
entered into the analysis program to set the analysis (time) window for each night’s 
sleep period. Analysis using the built-in sleep-scoring algorithm then delivered 14 
aetigraphie sleep parameters (Table 2.5).
The AWL software package calculated the following sleep parameters in clock times: 
sleep onset and wake-up time, sleep duration and duration o f night awakenings (Table 
2.5). For mathematical calculations and analysis of the data these were changed to 
dec.h.
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Table 2.5: Aetigraphie sleep parameters
Sleep parameter
Sleep latency (min)
Sleep onset time (dee.h)
Duration o f night awakenings/night (min) 
Time spent awake/night (%)
Wake-up time (dec.h)
Sleep duration (dec.h)
Sleep (%)
Sleep efficiency (%)
Mean sleep bout time (min)
Mean wake bout time (min)
Number of immobile phases 
Immobile time (%)
Total activity (activity counts) 
Fragmentation index
» Sleep duration: j^ Zeep Z^wrarZoM - MzgZz/ czwa^ e/zzMgj/^ zzgZzr
o  6iyj^zz/?ze(Z jZ g q p  (Zzzrarzo».' (Z z^ ^ rew ce  Z zeZ w ee» aM ù/ jZ e q p  o z z j e /
rz/Mg.
# Sleep (^ .'  pgrcgM/age q/^ ajjzz/MgeZ a^ Ze^  Z^zzra/zozz.
#  IFaAg/)zzgZzr p g r c e / z / a g g  wzZZzz/z aj-JZ/zzzg^Z jZ g g p  ^Zzzra/zozz.
# Sleep efficiency: sleep duration /  time in bed.
o  rzzzzg zzz bgüZ ob/azzzgzZ ^ ro/zz  rZzg .yzzZygg/zvg .yZggp ^Zzczz-zgj^ .
# Fragmentation index: pgz-ggzzZagg q/^  zzzzzzzz/g.y zzzovzzzg 4- pgz-gg/zragg q/^  
immobility. Values of > 50 are considered as bad sleep, values of < 20 are 
considered as good sleep.
2.6.3 Pittsburgh Sleep Quality Index (PSQI)
As an additional tool to assess subjective sleep quality the PSQI was administered at 
the end o f each light exposure (weeks 4 and 9) and four weeks after the end of the
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second light exposure (= two weeks aAer the end of the study) (post-study). Of the 36 
participants recruited in total, 30 participants performed an additional PSQI at the 
beginning of week 1 (chapters 3 and 4 for specific details). Each PSQI questionnaire 
provided seven component scores that were then summed to produce a global PSQI 
score (section 2.3).
2.7 Naps
During the entire study participants were asked to complete daily nap diaries similar to 
the sleep diaries. A nap was defined as any sleep outside their normal bedtime period. 
They were asked to record the duration, start and end time of all naps (Appendix J). 
Naps were only assessed subjectively not using aetigraphie data as the AWL is unable 
to distinguish between immobility (e.g. sitting quietly but awake) from napping 
behaviour. Therefore the subjective reports of napping were considered more reliable.
2.8 Daytime and time-in-bed activity levels
Daytime and time-in-bed were individually defined for each participant using their 
individual weekly mean bedtimes and get-up times, derived from their individual sleep 
diaries (similar to a study by Hood et a l,  2004). Total hourly activity values (counts 
per hour) were obtained from the AWL data and then summed to determine daytime 
and time-in-bed activity levels. From these hourly activity values the mean activity for 
each hour o f the day across each week was calculated.
2.9 Circadian rhythm analysis of activity
Firstly, a cosinor method was used for parametric analysis of the circadian rhythm of
activity (section 2.9.1). Secondly, a non-parametric rhythm analysis was conducted 
which is considered to be a more sensitive measurement o f the 24 hour activity profile 
(section 2.9.2).
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2.9.1 Parametric circadian rhythm analysis of activity
Fitting a cosinor model with a fixed period of 24 hours (the cosinor programme was 
kindly provided by Dr. D.S. Minors, University o f Manchester, UK) to the weekly 
means for each hour of the day provided 24 hour rest/activity rhythms for each week 
of the study. This best-fit periodic function produced three parameter estimations 
describing the shape of the derived curve: mesor (midline of the rhythm = average 
activity level), amplitude (difference between maximum and mesor) and the aerophase 
(peak of the activity rhythm). Mesor and amplitude are expressed in arbitrary units of 
activity, higher numbers represent larger movements.
2.9.2 Non-parametric circadian rhythm analysis of activity
Activity was further quantified and described by non-parametric circadian rhythm 
analysis (NPCRA) (the programme was kindly provided by Dr. E.J.W. Van Someren, 
University o f Amsterdam, The Netherlands). This type of analysis is used to 
determine the strength and reproducibility of the daily sleep-wake cycle across the 
study period. Eight circadian parameters (Van Someren et al, 1999) were calculated 
for each study week.
(1) The Interdaily Stability (IS) compares the similarity of activity patterns between 
days with values ranging from 0 to 1 (the higher the value the more stable and 
reproducible the rhythm is between days).
(2) The Intradaily Variability (IV) assesses the fragmentation of the rhythm (the 
frequency of transitions between rest and activity) within 24 hours. The higher the
score on a scale from 0 to 2 the more disturbed the rhythm is.
(3) L5 allots an average activity value for five consecutive hours of least activity 
within an average 24 hour pattern.
(4) L5 onset time indicates the start o f these five hours of least activity.
(5) MIO is an average activity value for the most active consecutive ten hours during 
an average 24 hour pattern.
(6) MIO onset time indicates the beginning o f these ten most active hours.
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(7) To quantify the amplitude (AMP) of an average 24 hour rhythm of activity the 
difference between the MIO and L5 is ealculated (expressed in arbitrary units of 
activity).
(8) The relative amplitude (RA) is the difference between MIO and L5 divided by the 
sum of MIO and L5. Higher scores on a scale from 0 to 1 indicate a stronger rhythm. 
Previous studies have validated the measurement of these parameters using actigraphy 
in older people (Van Someren, gr a/., 1996; Van Someren, g/ a/., 1999).
2.10 Subjective mood and alertness assessment
Subjective mood and alertness were assessed using four 9-point scales (Appendix K) 
as previously reported (Revell gZ a/., 2006; Lockley gt a/., 2008; Sletten gt a/., 2009):
1 : very alert 9: very sleepy
1 : very cheerful ^  9: very miserable
1: very ealm ^ 9: very tense
1 : very depressed ^  9: very elated
Additionally, the Karolinska Sleepiness Scale (KSS) (Akerstedt and Gillberg, 1990) 
(Appendix K) was used to assess subjective sleepiness during the previous 10 minutes:
1 : very alert
2:
3: alert, normal level 
4:
5: neither alert nor sleepy
6:
7: sleepy but no effort to stay awake
9: very sleepy, great effort to stay awake
Participants rated their mood, alertness and sleepiness in the morning after waking up 
and after completing the sleep diary, before lunch and at bedtime, throughout the entire 
study period.
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2.11 Performance assessment
The Digital Symbol Substitution Test (DSST) (Wechsler, 1955) was used as a measure 
of cognitive performance (attention and psychomotor speed) (Appendix L). The 
DSST is as follows: at the top of the page the numbers 0 to 9 are each assigned a
symbol (allocations of these are varied between pages). The numbers are then 
presented in rows in a random order and participants were required to draw the 
corresponding symbol below each number and complete as many substitutions as 
possible within two minutes. Participants completed the DSST three times each day 
after the mood and alertness scales (section 2.10). Before the start of the study (pre­
baseline) participants were asked to complete 5 data sheets as training/familiarisation.
2.12 Global cognitive performance
The Mini Mental State Examination (MMSE) (Folstein et a i,  1975) is a test for 
cognitive impairment and uses a set of five questions/tasks evaluating orientation, 
registration, short-term memory and language ability (e.g. “What year was last year?”, 
“Count backwards &om 50 by 5s”) (Appendix M). If all five questions/tasks are 
answered correctly a maximum score of 30 points can be obtained. MMSE scores of 
25 -  30 are considered to be normal, 2 4 - 1 8  indicates mild to moderate impairment, 
and scores of < 17 indicate severe impairment. The test was administered at the end of 
each period (weeks 1, 4, 6, 9 and 11) (Figure 2.1) by a researcher.
2.13 Daily rhythmic behaviour
The Social Rhythm Metric (SRM) (Monk et a/., 1990) measures the regularity o f a 
person's daily social rhythm (Appendix N) over at least one week. It records the 
timings of either 17 (long version, SRM-17) or 5 (short version, SRM-5) activities on a
daily basis. For this study the SRM-5 was used. Participants specified the timings for 
the following five given activities every day over a whole week: Get-up time, time of 
first contact with another person, start of the day’s main activity (domestic work, 
school, job, etc), dinner time, and bedtime. A summary score is obtained using an 
algorithm ranging from 1 to 7 (analysis programme kindly provided by Dr. T.H. 
Monk, University o f Pittsburgh, USA and adapted by Dr. R. Meadows, University of
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Surrey, UK). Higher scores indicate a more regular lifestyle and lower numbers 
represent more irregularity. All participants completed the SRM-5 during weeks 1, 4, 
6, 9 and 11 (Figure 2.1) and each week was scored separately.
2.14 Semi-structured interview
A semi-structured interview (Appendix O) was conducted to evaluate the self-rated 
effectiveness, perception, practicability and acceptability of both light conditions at the 
end o f weeks 1, 4, 6, 9 and 11 (Figure 2.1). Questions asked always addressed the 
same topics but were asked in a flexible way, e.g. “How did you find the lights”, “How 
are you getting on with everything?”.
2.15 Circadian phase assessment
The endogenous melatonin profile in urine, saliva or plasma is a robust and accepted
marker of the circadian clock (section 1.3.1.3). Melatonin and its major urinary 
metabolite, 6-sulphatoxymelatonin (aMT6s), can be employed to determine the 
amplitude (strength) and phase (internal timing) of the circadian clock. For this study 
aMT6s was chosen as a marker to assess the participants' circadian phase. It was 
hypothesised that light exposure would strengthen the circadian rhythm increasing the 
amplitude of the melatonin rhythm. aMT6s was measured using a radioimmunoassay 
(RIA) described by Arendt et al. (1985) and modified by Aldhous and Arendt (1988).
2.15.1 Urine sampling
During weeks 1, 4, 6 and 9 of the study (Figure 2.1) participants collected sequential 
timed urine samples over 39 h (36 h for the first and second collection of the first six 
participants; section 6.3.2). Each 39 h collection period comprised two nights and the 
day in between (from 21:00 h on day 1 until 12:00 h on day 3) and was divided into 11 
collection bins/periods (yielding a maximum of 11 samples and a maximum of ten for 
the 36 h collection period, respectively). The two overnight collections were &om 
bedtime until wake-up/get-up time (ea. 8 h each) whereas the daytime collection was 
split into approximately 3 hour intervals. For each of the 11 samples the total amount 
of urine passed was recorded and a 5 ml aliquot kept at 4°C or below in the
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participants' home &idge. A researcher then collected the samples and these were 
stored at -20°C at the University of Surrey until analysis. Instructions on how to 
collect the urine (Appendix P-I), the recording sheet (Appendix P-Ii) and the necessary 
equipment were provided.
2.15.2 Principle of the aMT6s radioimmunoassay (RIA)
The diluted urine samples (containing unlabeled antigen, aMT6s) were mixed with a 
specific amount of sheep anti serum to aMT6s and radiolabelled iodinated aMT6s 
(labelled antigen) and then incubated. Unlabelled and labelled antigens compete for 
the limited number of binding sites on the antibody until equilibrium is reached. As 
charcoal binds only to small molecules, the antibody-bound labelled antigen could be 
separated from the free labelled antigen using charcoal. Radioactivity was then 
measured in the unbound fraction (charcoal pellet). The higher the radioactivity the 
more of the free labelled antigen was in the pellet and less of it was antibody-bound. 
Conversely, more unlabelled antigen was bound to the antibodies, i.e. the amount of 
aMT6s in the urine samples was high. To determine the concentration of aMT6s in the 
urine samples the measured amount of radioactivity was compared to a standard curve 
consisting o f a set of standards o f known aMT6s concentration.
2.15.2.1 Radioimmunoassay reagents
(1) Tricine buffer (O.IM); The tricine buffer was made up of tricine (0.1 mol/L) 
(Sigma Ltd., UK, product number T-0377), 0.9% NaCl and 0.1% gelatine in reverse 
osmosis water (RO) to give 1 L o f stock solution (pH 5.5). To dissolve the gelatine the
stock solution was heated to 50°C for 30 min. The buffer was prepared freshly each 
week.
(2) Antiserum: Sheep anti-aMT6s antiserum (batch number G/S/1118-23884) was 
supplied lyophilised by Stoekgrand, Ltd. (University o f Surrey, UK) and reconstituted
with 1 ml RO water and 9 ml of tricine buffer to provide an intermediate solution of 
1:100. Aliquots of 100 pi were stored at -20°C. Dilution of a 100 pi aliquot with 20 
ml tricine buffer gave sufficient antiserum for 100 sample tubes (final dilution of 
1:20000).
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(3) Charcoal stripped aMT6s-ffee urine: Supplied frozen in 150 pi aliquots by 
Stoekgrand Ltd. 50 pi made up to 12.5 ml tricine buffer giving a final dilution of 
1:250.
(4) Dextran-eoated charcoal (separation system): Activated charcoal (Sigma Ltd., 
product number C-5260) was suspended in tricine buffer for 5 minutes and centrifuged 
at 4°C for another 5 minutes. The supernatant and all fines around the sides of the 
vessel were discarded. After resuspension of the charcoal to its original volume with 
tricine buffer, 0.02% dextran T-70 (Sigma Ltd., product code D-1390) was added and 
stirred for at least one hour at 4°C. It was stored at 4°C and made freshly each week.
(5) Radiolabel: *^^I-aMT6s was made in house (Aldhous and Arendt, 1988) and 
supplied by Stoekgrand Ltd. The stock was diluted with tricine buffer to provide 8000 
to 10000 cpm per 100 pi.
(5) aMT6s standards: 500 pg aMT6s was supplied by Stoekgrand Ltd. at 200 pg/ml in 
a 1:250 dilution with charcoal stripped urine. Further dilutions in charcoal stripped 
aMT6s-free urine provided standards for the standard curve ranging from 0 to 50 
ng/ml aMT6s as shown in Table 2.6.
Table 2.6: Assay standards
aMT6s standard 
200 pg/ml (pi)
aMT6s free urine 1:250 
dilution (pi)
aMT6s concentration 
(ng/ml)
0 500 0
5 495 0.5
10 490 1
20 480 2
40 460 4
70 430 7
100 400 10
200 300 20
500 0 50
2.15.2.2 Radioimmunoassay procedure
Urine samples, total counts, non-specific binding tubes, standards and quality controls 
(QC, low, medium and high) were prepared in duplicate. The zero binding tubes (0
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pg/ml aMT6s) were prepared in quadruplicate. All tubes had a final volume of 900 pi. 
The urine samples and the quality controls were diluted 1:250 with assay buffer using 
an automatic diluter (Hamilton Mierolab, USA). The urine samples, quality controls 
and the standards were in 500 pi and were incubated with 200 pi antiserum for 30 
minutes at room temperature. Then 100 pi of ’^^I-aMT6s were added to each tube, 
vortex-mixed and the whole assay incubated overnight at 4°C. During and 30 minutes 
before additional charcoal was continuously stirred; 100 pi o f the dextran-eoated 
charcoal was added to the tubes and incubated for 15 minutes at 4°C. The addition of 
charcoal to all tubes was done rapidly to minimise intra-assay variation. After the 
incubation period all tubes were centrifuged (Sovrall RC 3B Plus, Kendro Laboratories 
Ltd.) at 3000 rpm for 15 minutes at 4°C. Immediately after, the supernatant was 
discarded. The radioactivity of the non-antibody-bound fraction (in the charcoal 
pellet) was counted in a gamma counter (Wizard Perkin Elmer). The aMT6s 
concentrations were calculated using the “RIAcalc” software program and the aMT6s 
standard curve.
2.15.2.3 Cosinor analysis
Cosinor analysis is a curve fitting procedure that assumes the time series is sinusoidal 
in shape and therefore fits the best-fitting cosine curve to the data by the method of 
least squares (Nelson a/ a/., 1979, Minors and Waterhouse, 1988). This curve-fitting 
method can be used for temporally unequal spaced data points (e.g. due to missing 
data points). Using two estimates of “goodness o f fit” it determines the validity o f two 
(out of three) parameters derived from the cosinor analysis: the acrophase time (peak 
time) and amplitude (mean to peak value). The first estimation is the percentage 
variability in the data accounted by the cosine wave. It is given as a percent rhythm 
(%R), and a 100% rhythm would mean that all points of the time series fall onto the 
curve and therefore the larger the percentage the better the fit. The second estimation 
is the likelihood o f the data points fitting a straight line instead of a cosine curve or 
how probable it is that the data fit the cosine curve simply by chance. If the 
probability for the times series to fit a straight line is < 5% (p < 0.05) then a 
'significant fit' to the cosine curve is believed to have occurred (Nelson cr a/., 1979). 
The third cosinor derived parameter is the mesor which is the mean aMT6s 
concentration within the period.
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The aMT6s eoneentrations measured by the RIA in ng/ml were calculated in ng 
produced per min (ng/min). Using aMT6s concentration and the urine volume the 24 h 
output/production (pg/24 h) was calculated. The aMT6s acrophase times were 
accepted if the cosinor fit was significant at 0.1 and the variance (percentage rhythm) 
accounted for by the cosine curve was greater than 50%. This was due to the low 
number of data points/24 h.
2.16 Activities diary and appetite assessment
Participants were asked to complete an hourly activity diary (Appendix Q) for every 
day of the study approximately between get-up and bedtime (Figure 2.2).
Additionally, they were asked to rate their appetite (Appendix R) before and after 
lunch every day of the study (Figure 2.2). However, insufficient records o f both the 
activity diaries and appetite questionnaires did not permit data analysis, thus no data 
are presented.
2.17 Data analysis
Data analysis was done separately but identically for the low irradiance light study 
(chapter 3) and the high irradiance light study (chapter 4) (section 2.17.1). 
Subsequently, the data o f both light irradiance studies were analysed together (section
2.17.2; chapter 5). The significance level was set to p < 0.05 for all analyses. Section
2.17.3 refers to the statistical analysis for the aMT6s data where the significance level 
was set to p < 0.01.
2.17.1 Data analysis of each study
Weekly mean values were obtained for each outcome variable for each participant. 
Week 6 (second washout week) also served as the baseline week for the second light 
condition/exposure. For analysis purposes a total mean value of the three weeks of the 
blue-enriched light and the three weeks of the control light exposure were calculated. 
The same was done for period 1 (three weeks of the first light exposure irrespective of 
the light condition) and period 2 (three weeks o f the second light exposure irrespective 
of the light condition).
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The statistical analysis was carried out in three parts:
1. Testing for a carry-over effect
General Lineai Model Analysis of Variance for repeated measures (PROC GLM 
ANOVA) (SAS version 9.1, SAS Institute Inc., Cary, NC, USA) was performed taking 
light condition and sequence effects into consideration. No carry-over effect was 
present when p > 0.05 and further analysis was performed.
2. Testing hypothesis (1):
Sleep, activity, daytime mood and alertness, and cognitive performance
parameters will improve with artificial light exposure compared to the baseline 
(no light condition) and washout period.
The two light administration episodes were analysed separately. For each parameter a 
one-way repeated measures analysis o f variance (ANOVA) was carried out (GraphPad 
Prism version 5.03). A Bonferroni correction was made post hoc when multiple 
comparisons were computed. The six weekly mean values for each participant were 
compared with study week as a factor: the study week before the light exposure 
(baseline = BA), the three weeks o f light exposure (LI, L2, and L3) and the two weeks 
of washout after the light exposure (WAl and WA2). This analysis assessed any 
differences between the six weeks (referred to as light administration episode, section 
2.4). Analysis of the PSQI data was done on the global and component PSQI scores.
3. Testing hypothesis (2):
Sleep, activity, daytime mood and alertness, and cognitive performance
parameters will improve significantly more with the blue-enriched white light 
compared to the control white light condition.
The mean score of each outcome variable of the light exposure weeks 2, 3 and 4, and 
weeks 7, 8 and 9 were calculated and corrected for appropriate baseline (by 
subtraction). The calculations of the means were done separately for the blue-enriched 
and control light exposure. To compare the effectiveness of the two light conditions 
with each other (light condition/treatment effect) an average score of the two means
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(adjusted for baseline) of each light was used. Period effects were assessed eomparing 
the first light exposure period (weeks 2 to 4, ac^usted for baseline) with the second 
light exposure period (weeks 7 to 9, ac^usted for baseline), irrespective of the light 
condition (17000 K or 4000 K). This data analysis (using PROC GLM ANOVA) was
done for all parameters except the PSQI data. For PSQI data there was no second 
baseline value, i.e. at week 6, and therefore no baseline adjustment could be made.
To test for an effect of light condition on start light exposure times in the morning and 
evening paired Student's t-tests were performed (GraphPad Prism version 5.03).
2.17.2 Analysis of the combined studies
Data from both studies (low and high light irradiance) were combined for this analysis. 
Hypothesis (2) from above was amended and the following hypothesis (3) was tested:
Sleep, activity, daytime mood and alertness, and cognitive performance 
parameters will improve significantly more with the blue-enriched white light 
compared to the control white light condition.
Low and high irradiance light will affect the measured parameters differently 
(irradianee effect). Furthermore, sleep, activity, daytime mood and alertness, 
and cognitive performance parameters will show the greatest improvement 
with the blue-enriched white light of high irradianee.
Light irradianee was treated as a fixed effect and PROC GLM ANOVA was used to 
compare the two light conditions and the two light irradiances using the means 
obtained under the two light conditions (blue-enriched and control light) at each of the 
two irradiances (low and high), adjusted for baseline. Effects of light condition, 
period, carry-over and irradianee were assessed. This analysis was done for all 
parameters except the PSQI data.
To test for an effect o f light condition and irradianee on start light exposure times in 
the morning and evening a one-way repeated measures ANOVA (with-in subject 
factor: light condition; between subject factor: light irradianee) was performed (SPSS 
version 16.0).
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2.17.3 Urinary aMT6s data analysis
The methods for statistical analysis o f the aMT6s data are presented in chapter 6.
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3 Pilot study: Effects of low irradianee lights on older people
3.1 Introduction
Circadian rhythms in behaviour, physiology and performance alter with age; this is 
espeeially apparent in the sleep-wake rhythm whieh ean lead to sleep problems in 
older people (seetion 1.7.2). Epidemiological studies suggest that more than 40% of 
the older population suffer from sleep problems such as earlier bed- and wake-up 
times, more frequent awakenings during the night and less deep sleep (seetion 1.7.2). 
Furthermore, although not a noticeable problem for the individual, a phase-advance in 
eircadian timing and a reduction in circadian amplitude have been reported (sections
1.7.1.3 and 1.7.2) which might offer a biologieal explanation for the observed sleep 
problems. Several studies have also reported a decrease in daytime alertness and 
cognition among older individuals (section 1.7.2) and suggested an association 
between reduced sleep quality and impaired daytime functioning (section 1.7.2). 
Although a very large number o f sleep studies have been performed (seetion 1.7.3.1 
and Table 1.1) only a few studies have looked at alternative forms of non- 
pharmacological treatment, e.g. light therapy to ameliorate sleep problems in older 
community-dwelling people. In addition, the relationship between sleep problems and 
daytime alertness in this population still needs more investigation.
It is likely that sleep disturbances in older people are driven by multiple mechanisms 
(section 1.7.2). For example, in older individuals, poor or altered entrainment of the 
circadian system with the 24 h light-dark cycle, the most potent zeitgeber for the 
circadian clock, may result in weakened/dampened oscillations (and output signals) of 
the SCN (the master circadian master eloek) (seetion 1.7.1). This alteration of 
entrainment might be due to (i) redueed photie and soeial signals .yc, (ii) a redueed 
sensitivity to these zeitgebers, (iii) a deereased neuronal activity within the SCN 
(section 1.7.1.2) or a combination o f all these faetors. Another possible meehanism is 
a phase advanee of the eircadian timing system (seetions 1.7.1.3 and 1.7.2.1.1). 
Furthermore, changes in the homeostatic drive for sleep might also occur in older 
healthy individuals (seetion 1.7.2.2). In older people sleep pressure might dissipate 
faster during the sleep period, whieh eould explain early morning awakenings and/or 
the pressure on sleep initiation is lower, prolonging sleep latency (Duffy e/ a/., 1998). 
Additionally, the interaction between the circadian and homeostatic processes might be
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altered. It should also be noted that sleep problems are often seeondary to other 
illnesses, e.g. depression, or medieation. Therefore, tlie current study investigated 
sleep problems in healthy older people.
Currently, pharmaeologieal medication is the most eommon form of treatment for 
sleep problems (seetion 1.7.3). Medication however, can have various adverse side- 
effects (section 1.7.3) including tolerance towards the treatment) and aggravated 
impairment o f daytime performance (seetion 1.7.3), although new sleep medieation, 
such as non-benzodiazepine agents, have less adverse side effects (section 1.7.3).
As discussed in seetion 1.1.2, the light-dark cycle is the primary zeitgeber for the 
human circadian system. Recent research indicates that the human circadian system is 
not only sensitive to changes in the timing, duration and/or amount (irradianee) o f light 
(seetion 1.6.4) but also to specific wavelengths o f light (Brainard c/ a/., 2001; Thapan 
g/ a/., 2001). Short wavelength blue light has been shown to be most effective 
wavelength to shift the circadian phase and synchronise the biological clock (section 
1.6.4.1). Other light wavelengths may also affect non-visual responses proven to 
influence the circadian system (seetion 1.5.3).
Daily light exposure in both healthy and demented older people is often reduced 
(seetion 1.7.1.1.2) which can cause eircadian alterations leading to sleep problems. 
This could be due to less time spent outdoors, low indoor light levels and/or age- 
related physiological changes at the eye such as reduced pupil size, increased lens 
density and altered pigmentation (seetion 1.7.1.1.1). These lens changes impede light 
transmission especially of short wavelength blue light potentially reducing the 
effectiveness o f light on the biologieal eloek.
Controlled light exposure appears promising to improve sleep problems and daytime 
cognitive impairments in older adults. Several studies have used bright white light as 
an alternative to the commonly prescribed hypnotics (section 1.7.3.1 and Table 1.1), 
yet, only few groups have studied community-dwelling older people (seetion 1.7.4). 
The results suggest that administration of bright white light not only has the ability to 
improve sleep (seetion 1.7.3.1 and Table 1.1) but also to enhance daytime performance 
(Murphy and Campbell, 1996; Kobayashi a/ a/., 1999; Kohsaka e/ a/., 2000) in older 
independently living adults. To date, no one has looked at whether enhancing the
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amount of blue wavelengths in polychromatic white light benefits light 
therapy/exposure in community-living older adults with sleep problems.
3.2 Aims and hypotheses
The aim of the present study was to assess and compare the effset of exposure to a 
blue-enriched white light (17000 K) and a control white light (4000 K) on subjective 
and actigraphie assessment of sleep, activity, daytime mood and alertness and 
cognitive performance in healthy older people (> 60 years) with self-reported sleep 
problems (assessed with Pittsburgh Sleep Quality Index > 5). The two photon- 
matched light conditions were of low irradianee and delivered as a skeleton 
photoperiod for three weeks each.
The two working hypotheses of this study are:
Hypothesis!: Both low irradianee light conditions will improve subjective and 
actigraphie sleep, activity, daytime mood and alertness, and cognitive performance 
compared to the no light conditions (baseline and washout).
Hypothesis:: The magnitude o f the responses elicited by the blue-enriched white light 
will be greater than that of the control white light condition (speetral-sensitivity 
effect).
3.3 M ethods
For full details of the methods and the study design see General Methodology, chapter
2. Outlined here are the methodologies specific to the low irradianee light study which 
served also as a pilot study. A brief summary o f the data analysis will be given. A 
favourable ethical opinion for this study was obtained from the University of Surrey 
Ethics Committee (EC/2006/57/SBMS) (Appendix S).
3.3.1 Participants
Fifteen participants were recruited to the pilot study and studied for 11 consecutive 
weeks either during October -  December 2006 or January -  March 2007. Participants
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were community-dwelling older people (9 females and 6 males; age range 6 0 - 7 3  
years; mean ± SD: 65.6 ± 4.0 years) who were not in full-time employment (six in 
part-time employment). Of the 15 participants three were single, five divorcees, one 
widow and six were married. Table 3.1 presents the demographics of all 15 
participants; participants are separated by season and first light condition they 
received.
Statistical analysis of sleep and activity data could be performed on only 12 
participants for the following reasons: one participant (HLS031, female) submitted 
incomplete data and two other participants (HLS030, female, and HLS043, male) 
withdrew because of reported headaches during and/or after the first light treatment 
(the blue-enriched light condition in both cases) after having completed only six weeks 
of the 11-week study.
Table 3.1: Demographics of the participants
Group Code Age(years) Gender Marital status Employment
Oct -  Dec HLS026 65 F Widow Retired
Oct -  Dec HLS029 67 F Married Retired
Oct -  Dec HLS031* 67 F Single Retired
Oct - Dec HLS019 65 F Single Retired
Oct -  Dec HLS032 65 F Married Part-time
Oct -  Dec HLS037 61 M Married Retired
Jan -  Mar HLS030* 68 F Divorced Retired
Jan -  Mar HLS039 73 F Divorced Part-time
Jan -  Mar HLS041 61 F Divorced Part-time
Jan -  Mar HLS043* 66 M Married Retired
Jan -  Mar HLSOlO 71 M Single Part-time
Jan -  Mar HLS0I8 60 F Married Part-time
Jan -  Mar HLS036 60 M Divorced Part-time
Jan -  Mar HLS044 65 M Married Retired
Jan -  Mar HLS047 70 M Divorced Retired
65.6
±4.0
(mean
±SD)
9 F, 
6M
6 married, 
1 widow,
5 divorced, 
3 single
9 retired, 
6 part-time
B lue font: participants w ho received the b lue-enriched light first. Y e llo w  highlight: participants w ho  
received the control light first. * indicates participants not included in the statistical analysis.
Table 3.2 presents the screening values for the study population. The PSQI score 
(sections 2.3 and 2.6.3) was the principal measure to determine eligibility for inclusion 
to the study. The global PSQI score for the total study population (n = 15) was 13.4 ±
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2.2 (mean ± SD) (range 10 -  17). The Home-Ostberg momingness-eveningness score 
(MEQ) was 60.3 ± 10.0 (mean ± SD), ranging between 39, a moderately evening type 
(participant HLS044), and 76, a definite morning type (participant HLS018). Three 
other participants were definite morning types (MEQ scores between 70 -  86), five 
were moderately morning types (MEQ seores between 59 -  69) and five partieipants 
were neither types (MEQ scores between 42 -  58). The mean (± SD) score for the 
Beck Depression Inventory (EDI) fell within the minimal range from 0 - 1 3  (section 
2.3). Participants HLS037 and HLS036 scored 21 or higher on the EDI (indicating 
moderate depression). Two of the 15 participants, HLS32 and HLS037, had Epworth 
Sleepiness Scale scores of 12 and 14, respectively, indicating increased daytime 
sleepiness (threshold of 10; section 2.3).
Table 3.2: Results of the screening questionnaires of the study participants
Code PSQI Horne-Ostberg
Questionnaire
Epworth Sleepiness 
Scale
Beck Depression 
Inventory
HLS026 17 60 3 14
HLS029 12 56 2 7
HLS031* 16 55 2 9
HLS019 16 50 9 15
HLS032 14 70 12 0
HLS037 11 52 14 21
HLS030* 10 64 2 6
HLS039 12 52 1 3
HLS041 15 61 8 8
HLS043* 12 71 5 4
HLSOlO 15 65 6 7
HLS018 11 76 9 7
HLS036 14 73 9 22
HLS044 15 39 8 5
HLS047 11 60 3 10
Mean ± SD 13.4 ± 2.2 60.3 ± 10.0 6.2 ± 4.0 9.2 ± 6.3
Range 10-17 39- 76 1 - 14 0 - 2 2
B lue font: participants w ho received the blue-enriched light first. Y e llo w  highlight: participants w ho  
received the control light first. * indicates participants not included in the statistical analysisT
Details of the participants’ ocular status obtained from ophthalmological examination 
by a registered optician and self-reported alcohol, cigarette and medieation 
consumption are presented in Tables 3.3 and 3.4, respectively. For four participants 
(HLS018, HLS029, HLS031 and HLS043) no ophthalmological data were obtained. 
This was either due to the optician not providing the results or to the participants being 
unable to attend their appointment.
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None of the 11 examined participants suffered from a serious eye condition although 
three participants (HLSOlO, HLS030 and HLS039) showed signs of an early cataract. 
The photopic and scotopic pupil sizes fell within the expected range for the age of 
participants (Sample e/ a/., 1988; Brown er a/., 2008). None o f the participants was 
colour blind according to the Ishihara Colour Blindness Test (range: no errors -  4 
errors). Ten participants wore glasses; two did not wear glasses at all and three wore 
glasses only for reading. None of the medication the participants said they were taking 
is known to affect sleep or the endogenous melatonin rhythm (Table 3.4). All 
participants’ alcohol consumption was under the recommended weekly limit (14 units 
for women and 21 units for men, respectively). Only participants HLS018 and 
HLS043 were regular smokers, all other participants were non-smokers.
3.3.2 Light parameters
Details o f the light sources, including photon density calculations and settings, which 
were applied in this study, have been described in detail in section 2.5.4.2.5. The blue- 
enriched light source contained double the amount of short wavelengths blue photons 
than the control light source. The photon densities of the light sources, however, were 
similar. Table 3.5 presents only a simple comparison of the photon densities used for 
the blue-enriched light and the control light source.
Table 3.5: Administered photon densities of the two light sources
Blue-enriched light Control light
Colour temperature (K) 17000 4000
Total photons (photon/cmVsec) 3.59 X 10^ " 3.65 X 10"
‘Blue’ photons
(400-490 nm) (photon/cm^/sec)
1.77 X 10‘^ 8.86 X lO"
3.3.3 Pittsburgh Sleep Quality Index (PSQI)
Specific to the current study was that the first six participants, HLS019, HLS026, 
HLS029, HLS32, HLS37 (and HLS31 who was not part of the statistical analysis) of 
the study completed only four PSQIs questionnaires: at screening and the end of week 
4, week 9 and two weeks post-study. The remaining nine participants (including
participants HLS030 and HLS043 who were not part of the statistical analysis)
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completed an additional PSQI questionnaire at the begirming of week 1 (section 2.6.3). 
Data analysis was therefore performed on the 12 participants who were included in all 
of the statistical analysis and for the seven participants who completed the additional 
PSQI.
3.3.4 Statistics
The detailed data analysis is described in section 2.17, and only a brief summary o f the 
stepwise analysis process will be presented here. Carry-over effect was assessed using
General Linear Model Analysis of Variance for repeated measures (PROC GLM 
ANOVA). The raw data from 12 participants was used for every analysis using PROC 
GLM. The effect o f both light conditions compared to baseline and washout were 
analysed separately using one-way repeated measures ANOVA with Bonferroni
hoc test for multiple comparisons. Both global and component PSQI scores were 
analysed separately for all 12 participants and the seven participants who completed 
the additional PSQI. Effects o f light condition (blue-enriched light vs. control light) 
and period effects (first exposure vs. second light exposure period) were assessed using 
PROC GLM ANOVA (with mean values adjusted for baseline for each parameter). 
No analysis using PROC GLM was performed on the PSQI data.
For analysis purposes the data were divided into light administration episodes which 
consisted of six weeks: one week baseline (BA), three weeks of light exposure period 
(LI, L2 and L3) followed by two weeks of washout (WAl and WA2). This division 
into weekly episodes was applied to all measurements prior to statistical analysis. The 
second week o f washout (WA2) after the first light exposure acted as the baseline 
week (BA) for the second light exposure period (Table 2.1 and Figure 2.1).
3.4 Results
Only parameters that showed a statistically significant change during one or both light 
administration episodes are reported in the following sections. In a few cases, non­
significant (NS) results are also presented to aid interpretation of the results (this is
stated in the relevant sections). Decimal hours (mean ± SEM) are reported for all 
clock times, durations and differences in timing unless otherwise stated.
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3.4.1 Light exposure
Daily light exposure was scheduled as a skeleton photoperiod, i.e. 2 h in the morning 
and for 2 h in the evening (section 2.5.1). Participants were permitted to choose light 
exposure times that suited their schedules. Table 3.6 shows the mean (± SEM) o f self- 
reported start and end (clock) times for the morning (am) and evening (pm) light 
exposure sessions and o f the duration o f the light exposure sessions (corrected for 
breaks taken) for each light condition.
Table 3.6: Self-reported start and end (clock) times and duration (mean ± SEM) of the light
Start (h:min) End (h:min) Duration (h:min)
Blue-
enriched
light
am 07:52 ±00:15 09:50 ±00:13 01:50 ±00:03
pm 18:21 ±00:17 20:30 ±00:18 01:55 ±00:06
Control
light
am 07:51 ±00:15 09:52 ±00:12 01:52 ±00:04
pm 18:16±00:19 20:18 ±00:20 01:58 ±00:02
As can be seen from Table 3.6, participants generally followed the instructions for the 
light administration. Participants completed more than 90% of the aspired exposure
time for each light session in the morning and evening (42 h in each light condition for 
the morning and evening session, respectively). Paired Student’s t-tests did not reveal 
any significant differences in the timing and duration of the light exposure between the 
light conditions.
3.4.2 Subjective sleep maps
Subjective sleep maps are shown in Figure 3.1, for participant HLS026, and in Figure 
3.2, for participant HLS047. Time trying to sleep in the evening and wake-up times 
(during the night and in the morning), derived from the subjective sleep diaries, were 
plotted for each day of weeks 1, 4 and 6 (part o f the first light administration episode), 
and weeks 6, 9 and 11 (part o f the second light administration episode). For 
participant HLS026 acrophase times of aMT6s, the m^or urinary melatonin metabolite 
(chapter 6), were obtained and are indicated in the sleep map. Neither of the two 
participants reported naps throughout the entire study.
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Figure 3.1: Subjective sleep maps o f  participant H L S026. A ) W k l, w eek  1, baseline; W k4, 
w eek 4, last w eek  o f  blue-enriched light exposure; W k 6, w eek 6, last w eek  o f  washout; and B) 
W k 6, baseline; W k 9, last w eek  o f  control light exposure; W k 11, last w eek  o f  washout 
{: w eek  o f  baseline/w ashout; {: w eek  o f  blue-enriched light exposure; {: w eek  o f  control light 
exposure; ★ : aM T 6s acrophase time; black bars: sleep; w hite bars: wake; grey bars: sleep  latency; 
y e llo w  bars: tim e awake at night; green line separates the w eeks.
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Figure 3.2: Subjective sleep maps o f  participant H L S047. A ) W k 6, w eek 6, last w eek  o f  
washout; Wk 9, w eek  9, last w eek o f  blue-enriched light exposure; W k 11, w eek  11, last w eek  
o f  washout; and B) W k l, w eek 1, baseline; W k4, last w eek  o f  control light exposure; W k 6, 
last w eek  o f  washout.
{; w eek  o f  baseline/w ashout; {; w eek  o f  blue-enriched light exposure; {; w eek  o f  control light 
exposure;"^: aM T 6s acrophase time; black bars: sleep; w hite bars: wake; grey bars: sleep  latency; 
ye llo w  bars: tim e awake at night; green line separates the w eeks.
3.4.3 Subjective sleep
On each study day participants completed a sleep diary upon awakening in the 
morning (Appendix I). From these diaries the subjective sleep parameters were 
obtained (Table 2.4) and analysed (sections 2.17 and 3.3.4). A carry-over effect was 
only observed (using PROC GLM) for subjective get-up time which was therefore 
excluded from any further analysis.
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3.4.3.1 Sleep latency
As can been seen in Figure 3.3, a significant reduction in sleep latency was observed 
following exposure to blue-enriched light compared to baseline (F = 3.51, p < 0.01). 
Sleep latency was on average reduced by 14 min during the two washout weeks 
(WAl: 27 + 8 min and WA2: 27 ± 8 min) compared to baseline (41 ± 9 min). During 
and aAer the control light exposure sleep latency was significantly reduced (F = 4.50, p 
<0.01) during the second (32 + 8 min) and third (3 1 + 9  min) week of light exposure 
and the first week of washout (28 ± 8 min) compared to baseline (48 + 11 min). Sleep 
latency began to increase again in the second week o f washout (NS).
60 n
40-
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BA L1 L2 L3 WA1 WA2
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Figure 3.3: Sleep latency (mean ±  SEM , n = 12) during the blue-enriched (-o-) and control (■) 
light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0 .05 com pared to B A  o f  the blue-enriched light; * p <  0.05 and ** p <  0.01 com pared to B A  o f  
the control light.
3.4.3.2 Sleep onset time
The weekly subjective sleep onset data are shown in Figure 3.4, and a significant effect 
on the time o f sleep onset was only observed following the control light administration 
episode (F = 2.78, p < 0.05). Following the control light exposure, sleep onset was 
advanced by about 0.4 h in the first week of washout (24.0 + 0.3 h) compared to 
baseline (24.4 ± 0.2 h). Though not statistically significant, in the second week of 
washout sleep onset was again delayed. During the blue-enriched light the time of 
sleep onset did not differ significantly from baseline and advanced slightly in the 
washout period.
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Figure 3.4: Sleep onset (mean ± SEM, n = 12) during the blue-enriched (-0-) and control (■) 
light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
* p < 0.05 com pared to B A  o f  the control light.
3.4.3.3 Duration of night awakenings/night
Figure 3.5 presents weekly data for subjeetive duration o f night awakenings/night. 
The duration of night awakenings showed a signifieant reduction (F = 2.85, p < 0.05) 
of 26 + 12 min during the third week o f control light (23 ± 5 min) compared to 
baseline (49 ± 13 min). In the washout the time spent awake per night increased again 
(NS). During the weeks o f blue-enriched light exposure a similar, but not statistically 
significant, decrease in the duration of night awakenings occurred.
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Figure 3.5: Duration of night awakenings/night (mean ± SEM, n = 12) during the blue-
enriched (-0-) and control (■) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
** p <  0.01 com pared to B A  o f  the control light.
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3.4.3.4 Wake-up time
Subjective wake-up time, illustrated in Figure 3.6, changed significantly during both 
the blue-enriched light (F = 2.83, p < 0.05) and control light (F = 2.54, p < 0.05) 
episodes. Wake-up time was significantly advanced with the blue-enriched light by 
approximately 0.5 h in the second week o f light exposure (6.6 + 0.4 h) compared to 
baseline (7.1 + 0.4 h). Wake-up time delayed again by approximately 0.5 h in washout 
week two (7.1 ± 0.3 h) compared to the second week of light exposure. With the 
control light wake-up time advanced significantly (F = 2.54 p < 0.05) by 0.6 h in the 
third week of light exposure (6.7 ± 0.4 h) compared to the baseline week (7.2 ± 0.3 h). 
During both light episodes the wake-up time delayed in the second week of washout 
(NS).
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Figure 3.6: W ake-up time (mean ±  SEM , n =  12) during the blue-enriched (-o-) and control 
(■) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0 .05  com pared to B A  and W A 2 o f  the b lue-enriched light; * p <  0 .05 com pared to B A  o f  the 
control light.
3.4.3.S Sleep duration
The weekly data for subjective sleep duration are shown in Figure 3.7. A significant 
increase in sleep duration following the blue-enriched light exposure (F = 2.72, p < 
0.05) was found for the second week of washout (6.6 ± 0.2 h) compared to the second 
week o f light exposure (5.9 ± 0.3 h). Sleep duration during the control light 
administration episode showed no significant changes.
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Figure 3.7: Sleep duration (mean ± SEM, n = 12) during the blue-enriched (-o-) and control 
(«) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
A p < 0.05 compared to L2 o f the blue-enriched light.
3.4.3.6 Sleep efficiency
A significant increase in subjective sleep efficiency (Figure 3.8) for the blue-enriched 
(F = 2.79, p < 0.01) and control (F = 4.11, p < 0.05) light administration episodes was 
observed. During the control light sleep efficiency significantly increased in the third 
week of light exposure (87.5 ± 1.7%) when compared to baseline (79.4 ± 3.1%) by 8.1 
± 3.4%, and in the first washout week (84.9 ± 2.3%) by 7.1 + 2.5% compared to the 
baseline week. However, during WA2 sleep efficiency began to decrease again (NS).
9 5 i
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Study week
Figure 3.8: Sleep efficiency (mean ± SEM, n = 12) during the blue-enriched (-o-) and control 
(m) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: w ashout period.
A p < 0.05 compared to BA of the blue-enriched light; * p < 0.05 and ** p < 0.01 compared to BA of
the control light.
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A significant increase in sleep efficieney by 5.6 + 3.5% following the bine-enriched 
light exposure was observed in the second week o f washout (88.1 ± 2.2%) compared to 
baseline (82.5 ± 2.2%).
3.4.3.7 Sleep quality
Figure 3.9 shows the weekly mean subjective sleep quality data before, during and 
after each light exposure. Sleep quality was rated on a 1 9 scale every morning (1 =
best sleep, 9 = worst sleep; section 2.6.1). Following the control light exposure sleep 
quality had significantly improved (F = 4.03, p < 0.01) by about 0.7 points in the first 
week of washout (5.4 ± 0.5 points) compared to baseline (6.1 + 0.4 points) and to the 
second week of light exposure (6.2 + 0.4 points). The lowest sleep quality score 
during the blue-enriehed light administration episode was observed in L3. However, 
this improvement was not statistically different from the other weekly means during 
the blue-enriched light administration episode.
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Figure 3.9: Sleep quality (mean ± SEM, n = 12) during the blue-enriched (-o-) and control (■) 
light administration episodes. A lower value indicates better sleep quality.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p <  0 .05 com pared to B A  and L2 o f  the control light.
3.4.3.S Comparison of the light conditions and exposure periods
Overall, there were no statistically significant differences between the light conditions
or exposure periods on subjective sleep using PROG GLM (sections 2.17 and 3.3.4).
The mean (± SEM) values for the three weeks (LI, L2 and L3) of the blue-enriched
and control light exposure for each subjective sleep parameter are given in Table 3.7.
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T ab le 3.7: Subjective sleep parameters (mean ± SEM, n = 12) for the three weeks of blue -
Subjective sleep parameter Blue-enriched light Control light
Bedtime (dec.h) 23.3 ±0 .2 23.2 ±0 .2
Time trying to sleep (dec. h) 23.7 ± 0.2 23.6 ± 0 .2
Sleep latency (min) 34 ± 9 33 ± 8
Sleep onset time (dec. h) 24.2 ± 0.2 24.1 ± 0 .2
Number o f night awakenings/night 1.1 ± 0.2 1.3 ± 0.2
Duration of night awakenings/night (min) 25 ± 7 30 ± 7
Wake-up time (dec. h) 6.7 ± 0.3 6.8 ± 0.3
Get-up time (dee. h) 7.5 ± 0.2 7.6 ± 0 .2
Sleep duration (dec. h) 6.1 ± 0.3 6.2 ±0.3
Sleep effieieney (%) 86.2 ± 2.3 85.5 ±1 .7
Sleep quality (l=best sleep, 9=worst 
sleep)
5.5 ± 0.5 6.0 ± 0.4
indicates carry-over effect (PROC GLM).
3.4.4 Actigraphic sleep
All participants wore an AWL continuously on their non-dominant wrist throughout 
the 11-week study period (section 2.6.2); the aetigraphy data were analysed using the 
Aetiwateh software package (Sleep Analysis 7, version 7.23) prior to statistical 
analysis (see following sections). Statistically significant differences will be presented 
in detail in the following sections. In some cases non-significant (NS) results are also 
presented to aid the interpretation of the results (this will be stated in the relevant 
sections). Decimal hours (mean + SEM) are reported for all clock times, durations and 
differences in timing unless otherwise stated.
3.4.4.1 Duration of night awakenings/night
As can been in Figure 3.10, actigraphic duration o f night awakenings/night decreased 
significantly (F = 3.75, p < 0.01) during and after the blue-enriched light exposure, i.e. 
in the third week of light exposure (55 ± 7 min) and the first week of washout (56 ± 7 
min) compared to the second week o f washout (65 ± 7 min). The duration of night
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awakenings/night during the three weeks of control light exposure was reduced 
compared to baseline (NS).
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Figure 3.10: Actigraphic duration of night a wakenings/night (mean ± SEM, n = 12) during the 
blue-enriched (-0-) and control (■) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
A p <  0.05 com pared to W A 2 o f  the blue-enriched light.
3.4.4.2 Mean wake bout time
In Figure 3.12 the weekly data for actigraphic mean wake bout time are shown. 
During the blue-enriched light exposure mean wake bout time showed a significant 
decrease (F = 2.83, p < 0.05) in the second week (2.5 ± 0.3 min) o f light exposure and 
first week o f washout (2.5 ± 0.2 min) compared to WA2 (3.0 ± 0.4 min).
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Figure 3.11: Mean wake bout time (mean ± SEM) during the blue-enriched (-0-) (n = 18) and 
control (■) light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
A p < 0.05 compared to WA2 o f the blue-enriched light.
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3.4.4.3 Wake-up time
The weekly data for the actigraphic wake-up time are shown in Figure 3.12. A 
statistically significant advance (F = 2.77, p < 0.05) in actigraphic wake-up time by 
approximately 0.4 h was observed during the second (7.0 ± 0.3) and third (7.0 ± 0.2 h) 
week of control light exposure compared to baseline (7.4 ± 0.3 h). During the blue- 
enriched light administration episode wake-up time showed a non-significant trend to 
advance compared to baseline.
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Figure 3.12: Actigraphic wake-up time (mean ± SEM, n = 12) during the blue-enriched (-0-) 
and control (■) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p <  0 .05 com pared to B A  o f  the control light.
3 4.4.4 Comparison of the light conditions and exposure periods
Significantly higher sleep efficiency (F (i, lo) = 5.02, p < 0.05) was observed with the
control light compared to the blue-enriched light exposure (after adjustment for
baseline) as shown in Figure 3.13. Sleep efficiency increased by 1.9 ± 0.9% during the
control light compared to its baseline. During the blue-enriched light the increase was
0.2 ± 0.6% compared to baseline. No other statistically significant differences in any
other actigraphic sleep parameters were found between the two light conditions. No
period or carry-over effects were observed.
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Figure 3.13: Sleep efficiency (individual and 3-week mean ± SEM) as change from baseline 
during the blue-enriched (o) and control light (■) exposure.
Blue-enriched: blue-enriched light exposure; Control: control light exposure.
The mean (± SEM) values for the three weeks (LI, L2 and L3) o f the blue-enriched 
and control light condition for each actigraphic sleep parameter are given in Table 3.8.
Table 3.8: Actigraphic sleep parameters (mean ± SEM, n = 12) for the three weeks of blue-
Actigraphic sleep parameter Blue-enriched light Control light
Sleep latency (min) 20 ± 5 18 ± 4
Sleep onset time (dec. h) 24.0 ± 0.2 23.8 ± 0.2
Duration of night awakenings/night (min) 57 ± 8 59 ± 9
Time spent awake at night (%) 13.5 ±1.8 13.7 ± 1.8
Wake-up time (dec. h) 7.0 ±0 .2 7.0 ± 0 .2
Sleep duration (dec. h) 6.1 ± 0.2 6.2 ± 0.2
Sleep (%) 86.5 ±1.8 86.3 ± 1.8
Sleep efficiency (%) 82.3 ±2 .2 82.7 ±2.1*
Mean length o f sleep bouts (min) 18 ± 1 18± 1
Mean length o f wake bouts (min) 3 ± 0 3 ± 0
Immobile time (%) 85.5 ± 1.5 85.7 ± 1.6
Immobile phases (number) 35.1 ±2.3 35.4 ± 2.4
Total activity score (activity counts) 9738 ± 2386 10276 ±2530
Fragmentation index 30.8 ± 3.3 30.4 ± 3 .0
* p < 0 .05  com pared to the blue-enriehed light (PRO C G LM ).
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3.4.5 Pittsburgh Sleep Quality Index (PSQI)
Data analysis was performed separately on 12 participants and seven participants. 
Statistically significant and non-significant results will be presented in the following 
sections. Lower PSQI scores indicate sleep improvement.
3.4.5.1 Global PSQI score
Figure 3.14A presents the PSQI scores (mean ± SEM) of the 12 participants. A 
significant reduction in PSQI scores was observed after the blue-enriched light (10.3 ± 
0.8), after the control light (10.7 ± 0.6) and four weeks after the second light exposure 
(post-study) (8.8 ± 1.3) compared to the score at screening (13.6 ± 0.6) (F = 11.53, p < 
0.001). Figure 3.14B shows the PSQI scores of the seven participants who completed 
the PSQI at five time points during the study. Significantly reduced PSQI scores were 
observed after the blue-enriched light (9.9 ± 1.3) and post-study (8.4 ± 1.6) compared 
to the PSQI score at screening (13.3 ± 0.7). A significantly reduced PSQI score (F = 
6.51, p < 0.01) was also observed post-study compared to the PSQI score at week 1 
( 12.0 ± 1.0).
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Figure 3.14: PSQI scores prior to the study, after the blue-enriched and control light exposure 
and four weeks after the second light exposure. A) n = 12 (mean ± SEM) and B) n =7 (mean ± 
SEM) including an additional PSQI score at the start of week 1.
Screening: at screening; W k l: w eek  1; Blue: b lue-enriched light; Control: control light.
* p < 0.05, ** p < 0.01 and *** p < 0.001 compared to the PSQI score at screening; A p < 0.05 
com pared to the PSQI score at the start o f  w eek  1.
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3 4.5.2 PSQI component scores
The PSQI component scores for sleep quality, sleep latency, habitual sleep efficiency, 
sleep duration and daytime dysfunction showed significant changes after light 
exposure. Lower PSQI scores indicate fewer sleep problems (PSQI score range 0 -  3).
3.4.5.2.1 PSQI sleep quality
Sleep quality measured with the PSQI is shown in Figure 3.15 (A and B); a lower 
score indicates better sleep.
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Figure 3.15: PSQI sleep quality scores prior to the study, after the blue-enriched and control 
light exposure and four weeks after the second light exposure. A) n = 12 (mean ± SEM) and
B) n =7 (mean ± SEM) including an additional PSQI score at the start of week 1.
Screening; at screening; W k l: w eek  1; Blue: blue-enriched light; Control: control light.
* p <  0.05 and ** p <  0.01 com pared to the screening score; A p <  0 .05  com pared to the score at the start 
o f  w eek 1.
Figure 3.15A presents sleep quality scores for all 12 participants. A statistically 
improved (F = 7.51, p < 0.0001) sleep quality score was observed after the blue- 
enriched light (1.7 ± 0.2), after the control light (1.8 ± 0.2) and post-study (1.7 ± 0.3) 
compared to the score at screening (2.4 ± 0.2). Figure 3.15B shows the subjective 
sleep quality for the seven participants who completed the additional PSQI at the 
beginning of week 1. The sleep quality score significantly improved (F = 7.53, p < 
0.001) after the blue-enriched light (1.6 ± 0.3) and at post-study (1.4 ± 0.4) compared 
to the score at screening (2.6 ± 0.6). Sleep quality was also improved at post-study 
compared to week 1 (2.3 ± 0.2).
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3.4.S.2.2 PSQI sleep latency
The sleep latency scores for 12 participants are shown in Figure 3.16A; Figure 3.16B 
shows the sleep latency scores (NS) for the seven participants who completed an 
additional PSQI questionnaire at the beginning of week 1.
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Figure 3.16: PSQI sleep latency scores prior to the study, after the blue-enriched and control 
light exposure and four weeks after the second light exposure. A) n = 12 (mean ± SEM) and 
B) n =7 (mean ± SEM) including an additional PSQI score at the start of week 1.
Screening: at screening; Wkl: w eek  1; Blue: blue-enriehed light; Control: control light.
* p <  0 .05 and ** p <  0.01 compared to the screening score.
As can be seen in Figure 3.16A the scores for sleep latency decreased significantly (F 
= 6.67, p < 0.05) after the blue-enriched light (1.6 ± 0.3), after the control light (1.7 ± 
0.3) and post-study (1.5 ± 0.3) compared to the score at screening (2.5 ± 0.2). No 
significant differences were observed when analysing the seven participants with an 
extra PSQI separately (Figure 3.16B).
3.4.5.2.3 PSQI habitual sleep efficiency
Figure 3.17A illustrates the data for the habitual sleep efficiency scores for all 12
participants and Figure 3.17B illustrates this for seven participants who completed an 
extra PSQI.
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Figure 3.17: PSQI sleep efficiency scores prior to the study, after the blue-enriched and 
control light exposure and four weeks after the second light exposure. A) n = 12 (mean ± 
SEM) and B) n =7 (mean ± SEM) including an additional PSQI score at the start of wk 1. 
Screening: at screening; W k l: w eek  1; Blue: blue-enriched light; Control: control light.
* p  <  0.05 com pared to the score at screening.
The sleep efficiency score improved signiftcantly (F = 3.03, p < 0.05) at post-study 
(1.8 ± 0.3) compared to the score at screening (2.7 d: 0.3) for the 12 participants 
(Figure 3.17A). Figure 3.17B presents the sleep efficiency scores for the seven 
participants. The score for sleep efficiency was significantly lower (F = 3.00, p < 
0.05) (indicating improved sleep efficiency) at post-study (1.6 ± 0.4) when compared 
to the score at screening (2.9 ± 0.1).
3.4.5.2.4 PSQI sleep duration
The scores for sleep duration as measured with the PSQI are presented in Figure 3 .ISA 
all 12 participants and in Figure 3.18B for seven participants. As can be seen in Figure 
3.ISA, the score for sleep duration was significantly decreased (F= 4.46, p < 0.01) at 
post-study (l.S  ± 0.3) compared to the scores at screening (2.5 ± 0.2), after the blue- 
enriched light (2.4 ± 0.4) and the control light (2.5 ± 0.2). The sleep duration scores 
for seven participants (Figure 3.1 SB) showed a significant improvement (F = 3.00, p < 
0.5) in sleep duration score post-study (1.7 ± 0.3) compared to the blue-enriched light 
(2.6 ± 0.2) and the control light (2.6 ± 0.2) scores.
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Figure 3.18: PSQI sleep duration scores prior to the study, after the blue-enriched and control 
light exposure and four weeks after the second light exposure. A) n = 12 (mean ± SEM) and
B) n =7 (mean ± SEM) including an additional PSQI score at the start of week 1.
Screening: at screening; Wkl: week 1; Blue: blue-enriched light; Control: control light.
* p <  0.05 com pared to the post-study score.
3.4.5.2.5 PSQI daytime dysfunction
Daytime dysfunction scores are shown in Figure 3.19; the scores for all 12 participants 
are shown in Figure 3.19A and for the seven participants in Figure 3.19B.
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Figure 3.19: PSQI daytime dysfunction scores prior to the study, after the blue-enriched and 
control light exposure and four weeks after the second light exposure. A) n = 12 (mean ± 
SEM) and B) n =7 (mean ± SEM) including an additional PSQI score at the start of week 1. 
Screening: at screening; W k l: w eek  1; B lue: b lue-enriched light; Control: control light.
* p < 0 .05 and ** p < 0.01 com pared to the screening score.
The score for daytime dysfunction decreased significantly (F = 5.10, p < 0.01) after the 
blue-enriched light condition (0.8 ± 0.2) and at post-study (week 13) (0.7 ± 0.2) when 
compared to the score at screening (1.3 ± 0.2). No significant differences were
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observed when separately analysing the seven participants who completed an extra
PSQI at the start of week 1.
3.4.6 Subjective naps
Of the 12 participants eight participants (67%) reported napping. All subsequent nap 
analysis was conducted on these eight participants. No carry-over effect was observed 
for the daily duration o f naps or the daily number of naps.
3.4.6.1 Duration and number of naps
Figures 3.20A and 3.20B illustrate the weekly mean (± SEM) nap duration and number 
of naps per day before, during and after each of the light exposures.
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Figure 3.20: Subjective napping (mean ± SEM, n = 8) during the blue-enriched (-o-) and 
control (■) light administration episodes. A) nap duration in minutes per day and B) nap 
number per day.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
The subjective duration of naps per day did not change significantly during any of the 
light administration episodes (Figure 3.20A). Figure 3.20B shows the subjective 
number of naps taken per day (mean ± SEM) before, during and after light exposure.
No statistically significant change in the number of naps taken per day during the 
control or blue-enriched light administration episode was observed.
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3.4.6.2 Comparison of the light conditions and exposure periods
No significant difference in subjective nap duration between the three weeks of blue-
enriched light (14 ± 4 min) and the three weeks of control light (10 ± 2 min) was
observed. Similarly, no significant difference in the subjective number of naps per day
between the blue-enriched light (0.5 ± 0.0) and the control light (0.4 ± 0.0) condition
was observed. No effects of period and carry-over were observed for the subjective
number and duration of naps.
3.4.7 Daytime and time-in-bed activity
For each participant an average daytime and time-in-bed (night) were defined using 
individual subjective bedtimes and get-up times provided by the participants (section 
2.8). These times were then applied to the hourly activity values, obtained from the 
AWL data, to discriminate between daytime and time-in-bed activity levels.
3.4.7.1 Daytime activity
Daytime activity (mean ± SEM), during each light administration episode, is shown in 
Figure 3.21 A. Daytime activity was significantly increased (F = 3.56, p < 0.01) in the 
first week o f washout (22349 ± 4343 activity counts/h/day) compared to the first week 
of blue-enriched light exposure (19383 ± 3687 activity counts/h/day). No statistically 
significant differences of time-in-bed activity were observed before, during and after 
either of the two light exposures (Figure 3.2 IB).
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Figure 3.21: Activity levels (mean ± SEM, n = 12) during the blue-enriched (-o-) and control 
(■) light administration episodes for A) daytime activity and B) time-in-bed activity.
BA; baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0.05 com pared to LI o f  the blue-enriched light.
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3.4.T.2 Examples of activity profiles
Hourly mean activity levels were plotted for each week for each participant (derived 
from the activity counts per hour o f each day within the week). Figure 3.22 shows the 
first week o f washout (following control light exposure) of one participant (HLS026) 
as an example o f the 24 h activity profile with hourly mean activity levels (activity 
counts/hour). A clear differentiation between daytime and time-in-bed activity can be 
seen with increased activity occurring around 08:00 h, remaining high between 08:00 -  
18:00 h, declining between 19:00 -  24:00 h and with low activity between 01:00 -  
07:00 h.
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Figure 3.22: Mean (± SEM) hourly activity levels (activity counts/hour) for the first washout 
week (WAl, following control light exposure) of participant HLS026.
Representative 24 h activity plots are shown in Figure 3.23. Figure 3.23B portrays the 
activity levels during the second week o f control light exposure (L2) of participant 
HLSOIO. Activity between 09:00 h and 10:00 h and between 18:00 h and 19:00 h was 
reduced. This reduction in activity coincides with the times the participant reported 
sitting in front of the light box during the second week o f control light exposure (mean 
start and end time: morning 08:09 h -  09:52 h, evening 18:26 h -  20:26 h). Figure 
3.23A shows the corresponding baseline week (week 1) for this participant. For seven 
of the 12 participants similar patterns in the 24 h activity plots were observed whereas 
the other five participants had more varied 24 h activity plots.
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Figure 3.23: Mean (± SEM) hourly activity levels of participant HLSOIO: A) activity levels of 
week 1 (baseline) and B) activity levels of the second week (L2) of control light exposure. 
Arrows indicate the average time the light was administered in the morning (08:09 -  09:52 h) and in the 
evening (18:26 -  20:26 h) o f that week, coinciding with a reduction in activity levels.
3.4.T.3 Comparison of the light conditions and exposure periods
No statistically significant differences between the light conditions for daytime and
time-in-bed activity were found. Daytime activity levels (mean ± SEM) as activity
counts per hour were 20893 ±415 for the blue-enriched light and 20526 ± 329 for the
control light. Time-in-bed activity as counts per hour were for the 2179 ± 64 blue-
enriched light and 2110 ± 68 for the control light. Daytime and time-in-bed activity
did not show any effect of period and carry-over.
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3.4.8 Parametric (cosinor) analysis of activity
A mean hourly 24 h profile was created for each participant for each week o f the study 
and a goodness-of^flt curve (sine wave) was then fitted to the data (section 2.9.1). All 
data exhibited a significant fit (p < 0.05) to the sine curve. Analysis o f the cosinor 
(parametric) estimates of the mesor, amplitude and acrophase time was performed.
3.4.8.1 Light administration episodes
No significant effect of study week on the activity rhythm for either of the light 
administration episodes was observed.
3.4.8.Z Comparison of the light conditions and exposure periods
No statistically significant effect of light condition or carry-over for any o f the cosinor
estimates (acrophase time, mesor and amplitude) was found when comparing the light
conditions (PROC GLM). No period effects were found for any of the three cosinor
estimates (PROC GLM). Table 3.9 presents the mean (± SEM) for mesor, amplitude
and acrophase of activity for each light exposure week, the corresponding baseline 
week and the two washout weeks.
Table 3.9: Mesor, amplitude and acrophase for each week of the blue-enriched and control
Mesor 
(activity counts x 10^ )
Amplitude 
(activity counts x 10^ )
Acrophase time 
(dec.h)
Blue-
enriched Control
Blue-
enriched Control
Blue-
enriched Control
BA 12.9 12.6 11.9 11.4 13.6 13.6±1.3 ±1.2 ± 1.5 ±1.4 ±0.2 ±0.3
LI 12.4 12.4 11.3 11.6 13.7 13.9± 1.3 ± 1.6 ± 1.5 ± 1.7 ± 0.2 ±0.2
L2 13.2 12.6 12.3 11.1 13.7 13.8± 1.4 ± 1.3 ±1.6 ± 1.3 ±0.2 ±0.3
L3 13.2 13.2 12.3 12.3 13.9 13.6± 11.5 ±1.7 ±1.6 ± 2.0 ±0.2 ±0.2
WAl 13.9 13.3 12.5 12.4 13.7 13.4± 1.5 ± 1.5 ± 1.7 ± 1.7 ± 0.2 ±0.2
WA2 13.4 12.9 11.9 12.0 13.7 13.7± 1.3 ± 1.4 ± 1.7 ± 1.5 ±0.2 ±0.3
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
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3.4.9 Non-parametric circadian rhythm analysis (NPCRA) of activity 
NPCRA delivered the following parameters (mean ± SEM): IS (interdaily stability), IV 
(intradaily variability), L5 (the mean value of the 5 least active hours) and L5 onset 
time (onset time of the 5 least active hours), MIO (mean value of the 10 most active 
hours) and MIO onset time (onset time o f the 10 most active hours), AMP (amplitude) 
and RA (Relative Amplitude: [MIO + L5)/(M10 -  L5]) (section 2.9.2).
3.4.9.1 IS
Figure 3.24 shows the weekly mean (± SEM) data for the IS. A statistically significant 
improvement (F = 2.74, p < 0.05) o f the IS, indicated by a higher value, was found for 
the first washout week (0.7 ± 0.0) compared to the second week of control light 
exposure (0.6 ± 0.0). No other NPCRA parameter showed a significant difference 
during either of the light administration periods (using one-way repeated measures 
ANOVA with time as a factor).
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Figure 3.24: Interdaily Stability (IS) (mean ± SEM, n = 12) during the blue-enriched (-0-) and 
control (■) light administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p <  0 .05  eom pared to L2 o f  the control light.
As an example of the stability of the NPCRA parameters throughout the study, the RA 
data are presented in Figures 3.25A (group mean) and 3.25B (participant HLS044).
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Figure 3.25: Relative amplitude (RA) of actigraphic data for blue-enriched (-o-) and control 
(■) light administration episodes. A) weekly means (± SEM) of n = 12 participants and B) 
participant HLS044 (single weekly values).
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
3.4.9.2 Comparison of the light conditions and exposure periods
Comparing the effectiveness of the light conditions (PROC GLM) did not reveal any
significant differences for any NPCRA parameter. No period and carry-over effects
were observed. Table 3.10 presents the mean data (± SEM) of the blue-enriched and
control light exposure for the eight NPCRA parameters.
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Table 3.10: Mean (± SEM, n = 12) data for the NPCRA parameters for the 3 weeks of bliie-
Parameter Blue-enriched light Control light
IS 0.65 ± 0.03 0.6 0 ±0 .04
IV 0.82 ± 0.06 0.85 ± 0.06
L5 22:b5 20 ± 4
L5 onset time (dec. h) 1.19 ±0.28 1.12 ±0.33
MIO 438 ± 89 4 2 8 ± 100
MIC onset time (dec. h) 8.40 ± 0.23 8.51 ±0.24
AMP 417 ± 8 6 432 ± 97
RA 0.90 ± 0.02 0.90 ± 0.02
IS; interdaily stability; IV: intradaily variability; L5: m ean o f  the 5 least active hours; L5 onset time: 
onset o f  the 5 least active hours; MIO: m ean o f  the 10 m ost active hours; MIO onset time: onset o f  the 
10 m ost active hours; AM P: am plitude; RA: relative am plitude
3.4.10 Subjective mood and alertness
Subjective mood and alertness were assessed using four validated 9-point scales and
the Karolinska Sleepiness Scale (KSS) completed three times a day over the entire 11- 
week study period; in the morning after waking, before lunch and in the evening 
(section 2.10). Parameters for which statistically significant changes were observed 
are presented in the following sections. Additionally, non-significant (NS) results are 
presented if this aids the interpretation of the results (this will be stated in the relevant 
sections).
3.4.10.1 Cheerfulness
The weekly data for subjective cheerfulness in the morning and before lunch are 
shown in Figures 3.26A and 3.26B, respectively. Following the control light 
cheerfulness in the morning was significantly elevated (F = 6.15, p < 0.001) by -  0.8 
points during the washout period (W Al: 4.1 ± 0.4 and WA2: 4.0 ± 0.4 points) 
compared to baseline (4.8 ± 0.4 points), and during washout week two when compared 
to each light exposure week (LI: 4.7 ± 0.4, L2: 4.7 ± 0.4 and L3: 4.6 ± 0.4 points). 
Before lunch a significant elevation (F = 2.95, p < 0.05) in cheerfulness in the washout 
period (WA1:3.7 ± 0.3 and WA2: 3.6 ± 0.3 points) compared to baseline (4.1 ± 0.3 
points) o f the control light administration episode was also observed. No significant 
changes were found for cheerfulness in the evening (Figure 3.26C). Cheerfulness did
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not change significantly during the blue-enriched light administration episode.
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Figure 3.26: Cheerfulness during the blue-enriched (-o-) and control light (■) administration 
episode (mean SEM, n = 12): A) in the morning, B) before lunch and C) in the evening.
A lower value indicates an increase in cheerfulness.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
* p <  0 .05  com pared to B A ; ** p < 0.001 com pared to B A  and L2; A p <  0.05 com pared to W A2; #  p <  
0.05 compared to BA of the control light.
3.4.10.2 Calmness
Figures 3.27A, 3.27B and 3.27C show the data for subjective calmness in the morning, 
before lunchtime and in the evening, respectively. Following the control light 
exposure calmness in the morning was significantly increased (F = 4.62, p < 0.01) in 
the washout period (W Al: 3.9 ± 0.4 and WA2: 3.9 ± 0.4 points) compared to the 
second week of light exposure (4.5 ± 0.4) (Figure 3.29A). Calmness before lunch 
significantly increased (F = 3.01, p < 0.05) in second week o f washout (3.6 ± 0.3 
points) compared to the second (4.1 ± 0.3 points) and third (4.1 d: 0.4 points) week of 
control light exposure (Figure 3.27B). No significant changes were found for 
calmness in the evening (Figure 3.27C). In addition, no significant changes in 
calmness were observed during the blue-enriched light administration episode.
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Figure 3.27: Calmness during the blue-enriched (-o-) and control light (■) administration 
episode (mean ± SEM, n = 12): A) in the morning, B) before limch and C) in the evening.
A lower value indicates an increase in calmness.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
* p < 0.05 compared to L2 and L3; ** p < 0.01 compared to L2 o f  the control light.
3.4.10.3 Comparison of the light conditions and exposure periods
The effectiveness of the two light conditions to affect subjective mood and alertness
parameters was compared using PROC GLM. Control light significantly increased 
cheerfulness before lunchtime by 0.3 ± 0 .1  points (F (]_ lo) = 5.02, p < 0.05) compared 
to the blue-enriched light (after adjustment for baseline) (Figure 3.28).
Subjective sleepiness (KSS) significantly decreased (F (i, ]0) = 6.33, p < 0.05) in the 
morning with blue-enriched light by 0.4 ± 0.2 points compared to the control light 
(after adjustment for baseline). Figures 3.29A, 3.29B and 3.29C show the data for the 
KSS in the morning, before lunch and in the evening, respectively. Looking at Figures 
3.29A, 3.29B and 3.29C it seems that overall participants felt less sleepy at lunchtime 
than in the morning and evening, respectively. This variation across the day did not 
differ between the two light administration episodes. No period or carry-over effects 
were found for any mood and alertness parameter.
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Figure 3.28: Cheerfulness before lunch as change from baseline for the mean (± SEM) of the 
blue-enriched (open bar) and control light (closed bar) exposure.
Blue: blue-enriched light exposure; Control: control light exposure.
* p < 0.05 com pared to the blue-enriched light
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Figure 3.29: KSS during the blue-enriched (-o-) and control light (■) administration episode 
(mean ± SEM, n = 12): A) in the morning, B) before lunch and C) in the evening.
A lower value indicates a decrease in sleepiness.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
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3.4.11 Performance assessment
The Digital Symbol Substitution Test (DSST) was carried out three times per day after 
the mood and alertness assessment throughout the duration of the study (section 2.11) 
(Appendix L). Since a carry-over effect was observed at each of the three time points, 
presumably due to a practice effect, no further analysis was carried out on these data.
3.4.12 Global cognitive performance
As an indicator of global cognitive performance the Mini Mental State Exam (MMSE) 
was delivered to each participant by a researcher at five time points during the study 
period (section 2.12) (Appendix M). Table 3.11 presents the five MMSE scores for 
each participant, obtained before (baseline) and at the end of each light condition 
(blue-enriched and control light, respectively) and at the end o f the study (week 11).
A paired Student's t-test showed a statistically significant (p < 0.05) increase in week 
11 (last study week) (29.9 ± 0 .1 ) when compared to the score for the first week o f the 
study (29.2 ± 0.3).
Table 3.11: Individual MMSE scores (n = 12) before, at the end of each light exposure and at
Participant Baseline Blue Baseline Control Week 11 Mean
HLS026 28 29 29 30 29 29
HLS029 30 29 30 30 30 30
HLS039 28 29 30 30 30 29
HLS041 30 29 30 30 30 30
HLSOIO 30 30 30 30 30 30
HLS018 30 30 30 30 30 30
HLS019 30 29 30 30 30
HLS032 30 30 30 29 30 30
HLS036 30 30 30 30 30 30
HLS037 30 30 29 29 30 30
HLS044 30 30 28 29 30 29
HLS047 29 30 28 30 30 29
Mean
SD
SEM
29.6
0.8
0.2
29.6
0.5
0.2
29.4
0.8
0.2
29.8
0.5
0.1
29.9
0.3
0.1
29.7
0.3
0.1
Baseline; w eek  1 or w eek 6; Blue: blue-enriched light; Control: control light. 
Blank cell: no data available.
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3.4.12.1 Changes during each light administration episode
No statistically significant differences were found for either of the two light conditions 
when comparing the values for the week before, at the end of light exposure and two 
weeks after light exposure (using one-way repeated measures ANOVA).
3.4.12.2 Comparison of the light conditions and exposure periods
No statistically significant difference in MMSE scores was found between the two
light conditions. No period or carry-over effects were observed (PROC GLM).
3.4.13 Daily rhythmic behaviour
The Social Rhythm Metric-5 (SRM-5) measures the regularity of five daily behaviours 
over at least one week (section 2.13) (Appendix N). Participants completed the SRM- 
5 during both baselines, the third week of each light exposure and during the last study 
week: weeks 1, 4, 6, 9 and 11. Table 3.12 presents each participant’s SRM-5 scores, 
separated by light condition. A higher score indicates a more regular life style.
A paired Student’s t-test (n = 9) showed no statistically significant change in SRM 
scores between week 11 (last study week) compared to the first week of the study.
Table 3.12: Individual SRM scores (n = 12) before, at the end of each light exposure and at
Participant Baseline Blue Baseline Control Week 11 Mean
HLS026 5.6 5.8 5.0 6.8 5.8
HLS029 6.6 6.6 5.2 4.6 5.4 5.8
HLS039 5.8 5.2 5.4 6.0 5.8 5.6
HLS041 3.6 4.2 4.0 4.8 5.6 4.2
HLSOIO 6.2 6.2 6.8 5.0 5.8 6.1
HLS018 6.8 7.0 5.0 6.6 6.2 6.4
HLS019 6.0 6.6 6.6 5.0 6.1
HLS032 6.0 6.2 5.2 5.2 5.8
HLS036 5.8 6.8 6.6 6.6 6.8 6.5
HLS037 6.8 5.2 5.4 5.2 5.8
HLS044 4.8 4 6.8 6.8 4.8 5.6
HLS047 5.6 6.2 6.6 6.4 6.2
Mean 5.9 5.7 5.5 6.0 5.6 5.8
SD 1.0 0.8 0.8 1.0 0.6 0.6
SEM 0.3 0.2 0.2 0.3 0.2 0.2
Baseline: week 1 or week 6; Blue: blue-enriched light; Control: control light. 
Blank cell: no data available.
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3.4.13.1 Changes during each light administration episode
Statistical analysis of the scores from the week before the light exposure (baseline, 
week 1 or 6), during the last week of light exposure and two weeks after the light 
exposure (washout, week 1 or 6) was performed on eight participants for the blue- 
enriched light and on 10 participants for the control light condition due to missing data 
points. No statistically significant change was revealed before, during or after either 
the blue-enriched light or the control light exposure.
3.4.13.2 Comparison of the light conditions and exposure periods
Comparing the effectiveness o f the light conditions with each other did not reveal any
significant differences between the two light conditions for the SRM-5 scores. Neither
a carry-over nor a period effect was observed (PROC GLM).
3.4.14 Semi-structured interview
A semi-structured interview (section 2.14) (Appendix O) was carried out before and 
after each light condition and at the end o f the study (weeks 1, 4, 6, 9 and 11). 
Participants were asked whether they had noticed any change in sleep or daytime
functioning as well as what their general perception of the lighting was. Table 3.13 
summarises the answers of those participants who made a direct comment on a light 
condition, i.e. noticed a difference in sleep and/or daytime functioning and/or their 
perception of the lights. However, not all participants gave comments on the lights nor 
noticed whether anything had changed for them. Five of the 12 participants made no 
comment on the blue-enriched light condition, and eight did not comment on the 
control light condition. Five participants (42%) made a direct positive comment on the 
blue-enriched light whereas one participant (8%) made a direct positive remark about 
the control light.
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Table 3.13: Participant’s self-reported light condition preference
Participant Blue-enriched light Participant Control light
HLS018 + Far better. HLS019 - Left eye was hurting a bit inbeginning.
HLS036 + This is better light, nicer to look at. HLS029 + Bright is nice.
HLS039 + Preferring this one. HLS037
-/4- Eyes burning a bit when
tired but sleep maybe be 
better.
HLS041 + Both ‘good’ but this is better. HLS047 - A bit intrusive.
HLS044 4- Makes me feel awake.
HLS047 +/- Better, despite a glare atthe start.
HLS037 - Makes eyes uncomfortable.
3.4.15 Tabular summary of significant results
The following Tables summarise the main statistically significant results found using 
one-way repeated measures ANOVA (comparing the six weeks of a light 
administration episode) and using PROG GLM. Table 3.14 presents the results for 
subjective and actigraphie sleep. Table 3.15 presents FSQI results (of all 12 
participants only), Table 3.16 shows the results of the activity analysis and Table 3.17 
presents the results o f the mood and alertness data.
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3.5 Discussion
The aim of this study was to assess the effectiveness of daily light exposure o f blue- 
enriched white light (17000 K) and control white light (4000 K), both of equal low 
irradiance, on subjective and actigraphie sleep, activity, daytime mood and alertness as 
well as cognitive performance in older community-dwelling people suffering from 
self-reported sleep problems. Compliance with the protocol was good with 
participants self-reporting to spend more than 90% of the requested time in front of the 
lights. The average duration of light exposure was more than 1.88 h per 2 h session 
(section 3.4.1).
3.5.1 Nighttime: Subjective and actigraphie assessment of sleep
In this section the effects o f light on sleep measured by actigraphy and assessed 
subjectively by the participants using sleep diaries are discussed. In addition, the PSQI 
global and component scores as another subjective measure o f sleep will be discussed.
3.5.1.1 Effects of the control light
For the control light administration episode, subjective sleep latency reduced and sleep 
efficiency improved during and after the light exposure when compared to the baseline 
week. A decrease in the subjective duration o f night awakenings and an advance in 
subjective and actigraphie wake-up time were found during the control light when 
compared to the baseline week. Subjective sleep quality improved after the light 
exposure (during the first washout week) compared to the baseline week and light 
exposure period. Subjective sleep onset time became earlier after the light exposure 
compared to baseline. These changes in sleep latency, sleep onset and wake-up time 
(subjective and actigraphie) as well as the reduction in the duration o f nocturnal 
awakenings (subjective) suggests that sleep has become more consolidated (Dijk gr a/., 
1999) during the control light administration episode. The observed improvements in 
the global PSQI score and the component PSQI scores for sleep latency and sleep 
quality, following the control light exposure compared to the screening, support this 
conclusion. In addition, the advance in wake-up time may be indicative of a change in 
circadian timing. Similar changes in objective sleep parameters have been obtained by 
others using bright white light exposure. Kohsaka a/. (2000) found a decrease in the 
number of nocturnal awakenings after 30 min exposure to bright light (6000 lux) in the
3-44
____________________________________________________________________Chapter 3
morning for six days in five men (mean age ± SEM: 69.0 ± 3.0 years) living in then- 
own homes. Ancoli-Israel a/. (2003) demonstrated a consolidation of nighttime 
sleep, i.e. lengthening of the maximum sleep bout at night, in 92 demented nursing 
home patients (mean age ± SD: 82.3 ± 7.6 years) following 2 h morning light 
treatment (2500 lux) for ten days.
It is therefore likely that the underlying mechanism driving the improved consolidation 
of sleep in this study also resulted from an effect on the circadian system and/or the 
homeostatic system. The decrease in sleep latency and advance o f sleep onset time 
may be indicative of a decreased circadian threshold for initiating sleep in the evening. 
By falling asleep quicker and having fewer disruptions during the night the 
homeostatic sleep pressure (the need to sleep), in turn, dissipated more rapidly and led 
to earlier wake times. This in turn can explain the observed increase in sleep 
efficiency. Fetveit and Bjorvatn (2004; 2005) also reported higher actigraphie sleep 
efficiency following bright light exposure (6000 -  8000 lux; 2 h daily for 2 weeks) in 
older demented people.
The improved sleep quality observed in the current study may result from a 
combination of all the other sleep improvements and hence explain why improvement 
in sleep parameters only appeared towards the end of the light administration period. 
Better sleep would have made the participants more rested in the morning resulting in 
better sleep quality ratings. Other studies also report improvements in sleep quality 
and sleep efficiency after bright light exposure. Campbell a/. (1993), for example, 
observed improvement in sleep of older community-dwelling people suffering from 
sleep-maintenance insomnia. In the home-based part (10 days) o f their study, eight 
participants were exposed to 2 h evening bright light ( -  4000 lux) and compared to a 
control group (eight participants) who received 2 h of dim red (50 lux) light. 
Subsequently, both groups received two evening light exposures in the laboratory with 
sleep assessments. The results showed not only a significantly improved sleep quality 
but also less time awake within the sleep period and an increase in objective sleep 
efficiency following the bright light treatment. Similar results are reported by Cooke 
et al. (1998). In their study, older community-dwelling women (mean age ± SD: 79.4 
± 6.7 years) received 30 min of white light (2000 lux) via a visor each evening for 14 
days. The authors observed a decrease in sleep latency, an increase in sleep duration 
and sleep efficiency, and an overall improvement o f sleep quality. Finally, in a study
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from Kohsaka e/ 6%/. (1998) nighttime activity measured with actigraphy was 
significantly reduced following six days of 30 min morning bright light exposure 
(6000 lux) suggesting improved sleep.
3.5.1.2 Effects of the blue-enriched light
Reduced subjective sleep latency and increased sleep efficiency were found following 
the blue-enriched light exposure when compared to baseline values. Sleep duration 
increased during the washout when compared to the second week of light exposure. A 
trend was also found for subjective sleep onset to advance in the washout period. 
Furthermore, the duration of subjective nocturnal awakenings showed a trend to 
decrease during the light exposure period. These results are similar to the findings 
with the control light, suggesting a consolidation of sleep at least partly due to light 
exposure. (It should be noted, though, that for the blue-enriched light changes in sleep 
parameters occurred mainly during the washout weeks.) This assumption is further 
strengthened considering the improvements in both the global and component PSQI 
scores for sleep latency, sleep quality and daytime dysfiinctioning (section 3.4.5.2) 
following the blue-enriched light exposure compared to the screening. The advance in 
subjective wake-up time during the blue-enriched light exposure, the decrease in 
actigraphie duration o f night awakenings and mean wake bout time, both during and 
after the blue-enriched light, when compared to the second week of washout are also in 
agreement with this notion. Supportive evidence o f actigraphie sleep consolidation in 
relation to increased light exposure comes from a study by Hood et al. (2004) who 
explored the relationship between naturalistic light exposure, activity and actigraphie 
sleep quality in older community-dwelling people. The major finding by Hood and 
colleagues (2004) was a positive correlation between actigraphie sleep quality 
(assessed by nocturnal immobility) and the duration of naturalistic light exposure 
(> 3000 lux) during daytime.
3.5.1.3 Comparison of the light conditions
Comparing the two light conditions directly, it was found that control light was 
significantly more potent to produce higher actigraphie sleep efficiency than the blue- 
enriched light. Sleep efficiency is a composite parameter, i.e. it is measured indirectly
using multiple sleep parameters. The accumulation of slight improvements in some of
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these parameters (not all statistically significant) during the control light exposure
could have led to the observed results.
Despite fewer statistically significant changes in subjective and actigraphie sleep 
during the blue-enriched light administration episode compared to during the control 
light administration episode, no major differences between the two light conditions 
were found. This is in agreement with studies in younger, healthy subjects, comparing 
the effectiveness of blue-enriched white light and control white light administration to 
phase shift the circadian system (Smith, a/., 2009, Smith and Eastman 2009). In 
these studies young, healthy men were exposed for 2 h either to bright white light 
(4100 K) or bright blue-enriched white light (17000 K), of similar photon density, 
either in the morning or evening depending on the desired phase shift. Few differences 
between the light sources were reported. Francis and colleagues (2008) also compared 
the effectiveness of blue-enriched (10000 K) and control white (5300 K) light in ten 
Antarctic Base personnel (mean age ± SD: 33 ± 7 years). In this study light exposure 
(8 h daily in the communal area) alternated every four to five weeks between the 
spring and autumn equinox. No large differences in circadian phase assessment (using 
aMT6s) and actigraphie sleep were observed apart from significantly increased sleep 
efficiency with the blue-enriched light intervention. This finding is contrary to the 
currently observed results. Difference between the studies might be due to the 
differences in study population (young va. old) and light parameters (e.g. colour 
temperature and irradiance). A recent study compared the phase delaying capacity of 
blue-enriched light and control white light in older people (Seheuermaier et ai, 2008). 
On four consecutive evenings a 2 h light pulse o f either white light (4100 K) or blue- 
enriched white light (17000 K) was given. Both lights produced phase delays (using 
melatonin in plasma and saliva as a marker) and no significant differences between the 
two conditions were observed. It has to be emphasised that the light intensity in their 
study was much lower than in most other light treatment studies (1200 lux for the 
white light and 500 lux for the blue-enriched light condition; 1.0 x lO’  ^
photons/cm^/sec each condition). For example. Van Hoof and co-workers (2009b) in a 
cross-over study failed to find statistical differences between the effect o f control white 
light (2700 K, ~ 500 lux) va. blue-enriched white light (17000 K, ~ 500 lux) on 
circadian rhythmicity and behaviour in older, demented people living in a care-home. 
The absence of any differences between the two light conditions in their study was
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partly explained by the low illumination levels applied. The light intensity levels used 
in the last two studies (Seheuermaier a/., 2008; Van Hoof g/ a/., 2009b) are more 
comparable to the current study as is the age range of the study populations. The low 
irradiance light levels used in the current study could also explain the lack of major 
differences observed between the two light conditions. Age-related changes of the eye 
(lens and retina) and light transmission through the lens might offer an explanation as 
to why no major differences were observed between the light conditions in any of the 
three studies.
When assessing the effectiveness of all-day exposure with blue-enriched light on 
subjective alertness and performance in an office environment different findings have
been reported, though. Work by Mills et al. (2007) and Viola et al. (2008) has shown 
beneficial effects for example on well-being and performance of blue-enriched light 
(17000 K) compared to control light (4000 K). However, these results remain 
somewhat controversial due to several shortcomings. The study by Mills et al. (2007) 
compared newly installed blue-enriched light with unchanged office lighting on a 
separate floor. Therefore, the photon densities o f the lights used were different and 
people were aware of the newly installed lights which likely biased their subjective 
assessment. In addition, only subjective ratings were used to measure the
effectiveness of the light conditions. In a cross-over design Viola g/ a/. (2008) 
installed two novel light conditions of similar lux level ( - 3 1 0  lux for the blue- 
enriched and -  421 lux for the white light). Light exposure with each condition was 
four weeks, all-day, over two different office floors. Again, only subjective
questionnaires and ratings (including nighttime sleep) were used to assess the effects 
of the light conditions. Since at any time the two floors had different lights during the 
study, participants might have been aware of this which could in turn have biased their 
responses. More and more people have heard about the positive effects of light and 
therefore the participants' expectations might also have biased the results o f the study.
Interestingly, in the current experiment some statistically significant changes in 
subjective and actigraphie sleep occurred after the light exposure during the washout 
compared to baseline. Compared to the current study most previous light exposure 
studies have been much shorter in duration and improvements were seen much earlier 
on during the period o f light exposure. These previous studies have also used much
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brighter white light (> 2500 lux as described by e.g. Youngstedt e/ a/., 2001, and Lack 
and Wright, 1993) than was used in the current study. It is possible that due to the low 
intensity/irradiance of the lights used in the present study any changes in the circadian 
and/or the homeostatic component(s) o f sleep regulation might have taken longer to be 
measurable.
An alternative interpretation for the observed changes during the washout period is a 
so-called 'end of study effect'. Support for both explanations comes from the finding 
that improvements in the global and component PSQI scores occurred four weeks after 
the last light exposure week (post-study, week 13). A very speculative question may 
arise when looking at the results of the PSQI data (global and component scores). 
Eight out of the 12 participants received the blue-enriched light as their second light 
condition. The PSQI scores after the blue-enriched light were slightly lower (non- 
significant) when compared to after the control light. Improvements of subjective and 
actigraphie sleep seen over the blue-enriched light administration episode also 
occurred mainly after the light exposure. Whether or not, if taken together, this might 
indicate a longer lasting (and more slowly developed) improvement in sleep with blue- 
enriched light exposure remains unclear. A further cross-over design study with a 
more balanced sample size for the order of light condition might be able to unravel this 
in more detail (chapter 4).
It is also possible that the observed differences between the light exposure and 
washout periods were at least partly due to changes in the participants' routine. The 
study protocol requirements provided the participants with an additional daily routine,
i.e. sitting during the light exposure sessions, completing daily tests and 
questionnaires. However, during the washout weeks when some improvements 
occurred, this routine was less strict and aAer the study they had the day entirely 'free'.
In order to prevent a phase shift o f the circadian system and to increase circadian 
amplitude and strengthen entrainment the present study used a skeleton photoperiod 
with light exposure in the morning and evening. However, the observed advance of  
the wake-up time during both light exposure conditions not only suggests a 
consolidation of sleep but also a potentially stronger effect of the morning light 
exposure to produce a phase advance. It is likely that some participants received the 
morning light exposure at a more sensitive part of the PRC resulting in a phase
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advance. Older people have already advanced wake-up times which are likely a result 
of not being able to maintain sleep at certain circadian phases (Duffy and Czeisler, 
2002). Furthermore, older people may be more responsive to morning light than 
evening light exposure. Indeed, a reduced sensitivity to low to moderate light levels 
(50 -  1000 lux) in older men during nighttime has been reported previously (Duffy 
a/., 2007) and supports this view. Contrary to these findings is a study by Klerman e/ 
a/. (2001) reporting no reduction in the ability to phase delay but attenuation to phase 
advance in older people following bright light exposure ( -  10000 lux). The 
discrepancy between these two studies may be explained by the different light 
intensities used.
3.5.2 Daytime: Subjective napping, mood and alertness
In the following sections the effects of light exposure on subjective napping using nap
diaries (section 3.5.2.1), and daytime mood and alertness (section 3.5.2.2) will be 
discussed.
3.5.2.1 Subjective napping
In the current study eight participants (67%) reported napping. No significant changes 
in nap duration per day and number of naps per day before, during or after either light 
exposure were observed. When comparing the effectiveness o f the two light 
conditions no significant differences in napping were observed.
The average nap duration per day was 10 ± 4 min during the blue-enriched light and 10 
± 2 min during the control light exposure. The range of common, natural nap 
durations reported in the literature ranges from 23.3 to 45 min (Yoon et a l, 2003a), 
Dautovich e/ a/. (2008) observed naps o f 18 ± 22 min (evening naps included) and 
Ohayon and Vecchierini (2005) reported nap durations of 13.5 ± 0.0 min. The 
findings of the current study are at the lower end o f this spectrum.
The average number of naps per day was 0.5 ± 0.0 for the blue-enriched light and 0.4 ± 
0.0 for the control light exposure. Compared to other studies in older people (Buysse 
e/ a/., 1992, Dautovich e/ a/., 2008) the values of the current study are lower, though 
Yoon and colleagues (2003a) reported a lower average nap frequency of one per week. 
The current study population consisted of rather ‘young’ healthy older individuals
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(mean ± SD: 65.6 ± 4.0 years) who were still active with social commitments and 
therefore might not have had many nap opportunities or not felt the need to nap. Data 
from Jacobs and colleagues (1989) corroborates this explanation. These authors 
suggested that an increase in daytime activity might contribute to a decrease in 
napping. Furthermore, Asplund and Aberg (1998) reported that napping is more 
frequent in older woman suffering from poor health compared to healthy older woman 
(age range 40 -  64 years). Another reason for the low h-equency of napping might 
have been that the study participants, despite suffering from self-reported sleep 
problems, did not have severely compromised daytime well-being/functioning and 
therefore did not suffer from increased daytime sleepiness (Frisoni e/ (3/., 1996). 
McGhie and Russell (1962) also found that only 1.76% of 'poor sleepers’ who took 
part in their study reported napping during the day.
Reports whether insufficient nighttime sleep causes more daytime napping have not
been consistent and it is debatable whether daytime naps are beneficial or not. 
Especially in community-dwelling, healthy, older people this association lacks 
investigation (Goldman et al, 2008). A study by Metz and Bunnell (1990) could not 
find an association between nighttime sleep disturbances and an increase in daytime 
napping. Hoch et al (1992) compared daytime sleepiness and performance of older 
and younger adults and concluded that the observed moderate decline in performance 
in the older group was not due to an increase in daytime sleepiness. Similarly, Frisoni 
a/. (1996) suggested that napping in older people is not only related to nocturnal 
awakenings but to an individual per Ac. Campbell and colleagues (2005) draw a 
similar conclusion about the existence of "nappers” and "non-nappers”. In a 
controlled laboratory study, these authors compared nighttime sleep, performance and 
CBT of 32 healthy participants (age > 55 years) who either napped in the afternoon or 
remained sedentary during a 2 h nap opportunity. The authors reported that although 
all participants napped when given the opportunity the duration varied considerably 
(11.5 -  108.5 min). These findings suggest that napping in the afternoon can have 
beneficial effects as in some participants this procedure was able to balance sleep loss 
of the prior night.
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3.S.2.2 Mood and alertness
A significant improvement in subjective mood was observed following the control 
light exposure during the washout weeks. Cheerfulness improved in the morning after 
the control light exposure when compared to the baseline week and during the light 
exposure; and improved at lunchtime after the light exposure when compared to 
baseline. Calmness improved in the morning and before lunchtime after the control 
light compared to during the light exposure. Participants also reported to be relieved 
of "not being obliged any longer to get-up and sit in front of the light box". This relief 
might have contributed to the improvements in mood in the morning and at lunchtime 
during the washout weeks. However, the improvement in mood in the morning may 
also be related to the improved subjective sleep quality observed in the washout.
The positive influence of bright white light administration on mood has been widely 
demonstrated as an effective non-pharmacological treatment of SAD (Rosenthal et al., 
1984; reviewed in Tam a/., 1995). Recent studies, assessing the effects of blue light 
or blue-enriched white light on treating SAD, have also shown positive results 
(Glickman gr 6z/., 2006; Anderson g^  a/., 2009). The alerting effects o f nighttime and 
daytime bright white light exposure have been investigated in many previous studies 
(Campbell and Dawson, 1990; Daurat et ai, 1993; Cajochcn et al, 2000). Badia and 
colleagues (1991), for example, found an improvement of subjective alertness during 
bright white light (5000 lux) treatment at night but not during the day or during dim 
light (50 lux) treatment. Lafrancc et al. (1998) did not find a change in daytime 
alertness after bright white light (10000 lux) exposure. By contrast, a study by Phipps- 
Nelson and colleagues (2003) found a positive effect of daytime light exposure on 
subjectively assessed sleepiness and objective alertness in younger adults.
The relationship between disturbed sleep, mood and light exposure in older 
community-dwelling people, however, has to date not been much studied. Genhart g/ 
a/. (1993) showed that older non-depressed women felt worse (more irritable, anxious 
and agitated) following seven days of bright light treatment (2500 lux for 2.5 h in the 
morning and evening, respectively). A possible reason for these negative mood 
feelings might have resulted directly from the intrusion of the light administration 
itself. A similar effect might have caused the observed improved mood after the 
control light exposure during the washout period in the present study. A study by 
Kohsaka gr a/. (1999), however, in which older community-dwelling women received
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1 h of moderately bright light (1000 lux) in the morning for six days showed 
improvements of various subjective mood parameters as well as o f sleep consolidation 
during the light exposure period. Reduced evening agitation in institutionalised older 
adults has also been reported in a study by Lovell and colleagues (1995).
No changes were observed on mood measurements in the evening. This may simply 
result from the evening light exposure being less burdensome to the participants than 
the morning exposure. Another explanation might be the reduced sensitivity o f the 
circadian system to phase delay with low to moderate light levels (50 -  1000 lux) in 
older people (Duffy g/ 6?/., 2007). This reduction in sensitivity might comprise the 
circadian system as a whole thereby weakening the circadian arousal signal. The 
build-up of the homeostatic need for sleep would be stronger suppressing the acute 
alerting effects of light. The light levels used in the current study were also of 
moderate intensity and therefore possibly too low to cause a change in mood in the 
evening.
Surprisingly, mood in the present study only improved after the control light and not 
after the blue-enriched light exposure. Recent laboratory studies have reported an 
alerting effect of short wavelength blue light. The majority of these studies, however, 
used monochromatic blue light and the study populations consisted mainly o f younger 
adults (age range: 2 1 - 2 9  years) who were tested either at nighttime (Cajochen gr a/., 
2005; Lockley gr a/., 2006) or in the morning (Revell gr a/., 2006). By contrast, a 
study by Sletten gr a/. (2009) compared the effectiveness of morning monochromatic 
blue and green light on subjective alertness and mood in older and younger men. The 
authors reported an improvement in mood (reduced sleepiness and improved alertness) 
with blue light in younger but not older men. This was explained by a diminished 
transmission of short wavelength light through the lens in the older adults and the 
consequences this has on the acute effects o f light. How this may explain the current 
findings remains unclear.
Direct comparison of the blue-enriched and the control light conditions revealed two 
significant differences in mood parameters. Control light significantly increased 
cheerfulness at lunchtime compared to the blue-enriched light. This effect is 
consistent with the aforementioned findings for the control light. Significantly
reduced sleepiness (as measured with the KSS) in the morning was observed with the
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blue-enriched light compared to the control light exposure. Considering the advance 
in subjective wake-up time and decrease in actigraphie measured time o f nocturnal 
awakenings during the blue-enriched light, this reduced subjective sleepiness in the 
morning might result &om more consolidated sleep. Rüger g/ a/. (2006) investigated 
the association between the effects of bright light exposure on sleepiness with time-of- 
day (day VA. night). No difference in the reduction o f sleepiness was observed after 
bright light exposure during the day and at night. The study by Phipps-Nelson and 
colleagues (2003), however, did see an improvement in subjective and objective 
sleepiness and performance with 4 h of bright light exposure (mean o f 1056 lux) 
compared to a control dim light exposure group (mean of 3.3 lux). Interestingly, for 
subjective sleepiness this effect of light was not observed until 1 h after exposure 
onset. The authors suggested that depending on what is measured as the 
"manifestation" of the acute effects o f light, this "manifestation" might involve 
different cognitive pathways and hence differences in the timing of the "manifestation" 
measured can occur. In our study, mood, alertness and sleepiness were only assessed 
before or after light exposure and not during the light exposure. The time-span 
between light exposure and assessment of mood, alertness and sleepiness was likely 
too wide to detect any acute effects o f light.
Taken together, the findings of the present study suggest that the effect of light
exposure on mood in older people depends (i) on the study population (normal, 
depressed or demented), (ii) at what time-of-day, (iii) in which way the light is 
administered (whether it interferes with general activities or not) and (iv) on the 
spectral composition of the light being used.
3.5.3 Activity rhythms
The question whether light exposure changes activity levels (i.e. showing more activity 
during the day and less activity at night) was analysed using simple day- and nighttime 
activity analysis, as well as cosinor and non-parametric circadian rhythm analysis 
(NPCRA). These results are discussed together. Cosinor analysis is a robust and 
effective method to describe the general pattern of the rest-activity rhythm. The 
NPCRA, however, has been reported to be a more sensitive method to describe 
changes and characteristics of the 24 h rest-activity profile in older people (Van 
Someren, er a/., 1996; Van Someren, er a/., 1999).
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Using cosinor based parametric rhythm analysis no statistically significant changes for 
the mesor, acrophase and amplitude of the activity rhythm were observed with either 
of the two light conditions. The data show consistency and stability in activity levels 
over the study period and thus provide a representative example for the activity rhythm 
in healthy, older, community-living adults with self-reported sleep problems (living in 
the south-west o f England, UK) during the autumn-winter months.
Following the blue-enriched light daytime activity increased significantly in the first 
week of washout compared to the first week o f light exposure. Whether this finding is 
physiologically relevant or merely an artefact is not known. An explanation for the 
increased activity could be that the participants no longer had to sit for four hours each 
day during the washout period and made up for the 'losf time. However, these 
changes in daytime activity were not observed following the control light exposure.
As mentioned before the study population consisted of mainly 'young’ older adults 
who were still engaged in an active social life, i.e. being active during the day, with 
rare and infrequent napping. It can be assumed that their daytime activity levels were 
not comprised and thus any increase in activity as a result o f light exposure could not 
be detected. Care-home residents in most previous studies were generally older, less 
active (Van Someren a/., 1996), had low(er) light exposure (Shochat e/ a/., 2000) 
and/or suffered from some form of dementia, the latter often accompanied by a more 
disturbed rest-activity rhythm including nighttime wandering and agitation. In these 
studies changes in nighttime activity levels and a more balanced rest-activity rhythm 
have been reported following medium to bright light exposure (Van Someren <3/., 
1997a; Mishima et al, 1998; Ancoli-Israel et al, 2002). A possible reason for the 
discrepant findings between previous studies and the current one might therefore be 
the difference between the study populations and the study environment 
(institutionalised VA. community-dwelling) (Dowling g/ a/., 2005). The results h-om 
the NPCRA further support this explanation. A significant increase was only observed 
for the Interdaily Stability (IS) during the washout after the control light exposure 
compared to during the light exposure. An increase in IS means that the coupling 
between the rest-activity rhythm to external zeitgeber, e.g. light-dark cycle, became 
stronger (Van Someren gr «3/., 1999). This result may represent a 'delayed’ effect of
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the light similar to the findings for subjective and actigraphie sleep (sections 3.4.3 and 
3.4.4). It could also reflect the changes in the study protocol during and after the light 
exposure. A care-home study by Van Someren a/. (1997a) of older adults with 
various stages of dementia has reported similar improvements in the IS, however, this 
was observed during the light exposure. Interestingly, it seemed that in this study 
(Van Someren e/ a/., 1997a) participants with more severe rhythm disturbances 
responded better to the light exposure. Dowling a/. (2005) also reported a 
correlation between the level of impaired rest-activity rhythms (in severely demented 
elderly) and the response to the light treatment. Values for the NPRCA parameters 
which arc associated with daytime and timc-in-bed (nighttime) activity levels obtained 
in these studies (Van Someren e/ a/., 1996; Van Someren e/ a/., 1997a; Dowling eA a/.,
2005) arc very different, i.e. worse, compared to the values obtained in the current 
study. However, in contrast to these studies, Sloane er a/. (2007) exposed demented 
older adults to bright light (morning, evening and all-day) and only found a significant 
effect on nighttime sleep but not on circadian rhythmicity of activity (as assessed by 
actigraphy). Environmental illumination has also been shown to influence the severity 
of rest-activity rhythm disturbances, less light exposure or low light levels in general 
promoting disturbances (Campbell er <3/., 1988; Bliwise er a/., 1992; reviewed in 
Bliwise, 1993; Van Someren a/., 1996; Ancoli-Israel a/., 1997b). Since the study 
population of the current study was still active and exposed to both indoor and outdoor 
light this might further account for the observed consistency of most NPCRA 
parameters.
3.5.4 Cognition and daily rhythmic behaviour
Poor sleep is often accompanied by cognitive impairment (reviewed Doran er 6)/.,
2006). Oosterman a/. (2009) measured the rest-activity rhythm using actigraphy 
and assessed cognitive function using a neuropsychological test battery in 144 
community-dwelling older adults (mean ± SD: 69.5 ± 8.5 years). They found a 
correlation between the fragmentation of the rest-activity rhythm, assessed using the 
IV, and age-related cognitive decline. Similar findings have been reported by Jelicic gr 
a/. (2002) and Blackwell g^  a/. (2006). In a telephone survey Ohayon and Vecchierini 
(2005) interviewed 1026 older adults over 60 years of age about their sleep and 
performed cognitive tests. The authors concluded that poor health and cognitive
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impairment play a role in the development of sleep problems. It may also be possible 
that sleep problems lead to cognitive impairment as it has been shown that sleep is 
important for memory consolidation (reviewed in Walker and Stickgold, 2004). 
Furthermore, studies in animals and humans have shown that an irregular sleep-wake 
cycle can adversely affect cognitive performance (Fekete (z/., 1985; Cho, 2001).
Cognitive impairment in the current study population was low as assessed via the Mini 
Mental State Exam (MMSE) with a mean (± SD) score of 29.2 ± 0.9 at the beginning 
of the study (measured at the end of week 1). It is questionable whether the observed 
significant increase in the MMSE scores at the end o f the study (week 11) when 
compared to the score of week 1 represents a real improvement or if it is more likely to 
be due to habituation with the MMSE test. This view is supported by previous reports 
that the MMSE is not sensitive enough to detect subtle cognitive changes in healthy 
and cognitively unaffected older people. In a study by Proust-Lima et al. (2007) the 
MMSE was administered to older people with different cognitive impairments. The 
authors found a better predictability of impairment with MMSE the more cognitively 
impaired older people were. Furthermore, they showed that there was a ceiling effect 
for the MMSE and concluded that the MMSE is not appropriate to be used in healthy 
cognitive ageing. This is also reflected in the results of the current study. Taken 
together, the high level of cognitive functioning and the stability of the rest-activity 
rhythm, as indicated by a mean (+ SEM) IV value o f 0.78 ± 0.04 during week 1, show 
clearly that our study population did not suffer from severe sleep problems and was 
healthy and active instead.
Analysis of the daily rhythmic behaviour using the Social Rhythm Metric (SRM) 
(sections 2.13 and 3.4.13) showed that lifestyle regularity did not change over the 
duration of the study. No statistically significant changes were observed following 
either light exposure or between the light conditions. The weekly score ranged 
between 3.6 and 6.8 indicating that these older, healthy participants had a regular life 
style. This is in agreement with previous studies (Monk a/., 1992b; 1997b), though 
the current values are slightly higher. A regular life style, indicated by higher SRM 
scores, has been associated with better (subjective) sleep quality, as assessed by the 
PSQI, in a cohort o f 19 to 49 year old adults as shown by Monk g/ a/. (2003). 
Therefore, it seems unlikely that the reported sleep problems of the current study 
population are primarily a result o f poor entrainment between non-photic (social)
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zeitgebers and the circadian system. Leading a regular life style might have helped the 
participants to adapt to the age-related changes in sleep and the circadian timing 
system, preventing more severe dysfunctioning. Alternatively, they might always have 
lived a rigid routine which now protects them h"om any age-related worsening of 
sleep-wake problems (Monk et al, 1992b). This finding, together with the results for 
activity and cognition, suggests that it may be a degeneration of parts o f the circadian 
system such as a diminished ability to entrain to non-social zeitgebers, e.g. light, that 
play a role in causing sleep problems in older people (Huang e/ a/.. 2002). Problems 
of the sleep-wake cycle may also (partly) arise h"om degeneration of an impaired 
transduction of the circadian signal into overt, downstream rhythms (Monk and 
Kupfcr, 2000; Yoon et a l, 2003b). In addition, there may be age-related changes of 
the SCN itself as animal data on the functionality of the SCN (Swaab et al, 1985; 
Watanabc et al, 1995; Aujard et al, 2006) and studies of post-mortem human SCN 
have suggested (Swaab er a/., 1985; reviewed in Hofman and Swaab, 2006). As 
mentioned before, it is uncertain to which degree the study population suffered from 
severe sleep problems.
3.5.5 Limitations of the study
The current study was particularly limited in two ways which will be discussed here. 
(Chapter 7 provides a more detailed discussion of the study limitations.)
Firstly, due to the exclusion of three o f the 15 study participants h"om the statistical 
analysis, the sample size was reduced and the sample size for the order of the light 
conditions was unbalanced. This might have had an effect on the observed results.
Secondly, considering the low light irradiances used, a longer light exposure, i.e. 
increased daily duration and increased length o f light exposure period, might have 
achieved a more pronounced improvement in sleep and daytime behaviour. A longer 
washout period might also have been preferable as this could have eliminated some of 
the carry-over effects that were observed in the subjective get-up time and the 
performance data. In addition, using the second washout week as the baseline week 
for the second light exposure might have confounded some of the data. However, 
extending the length o f the light exposure and the washout periods would have 
increased the overall length of the study and made it more difficult to recruit study
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participants. Additionally, an overall increase in the study length would have made it 
more difficult to complete the study within a season of short photopcriod; the study 
was designed to commence in September and January and end in December and 
March, respectively.
In an attempt to address the possible lack of effect due to insufficient light exposure 
instead o f lengthening the light exposure duration and number o f study weeks, a 
modified fbllow-on cross-over study was conducted (chapter 4). This study included 
light exposure at a 2.5-fold higher light irradiance as well as a larger and more 
balanced sample size.
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4 Effects of high irradiance lights on older people
4.1 Introduction
Numerous non-visual behavioural and physiological functions in mammals are directly 
influenced by light (e.g. pupil reflex, heart rate, alertness) (section 1.6.2). Amongst 
other light characteristics (section 1.6.4), it is the variation in the irradiance o f the 
environmental light that will determine non-visual responses (changes) in behaviour 
and physiology. Non-visual responses to light can be divided into acute and circadian 
responses (photoentrainment through irradiance changes o f light at dusk and dawn). 
These are mediated via ipRGCs and the RHT which transmits photic information from 
the retina to the SCN and other brain regions (sections 1.2.1.2.2 and 1.5.2.1). The 
visual system (section 1.5.1) whose main task is image detection, however, receives 
little input via this non-photic pathway and hence its responses are not considered to 
be irradiance-driven.
Alterations o f several facets of sleep have been reported for both healthy and 
physically and/or mentally compromised older people (section 1.7.2). The most 
common complaints are of frequent nocturnal awakenings and earlier sleep timing 
(section 1.7.2). Underlying these sleep problems might be changes in the homeostatic 
and/or circadian regulation of sleep (section 1.7.2).
Age-related changes have also been observed for the different components of the 
circadian timing system. In particular, these cover alterations at the eye level, i.e. lens 
density and transmission, pupil size, and number and structure of photoreceptors 
(section 1.7.1.1.1). These ocular changes affect the way light signals are processed. In 
addition, age-related alterations of the SCN clock have been reported (section 1.7.1.2). 
Inconsistent or reduced exposure to (environmental) light (sectionl.7.1.1.2) could 
affect both input and output o f the circadian clock and hence misalign the circadian 
and homeostatic systems as well as their regulatory interaction which in turn disturbs 
normal sleep patterns. Administration of light has been reported to strengthen the 
signals to and from the circadian clock and to improve sleep and reduce decrements in 
daytime functioning (section 1.7.3.1 and Table 1.1).
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The results of the pilot/low irradiance light study (chapter 3) demonstrated that timed 
light exposure can significantly influence subjective and objective sleep, the activity 
rhythm and mood parameters. However, these statistically significant changes were 
limited to a few o f the measured parameters (Tables 3.14, 3.15, 3.16 and 3.17) during 
or after exposure to blue-enriched white (141 pW/cm^, 3.59 x lO'"* photon/cm^/sec) or 
control white light (133 pW/cm^, 3.65 x lO''^  photon/cm^/sec). In addition, there were 
few differences between the two light conditions (Tables 3.14, 3.15, 3.16 and 3.17). 
Recent studies have shown that non-visual responses (melatonin suppression, phase 
shifting) are irradiance dependent (Boivin er 6z/., 1996; Zeitzer a/., 2000; Gooley e/ 
a/., 2010). It was therefore decided to investigate whether increased light irradiance 
would enhance the magnitude of responses (irradiance effect) in the same parameters 
measured in the pilot/low irradiance light study. Thus for the current study the 
irradiances of the lights used were increased 2.5-fold and the number of individuals 
studied was increased.
4.2 Aim s and hypotheses
The aim of the present study was to determine whether an increase in light irradiance 
would result in (i) a greater magnitude o f response (irradiance-dependency effect) and 
(ii) a clearer differentiation between the two light conditions (spectral sensitivity 
effect) on subjective and actigraphie sleep, activity, daytime mood and alertness, and 
cognitive performance in older, healthy community-dwelling people (> 60 years) with 
self-reported sleep problems. The same protocol as described in chapters 2 and 3 
would be followed.
The working hypotheses of this study are:
Hypothesis 1: Both high irradiance light conditions will improve subjective and 
actigraphie sleep, activity, daytime mood and alertness, and cognitive performance 
compared to the no light conditions (baseline and washout).
Hypothesis]: The magnitude of the responses elicited by the blue-enriched white light 
will be greater than that of the control white light condition (spectral-sensitivity 
effect).
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4.3 M ethods
For full details of the methods and the study design see General Methodology, chapter
2. Outlined here are the specifically modified methods applied in the high irradiance 
light study and a brief summary of the data analysis process. A favourable ethical
opinion for this study was obtained from the University of Surrey Ethics Committee 
(EC/2006/57/SBMS) (Appendix S).
4.3.1 Participants
Table 4.1 presents the demographies of all 21 participants studied subdivided by 
season and first light condition received. Nine participants (HLS054 to HLS078) were 
recruited to the study during September -  December 2007 and one participant 
(HLS080) was studied from December 2007 -  February 2008 (included in the 
September -  December count). Three participants (HLS089, HLS092 and HLS112) 
took part during February -  April 2008 and eight participants (HLS120 to HLS143, 
indexed by an asterisk [*] in Table 4.1) were studied during September -  December 
2008. Participants were community-dwelling older people (16 females and 5 males; 
age range 6 1 - 7 6  years; mean + SD: 67.2 ± 4.8 years) none of whom were in full-time 
employment (two in part-time and two self-employed). Of the 21 participants three 
were single, two divorcees, five widows and 11 were married. Ten participants 
received the blue-enriched light first and 11 received the control light first.
The results from the screening questionnaires for the high irradiance light study 
population are presented in Table 4.2. The population did not differ significantly to 
that of the pilot/low irradiance light group in their demographies (Table 3.2). As for 
the pilot study, the global PSQI score (sections 2.3 and 2.6.3) served as the primary 
tool (measure) to determine eligibility for inclusion to the study. The study population 
had a mean (± SD) PSQI score of 11.9 ± 2.9 showing no statistical difference with the 
mean of the pilot group o f 13.4 ± 2.2 (mean ± SD) (unpaired Student’s t-test). The 
Home-Ostberg momingness-eveningness score (MEQ) mean (± SD) was 58.2 ± 11.6, 
ranging from 28 (definitely evening type, participant HLS120) to 74 (definitely 
morning type, participant HLS092). Participant HLS134 was a moderately evening 
type, HLS054 and HLS125 were definitely morning types (MEQ scores between 70 -  
86), seven participants were found to be neither types (MEQ scores between 42 -  58) 
and nine were moderately morning types (MEQ scores between 59 -  69). Participants
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HLS058, HLS061, HLS129 and HLS142 exceeded the threshold of 10 (section 2.3) for 
the Epworth Sleepiness Seale (ESS) indicating an increase in daytime sleepiness. The 
mean (± SD) score for the Beck Depression Inventory (BDI) was 10.9 ± 6.0 and fell 
within the minimal range (BDI score: 0 -  13, section 2.3). Only participant HLS139 
scored over 21 on the BDI indicating a moderate depression.
Table 4.1: Demographics of the study participants
Group Code Age(years) Gender Marital status Employment
Sep -  Dec HLS054 69 M Married Retired
Sep -  Dec HLS058 69 F Married Retired
Sep -  Dec HLS066 68 F Married Retired
Sep -  Dec HLS067 63 F Married Part-time
Sep -  Dec HLS080 73 F Widow Retired
Sep -  Dec HLS120* 75 F Single Retired
Sep -  Dec HLS125* 65 M Married Self-employed
Sep -  Dec HLS142* 72 F Widow Part-time
Sep -  Dec HLS143* 62 F Married Self-employed
Sep -  Dec HLS055 68 F Widow Retired
Sep -  Dec HLS06I 63 F Divorced Retired
Sep -  Dec HLS064 73 M Single Retired
Sep -  Dec HLS070 71 F Married Retired
Sep -  Dec HLS078 61 F Widow Retired
Sep -  Dec HLS129* 62 F Divorced Retired
Sep -  Dec HLS130* 67 F Married Retired
Sep -  Dec HLS134* 61 F Single Retired
Sep -  Dec HLS139* 62 F Married Retired
Feb -  Apr HLS112 76 M Married Retired
Feb -  Apr HLS089 68 M Married Retired
Feb -  Apr HLS092 63 F Widow Part-time
67.2
±4.8
(mean
±SD)
16 F, 
5M
11 married, 
3 single,
5 widowed, 
2 divorced
17 retired,
2 self-employed, 
2 part-time
B lue font: participants w ho received the blue-enriched light first. Y e llo w  highlight; participants w ho  
received the control light first. * indicates participants studied during Septem ber -  D ecem ber 2008.
Table 4.3 and Table 4.4 present details of the participants’ ocular status obtained from 
ophthalmologieal examination by a registered optician and self-reported alcohol, 
cigarette and medication consumption, respectively. For participant HLS112 no 
ophthalmologieal data were obtained as the participant was unable to attend the 
appointment. None o f the 20 participants examined suffered from a serious eye 
condition; four (HLS055, HLS061, HLS070 and HLS129) showed signs of an early
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cataract whilst HLS058 and HLS064 had had cataracts removed before entering the 
study.
Table 4,2: Results of the screening questionnaires of the study participants
Code PSQI Horne-Ostberg
Questionnaire
Epworth Sleepiness 
Scale
Beck Depression 
Inventory
HLS054 8 72 5 8
HLS058 15 54 13 1
HLS066 10 66 5 6
HLS067 11 55 9 8
HLS080 11 64 3 14
HLS120 16 28 6 14
HLS125 15 72 8 13
HLS142 13 63 11 17
HLS143 8 42 6 4
HLS055 16 61 4 11
HLS061 10 52 11 5
HLS064 14 57 6 16
HLS070 16 66 1 17
HLS078 7 62 3 8
HLS129 10 61 15 10
HLS130 11 54 5 3
HLS134 10 39 5 13
HLS139 14 49 8 26
HLS112 14 68 7 9
HLS089 11 64 5 18
HLS092 9 74 8 7
Mean ± SD 11.9 ±2.9 58.2 ± 11.6 6.9 ± 3.5 10.9 ± 6.0
Range 7 - 1 6 28- 74 1 - 1 5 1 - 2 6
B lue font; participants w ho received the b lue-enriched light first. Y e llo w  highlight; participants w ho  
received the control light first.
The photopic and seotopic pupil sizes fell within the expected range for age (Sample et 
al, 1988; Brown et al, 2008). According to the Ishihara Colour Blindness Test none 
of the participants were colour blind (range: no errors -  3 errors). Twelve participants 
wore glasses; five did not wear glasses at all and four wore glasses for reading only. 
None of the medication the participants reported they were taking is known to affect 
sleep or the endogenous melatonin rhythm (Table 4.4). All participants’ alcohol 
consumption was under the recommended weekly limit (14 units for women and 21 
units for men). All were non-smokers.
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4.3.2 Light parameters
The irradiances of the light sources applied in this study were 2.5-fold higher than the 
light irradiances used in the pilot study (sections 2.5.4.2.5 and 3.3.2). The parameters 
of the light sources are presented in Table 4.5. The blue-enriched light (17000 K) 
source contained double the amount of short (blue) wavelengths photons than the
control light (4000 K) source. The two lights were photon-matched.
Table 4.5: Administered photon densities, irradiances and lux level of the two light sources
Blue-enriched light Control light
Colour temperature (K) 17000 4000
Total photons (photon/cmVsec) 8.97 X  10‘^ 9.13 X  lO’^
Total photons (photon/cm^/sec) corrected for 
age-related lens transmission
6.50 X  10*^ 7.70 X  10*^
‘Blue’ photons
(400-490 nm) (photon/cmVsec)
4.43 X 10^ ^ 2.22 X  lO'^
‘Blue’ photons
(400-490 nm) (photon/cm^/sec) 
corrected for lens transmission
2.27 X  10^ ^ 1.13 X  10*^
Melanopsin stimulating photons 
(photon/cmVsee)
2.49 X  10'^ 1.57 X  10*^
Photons: 491-700 nm (photon/cm^/sec) 4.5 X 10^ ^ 6.9 X  10'^
‘Green’ photon
(500-570 nm) (photon/cmVsec)
1.5 X  10*^ 1.7 X  lO'^
Photons: 570-650 nm (photon/cmVsec) 2.5 X  lO'^ 4.4 X  10*^
Irradiance (pW/cm^) 353 332
Lux 1100 1200
4.3.3 Pittsburgh Sleep Quality Index (PSQI)
For the current high irradiance study the entire study population (n = 21) was
requested to complete the PSQI questionnaires on five occasions. Five participants, 
however, failed to complete all five PSQI questionnaires and had to be excluded from 
the repeated measures analysis. In addition, HLS058 was excluded as this participant 
took melatonin after the end of the study which could have influenced the post-study 
PSQI score.
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4.3.4 Statistics
The data analysis process is described in detail in section 2.17. Briefly, a carry-over 
effect was assessed using General Linear Model Analysis of Variance for repeated 
measures (PROC GLM ANOVA). The raw data from all 21 participants were used for 
every analysis using PROC GLM ANOVA, unless otherwise stated. The effect of 
both light conditions compared to baseline and washout were analysed separately 
using one-way repeated measures ANOVA with Bonferroni /zoc test for multiple 
comparisons. Effects of light condition (blue-enriched light v.y. control light) and 
period effects (first light exposure period compared to the second light exposure 
period, irrespective o f the light condition) were assessed using PROC GLM ANOVA 
(with the means of the three week light exposure ac^usted for baseline for each 
parameter). No analysis using PROC GLM was performed on the PSQI data.
Data for all parameters were missing from participant HLS078 for the third week of 
blue-enriched light exposure and from participant HLS089 for week I I ,  the second 
week of the final washout (following blue-enriched light exposure). Actigraphy data 
from participant HLS061 for week 10 (= first week of the final washout) were missing. 
For participant HLS139 measurement of mood, alertness and performance at 
lunchtime for week 11 were missing. Thus, one-way repeated measures ANOVA of 
subjective sleep included 19 participants whilst analysis of actigraphic sleep, 
suiyective mood and alertness, and performance as well as the parametric and non- 
parametric circadian rhythm analysis (NPCRA) was performed on data from 18 
participants during the blue-enriched light administration episode. Analyses during the 
control light administration episode included all 21 participants. PSQI data were 
missing from participants HLS058, HLS064, HLS089, HLSl 12, HLS134 and HSL143 
as they failed to complete all five PSQI questionnaires and were therefore excluded 
from the analysis.
For the analysis the data were divided into light administration episodes which 
consisted of six weeks: one week baseline (BA), three weeks of light exposure period 
(LI, L2 and L3) followed by two weeks of washout period (W Al and WA2). The 
second washout week (WA2) after the first light exposure acted as the baseline week 
(BA) for the second light exposure period (Table 2.1 and Figure 2.1). This division 
into weekly episodes/bins was applied to all measurements (prior to statistical 
analysis).
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4.4 Results
Parameters that showed a statistically significant change during one or both light 
administration episodes are reported in the following sections. However, for some 
parameters non-significant (NS) results are also presented to aid the interpretation of 
the results (stated in the relevant sections). Decimal hours (mean ± SEM) are reported 
for all clock times, durations and differences in timing unless otherwise stated.
4.4.1 Light exposure
Daily light exposure was scheduled for 2 h in the morning and for 2 h in the evening 
(section 2.5.1). Participants were permitted to choose light exposure times that suited 
their schedules. Table 4.6 shows the mean (± SEM) o f the self-reported start and end 
(clock) times for the morning (am) and evening (pm) light exposure sessions and of 
the duration of the light exposure sessions (corrected for breaks taken) for each light 
condition. Data for the blue-enriched light exposure is compiled from 18 participants, 
and 19 participants comprise the data for the control light exposure.
As can be seen from Table 4.6, compliance to the light administration protocol was 
good with little variation between participants. Participants completed more than 83% 
of the aspired exposure time (42 h) for each light session in the morning and evening. 
The average duration per light exposure session was more than 01:48 h.
Table 4.6: Self-reported start and end (clock) times and duration (mean ± SEM) of the light
Start (h:min) End (h:min) Duration (h:min)
Blue-
enriched
light
am 08:09 ±00:17 10:05 ±00:17 01:49 ±00:04
pm 18:33 ±00:12 20:39 ±00:12 01:54 ±00:02
Control
light
am 07:53 ±00:16 09:52 ±00:16 01:50 ±00:02
pm 18:21 ±00:11 20:30 ±00:12 01:57 ±00:01
A paired Student's t-test revealed a statistically significant (p < 0.05) earlier mean start 
time in the morning for the control light exposure compared to the blue-enriched light
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exposure time. No other significant differences in the timing and duration between the 
light condition sessions were observed.
4.4.2 Subjective sleep
All participants completed a daily sleep diary upon awakening in the morning 
(Appendix I). From the sleep diaries the subjective sleep parameters were obtained
(Table 2.4). A carry-over effect was only observed (using PROC GLM) for sleep 
quality which was therefore excluded from the subsequent analysis. Sleep parameters 
which showed a significant change during one or both light administration episodes 
are reported in the following sections. In some cases non-significant (NS) results are 
also presented to aid interpretation of the results (stated in the relevant sections).
4.4.2.1 Bedtime
Figure 4.1 shows the subjective bedtime during both light administration episodes. A
significant effect of light on bedtime was observed during exposure to blue-enriched 
light compared to baseline week (F = 3.97, p < 0.01). On average bedtime was 
delayed by approximately 18 ± 6 min during the first and third week (23.1 ± 0.2 h) and 
by 19 ± 5 min during the second week (23.1 ± 0.2 h) of light exposure when compared 
to baseline (22.8 ± 0.2 h). During the control light exposure bedtime showed a trend to 
become earlier compared to baseline, though non-significant (NS).
23.5i
AA
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uOJ■D
23.0-
%
m
22.5
L2 L3 WA1 WA2BA L1
Study week
Figure 4.1: Bedtime (mean ± SEM) during the blue-enriched (-0-) (n = 19) and control (■) 
light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0.05 and AA p < 0.01 compared to B A  o f  the b lue-enriched light.
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significant effect o f light on bedtime was observed during exposure to blue-enriched 
light compared to baseline week (F = 3.97, p < 0.01). On average bedtime was 
delayed by approximately 18 + 6 min during the first and third week (23.1 ± 0.2 h) and 
by 19 ± 5 min during the second week (23.1 + 0.2 h) of light exposure when compared 
to baseline (22.8 ± 0.2 h). During the control light exposure bedtime showed a trend to 
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Figure 4.1: Bedtime (mean ± SEM) during the blue-enriched (-0-) (n = 19) and control (■) 
light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W Al, WA2: washout.
A p < 0 .05 and AA p <  0.01 com pared to B A  o f  the blue-enriched light.
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4.4.2.2 Time trying to sleep
The data for the weekly subjective time trying to sleep are shown in Figure 4.2. Time 
trying to sleep was significantly later (F = 2.45, p < 0.05) during the third week of the 
blue-enriched light exposure (23.4 ± 0.2 h) (and later, yet NS, during the first and 
second week o f light) compared to baseline (23.1 ± 0.8 h). During the control light 
administration episode the time trying to sleep did not differ significantly.
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Figure 4.2: Time trying to sleep (mean ± SEM) during the blue-enriched (-0-) (n = 19) and 
control (■) light (n = 21) administration episodes.
BA; baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0 .05 com pared to B A  o f  the blue-enriched light.
4.4.2.3 Get-up time
Figure 4.3 presents the weekly data for the subjective get-up time. During the control 
light get-up time was significantly earlier (F = 4.50, p < 0.001) by 20 ± 5 min in the 
first week of light exposure (LI) compared to the first week o f washout, and by 19 ± 5 
min in the third week of light exposure (L3) compared to washout weeks WAl and 
W A 2(7 .7± 0 .2h for  both).
4.4.2.4 Comparison of the light conditions and exposure periods
The effectiveness of the two light conditions on subjective sleep was compared
(sections 2.17 and 4.3.4). A significant (F (i, ,9) = 4.80, p < 0.05) difference between
the two light conditions was observed for subjective time trying to sleep (Figure 4.4).
With the blue-enriched light exposure time trying to sleep was 18 + 5 min later
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compared to its baseline and with the control light exposure time trying to sleep was
later by 1 ± 5 min compared to its baseline.
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Figure 4.3: Get-up time (mean ± SEM) during the blue-enriched (-o-) (n = 19) and control (■) 
light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, WA2: washout.
* p < 0.05 and ** p < 0.01 com pared to L3 o f  the control light; ^ p  < 0.05 com pared to LI o f  the control 
light.
Blue Control
Light condition
Figure 4.4: Time trying to sleep (mean ± SEM, n = 21) as change from baseline during the 
blue-enriched (open bar) and control (closed bar) light exposure.
Blue: blue-enriched light exposure; Control: control light exposure.
* p < 0.05  com pared to the control light.
No period effects were observed. The mean (± SEM) values for the three weeks (LI, 
L2 and L3) o f the blue-enriched and control light exposure for each subjective sleep 
parameter are given in Table 4.7.
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Table 4.7: Subjective sleep parameters (mean ± SEM, n = 21) for the three weeks of blue-
enriched and control light exposure
Subjective sleep parameter Blue-enriched light Control light
Bedtime (dee.h) 23.1 ±0 .2 23.0 ± 0 .2
Time trying to sleep (dec. h) 23.4 ±0.2* 23.3 ± 0 .2
Sleep latency (min) 32 ± 6 34 ± 7
Sleep onset time (dec. h) 23.9 ± 0.2 23.8 ± 0 .2
Number of night awakenings/night 1.7 ± 0.2 1.7 ± 0.2
Duration of night awakenings/night (min) 43 ± 7 44 ± 9
Wake-up time (dec. h) 6.7 ± 0.3 6.8 ± 0.3
Get-up time (dec. h) 7.6 ± 0.2 7.4 ± 0 .2
Sleep duration (dec. h) 6.5 ±0.3 6.4 ± 0.2
Sleep efficiency (%) 84.4 ± 2.2 83.7 ±2 .5
Sleep quality (l=best, 9=worst)°" 5.1 ±0 .2 5.1 ±0 .2
* p  < 0 .05  com pared to the control light; * indicates carry-over effect (PROC G LM ).
4.4.3 Actigraphic sleep
All participants wore an AWL continuously on their non-dominant wrist throughout 
the 11-week study period (section 2.6.2). From these recordings, actigraphic sleep 
parameters were analysed using the Actiwatch software package (Sleep Analysis 7, 
version 7.23) prior to statistical analysis (see following sections). Those actigraphic 
sleep parameters showing a statistically significant change during either light 
administration episode are presented. In some cases non-significant (NS) results are 
also presented to aid interpretation of the results. No carry-over effect was observed 
for any of the actigraphic sleep parameters. Unless otherwise stated, decimal hours 
(mean + SEM) are reported for all clock times, durations and differences in timing.
4.4.3.1 Sleep onset time
The weekly data for actigraphic sleep onset time is depicted in Figure 4.5. A 
significant delay (F = 2.68, p < 0.05) in the second week of the blue-enriched light
exposure (L2) (23.8 ± 0.2 h) was observed compared to baseline (23.4 ± 0.2 h).
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Figure 4.5: Actigraphic sleep onset time (mean ± SEM) during the blue-enriched (-o-) (n 
18) and control (■) light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; WAl, WA2: washout.
A p < 0.05 compared to BA of the blue-enriched light.
By contrast, the time of sleep onset during the control light administration episode did 
not change significantly between baseline, light exposure and washout.
4.4.3.2 Mean wake bout time
In Figure 4.6 the weekly data for actigraphic mean wake bout time is shown. During 
the blue-enriched light exposure mean wake bout time showed a significant decrease 
(F = 2.69, p < 0.05) in the second (2.8 ± 0.3 min) and third (2.8 ± 0.4 min) week of
light exposure compared to WA2 (3.0 ± 0.4 min).
4.4.3.3 Comparison of the light conditions and exposure periods
Using PROC GLM, a significantly (F (i, 19) = 9.20, p < 0.01) later actigraphic sleep
onset time by 16 ± 5 min was observed with the blue-enriehed light compared to the
control light. Figure 4.7 shows the change in sleep onset time from baseline. Sleep
onset time was 19 ± 3 min later during the blue-enriched light compared to its baseline
and 3 ± 4 min later during the control light compared to its baseline. No other
statistically significant differences between the two light conditions were found and no
period effects were observed for any other actigraphic sleep parameters.
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Figure 4.6: Mean wake bout time (mean ± SEM) during the blue-enriched (-0-) (n 
control (■) light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; WAl, WA2: washout.
A p < 0.05 compared to WA2 of the blue-enriched light.
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Figure 4.7: Actigraphic sleep onset time (mean ± SEM, n = 21) as change h-om baseline 
during the blue-enriched (open bar) and control (closed bar) light exposure.
Blue: blue-enriched light exposure; Control: control light exposure.
** p <  0.01 com pared to the control light.
The mean (± SEM) values for the three weeks (LI, L2 and L3) o f the blue-enriched 
and control light condition for each actigraphic sleep parameter are given in Table 4.8.
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Table 4.8: Actigraphic sleep parameters (mean ± SEM, n = 21) for the three weeks of blue-
Actigraphic sleep parameter Blue-enriched light Control light
Sleep latency (min) 19 ± 3 1 8 ± 3
Sleep onset time (dec. h) 23.7 ±0.2** 23.6 ±0 .2
Duration of night awakenings/night (min) 65 ± 7 59 ± 9
Time spent awake at night (%) 14.6 ±1 .4 14.3 ± 1.7
Wake-up time (dec. h) 7.1 ± 0.2 6.9 ±0 .2
Sleep duration (dec. h) 6.3 ± 0.2 6.3 ± 0.2
Sleep (%) 85.4 ± 1.4 85.7 ± 1.7
Sleep efbeiency (%) 81.6± 1.7 82.2 ± 2.0
Mean length of sleep bouts (min) 18± 1 18± 1
Mean length o f wake bouts (min) 3 ± 0 3 ± 0
Immobile time (%) 83.8 ± 1.5 84.4 ± 1.9
Immobile phases (number) 37.3 ± 1.9 35.6 ± 2.0
Total activity score (activity counts) 9109± 1270 9345 ±2143
Fragmentation index 35.5 ±2.8 34.0 ±3.3
** p < 0.01 com pared to the control light (PRO C G LM ).
4.4.4 Pittsburgh Sleep Quality Index (PSQI)
Data analysis of the global PSQI score and its seven component scores are presented 
on 15 participants. Only PSQI component scores for which significant changes were 
observed are presented in the following sections. Lower PSQI scores indicate sleep 
improvement.
4.4.4.1 Global PSQI score
Figure 4.8 presents the global PSQI scores for the 15 participants from whom all five 
assessments were obtained. A significant reduction (F = 7.51, p < 0.0001) in PSQI 
scores (mean ± SEM) was observed after the blue-enriehed light (8.9 ± 0.7) and the 
control light (8.9 ± 0.7) exposure compared to the score at screening (11.8 ± 0.8).
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Figure 4.8: PSQI scores (mean ± SEM, n = 15) prior to the study, at the start of week 1, after 
the blue-enriched and control light exposure and four weeks after the second light exposure. 
Screening: at screening; W k l: w eek  1; Blue: blue-enriched light; Control: control light.
*** p < 0.001 compared to the PSQI score at screening.
4.4.4.2 PSQI component scores
The component scores for sleep quality and use of sleep medication showed significant 
changes aAer light exposure. Lower PSQI scores indicate fewer sleep problems and
fewer use of medication (PSQI score range 0 -  3).
4.4.4.2.1 PSQI sleep quality
Figure 4.9 depicts sleep quality measured with the PSQI for 15 participants.
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Figure 4.9: PSQI sleep quality scores (mean ± SEM, n = 15) prior to the study, at the start of 
week 1, after the blue-enriched and control light exposure and four weeks after the second 
light exposure.
Screening: at screening; Wkl: week 1; Blue: blue-enriched light; Control: control light.
* p < 0.05 compared to the screening score; A p < 0.05 compared to the score at the start of week 1.
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A statistically improved (F = 4.47, p < 0.01) sleep quality score was observed after the 
blue-enriched light condition (1.4 ± 0.2) and the control light condition (1.5 ± 0.1) 
when compared to the score at screening (2.1 ± 0.2). Additionally, a significant 
improvement was found after the blue-enriched light condition compared to the PSQI 
sleep quality score at the beginning of week 1 (2.0 ± 0.2).
4.4.4.2.2 PSQI use o f sleep medication
The scores for use o f sleep medication arc shown in Figure 4.10. Significantly lower 
scores (F = 3.62, p < 0.05) were observed after the blue-enriched light (0.0 ± 0.0) and 
the control light condition (0.1 ± 0.1) compared to the score at the beginning of week 1 
(0.7 ± 0.3).
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Figure 4.10: PSQI use of sleep medication scores (mean ± SEM, n = 15) prior to the study, at 
the start of week 1, after the blue-enriched and control light exposure and four weeks after the 
second light exposure.
Screening: at screening; W k l: w eek  1; Blue: blue-enriehed light; Control: control light.
* p < 0.05 compared to the screening score.
4.4.5 Subjective naps
O f the 21 participants studied 16 participants (76%) reported napping. All subsequent 
nap analysis was performed for these 16 participants. No carry-over effect was 
observed for the duration of naps or the number of naps per day.
4.4.5.1 Duration and number of naps
Figures 4.1 lA  and 4.1 IB illustrate the weekly mean (± SEM) nap duration and number 
o f naps per day before, during and after each of the light exposures.
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Figure 4.11: Subjective napping (mean ± SEM, n = 16) during the blue-enriched (-o-) and 
control (■) light administration episodes. A) nap duration in minutes per day, and B) number 
of naps per day.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
As can be seen from Figure 4.11 A, the subjective duration of naps per day did not 
change significantly during the control or blue-enriched light administration episodes. 
Figure 4.1 IB portrays the number of naps taken per day before, during and after light 
exposure. No statistically significant change in the number of naps taken per day was 
observed for either of the light administration episodes. However, both the number 
and duration o f naps show some NS changes over the light administration episodes.
4.4.5.2 Comparison of the light conditions and exposure periods
No significant difference in subjective nap duration (mean ± SEM) between the three
weeks of blue-enriched light (10 ± 2 min) and the three weeks of control light (18 ± 5
min) exposure was observed. Similarly, no statistically significant difference in the
number o f naps per day (mean SEM) between the blue-enriched light (0.3 ± 0 .1 ) and
the control light (0.4 ±0 .1) condition was seen. No period effect was observed.
4.4.6 Parametric (cosinor) analysis
A mean hourly 24 h profile was created for each participant for each week of the study 
and a goodness-of-fit curve (sine wave) was fitted to the data (section 2.9.1). All data 
exhibited a significant fit (p < 0.05) to the sine curve. Mean (± SEM) cosinor 
(parametric) analysis estimates o f the acrophase time, mesor and amplitude of the 
activity rhythm were obtained. Only statistically significant changes are presented.
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4.4.6.1 Light administration episodes
4.4.6.1.1 A crop hase time
Shown in Figure 4.12 are the weekly data for the activity acrophase time which was 
significantly delayed during both the blue-enriched light (F = 2.42, p < 0.05; n = 18) 
and control light (F = 3.22, p < 0.01; n = 21) exposure compared to the washout 
weeks. With the blue-enriched light exposure the delay in the acrophase time was 
observed in the first week of light exposure (14.3 ± 0.2 h) compared to the second 
week of washout (13.5 ± 0.2 h). During the second week of control light exposure a 
significantly delayed acrophase time (14.0 ± 0.2 h) compared to both washout weeks 
(13.5 ± 0.2 h and 13.6 ± 0.2 h, respectively) was observed.
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Figure 4.12: Acrophase time of the activity rhythm (mean ± SEM) during the blue-enriched (- 
0-) (n = 18) and control (■) light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
A p <  0.05 com pared to LI o f  the blue-enriched light; * p < 0 .05  com pared to L2 o f  the control light.
4.4.6.1.2 Mesor and amplitude
Figure 4.13 illustrates the weekly data for the mesor of the activity rhythm. A 
significantly lower mesor (F = 3.09, p < 0.05) was observed for the baseline week 
(11.2 ± 0.5 activity counts x 10 )^ and during the first week o f control light exposure 
(11.2 ± 0.5 activity counts x 10 )^ compared to the first week of washout (12.2 ± 0.6 
activity counts xlO^).
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Figure 4.13: Mesor of the activity rhythm (mean ± SEM) during the blue-enriched (-o-) (n 
18) and control (■) light (n = 21) administration episodes.
BA; baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p <  0 .05 com pared to W A l o f  the control light.
Table 4.9 presents the mean (± SEM) amplitude of activity for each light exposure 
week, the corresponding baseline week and the two washout weeks. There were no 
statistically significant changes between the light exposure weeks and the baseline and 
washout weeks for either light condition.
Table 4.9: Mean (± SEM) data for amplitude for each week of the blue-enriched and control
Amplitude 
(activity counts x 10 )^
Blue-enriched Control
BA 9.9 ± 0.5 9.7 ±0.5
LI 10.1 ±0.6 9.9 ±0.5
L2 9.6 ±0.7 9.9 ± 0.6
L3 10.7 ±0.7 9.9 ± 0.5
WAl 9.8 ± 0.5 10.6 ±0.6
WA2 9.7 ± 0.6 9.7 ± 0.5
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
N  =  21 ; note that L3, W A l and W A 2 o f  the blue-enriched light: n =  18.
4.4.6.2 Comparison of the light conditions and exposure periods
No statistically significant effect o f light condition for any of the cosinor estimates
(acrophase time, mesor and amplitude) were found comparing the light conditions. No
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carry-over effects were observed. Period effects, however, were found for all three 
cosinor estimates.
4.4.6.2.1 A crop hase time
A significant period effect (F (i, 19) = 7.64, p < 0.05) was found for the acrophase time. 
The second period had a significantly more delayed acrophase time compared to the 
first period, irrespective the light condition (Figure 4.14).
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Figure 4.14: Acrophase time of the activity rhythm (mean ± SEM, n = 21) as change from 
baseline during the first (open bar) and second (closed bar) period of light exposure.
Period 1: first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
4.4.6.2.1 Mesor
A significant effect of period on the activity mesor (F 19) = 8.63, p < 0.01) was 
observed with a difference of 834 ± 276 (activity counts) between the periods. The 
mesor was significantly increased during the second period compared to the first 
period (Figure 4.15).
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Figure 4.15: Mesor of the activity rhythm (mean ± SEM, n = 21) as change &om baseline 
during the first (open bar) and second (closed bar) period of light exposure.
Period 1: first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
4.4.6.23 Amplitude
For the amplitude o f activity a statistically significant difference (F (i, 19) = 18.58, p < 
0.001) of 1360 ± 306 (activity counts) was observed between the two periods. The 
second period had a significantly higher amplitude compared to the first period.
4.4.7 Non-parametric circadian rhythm analysis (NPCRA)
NPCRA delivered the following parameters (mean ± SEM): IS (interdaily stability), IV 
(intradaily variability), L5 (mean value of the 5 least active hours) and L5 onset time 
(onset time o f the 5 least active hours), MIO (mean value of the 10 most active hours) 
and MIO onset time (onset time o f the 10 most active hours), AMP (amplitude) and 
RA (Relative Amplitude: (MIO + L5)/(M10 -  L5)) (section 2.9.2).
4.4.7.1 Light administration episodes 
4.4.7.2.7 M20
Figure 4.16 shows the weekly data for the MIO. A significant increase (F = 2.89, p < 
0.05) in MIO was found during the first week of washout (342 ± 1 7 )  compared to 
baseline (312 ± 13) of the control light administration episode. During the blue- 
enriched administration episode no significant changes were observed.
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Figure 4.16: MIO (mean ± SEM) during the blue-enriched (-0-) (n = 18) and control (■) light 
(n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p < 0.05 compared to BA of the control light.
4.4.7.1.2 MIO onset time
The weekly data for the MIO onset time are presented in Figure 4.17. The MIO onset 
time showed a significant (F = 2.69, p < 0.05) delay o f 37 ± 11 min during the first 
(9.0 ± 0.3 h) and second (9.0 ± 0.3 h) week of the blue-enriched light exposure 
compared to the second week of washout (8.4 ± 0.2 h). Despite the delay (NS) of the 
MIO onset time during the second week of control light exposure (Figure 4.17), no 
statistically significant differences were found during this light administration episode.
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Figure 4.17: MIO onset time (mean ± SEM) during the blue-enriched (-o-) (n
control (■) light (n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; WAl, WA2: washout.
A p < 0.05 compared to WA2 of the blue-enriched light.
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4.4.7.1.3 A mplitude (AMP)
The weekly data for the AMP are presented in Figure 4.18. For the AMP a significant 
increase (F = 2.50, p < 0.05) was found in the first week of washout (319 ± 17) 
compared to the baseline week (292 ± 13) of the control light administration episode. 
No significant changes were observed during the blue-enriched light administration 
episode.
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Figure 4.18: AMP (mean ± SEM) during the blue-enriched (-0-) (n = 18) and control (■) light 
(n = 21) administration episodes.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p < 0.05 compared to BA of the control light.
4.4.7.2 Comparison of the light conditions and exposure periods
Comparing the effectiveness of the light conditions (using PROC GLM) did not reveal
a significant difference between the light conditions for any of the NPCRA parameters.
No carry-over effects were found. Table 4.10 presents the mean data (± SEM) of each
light exposure for all NPCRA parameters.
By contrast, period effects were observed for the IS, IV and MIO. These will be 
discussed in the following sections.
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Table 4.10: Mean (± SEM, n = 21) data for the NPCRA parameters for the 3 weeks of blue-
Parameter Blue-enriehed light Control light
IS 0.62 ± 0.03 0.63 ±0.03
IV 0.81 ±0.05 0.81 ± 0.04
L5 21 ± 3 21 ± 4
L5 onset time (dec. h) 24.94 ± 0.26 24.64 ± 0.28
MIO 319±  13 319±  14
MIO onset time (dec. h) 8.85± 0.24 8.65 ± 0.24
AMP 298 ± 13 298 ± 13
RA 0.88 ± 0.02 0.88 ± 0.02
IS: interdaily stability; IV: intradaily variability; L5: m ean o f  the 5 least active hours; L5 onset time: 
onset o f  the 5 least active hours; MIO: m ean o f  the 10 m ost active hours; MIO onset time: onset o f  the 
10 m ost active hours; AM P: am plitude; RA: relative am plitude.
.^4.7.27 7^
Figure 4.19 shows the IS for which a period effect with a significant difference (F (i, 19)
= 5.85, p < 0.05) of 0.05 ± 0.02 was identified (irrespective of the light condition). 
The second period showed a significantly more stable rhythm compared to the first 
period.
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Figure 4.19: Interdaily Stability (IS) (individual and mean ± SEM, n = 21) as change from 
baseline during the first (0) and second (■) period of light exposure.
Period 1: first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
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Figure 4.20 portrays the IV for which a significant period effect (F (i, ,9) = 4.74, p < 
0.05) was also observed. Irrespective of the light condition, the second period showed 
a less fragmented rhythm by 0.09 ± 0.04 compared to the first period.
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Figure 4.20: Intradaily Variability (IV) (mean ± SEM, n = 21) as change &om baseline during 
the first (open bar) and second (closed bar) period of light exposure.
Period 1 : first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
A significant difference (F (i, 19) = 14.60, p < 0.01) between the two periods was 
identified for the MIO, shown in Figure 4.21. The MIO was significantly higher in the 
second period compared to the first period.
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Figure 4.21: MIO (mean ± SEM, n = 21) as change &om baseline during the first (open bar) 
and second (closed bar) period of light exposure.
Period 1 : first light exposure; Period 2: second light exposure.
** p < 0.001 compared to the first period.
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4.4.7.2.4 A mplitude (AMP)
In addition, the AMP showed a significant period effect (F (i, 19) = 12.05, p < 0.01). 
The activity amplitude during the second period was significantly higher compared to 
the first period.
4.4.8 Subjective mood and alertness
To assess subjective mood and alertness four validated 9-point scales and the 
Karolinska Sleepiness Scale (KSS) were used. These scales were completed three 
times per day over the entire study period, namely in the morning upon waking up, 
before lunch and in the evening (section 2.10). Parameters for whieh statistically 
significant changes were observed are presented. Additionally, non-significant (NS) 
results are presented if this aids interpretation of the results (this will be stated in the 
relevant seetions). A carry-over effect was observed for depression in the morning; the 
morning depression data were therefore exeluded from any further analysis.
4.4.8.1 Alertness
Alertness data in the morning, before lunch and in the evening are presented in Figures 
4.22A, 4.22B and 4.22C, respectively. During the control light administration episode, 
alertness increased significantly in the morning (F = 3.56, p < 0.01) during L3 (4.4 ± 
0.2 points), W Al (4.4 ± 0.2 points) and WA2 (4.3 ± 0.2 points) compared to the 
baseline (4.8 ± 02 points) (Figure 4.22A). For alertness before lunch and in the 
evening, illustrated in Figures 4.22B and 4.22C, no signifieant changes were observed 
during the control light administration.
During the blue-enriched light administration episode alertness before lunch was 
significantly increased (F = 3.12, p < 0.05) by -  0.4 points during the third week (3.7 ± 
0.2 points) o f light exposure compared to baseline (4.1 ± 0.2 points) (Figure 4.22B). 
No significant changes were found for alertness in the morning or evening throughout 
the blue-enriched light administration period (Figures 4.22A and 4.22C).
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Figure 4.22: Alertness (mean ± SEM) during the blue-enriched (-0-) (n = 18) and control light 
(■) (n = 21) administration episode: A) in the morning, B) before lunch and C) in the evening. 
A lower value indicates an increase in alertness.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
* p < 0.05 compared to BA of the control light. A p < 0.05 compared to BA of the blue-enriched light.
Furthermore, looking at Figures 4.22A, 4.22B and 4.22C it seems that overall 
participants were more alert before lunchtime than in the morning and evening, 
respectively. This variation across the day is recognisable during both light
administration episodes.
4.4.8.2 Cheerfulness
Figures 4.23A, 4.23B and 4.23C illustrate the data for cheerfulness in the morning, 
before lunch and in the evening, respectively. In the morning following the control 
light exposure cheerfulness was significantly elevated (F = 4.51, p < 0.001) by -  0.4
points in the washout (W Al: 3.9 ± 0.3 points and WA2: 3.9 ± 0.3 points) compared to 
baseline (4.3 ± 0.3 points) as well as during W Al compared to the first week of control 
light (4.3 ± 0.3 points). No significant changes were found for cheerfulness before 
lunchtime or in the evening throughout the study period. No significant changes in
cheerfulness were observed during the blue-enriched light administration episode.
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Figure 4.23: Cheerfulness (mean ± SEM) during the blue-enriched (-o-) (n = 18) and control 
light (■) (n = 21) administration episode: A) in the morning, B) before lunch and C) in the 
evening.
A lower value indicates an increase in cheerfulness.
BA: baseline; L1-L3; light exposure period; W A l, W A2: washout.
* p < 0.05 and ** p < 0.01 compared to BA; ^ p < 0.05 compared to LI of the control light.
4.4.S.3 Depression
The weekly data for depression before lunch and in the evening are shown in Figures 
4.24A and 4.24B. Before lunchtime during the third week of the blue-enriched light 
exposure depression (5.8 ± 0.3 points) decreased significantly (F = 3.67, p < 0.01) 
compared to the first (5.5 ± 0.2 points) and second (5.5 ± 0.2 points) week of light 
exposure. No significant changes in depression at any time point were observed 
during the control light administration episode.
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Figure 4.24: Depression (mean ± SEM) during the blue-enriched (-o-) (n = 18) and control 
light (■) (n = 21) administration episode; A) before lunch and C) in the evening.
A higher value indicates an increase in elation.
BA: baseline; L1-L3: light exposure period; WAl, WA2: washout.
A p < 0.05 and AA p < 0.01 compared to L3 of the blue-enriched light.
4.4.S.4 Karolinska Sleepiness Scale (KSS)
Illustrated in Figures 4.25A, 4.25B and 4.25C are the weekly data (mean ± SEM) for 
the KSS in the morning, before lunch and in the evening. In the third week during the 
control light exposure (4.0 ± 0.2 points) and both washout weeks (W Al: 4.0 ± 0.2, 
WA2: 4.0 ± 0.2 points) the KSS decreased significantly in the morning (F = 8.41, p < 
0.001) compared to baseline (4.9 ± 0.3 points) and the first week (4.6 ± 0.2 points) of 
control light (Figure 4.25A). In the evening (Figure 4.25C) the KSS decreased 
significantly (F = 2.38, p < 0.05) in the second (4.2 ± 0.2 points) and third (4.4 ± 0.3 
points) week of control light compared to baseline (4.9 ± 0.3 points). No significant 
changes were observed for lunchtime scores (Figure 4.25B).
During the blue-enriched light administration episode no statistically significant 
changes were observed. However, there was an increase in alertness before lunch 
during the third week of blue-enriched light (3.2 ± 0.3 points) compared to baseline 
(3.4 ± 0.2 points). This difference, however, was not statistically significant (p < 
0.09).
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Figure 4.25: KSS (mean ± SEM) during the blue-enriched (-o-) (n = 18) and control light (■) 
(n = 21) administration episode: A) in the morning, B) before lunch and C) in the evening.
A lower value indicates a decrease in sleepiness.
BA: baseline; L1-L3: light exposure period; W A l, W A2: washout.
^  p <  0 .05  com pared to L I; * p <  0 .05  and *** p <  0 .001 com pared to B A  o f  the control light.
A time-of-day effect with an increase in alertness around lunchtime was evident during 
both light administration episodes (Figure 4.25).
4.4.8.5 Comparison of the light conditions and exposure periods
No differences comparing the effectiveness o f the two light conditions to affect
subjective mood and alertness were found. Cheerfulness before lunch showed a
significant period effect (F (i, 19)= 4.91, p < 0.05) with the second light exposure period
showing an increase in cheerfulness by 0.3 ± 0.1 points compared to the first period
(Figure 4.26).
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Figure 4.26: Cheerfulness before lunch (mean ± SEM, n = 21) as change from baseline during 
the first (open bar) and second (closed bar) period of light exposure. A lower value indicates 
an increase in cheerfulness.
Period 1 : first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
4.4.9 Performance assessment
The Digital Symbol Substitution Test (DSST) was performed three times per day after 
the mood and alertness assessment throughout the study period (section 2.11) 
(Appendix L). Examination of the data shown in Figure 4.27 suggests that a practice 
effect occurred as DSST values rose during the study indicating consistent 
improvement during the study period. Period effects were observed in the morning (F 
(1, 19) = 36.39, p < 0.0001), before lunchtime (F (i, 19) = 19.04, p < 0.001) and in the 
evening (F (i, 19)=  21.65, p < 0.001). For all three time points the first period showed 
improved performance compared to the second period regardless of the light condition. 
Due to the practice effect no further analysis was carried out on these data.
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Figure 4.27: DSST (means ± SEM %, n = 21): A) in the morning, B) before lunch and C) in 
the evening. Each individual’s data were normalised to week 1. At all three time points a 
clear increase (practice efïect) can be seen across the study.
4.4.10 Global cognitive performance
The Mini Mental State Exam (MMSE) provides an indication of cognitive 
performance. The exam was delivered by a researcher to each participant at five times
points during the study period (section 2.12) (Appendix M). Presented in Table 4.11 
are the five MMSE scores for each participant, obtained before (baseline) and at the 
end of each light condition (blue-enriched and control light, respectively) and at the 
end of the study (week 11).
A paired Student’s t-test showed a statistically significant (p < 0.01) increase in 
MMSE scores in week 11 (last study week) (29.9 ± 0 .1 )  when compared to the first 
week of the study (29.2 ± 0.2).
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Table 4.11: Individual MMSE scores (n = 21) before, at the end of each light exposure and at
Participant Baseline Blue Baseline Control Week 11 Mean
HLS054 28 30 30 30 30
HLS058 28 30 30 30 30 30
HLS066 29 29 30 30 30 30
HLS067 30 29 30 30 30 30
HLS080 30 30 30 30 30 30
HLS112 27 30 30 30 28 29
HLS120 30 30 30 30 30 30
HLS125 30 30 30 30 30 30
HLS142 30 30 30 30 30 30
HLS143 30 30 30 30 30 30
HLS055 30 30 30 30 30 30
HLS061 30 29 30 30 30 30
HLS064 29 30 28 28 30 29
HLS070 30 29 29 30 29 29
HLS078 28 29 29 29 30 29
HLS089 30 30 29 30 30 30
HLS092 30 30 30 29 30 30
HLS129 30 30 30 30 30 30
HLS130 30 30 29 30 30 30
HLS134 30 30 30 29 30 30
HLS139 29 30 28 30 30 29
Mean 29.4 29.8 29.6 29.8 29.9 29.7
SD 0.9 0.4 0.7 0.6 0.5 0.3
SEM 0.2 0.1 0.1 0.1 0.1 0.1
Baseline: w eek  1 or w eek 6; Blue: 
Blank cell: no data available.
blue-enriched light; Control: control light.
4.4.10.1 Changes during each light administration episode
Figure 4.28 shows the MMSE scores at baseline, at the end and two weeks after each 
light exposure (washout). In the washout following the blue-enriched light exposure 
the mean MMSE score (30.0 ± 0.1) was significantly higher (F = 4.11, p < 0.05) 
compared to the score before the exposure (29.4 ± 0.2) (using one-way repeated 
measures ANOVA). No statistically significant differences were found before, at the 
end and after the control light exposure.
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Figure 4.28: MMSE scores (mean ± SEM) before and after exposure to the blue-enriched (-o-) 
(n = 21) and the control light (■) (n = 20).
Baseline: 1 w eek  before the light; Light: end o f  blue-enriched or control light; W ashout: 2 w eek s after 
the light.
A p <  0 .05 com pared to B aseline o f  the blue-enriched light.
4.4.10.2 Comparison of the light conditions and exposure periods
No statistically significant difference in MMSE scores was found between the two
light conditions. No period or carry-over effects were observed (PROC GLM).
4.4.11 Daily rhythmic behaviour
As a measurement of the regularity of daily behaviours the Social Rhythm Metric-5 
(SRM-5) was used. Participants completed the SRM-5 before (baseline) and during 
the third week of each light condition as well as during the last study week; weeks 1, 4, 
6, 9 and 11. The SRM-5 scores for each participant of the five time points measured, 
separated by light condition, are presented in Table 4.12. A higher score indicates a 
more regular life style.
No significant change in SRM scores between the first (week 1) and last week (week 
11) o f the study was found (paired Student's t-test, n = 13).
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Table 4.12: Individual SRM scores (n = 21) before, at the end of each light exposure and at
Participant Baseline Blue Baseline Control Week 11 Mean
HLS054 5.6 6.6 6.0 6.0 6.1
HLS058 5.2 6.0 4.8 4.6 4.8 5.1
HLS055 5.8 5.2 5.3 5.2 5.4
HLS066 7.0 6.2 6.2 6.8 6.8 6.6
HLS067 5.8 5.8 6.0 5.2 5.7
HLS080 5.6 5.6 5.0 6.2 5.8 5.6
HLS112 6.8 6.2 5.6 6.2
HLS120 4.2 2.8 5.6 3.4 3.0 3.8
HLS125 5.2 5.4 5.0 5.2
HLS142 4.0 4.3 7.0 5.5 4.0 5.0
HLS143 6.4 6.2 6.8 6.6 6.5
HLS061 4.6 4.2 4.4
HLS070 6.4 5.2 4.0 6.6 5.6
HLS078 5.4 3.0 6.6 5.0 5.3 5.1
HLS089 6.8 6.2 6.2 6.4
HLS092 5.0 4.4 6.0 5.0 6.4 5.4
HLS129 4.6 5.0 5.4 5.4 5.4 5.2
HLS130 5.8 5.0 6.0 6.4 5.8 5.8
HLS134 3.6 5.8 5.0 4.8
HLS139 5.2 5.6 5.6 6.0 5.6
Mean 5.4 5.3 5.8 5.6 5.3 5.5
SD 0.9 1.2 0.7 0.9 1.0 0.7
SEM 0.2 0.3 0.2 0.2 0.3 0.2
Baseline: week 1 or week 6; Blue: blue-enriched light; Control: control light.
Blank cell: no data available.
4.4.11.1 Changes during each light administration episode
Statistical analysis (one-way repeated measures ANOVA) of the scores from the week 
before (baseline, week 1 or 6), during the last week o f light exposure (blue-enriched or 
control) and two weeks after the light exposure (washout, week 6 or 11) did not reveal 
any significant changes (blue-enriched light: n = 11; control light: n = 10).
4.4.11.2 Comparison of the light conditions and exposure periods
Comparison o f the two light conditions with each other did not reveal any statistically
significant difference in SRM-5 scores. No period or carry-over effects were observed
(PROC GLM).
4-38
____________________________________________________________________Chapter 4
4.4.12 Semi-structured interview
A semi-structured interview (section 2.14) was carried out before and after each light 
condition and at the end of the study (weeks 1, 4, 6, 9 and 11). Participants were asked 
whether they had noticed any change in sleep or daytime functioning as well as what 
their general perception of the lighting was. Table 4.13 summarises the answers of 
those participants who made a direct comment on a light condition, i.e. noticed a 
difference in sleep and/or daytime functioning and/or their perception o f the lights. 
However, not all participants gave comments on the lights nor noticed whether 
anything had changed for them. Twelve participants (57%) made no comment on the 
blue-enriched light condition, and eleven did not comment on the control light 
condition. Six participants made a direct positive comment on the blue-enriched light 
and seven participants (33%) made a direct positive remark about the control light.
Table 4.13: Participant’s self-reported light condition preference
Participant Blue-enriched light Participant Control light
HLS055
(+) Eyes sore after sessions did 
not like this light but sleep is
better with this light.
HLS061 + Possibly better.
HLS061 + Preferring this one. HLS066 + More effective, more energy.
HLS078 - Causes headaches, had to stop this light. HLS078 + Helped with migraines.
HLS089 - Slight headaches. HLS089 - Slight headaches.
HLS092 + Better than other. HLS092 + Likes it.
HLSI12 + More effective. HLS125HLS129 + Might be better.
HLS130 + Sleep better with this one. HLS134 - Jittery.
HLS134 + Better, friendlier, calming effect. HLS143 + This one is better.
HLS142 + Calming. HLS142 (+) If, then this is working better. Calming.
4.4.13 Tabular summary of significant results
The following Tables summarise the main statistically significant results found. Table 
4.14 presents the results for subjective and actigraphic sleep. Table 4.15 presents 
PSQl results. Table 4.16 shows the results of the activity analysis and Table 4.17 
presents the results of the mood and alertness data.
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4.5 Discussion
The aim of this study was to assess the effectiveness of a twice daily light exposure 
(skeleton photoperiod) o f blue-enriched white light (17000 K) and control white light 
(4000 K), of high irradiance, on subjeetive and actigraphic sleep, aetivity, daytime 
mood and alertness as well as cognitive performance in older community-dwelling 
people suffering from self-reported sleep problems. Compliance with the protocol was 
good with participants spending more than 83% of the requested time in front o f the 
lights. The average duration o f light exposure per session was more than 1.8 h per 2 h 
session (seetion 4.4.1).
4.5.1 Nighttime: Subjective and actigraphic assessment of sleep
In the following section the effects of light on sleep measured both subjectively (sleep 
diaries) and actigraphieally (AWLs) are discussed. This also includes discussion of 
the PSQI global and component scores.
4.5.1.1 Effects of the control light
For the control light administration episode, subjective get-up time became earlier 
during the first and last week of light exposure when compared to the washout weeks. 
This could be a result o f (i) a faster dissipation of sleep pressure (homeostatic drive for 
sleep), and/or (ii) a weaker circadian drive (opposing the homeostatie drive) to stay 
asleep or (iii) an interaction o f both o f these two regulatory systems or finally (iv) the 
morning control light exposure has shifted the clock to an earlier time. Visual 
inspection of the raw data of subjective wake-up time reveals a non-significant 
advance in the first and third light exposure weeks whieh could support this view. 
However, get-up time as opposed to wake-up time is mainly determined by an 
individual's conscious decision making and less likely influenced by the clock. The 
observed advance in get-up time in weeks LI and L3 might therefore be due to social 
commitments.
As no other subjeetive sleep parameters changed during the light administration 
episodes it seems more likely that factors not related to the light exposure (e.g. social 
circumstances) caused the earlier get-up time. The participants might simply have got 
out o f bed earlier in order to administer the 2 h light exposure prior to their daily
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chores. This explanation is supported by the observed significantly earlier start time of 
the control light exposure in the morning eompared to the blue-enriched light. In 
addition, the fact that get-up time was not advanced in the seeond week of light 
exposure challenges a biological explanation for these findings.
The results from the PSQI data show an improvement for the global and sleep quality 
scores following control light exposure compared to the scores at screening. 
Participants were allowed to take sleep medication during the study but were asked to 
keep it to a bare minimum. It is therefore tlroughl that the observed ehange in use of 
sleep medication is a result of the participants complying with the protocol rather than 
due to the light exposure per se. Subjective sleep quality (measured with the sleep 
diaries) showed a trend (p < 0.1) to improve from baseline to after the control light in 
the washout period. Based on all the findings for the control light administration 
episode it is possible to conclude that, in the absence of any change of any major 
subjective sleep parameter, the participants' overall impression of their sleep and its 
quality has improved due to exposure of control light.
4.5.1.2 Effects of the blue-enriched light
A significantly later subjective bedtime (weeks LI -  L3), time trying to sleep (week 
L3) and actigraphic sleep onset time (week L2) was found during the blue-enriched 
light exposure when compared to the baseline. Actigraphic mean wake bout time was 
reduced during the second and third week of blue-enriched light exposure compared to 
after the exposure (washout week two). The observed changes in bedtime and time 
trying to sleep are to a certain extent influenced by individual ehoiees as well as 
possible changes in sleep-wake regulation, e.g. later onset o f feeling sleepy. It is 
possible that the blue-enriched light exposure in the evening might have had an 
alerting effect keeping the partieipants up for longer (C^oehen a/., 2005). Looking 
at the KSS (subjective sleepiness) data (section 4.4.S.4) (subjective measurement of 
sleepiness) a tendency towards a reduced sleepiness in the evening during the blue- 
enriched light exposure can be seen (LI, L2, L3 and WAl compared to baseline).
The observed change in aetigraphic sleep onset to a later time, however, may simply 
be a result of the later bedtime and time trying to sleep. Alternatively, these changes in 
sleep timing could be due to changes in the circadian and homeostatic timing systems
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and to a lesser degree be influenced by behavioural changes of an individual. The 
arousal signal of the circadian system may have become stronger (higher threshold to 
initiate sleep) in the evening due to the blue-enriched light exposure and its acute 
alerting response. In a study by Munch et al. (2005) older subjects rated their 
sleepiness in the late afternoon and evening significantly higher compared to young 
eontrols during a 40 h nap protocol. This suggests that the circadian threshold to 
initiate sleep is normally lower in older people. An increase of the circadian arousal 
signal in the evening, as was possibly the case in the current study, would have 
counteracted the homeostatic drive for sleep.
The observed reduction in the mean wake bout length, together with the later sleep
(onset) time, hint towards a more consolidated sleep period. This sleep consolidation 
might be an effect of a further increase in sleep propensity towards bedtime due to a 
stronger circadian signal which might also be reflected in the improvement o f the 
global PSQI and sleep quality component score. It appears that, similar to the control 
light exposure, not many o f the sleep parameters were changed, but yet the 
subconscious notion or rating of an individual’s sleep quality was improved with the 
blue-enriched light exposure. The improvement in use of sleep medication after the 
blue-enriched light compared to the PSQI score at week 1 is most likely due to 
participants’ compliance to the protocol rather than an effect of the light.
4.5.1.3 Comparison of the light conditions
Direct comparison of the two light conditions showed a significant difference between 
the lights in delaying the time trying to sleep. The delay was significantly greater with 
the blue-enriched light than with the control light. The point to make here is that the 
observed change from baseline for the control light was very small and whether this 
represents a biological meaningful result is questionable.
The homeostatic and circadian timing systems can influence both sleep onset time and 
time trying to sleep. However, whereas the two timing systems could influence the 
actual sleep onset, time trying to sleep is additionally influenced by an individual’s 
social schedule. These results suggest that exposure to blue-enriched light decreased 
and/or delayed sleep propensity and/or increased the circadian arousal signal in the 
evening.
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Despite the aforementioned changes no other statistically significant responses and 
differences between the lights were identified. Observing only a few changes during 
each light administration episode and as well as between the two light eonditions is in 
agreement not only with the results of the low irradiance study (chapter 3) but also 
with previous studies (section 3.5.1.3). Age-related changes o f the eye (lens and 
retina) including reduced short wavelength light transmission through the lens might 
offer an explanation as to why no major differences were observed between the light 
conditions. A reduced light signal, especially if  deprived o f short wavelength light, 
provides impaired/reduced input to the circadian clock which in turn could produce 
weaker output signals. In contrast to the low irradiance light study the observed 
changes in the high irradiance light study occurred during the light exposure compared 
to the baseline whereas in the low irradiance light study changes occurred more often 
near the end of the light exposure and during the washout. Studies have shown that 
non-visual light responses are irradiance dependent (Boivin er a/., 1996; Zeitzer a/., 
2000; Gooley a/., 2010). Based on these findings it may be that the higher 
irradiance lights used in the current study were more effective at inducing changes in 
the circadian and/or homeostatie systems earlier within the light administration 
episodes.
4.5.2 Daytime: Subjective napping and mood and alertness
The effects o f light exposure on subjective napping are discussed in section 4.5.2.1.
The results for subjective mood and alertness are discussed in section 4.5.2.2.
4.5.2.1 Subjective napping
In the current study 16 participants (76%) reported napping. No significant changes in 
nap duration or number of naps before, during or after either light exposure were 
observed. No significant differences in napping behaviour were observed when 
comparing the two light conditions or periods.
The average nap duration per day was 18 ± 5 min during the control light and 10 ± 2 
min during the blue-enriched light exposure. Similar to the low irradiance light study, 
the observed nap duration was shorter than most previous studies have reported (23.3
to 45 min, Yoon et ai, 2003a). Since the current study did not differentiate between
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daytime and evening naps, i.e. naps within two hours of bedtime (Yoon er a/. 2003a) 
which are generally shorter, this might have contributed to the observed lower nap
duration.
The average number of naps per day was 0.3 ±0.1 for the blue-enriched light and 0.4 ± 
0.1 for the control light exposure. Similar to the findings o f the low irradiance study, 
the values for the current study were lower compared to most other studies (Buysse er 
a/., 1992; Dautovich a/., 2008). Yoon ef a/. (2003a) reported an average nap
frequency of one per week. The majority o f the participants of the current study 
(including those who napped) were middle-old individuals (Hummert, 1993), 65 -  74 
years, with an active lifestyle. The low frequency and short duration of naps observed 
in the present study could be attributable to their active and healthy lifestyle, to their 
not very severe sleep problems (resulting in less daytime sleepiness) (Metz and 
Bunnell, 1990; Duffy er a/., 2009) and/or to their personality traits (napper v.y. non- 
napper) (Frisoni et al., 1996; Campbell et al, 2005) as discussed for the low irradiance 
light study (section 3.5.2.1).
4.S.2.2 Mood and alertness
Few statistically significant changes in subjeetive mood and alertness were observed 
during either the blue-enriched or control light administration period. It should be 
noted that, whereas in the low irradiance light study most changes were observed 
during the washout period, mood changes in the current study were observed mainly in
the second and third week of the light exposure and during the washout eompared to 
the baseline and/or first week o f light exposure. The ability of light exposure to affect 
mood in younger adults in laboratory studies (Cajochen a/., 2005; Loekley er a/., 
2006; Revell et al, 2006) and as a potent non-pharmacological form of treatment of 
SAD (Rosenthal et al, 1984; reviewed in Tam et al, 1995) has been studied 
extensively (section 3.5.2.2). However, only a limited number of studies have looked 
at the effects of daytime light exposure on mood and alertness in older adults living in 
the community. One of these studies conducted in the laboratory (Sletten et al, 2009) 
investigated the effects of 2 h exposure to short wavelength (456 nm) and medium 
wavelength (548 nm) monochromatic light on mood and alertness assessed before, 
during and after the exposure in young and older people. With the blue light, levels of 
alertness and mood were significantly lower in the older group compared to the
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younger group. No differences were observed with the green light between the two 
groups.
To the authors’ knowledge no studies have investigated the effeetiveness of 
polychromatic light of different spectral composition on mood and alertness in older 
independently living people. Thus the results of the blue-enriched and control light 
exposure will be diseussed together. In the present study improvements in subjective 
alertness (morning) and sleepiness (morning and evening) only started to occur from 
the second or third week o f control liglit exposure and during the washout eompared to 
the baseline week. This delay in responsiveness, i.e. changes in alertness and 
sleepiness in the morning, are unlikely to be attributable to an aeute effect of the light 
since assessments in the morning were before the light exposure. A more plausible 
explanation is that the circadian pacemaker has been reset by the light exposure and 
this has influenced the strength and timing of the alertness rhythm.
A study by Rosenthal er a/. (1990) showed similar improvements in alertness for a 
group of patients suffering from delayed sleep phase syndrome (DSPS). In a cross- 
over design each patient was exposed to 2 h o f 2500 lux light (active condition) or to 
300 lux (control condition) in the morning, each for two weeks. An improvement in 
alertness in the morning with the active condition only started to oceur in the second 
week of light exposure. Rosenthal and colleagues explained this ‘delay’ in the effect 
with the time it takes for the human circadian system to re-entrain (Wever, 1979). 
Animal studies suggest that the rate o f entrainment ehanges with age (Buresova g/ a/., 
1990; Zee er a/., 1992) which might explain the delay in responsiveness as seen in the 
current study.
The underlying mechanism explaining the results of mood and alertness in the present 
study might be a phase advance of the circadian clock. It has been shown that phase 
adjustment to an earlier clock time occurs at a slower rate than inducing a phase delay 
in older people (Monk et al, 2000) which could explain the observed delay in 
responsiveness. However, this explanation contradicts the observed delay in sleep 
timing.
In the current study an improvement in cheerfulness in the morning during the washout 
eompared to baseline and the first week o f control light exposure was observed. This
is similar to the findings for the low irradiance light study. Again, different
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explanations are possible. Participants may have felt relieved of the obligation to get 
np and carry out the light exposure which was more of a burden in the morning than in 
the evening. This interpretation is supported by the observed delay in get-up time 
during the washout weeks. Alternatively, the improvements in alertness and sleepiness 
in the morning could have led to a more cheerful mood of the participants.
The observed reduction in sleepiness in the evening, however, is more likely to result 
from a direct acute effect of the light. This assessment was carried out before 
participants went to bed after the evening liglit exposure and improvements were only 
seen during the control light exposure episode. There was also a trend (non- 
significant) for alertness to increase in the evening during and after the control light 
exposure.
Interestingly, no statistically significant changes in mood or alertness were observed in 
the evening in the low irradiance light study. This suggests a potential light irradiance 
effect in the current study. Duffy er a/. (2007) also reported differenees in response 
(phase delay) to light exposure of different irradiances in older people when compared 
to younger adults. In their laboratory study healthy older people (68.3 ± 3.7 years) 
were exposed to white light of low, moderate and high intensities (2 -  8000 lux) for
6.5 h during subjective nighttime and their circadian phase delay response was 
assessed. Whereas the phase shifting response to light exposure of low to moderate 
light (50 -  1000 lux) was reduced in the older compared to the younger group, no 
differences in response to bright light was observed between the young and old 
partieipants. Light levels in the current study were on average 1150 lux and are 
therefore within the moderate to bright light category (Hebert et al,  1998; Duffy et al, 
2007). This might explain why some, but not many, changes were observed in the 
present study (as compared to the low irradiance light study with an average light level 
of ~ 400 lux). The results from the low and high irradiance light studies are consistent 
with other studies (Herljevic er a/., 2005; Duffy er a/., 2007) showing a reduced 
sensitivity of the circadian system to low to moderate evening light in older people.
Before lunchtime, alertness improved during the last week o f blue-enriehed light 
exposure compared to the baseline week. One explanation eould be that these 
improvements are sustained effects following the morning light exposure which took 
some time to develop due to age-related changes in the rate of re-entrainment in older
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people. This would also imply that the improvements are due to a combination of the 
acute and circadian effects o f light. However, if  acute effects were involved then a 
change should be observed immediately after every light session not only in the final 
week o f light exposure. Moreover, most studies assessing alertness, sleepiness and 
mood during and after nocturnal or diurnal light exposure do not report sustained 
effects (C^ochen e/ 2000; Rüger ür/., 2003; Rüger er a/., 2006). Alternatively, it 
is possible that the observed improvement in alertness is due to some participant 
outliers. Two outliers (participants HLS058 and HLS064) were identified and when 
excluded the statistically significant difference in alertness before lunchtime is no 
longer observed.
Depression ratings improved before lunchtime during the last week of blue-enriched 
light exposure compared to the first and seeond week of light exposure. An 
improvement in depression in the morning following blue-enriched light was observed 
but due to a carry-over effect these data had to be excluded. A reduction in depressive 
symptoms in response to all-day bright light exposure (1000 lux, maximum period of
3.5 years) has also been reported in a study by Riemersma-van der Lek and colleagues 
(2008) for a population of care-home residents. Light administration is a common 
treatment for SAD and depression. Many studies (Eastman er a/., 1998; Lewy er a/., 
1998; Terman er <?/., 1998) have reported beneficial effects of morning bright white 
light exposure in treatment of SAD patients. Dowling et al (2007) saw an 
improvement in depression scores in eare-home residents (mean ± SD 84 ± 10 years) 
following 1 h of bright light exposure (> 2500 lux) in the afternoon (15:30 -  16:30) 
Monday to Friday over 10 weeks. As Dowling and colleagues (2007) point out, the 
change in depression scores was rather small, yet statistically significant, making the 
meaningfulness of the result doubtful. The magnitude of changes in mood and 
alertness observed in the present study were also rather small and this raises the 
question, as already discussed for the mean wake bout time (section 4.5.1.2), o f the 
biological significance of these findings.
Direct comparison between the blue-enriched and the control light revealed no 
significant differences in any mood parameter. A period effect was observed for 
cheerfulness before lunchtime. During the second period cheerfulness was increased
compared to the first light exposure period, irrespective of the light condition. 
Generally, a period effect can be partly accounted for by habituation of the participants
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during the first exposure period. Participants have been ‘trained’ (conditioned) and 
know how best to incorporate the study requirements (e.g. light exposure, completion 
of questionnaires) in their daily routines and thereby the ‘burden’ of the study becomes 
less making participants more cheerful during the day. The observed period effect 
could also reflect an influence of season. For 18 participants (86%) in the high 
irradiance light study the second period fell within the winter season (November -  
February) during which the amount of natural light is reduced. Regardless of the light 
condition, the additional light in the morning may have created a greater contrast 
between night and day, thereby having an up-lifting effect on mood. The observed 
improvement before lunch could therefore be a sustained rather than an acute effect o f 
light.
As for the low irradiance light study, a time-of-day effect on some mood and alertness 
parameters was observed. This will be discussed in the final discussion.
4.5.3 Activity rhythms, cognition and daily rhythmic behaviour 
To examine whether light exposure changes activity patterns (i.e. being more active 
during the day and less activity at night) the 24 h rest-activity data were analysed using 
parametric (cosinor) and non-parametric analysis (NFCRA). Cosinor analysis is a 
simple, descriptive method (section 4.4.6) whereas NFCRA is considered to be a more 
sensitive method to assess small (treatment-induced) changes in the rest-activity 
rhythm (section 4.4.7) (Van Someren er a/., 1999).
With the control light an earlier acrophase time was observed during the washout 
weeks compared to the second week of light. Furthermore, the eosinor-derived mesor,
MIO and AMF (both assessed using NFCRA) showed an increase during the first week 
of washout compared to the baseline (and LI for the mesor) of the control light. This 
increase in activity and the earlier start o f activity during the washout could be a 
reflection o f the participants no longer being obliged to sit in &ont of the light box but 
‘regaining’ two hours o f activity in the morning and evening, respectively. The 
findings for the blue-enriched light might be interpreted in the same way. A delayed 
acrophase time during the first week of blue-enriched light together with a delayed 
MIO onset time during the first and second weeks o f light exposure compared to the 
last week of washout were observed.
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The fact that only a few changes in the activity rhythm were found during the current 
study can be interpreted in a similar way to what was done for the low irradiance light 
study (section 3.5.3). Briefly, the present study population consisted of adults which 
can be considered ‘young’ older people. Most of them were still engaged in an aetive 
social life, e.g. taking care o f grandchildren, part-time employment or self-employed. 
This is in contrast to a study population consisting of older demented people living in 
care-home facilities whose activities are limited (often with no clear distinction 
between day- and night activity levels); for this population, most previous studies have 
reported improvements in the rest-aetivity rhythm following bright light treatment (e.g. 
Satling/ar/., 1992; Fetveite^a/., 2003; section 1.7.3.1 and Table 1.1).
There are considerable differenees between healthy older community-dwelling people 
and those living in care-homes. Care-home residents have been shown to have lower 
daily activity levels and light exposure, less mental challenges and social commitments 
and more use of medication (Alessi e/ a/., 1995; Van Someren er a/., 1996; Shochat er 
al., 2000). The major differences, however, are the more severe disruption of the 
sleep-wake and rest-activity rhythm (Jacobs et al, 1989; Van Someren et al, 1996; 
Ancoli-Israel et a l, 1997b) and the level of cognitive status, i.e. dementia in the care- 
home patients; and a positive correlation has been shown to exist between these two 
parameters (Jacobs er a/., 1989; Witting er a/., 1990; reviewed in Vitiello e/ a/., 1992). 
These disturbances might be partly attributable to the reduced light exposure 
experienced by care-home residents (reviewed in Vitiello and Prinz, 1989; reviewed in 
Bliwise, 1993). Support for this view comes from reports showing that the more 
impaired the rest-activity rhythm and the higher the level of dementia of an older 
person the better the responsiveness to light exposure (Van Someren et al, 1996; 
Ancoli-Israel et al, 2003).
Dowling and colleagues (2005) reported NFCRA values for a population o f demented 
care-home residents before and after a 10 week light exposure trial (1 h light exposure 
of 2500 lux in the morning from Monday to Friday). Despite no overall improvements 
of the rest-activity rhythm and sleep parameters, they found that patients with a more 
severely disrupted rest-activity rhythm and who were more severely demented 
responded better to light exposure than those with fewer disturbances. They also 
reported NFCRA parameter values before and after light treatment which are more
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impaired than those obtained in the present study. This might imply that for the 
current study population the most sensitive NPCRA parameters, namely IS and IV, 
were already at high levels, making further improvements with light exposure more 
difficult. Similarly, Van Someren and colleagues (1997b) did not observe a change of 
the IS in a study using exercise as a tool to improve the circadian rest-activity rhythm 
of older men, aged 73 ± 15 years (mean ±SEM). These authors concluded that either 
the level of stability was already too high or the IS is not influenced by physical 
exercise or rather the coupling o f the rest-activity rhythm and the zeitgeber. 
Considering this stability and regularity of the pattern of the social rhythm (SRM 
scores) of the present study population this interpretation of an already high level of 
stability seems likely. The mean (± SEM) SRM score was 5.5 ± 0.2 for the study 
population indicating a high and reliable regularity of daily life activities (Monk et al, 
1992b) (section 4.4.11).
A further difference between participants of previous studies (demented care-home 
residents) and the current participants is the level of cognitive functioning. Several 
studies have shown that cognitive functioning (age-related or not) and sleep 
disturbances and &agmented rest-activity rhythms are associated (Jelicic er a/., 2002;
Blackwell et al, 2006; Carvalho-Bos et al, 2007; Oosterman et al, 2009), yet, the 
direction (cause and effect) o f this relationship is unknown. Carvalho-Bos and 
colleagues (2007) investigated the association of cognitive status and sleep 
disturbances in older (mean ± SD 85.5 ± 8.9 years) demented women living in care- 
home facilities. They showed that a higher cognitive function (assessed with the 
MMSE among other tools) was strongly correlated with a more stable and less 
fragmented rest-activity rhythm assessed with the IS, IV and RA, derived from two 
weeks of actigraphy data. Additionally, the authors saw a strong association between 
social isolation and curtailed cognitive functioning on the one side and reduced 
daytime activity levels (MIO) on the other. Less social interaction was also shown to 
be related to increased activity at nighttime (L5). Contrary to the patients studied by 
Carvalho-Bos et al (2007) the current study participants were not cognitively impaired 
with a mean (± SD) MMSE score at the start of the study of 29.2 ± 0.2 which remained 
stable throughout the study period. Although an improvement in the MMSE scores 
was observed between weeks I and 11, this is can be accounted for by conditioning or 
a practice effect rather than light exposure per se (see section 3.5.4 for an extensive
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discussion). The improvement in MMSE scores following the blue-enriched light 
exposure might be explained in the same way. As reported by Proust-Lima er a/. 
(2007), and similar to the results of the low irradiance light study, the MMSE is not 
sensitive enough to detect subtle cognitive changes in healthy, cognitively normal 
older people.
The present study population also showed a high regularity o f life style across the 
entire study as assessed with the SRM (sections 2.13 and 4.4.11). This finding is in 
agreement with previous studies of older people (Monk er a/., 1992b; 1997b) and the 
results of the low irradiance light study (section 3.5.4). As mentioned before, the 
participants were still engaged in daily social activities which might result in the 
observed stable values for the MIO and L5 (Table 4.10).
Based on the findings reported in the literature and the differences between care-home 
residents and community-dwelling older adults, we suggest that the current study 
population: (i) did not suffer from severe sleep problems, (ii) had no or little cognitive 
impairment and (iii) had social interactions and daily activities enabling them to 
maintain a stable and pronounced rest-activity rhythm, irrespective o f the light 
exposure. If already at a high level it might not have been possible to achieve a 
noticeable improvement of these parameters, with additional light exposure, despite 
using the sensitive non-parametric analysis method. It should also be mentioned that 
due to their active lifestyle participants may have been exposed to enough indoor and 
outdoor light to maintain most of the NPCRA parameters at a consistent level. Thus, 
an increase in light exposure and stabilisation o f the start and end (times) of the 
photoperiod was not able to elicit significant improvements in the activity rhythm.
For a few o f the parametric and non-parametric parameters a period effect was found. 
During the second period o f light exposure the eosinor-derived mesor and amplitude
were higher and the acrophase time was delayed. In addition, the IS and IV improved, 
and the MIO and AMP increased. These changes in acrophase, mesor, MIO and 
(cosinor- and NPCRA-derived) ampIitude/AMP reflect an increase in daytime activity 
with a delay in the activity onset time. The occurrence of a period effect might be 
explained in a similar way as for cheerfulness before lunchtime. The change in 
activity may partly be accounted for by conditioning of the participants during the first 
light exposure period. By the second light exposure period participants had likely
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elaborated how best to incorporate the study requirements, e.g. light exposure, 
completion of questionnaires, into their daily routines allowing the structure of their 
day to be more active. This increase in the amplitude of the activity rhythm may have
led to the observed improvement of the IV with more pronounced active bouts. 
However, it is also possible that the IV improved due to a reduced variability, i.e. 
reduced frequency and intensity of transitions between rest and activity. In this case, 
the activity increase might have induced more stable phases during which participants 
were activated reducing the transition to phases o f less activation. In a study by Van 
Someren er a/. (1997b) the authors found an improvement of the IV during and 
following physical exercise but no change in the RA. The authors suggested a 
reduction of variability that therefore led to an improvement of the IV. It may be 
hypothesised that if the current study population had had a less regular lifestyle and a 
more fragmented rest-activity rhythm the artificial light exposure could have led to an 
improved (more organised) activity pattern (Van Someren et al, 1996). The activity 
rhythm is both an output and an input of the SCN and it is difficult to say whether the 
increase in activity improved the IV or vice versa.
An alternative explanation is that the observed period effects are an effect o f the winter 
season during which the natural photoperiod is shorter compared to the summer 
photoperiod (Eastman, 1990). The IS is considered to be a sensitive parameter to 
detect a change in the rest-activity rhythm due to light exposure (i.e. treatment) (Van 
Someren et al, 1999). Improvement of the IS implies a more stable, consistent day-to- 
day variation (rhythmicity) of activity which is likely due to the stronger coupling of 
the rest-activity rhythm and the light zeitgeber and not an increase in activity per se 
(Van Someren er a/., 1997b). This consistency across days is reflected in the 
coherence of the daily rest-activity rhythm, as can be seen in the improvement o f the 
IV. However, it remains inconclusive whether the observed changes in activity, its 
pattern and fragmentation were caused by a stronger coupling of the rest-activity 
rhythm and the light signal.
Although the PROC GLM model did not detect any carry-over effects between the 
baselines for any of the parameters discussed above, slight, yet non-significant, 
differences in the baselines may have existed. Baselines starting at different levels 
could then have been at least partly responsible for the observed period effects.
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Since cheerfulness before lunchtime also increased during the second period it might 
be possible that a mutual relationship exists. By feeling more cheerful participants 
might have engaged in slightly more activity causing further changes of the IV or vice 
vcr.ya the increase in activity, which led to improvements of the IV, improved the
overall of feeling of well-being, i.e. improved cheerfulness.
4.5.4 Limitation of the study
There are some limitations to this study. For a more detailed discussion of the 
limitations o f the studies see chapter 7.
Firstly, although the light irradiance was higher in the present study, this still may not 
have been sufficient to produce effects on sleep, activity and mood. Secondly, 
although it was thought that the 2-week washout period in between the two light 
exposure periods was generally adequate in duration, it might have been too short for 
some parameters to return to baseline. Using the second washout week as the baseline 
week for the second light exposure might have confounded some data, especially in 
view of the observed carry-over and period effects. Thus a longer washout period may 
have been better. However, as discussed in chapter 3, extending the length o f the 
study period would have made recruitment even more difScult. Moreover, the study 
would then have been extended over more than two seasons leading to more changes 
in the environmental photoperiod.
Another potential limitation concerns the fact that only three participants were studied 
from February until April compared to 18 who were studied between September and 
December. The imbalance of participants studied in autumn winter compared to 
winter -> early spring may have introduced an effect o f season and changing 
photoperiod.
To the authors' knowledge no one has directly examined the effectiveness o f low and
high irradiance lights on sleep, activity and daytime mood in older people living in the 
community. The data from the low and high irradiance light studies were therefore 
combined and analysed together in chapter 5.
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CHAPTER FIVE 
COMBINED ANALYSIS 
OF LOW AND HIGH IRRADIANCE LIGHTS
Chapter 5
5 Combined analysis of low and high irradiance lights
5.1 Introduction
The magnitude of non-visual responses to light is dependent upon the characteristics of 
the light stimulus (section 1.6.4). To obtain knowledge o f time-of-day the human 
circadian timing system uses changes in three related properties of light which occur at 
twilight: a) the spectral composition, b) the amount of light (irradiance) and c) the 
position o f the light source (in relation to a fixed reference point) (reviewed in 
Roenneberg and Foster, 1997). The dedicated photoreceptor responsible for these 
changes and thereby mediating the subsequent non-visual responses in humans are 
ganglion cells which are intrinsically photosensitive (ipRGCs) (Berson et al, 2002) 
and contain the novel photopigment melanopsin (sectionl.5.2.1).
With age the prevalence of sleep problems increases even in healthy older adults 
(section 1.7.2). Apart from changes in sleep structure older people report an earlier
timing of sleep as well as shorter sleep episodes which is often accompanied by a 
decline in daytime alertness and performance. These changes could be due to a 
misaligned interaction between the circadian and homeostatic processes involved in 
sleep regulation (section 1.7.2).
Light is the most potent time cue o f the human circadian system (section 1.1.2). In
older people light exposure is reduced (section 1.7.1.1.2) either due to physiological 
changes o f the eye (section 1.7.1.1.1) and/or a more sedentary lifestyle, especially in 
care-home-bound older (demented) adults (Van Someren et al, 1996; Ancoli-lsrael et 
a/., 1997b). Thus it has been suggested that the observed sleep problems might partly 
be due to a lack of sufficient light. Indeed, daytime administration of bright white 
light in older people in care-homes has produced some beneficial effects on sleep and 
alertness as well as on the rest/activity rhythm (section 1.7.3.1 and Table 1.1).
The non-visual responses to light depend upon a combination o f wavelength and 
irradiance (as well as timing and duration) (section 1.6.4). The previous two chapters
(chapters 3 and 4) have addressed the study of different wavelengths (blue-enriehed V5. 
control white light) at two different irradiances (low vj. high irradiance) separately. In 
the current study the effects of the two different polychromatic light sources at two
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different irradiances are assessed simultaneously on sleep, activity, daytime mood and 
alertness and cognitive performance in older community-dwelling people. The 
datasets o f chapters 3 and 4 are joined and their combined analysis is presented.
5.2 Aim  and hypotheses
The aim of this analysis was to simultaneously assess and compare the effects of (1) 
the two photon-matched light conditions of different wavelengths (blue-enriched white 
light, 17000 K, v.y. control white light, 4000 K) and (2) the two different irradiances 
(low v.y. high irradiance). The low and high irradiance were -  3.6 x O'"* 
photons/cm^/sec and -  9.1 x 10^ "* photons/cm^/sec, respectively. Their effectiveness 
on subjective and actigraphic sleep, activity, daytime mood and alertness and cognitive 
performance in healthy, older people (> 60 years) was assessed using the data 
presented in chapters 3 and 4.
The four working hypotheses o f this study are:
Hypothesis]: Blue-enriehed white and control white light at both irradiances will 
improve subjective and actigraphic sleep, activity, daytime mood and alertness, and
cognitive performance compared to the no light conditions (baseline and washout).
Hypothesis:: The magnitude o f the responses elicited by the blue-enriched white light 
will be greater than that of the control white light condition despite being photon- 
matched (spectral sensitivity effect).
Hypothesis]: The magnitude o f the responses elicited by the two high irradiance light 
conditions will be greater than those elicited by the low irradiance light conditions 
(irradiance-dependency effect).
Hypothesis4: The magnitude o f the responses will be greatest with the blue-enriched 
white light at the higher irradiance.
5.3 M ethods
The data from the low (chapter 3) and high (chapter 4) irradiance light study groups 
were merged. The study methods are outlined in detail in chapters 2, 3 and 4.
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5.3.1 Participants
Participants were community-dwelling older people (23 female and 10 male; age range 
60 -  76 years), none of whom were in full-time employment. Twelve participants 
(participants HLS019 to HLS047) were studied in the pilot, low irradiance light study 
(chapter 3) either during October -  December 2006 or January -  March 2007. 
Twenty-one participants were studied in the high irradiance light study (chapter 4): 
Nine participants (HLS054 to HLS078) were recruited to the study during September -  
December 2007, one participant (HLS080) was studied from December 2007 -  
February 2008 (included in the September -  December participant count) and three 
participants (HLS089, HLS092 and HLSl 12) took part during February -  April 2008. 
Another eight participants (H LSl20 to HLS143) were studied during September -  
December 2008.
Table 5.1 presents the demographics and pre-screening values for the 33 participants 
for whom statistical analysis was performed. (Three participants of the low irradiance 
light study were excluded from statistical analysis due to incomplete datasets and are 
not shown in Table 5.1.) Twenty-three participants were studied in the autumn/winter 
season and ten during the winter/spring season. Fourteen participants received the 
blue-enriched light first and 19 received control light first.
The PSQI score (sections 2.3 and 2.6.3) was the principal measure used to determine 
eligibility for inclusion in the study (PSQI score > 5). The PSQI score for the study 
population was 12.2 ± 3.4 (mean ± SD) and the Home-Ostberg momingness- 
eveningness score (MEQ) was 59.3 ± 11.2 (mean ± SD).
Details of the participants’ ocular status obtained by ophthalmological examination, 
performed by an independent optician, and self-reported alcohol, cigarette and 
medication consumption are presented in chapter 3 (Tables 3.3 and 3.4) and chapter 4 
(Tables 4.3 and 4.4).
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Table 5.1: Dem ographics and screening results o f  33 participants analysed from the low  and
high irradiance lig It study
Group Code Age (years) Gender PSQI Horne-ÔstbergQuestionnaire
Oct -  D ec 2006 HLS026* 65 F 17 60
Oct -  D ec 2006 HLS029* 67 F 12 56
Jan -  Mar 2007 HLS039* 73 F 15 61
Jan -  Mar 2007 HLS041* 61 F 12 71
Sep -  D ec 2007 HLS054 69 M 8 72
Sep -  D ec 2007 HLS058 69 F 15 54
Sep -  D ec 2007 HLS066 68 F 10 66
Sep -  D ec 2007 HLS067 63 F 11 55
Sep -  D ec 2007 HLS080 73 F 11 64
Feb -  Apr 2008 HLS112 76 M 14 68
Sep -  D ec 2008 HLS120 75 F 16 28
Sep -  D ec 2008 HLS125 65 M 15 72
Sep -  D ec 2008 HLS142 72 F 13 63
Sep -  D ec 2008 HLS143 62 F 8 42
Jan -  Mar 2007 HLSOlO* 71 M 15 65
Jan -  Mar 2007 HLS018* 60 F 11 76
Oct -  D ec 2006 HLS019* 65 F 16 50
Oct -  D ec 2006 HLS032* 65 F 14 70
Jan -  Mar 2007 HLS036* 60 M 14 73
Oct -  D ec 2006 HLS037* 61 M 11 52
Jan -  Mar 2007 HLS044* 65 M 15 39
Jan -  Mar 2007 HLS047* 70 M 11 60
Sep -  D ec 2007 HLS055 68 F 16 61
Sep -  D ec 2007 HLS061 63 F 10 52
Sep -  D ec 2007 HLS064 73 M 14 57
Sep -  D ec 2007 HLS070 71 F 16 66
Sep -  D ec 2007 HLS078 61 F 7 62
Feb -  Apr 2008 HLS089 68 M 11 64
F e b -A p r  2008 HLS092 63 F 9 74
Sep -  D ec 2008 HLS129 62 F 10 61
Sep -  D ec 2008 HLS130 67 F 11 54
Sep -  D ec 2008 HLS134 61 F 10 39
Sep -  D ec 2008 HLS139 62 F 14 49
Mean ± SD 66.5 ± 4.7 23 F, 10 M 12.2 ±3.4 59.3 ± 11.2
B lue font: participants w ho received the blue-enriched light first 
received the control light first. Participants are separated by the 
indicates participants o f  the p ilo t/low  irradiance study.
Y ello w  highlight: participants w ho  
first light condition they received. *
5.3.2 Light parameters
Details of the light sources, including photon density calculations and settings, which 
were used in the low and high irradiance light studies, have been described in detail in 
chapters 2, 3 and 4. The photon density of the high irradiance lights was 2.5-fold 
higher than the low irradianee lights. In both studies the two light conditions 
contained the same total number of photons but the wavelength distribution of the two
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light sources varied; the blue-enriched light source contained approximately double the 
amount of short wavelengths blue photons compared to the control light source; in turn 
the control light condition contained more longer wavelength photons (> 490 nm) 
(Tables 3.5 and 4.5). Table 5.2 presents a simple comparison of the photon densities 
used for the blue-enriched light and the control light source in the low and high 
irradianee studies.
Table 5.2: Administered photon censities of the two light sources
Blue-enriched light Control light
Low
irradianee
High
irradianee
Low
irradianee
High
irradianee
Colour temperature (K) 17000 17000 4000 4000
Total photons 
(photon/cmVsec)
3.59 X 10^ ^ 8.97 X 10*^ 3.65 X 10'^ 9.13 X 10"
‘Blue’ photons
(400-490 nm) (photon/cmVsec)
1.77 X lO*'* 4.43 X 10*^ 8.86 X 10" 2.22 X 10"
5.3.3 Statistics
The data analysis is described in detail in section 2.17. Therefore, only a brief 
summary of the stepwise process will be given here. Light irradianee was 
implemented as a fixed effect. Carry-over effect was assessed using General Linear 
Model Analysis o f Variance for repeated measures (PROC GLM ANOVA). For every 
parameter the means from each light exposure were adjusted for baseline to assess any 
effect of light condition (treatment) and irradianee. To assess a period effect the 
means of the first and second exposure period (irrespective of the light condition) were 
at^usted for baseline (week 1 and week 6, respectively) and compared. PROC GLM 
was not performed on the PSQI data due to the lack of a second baseline value (week 
6).
5.4 Results
Presented here are parameters for which statistically significant differences between 
the light conditions (treatment effect), periods and/or light irradiances (intensity) were 
observed. In addition, significant interaction effects are presented. Regardless of
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whether a carry-over effect was observed during either the low or high irradianee light 
studies (chapters 3 and 4) parameters were re-analysed in this combined dataset. This 
was done since the earlier observed effects might have been due to low sample sizes of  
both studies.
Unless otherwise stated, decimal hours (± SEM) are reported for all clock times, 
durations and differences in timing. All data are plotted as change from baseline. The
term period refers to the three weeks of a light exposure. Effect of light condition 
refers to the comparison between the blue-enriched and control light condition. 
Sequence group is the order in which the light conditions were received, i.e. blue- 
enriched light followed by control light exposure or vzce (see section 2.4 for a 
list of the terminology).
5.4.1 Light exposure
Daily light exposure was scheduled for 2 h in the morning and for 2 h in the evening, 
respectively, (section 2.5.1) and participants were permitted to choose light 
exposure/administration times that suited their daily schedules. One-way repeated 
measures ANOVA (within-subject factor: light condition; between subject factor: 
irradianee) (SPSS version 16.0) revealed a significant (F (i, 26) = 6.80, p < 0.05) light 
condition x irradianee interaction effect. High irradianee control light showed an 
earlier start exposure time in the morning. No significant effects were observed for the 
mean evening light session start times.
5.4.2 Comparison of the study groups
Table 5.3 presents comparison of the demographics and screening questionnaire results 
of the low and high irradianee light study groups. Unpaired Student's t-tests did not 
reveal any statistically significant differences between the demographics o f the low 
and high irradianee light study groups.
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Table 5.3: Comparison of demographics and screening questionnaires of the two study 
groups
Irradianee study group Low High
N 12 21
Age (years, mean ± SD) 65.3 ± 4.4 67.2 ±4.8
Gender (female, male) 7,5 16,5
Pittsburgh Sleep Quality Index (mean ± SD) 13.6±2.1 11.9 ±2.9
Horne-Ostberg (mean ± SD) 59.5 ± 10.6 58.2 ± 11.6
Epworth Sleepiness Scale (mean ± SD) 7.0 ±4.1 6.9 ±3.5
Beck Depression Index(mean ± SD) 9.9 ± 6.8 10.9 ±6.0
Study period Oct 2006 - Mar 2007 Oct 2007 - Apr 2008
Sep - Dec 2008
Autumn/Winter (N) 5 18
Winter/Spring (N) 7 3
5.4.3 Subjective sleep
On each study day participants completed a sleep diary upon awakening in the
morning (Appendix I). From the sleep diaries the subjective sleep parameters were 
obtained (Table 2.4) and subjected to statistical analysis (sections 2.17 and 5.3.3). A 
carry-over effect was observed for bedtime and sleep duration, which were therefore 
excluded from any further analysis.
5.4.3.1 Time trying to sleep
Figure 5.1 shows the mean (± SEM) data of the blue-enriched light and control light 
exposure adjusted for baseline (either week 1 or week 6). A statistically significant 
effect of light condition (F (i, 31) = 6.31, p < 0.05) with a difference of 13 ± 6 min 
between the light conditions was observed for the time trying to sleep. With the blue- 
enriched light time trying to sleep was 12 ± 3 min later compared to its baseline 
whereas the control light advanced time trying to sleep by 1 ± 4 min compared to its 
baseline.
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Figure 5.1: Time trying to sleep (mean ± SEM, n = 33) as change from baseline during the 
blue-enriched (open bar) and control (closed bar) light exposure.
B lue-enriched: b lue-enriched light exposure; Control: control light exposure.
* p  <  0 .05 com pared to the control light.
S.4.3.2 Sleep latency
Figure 5.2 presents subjective sleep latency (mean ± SEM) under the low and high 
irradianee light exposure, irrespective o f light condition. A statistically significant
difference (F (i, 29) = 5.19, p < 0.05) between the two light irradiances was found. The 
change in sleep latency from baseline was significantly greater under the low 
irradianee light. With the lower irradianee light sleep latency was reduced by 10 ± 4 
min compared to baseline and with the higher irradianee light sleep latency was 
reduced by 1 ± 3 min compared to its baseline.
S.4.3.3 Get-up time
A significant sequence x light irradianee interaction was identified (F (i, 29) = 4.52, p < 
0.05) for get-up time. Receiving low irradianee light in the sequence group 'exposed 
to control light first’ had the earliest get-up time compared to baseline (30 ± 6 min). 
Get-up time had the least difference from baseline (0 ± 9 min) when receiving low 
irradianee light in the sequence group 'exposed to blue-enriched light first’.
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Figure 5.2: Subjective sleep latency (mean ± SEM, n = 33) as change from baseline during 
low (open bar) and high (closed bar) irradianee light exposure.
Low: lo w  irradianee light; High: high irradianee light.
* p <  0 .05 com pared to the high irradianee light.
5.4.4 Actigraphic sleep
Participants wore an AWL continuously on their non-dominant wrist throughout the 
11-week study period (section 2.6.2) and the actigraphy data were analysed using the 
Actiwateh software package (Sleep Analysis 7, version 7.23) prior to statistical
analysis. A carry-over effect was observed for actigraphic wake-up time which was 
therefore excluded from any further analysis.
5.4.4.1 Sleep onset time
Figure 5.3 illustrates actigraphic sleep onset time (mean ± SEM) for both light 
exposures irrespective of irradianee. A significant effect of light condition (F (i, 31) = 
8.90, p < 0.01) between the blue-enriched and control light exposure was found. 
During the blue-enriched light exposure sleep onset time was 13 ± 3 min later 
compared to its baseline whereas the control light was 1 ± 4 min earlier compared to 
its baseline.
5-9
Chapter 5
20n
CO
§ %10-
Q. c
W
q5
Blue-enriched Control
Light condition
Figure 5.3: Actigraphic sleep onset time (mean ± SEM, n = 33) as change from baseline 
during the blue-enriched (open bar) and control (closed bar) light exposure.
Blue-enriched: blue-enriched light exposure; Control: control light exposure.
* p <  0 .05 com pared to the control light.
Additionally, a significant irradianee effect (F (],29) = 5.40, p < 0.05) was identified for 
actigraphic sleep onset time as shown in Figure 5.4. The difference between the two 
light irradiances was 12 ± 4 min. The lower irradianee light exposure produced an 
earlier sleep onset whereas the higher irradianee light exposure produced a delayed 
sleep onset time (baseline-adjusted).
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Figure 5.4: Actigraphic sleep onset time (mean ± SEM, n = 33) as change from baseline 
during the low (open bar) and high (closed bar) irradianee light exposure.
Low: low irradianee light; High: high irradianee light.
* p < 0.05 compared to the high irradianee light.
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S.4.4.2 Duration of night awakenings/night
In Figure 5.5 the mean (± SEM) data, at^usted for baseline, of actigraphic duration of 
night awakenings per night are shown. A statistically significant irradianee effect (F (i, 
29) = 4.35, p < 0.05) was identified. Exposure o f low irradianee light reduced the 
duration of nocturnal wake time by approximately 7 ± 2 min (compared to baseline) 
whereas the high irradianee light reduced it by 1 ± 2 min.
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Figure 5.5: Duration of night awakenings/night (mean ± SEM, n = 33) as change from 
baseline during the low (open bar) and high (closed bar) irradianee light exposure.
Low: lo w  irradianee light; High: high irradianee light.
* p  < 0 .05  com pared the high irradianee light.
S.4.4.3 Percentage of time spent awake at night
For the baseline acijusted mean (± SEM) data o f time spent awake after sleep onset (%) 
the effect of irradianee approached statistical significance (F (i, 29) = 4.49, p = 0.0525) 
with a difference in time spent awake at night of 1.0 ± 0.5% between the two 
irradiances. With the low irradianee light time spent awake at night was less (0.8 ± 
0.4%) compared to baseline whereas with the high irradianee light time spent awake at 
night was 0.1 ± 0.3% longer than baseline.
5 4.4.4 Sleep efficiency
An irradianee effect was observed for actigraphic sleep efficiency. Irrespective of the 
light condition, the low irradianee light produced a statistically significant (F (i, 29) = 
4.49, p < 0.05) higher sleep efficiency (1.1 ± 0.6%) compared to baseline. The high 
irradianee light reduced sleep efficiency by 0.5 ± 0.4% compared to its baseline. Thus
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there was a difference of 1.6 ± 0.7% in actigraphic sleep efficiency between the low 
and high irradianee light studies.
5.4.4.S Fragmentation index
Figure 5.6 presents the fragmentation index comparing the mean (± SEM) data of the 
low and high irradianee light exposures. There was a significant difference (F (i, 29) = 
4.26, p < 0.05) between the two light irradiances, irrespective o f the light condition. 
The low irradianee light decreased the fragmentation index by 2.1 ± 0 .7  compared to 
its baseline whereas the high irradianee light showed a slight increase (0.4 ± 0.8).
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Figure 5.6: Fragmentation index (mean ± SEM, n = 33) as change from baseline during the 
low (open bar) and high (closed bar) irradianee light exposure.
Low: low irradianee light study; High: high irradianee light.
* p < 0 .05 com pared to the high irradianee light.
S.4.4.6 Immobile time (%)
The individual and mean (± SEM) data for immobile time (%) (number of immobile 
minutes over the assumed sleep period) are shown in Figure 5.7. A statistically 
significant difference (F (i, 29) = 5.54, p < 0.05) between the light irradiances in 
immobile time (%) was observed. The increase in immobile time (%) was 1.1 ± 0.4% 
with the low irradianee light whereas for the high irradianee light a decrease of 0.1 ± 
0.3% was found (baseline-at^usted).
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Figure 5.7: Immobile time (%) (individual and mean ± SEM, n = 33) as change from baseline 
during the low (o) and high (■) irradianee light exposure.
Low: low  irradianee light; High: high irradianee light.
* p < 0 .05  com pared to the high irradianee light.
5.4.5 Subjective naps
O f the 33 participants studied 24 participants (73%) reported naps. All subsequent 
analysis of nap behaviour was done on these 24 participants. No carry-over effects, no 
period effects and no differences between light conditions or light irradiances were 
observed for the daily duration and number of naps.
5.4.6 Parametric (cosinor) analysis of activity
A mean hourly 24 h activity profile was created for each participant for each study 
week and a goodness-of-fit curve (sine wave) was then fitted to the data (section 
2.9.1). Analysis of estimates of the acrophase time, mesor and amplitude of the fitted 
curve revealed no carry-over effect and no effect of light condition or light irradianee 
on any of the cosinor parameters of the activity rhythm.
5.4.6.1 Acrophase time
The acrophase time of the activity rhythm was significantly more delayed (F (i, 29) = 
4.30, p < 0.05) by ~ 17 ± 7 min in the second period (irrespective of light condition 
and irradianee) compared to the first period. In the first exposure period the acrophase 
time was delayed by 5 ± 6 min compared to its baseline and during the second period 
the acrophase time was delayed by 23 ± 6 min compared to its baseline.
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S.4.6.2 Mesor
A significant light condition x sequence x irradianee interaction (F (i, 29) = 4.28, p < 
0.05) was observed for the mesor of the activity rhythm. Receiving low irradianee, 
control light in the sequence group 'exposed to blue-enriched light first' produced the 
lowest mesor (281 ± 5 1 8  activity counts, baseline-adjusted). The highest mesor was 
achieved receiving high irradianee blue-enriehed light in the sequence group ‘exposed 
to control light first' (731 ± 227 activity counts, baseline-adjusted).
S.4.6.3 Amplitude
A significant effect o f period (F (i, 29) = 5.77, p < 0.05) was revealed for the amplitude 
of the activity rhythm. During the second period (irrespective of light condition and 
irradianee) the amplitude of the activity rhythm was higher by 944 ± 326 activity 
counts than during the first period.
5.4.7 Non-parametric circadian rhythm analysis (NPCRA) of activity
Only parameters for which statistically significant changes were observed are
discussed in the following sections. No carry-over effects were found.
5.4.7.1 IS
Figure 5.8 shows the mean data for the IS during the first and second period of light 
exposure. A statistically significant period effect (F 29) = 8.73, p < 0.001) was 
observed with a difference of -  0.06 ± 0.02 between the two periods. The second 
period produced a higher IS value (0.02 ± 0 .01) compared to its baseline indicating a 
more stable rhythm over the day. The score of the first period was 0.03 ± 0.01 lower 
compared to its baseline.
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Figure 5.8: Interdaily Stability (IS) (mean ± SEM, n = 33) as change from baseline during the 
first (open bar) and second (closed bar) period of light exposure.
Period 1: first light exposure; Period 2: second light exposure.
* p < 0.05 compared to the first period.
S.4.7.2 IV
For the IV the two light exposure periods differed significantly (F (i, 29) = 7.87, p <
0.01) from each other by 0.09 ± 0.03. For the second period a lower IV score (0.02 ± 
0.02) was found indicating a less fragmented rhythm compared to the first period (0.07
±0.02 higher than its baseline).
S.4.7.3 MIO onset time
Shown in Figure 5.8 are the individual and mean (± SEM) data for the MIO onset time 
for both the low and high irradianee lights (adjusted for baseline). A statistically 
significant irradianee effect (F (i, 29) = 12.55, p < 0.01) was found: the two light 
irradiances differed by 29 ± 9 min. The low irradianee lights showed an earlier MIO 
onset time compared to its baseline (9 ± 7 min) whereas the high irradianee light had a 
20 ± 6 min later MIO onset time compared to its baseline.
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Figure 5.9: MIO onset time (individual and mean ± SEM, n = 33) as change from baseline 
during the low (o) and high (■) irradianee light exposure.
Low: low  irradianee light; High: high irradianee light.
* p <  0 .05 com pared to the high irradianee light.
S.4.7.4 L5
The L5 showed a statistically significant light condition x sequence x irradianee 
interaction (F (i, 29) = 6.95, p < 0.05). The lowest L5 value was found in participants 
receiving control light of low irradianee in the sequence group ‘exposed to blue- 
enriched light first’ (7 ± 3, compared to baseline). The highest L5 score was observed 
in participants receiving high irradianee, blue-enriched light in the sequence group 
‘exposed to control light first’ (2 ± 2, compared to baseline).
5.4.8 Subjective mood and alertness
Subjective mood and alertness were assessed using four validated 9-point scales and 
the Karolinska Sleepiness Seale (KSS) completed three times per day over the entire 
11-week study period (section 2.10). Neither a carry-over effect nor any effect of light 
condition or period was observed for any of the mood and alertness outcomes. Those 
parameters for which statistically significant changes were observed are discussed in 
the following sections.
5.4.8.1 Cheerfulness
A statistically significant light condition x sequence x light irradianee interaction (F (i, 
29) = 5.36, p < 0.05) was observed for cheerfulness ratings before lunchtime.
5-16
____________________________________________________________________Chapter 5
Participants receiving blue-enriched light of low irradianee while in the sequence 
group 'exposed to control light first’ were the least cheerful compared to baseline (0.1
± 0 .1  points), whereas participants receiving control light of low irradianee while in 
the sequence group 'exposed to control light first’ were the most cheerful compared to 
baseline (0.3 ±0.1 points).
5.4.S.2 Depression
A significant sequence x irradianee interaction was observed for depression in the 
morning and evening (morning, F 29) = 4.96, p < 0.05; evening, F (i, 29) = 4.43, p <
0.05). At both time points the interaction was such that when in the sequence group 
'exposed to blue-enriched light first’ and receiving high irradianee light participants 
were the least depressed (by 0.2 ±0.1 points) compared to baseline. Participants were 
the most depressed in the morning with high irradianee light in the sequence group 
'exposed to control light first’. In the evening participants felt most depressed with 
low irradianee light in the sequence group 'exposed to blue-enriched first’.
5.4.8.3 KSS
The KSS in the morning showed a significant light condition x irradianee interaction
(F (i_ 29) = 5.84, p < 0.05) indicating that participants were least alert (by 0.1 ± 0.2 
points) compared to baseline when receiving control light o f low irradianee. 
Receiving high irradianee control light produced the greatest increase in alertness in
the morning compared to baseline (0.6 ± 0.2 points).
5.4.9 Performance assessment
The Digital Symbol Substitution Test (DSST) was carried out three times per day after 
the mood and alertness assessments throughout the duration of the study (section 
2.11). As can be seen in Figures 5.10A, 5.10B and 5.IOC a practice effect was 
evident. Statistically significant period effects were observed in the morning (F (i, 29) = 
27.19, p < 0.0001), before lunch (F (i, 29) = 16.71, p < 0.001) and in the evening (F 29) 
= 9.54, p < 0.01). For the morning, before lunchtime and evening assessments the first 
period showed higher DSST values than the second period regardless of the light 
condition. The increased DSST values (compared to baseline) indicate a
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learning/practice effect similar to that reported for each of the light irradianee studies
(sections 3.4.11 and 4.4.9). It therefore was decided not to perform any further 
analysis on this data.
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Figure 5.10: DSST (means ± SEM %, n = 33): A) in the morning, B) before lunch and C) in 
the evening. Each individual's data were normalised to week 1. At all three time points a
clear increase in DSST values can be seen across the study period (practice effect).
5.4.10 Global cognitive performance
The MMSE was performed at five time points during the study (section 2.12). No 
statistically significant differences between light conditions, periods or light 
irradiances were observed. No carry-over effect was found.
5.4.11 Daily rhythmic behaviour
The SRM-5 was performed at five time points during the study (section 2.13). No 
statistically significant differences between light conditions, periods or light 
irradiances were observed. No carry-over effect was found.
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5.5 Discussion
The aim of this chapter was to simultaneously assess the effectiveness o f daily light 
exposure of blue-enriehed white light (17000 K) and control white light (4000 K), at a 
low and high light irradianee, on subjective and actigraphic sleep as well as daytime 
mood and alertness in older community-dwelling people suffering from self-reported 
sleep problems. References to the results from the low and high light irradianee 
studies will be made when appropriate.
5.5.1 Effect of light condition
A statistically significant difference was found between the two light conditions for 
subjective time trying to sleep and actigraphic sleep onset time. With the blue- 
enriched light, both time trying to sleep and sleep onset time, was significantly delayed 
compared to the control light. It is possible, as already discussed in section 4.5.1.2, 
that the blue-enriched light strengthened the circadian arousal signal in the evening 
thereby opposing the homeostatic drive for sleep (Munch et a l,  2007).
The observed changes for the control light are very small and most likely result from 
variability of the low and high light irradiances. In the high irradianee light study, 
time trying to sleep and actigraphic sleep onset were also delayed with the control light 
but these changes were small. In the low irradianee light study, however, the weekly 
means of time trying to sleep and actigraphic sleep onset time were advanced during 
the control light, although this was non-significant. The low irradianee light study 
findings may only have a small effect on the combined dataset. Thus the control light 
results are inconclusive.
5.5.2 Effect of light irradianee
An unexpected result was observed when comparing the two light irradiances. A 
significantly greater improvement in sleep was found with the low irradianee light 
compared to the high irradianee light, irrespective o f the spectral composition of the 
light condition. With the low irradianee light the timing of sleep onset became earlier 
as evidenced by shorter subjective sleep latency and an earlier actigraphic sleep onset 
time. Furthermore, there was evidence of sleep consolidation during low irradianee 
light exposure as indicated by improvement of actigraphic sleep. Participants were
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less awake at nighttime, and both the duration o f night awakenings and the percentage 
of time spent awake at night were reduced. Nocturnal restlessness, as assessed by the 
fragmentation index and immobile time (%), also improved with the low irradianee 
light and this further supports the idea of sleep consolidation (Dijk er a/., 1999). These 
improvements might be explained by changes in the circadian and/or homeostatic 
system or an interaction between the two processes. The low irradianee light might 
have strengthened the circadian drive to promote sleep at night and wakefulness during 
the daytime through an increase of circadian amplitude (Dijk et al, 1999). 
Furthermore, an increased signal for wakefulness during the day could have led to 
greater sleep pressure and an increased homeostatic drive for sleep in the evening and 
at nighttime. It therefore appears that through the interaction o f the two processes 
sleep timing has become earlier and sleep has become more consolidated.
Actigraphic sleep efficiency is a composite parameter, i.e. it is measured indirectly 
using multiple actigraphic sleep parameters. The accumulation of slight improvements 
in some parameters, such as those discussed above, could have led to the observed 
improvement in actigraphic sleep efficiency during the low irradianee light exposure. 
Similar improvements in sleep in older people following daytime (bright) light 
exposure have been reported by others, with some studies being conducted in 
community-dwelling older adults (Kohasaka e/ a/., 1998; 2000) or in care-homes 
(Mishima a/., 1998; Ancoli-lsrael er a/., 2003). Fetveit and Bjorvatn (2004; 2005) 
also reported higher actigraphic sleep efficiency following bright light exposure. 
However, the light levels used in these studies were much higher (mainly > 1500 lux) 
than the ones applied in the current low ( -  390 lux) and high irradianee (1150 lux) 
light studies. The current finding of greater improvements in sleep with the low 
irradianee light is therefore rather surprising.
Previous studies have shown an irradiance-dependency for phase shifting (Boivin et 
a/., 1996; Zeitzer er a/., 2000; Gooley g/ a/., 2010) and it was therefore expected that 
in the current study the high irradianee light would produce greater effects compared 
to the low irradianee light. It should be emphasised, though, that these dose-response 
studies investigated young adults with no age-related ocular changes and who were 
dark-adapted which might have increased the participants’ sensitivity. Considering 
findings by Duffy g/ a/. (2007) of a decreased sensitivity to low to moderate light 
levels (-50 -  1000 lux) in older people, the observed superiority of the low irradianee
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light over the high irradianee light should be considered with caution. The hypothesis 
that both lights were equally ineffeetive in eliciting significant responses also needs to 
be treated with caution as, at least for subjective and objective sleep, beneficial 
changes with the low irradianee light were observed.
A more plausible hypothesis to explain the finding of increased effectiveness o f the 
low irradianee light is that many older people are more sensitive to glare and feel 
discomfort in environments of bright light (Bennett, 1977). The high irradianee light 
used in the present study might thus have caused considerable discomfort resulting in 
the participants occasionally but unintentionally looking away from the light source. 
Due to this behaviour, the overall amount o f light perceived with the high irradianee 
light would have been less compared to the low irradianee light, thus reducing the 
photic signal to the clock.
5.5.3 Effect of period
Period effects have been observed for the IS and IV as well as for the cosinor-derived 
acrophase time and amplitude of activity. Irrespective of light condition and light 
irradianee the second period produced greater changes than the first period. The 
changes in activity amplitude and acrophase time reflect an increase in activity with a 
delay in the activity onset time. The improvement o f the IV and IS indicate a more 
robust daily activity rhythm which is also more stable across the study days. As 
discussed for the period effects of the high irradianee study (section 4.S.2.2 and 4.5.3) 
three interpretations are possible to explain these effects.
Firstly, the observed period effect might be due to seasonal changes especially in the 
amount of environmental light (Eastman, 1990; Cole et al, 1995). For the majority of 
study participants (70%) the second light exposure occurred during the darker winter 
season. The circadian system might therefore have been more sensitive to the 
additional daily artificial light exposure presented as a skeleton photoperiod. Through 
this increased photic sensitivity the light in the morning and evening might have been 
perceived as a stronger signal (higher signal-to-noise ratio) of time-of-day leading to 
stronger responses. A study by Hebert et al (2002) provides support for this 
hypothesis. In their cross-over design study young, healthy subjects (mean ± SD 25.5 
± 6.4 years) spent one week in dim light (wearing goggles and reducing light levels to
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200 lux in their homes') and another week in bright light (> 4 h of outdoor light and/or 
using bright light boxes, 5000 -  7000 lux). On the last two days o f each week, plasma 
melatonin levels were assessed following a 3 h light exposure (500 lux) in the 
laboratory. Light-induced melatonin suppression was found to be significantly greater 
following the dim light exposure week compared to following the bright light exposure 
week. A laboratory study by Smith a/. (2004) controlling light history for only a 
short duration (63 h) demonstrated similar results in young healthy subjects (age range 
18-29 years). Their subjects were kept in an environment of either 200 lux or 0.5 lux 
prior to a 6.5 h light exposure at nighttime. Melatonin suppression was found to be 
significantly greater following the 0.5 lux prior light history condition. Taken 
together, these results show clearly that prior light history modulates light sensitivity. 
It seems reasonable to assume that the period effects observed in the present study 
were at least partly caused by the same mechanism, i.e. an increase in light sensitivity 
during the darker winter months. Especially improvement o f the IS, a parameter 
sensitive to detect a change in the rest-activity rhythm due to light exposure (Van 
Someren er a/., 1999), could be explained this way. A consequence of the changes in 
IS might have been reduced fragmentation of the daily rest-aetivity rhythm assessed by 
the IV.
Secondly, the observed period effects might be partly due to a behavioural adjustment 
of the participants’ daily routines to the required daily light exposure. Since period 
effects were only observed for parameters assessing the activity rhythm it seems likely 
that it is more an adaptive change of behaviour resulting in an increase of activity 
amplitude with a more structured and stable rhythm during (IV) and across days (IS). 
The improvement of the IV could then also be explained by an increase in activity 
levels or a more structured activity rhythm (i.e. blocks of activity).
Finally, despite the PROC GLM model not detecting any carry-over effects between 
the baseline weeks for any of the parameters discussed above, slight, yet non­
significant, differences occurred. Visual comparison of the parameter means obtained 
during the two light conditions show that these parameters were mostly similar 
between both light conditions (Tables of blue-enriched and control light exposure. 
Tables 3.10 and 4.10). Furthermore, it is thought that the 2-week washout period was 
sufficient in duration to eliminate any significant residual effects of the first period. 
However, it is possible that the combination of even non-significant differences
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between baseline weeks and periods may have been enough to induce some o f the 
observed period effects.
5.5.4 Interaction effects
The largest effect on subjective get-up time was observed when receiving low 
irradiance light and being in the sequence group 'exposed to control light first' (24% 
of the participants). The smallest change (to an earlier time, too) was achieved when 
receiving low irradiance light and being in the sequence group 'exposed to blue- 
enriched light first'. Visual inspection of the means of each light condition shows an 
earlier get-up time with the control light than with the blue-enriched light (non- 
significant). From this it seems possible to conclude that exposure to control light per 
jg leads to an earlier get-up time. This effect might be increased when blue-enriched 
light is received second. In line with this notion is the finding that control light also 
advanced subjective time trying to sleep and aetigraphic sleep onset time.
For the mesor and L5 of the activity rhythm the lowest values were observed when 
receiving low irradiance control light in the sequence group 'exposed to blue-enriched 
first'. The highest values were achieved if  receiving high irradiance blue-enriched
light in the sequence group 'exposed to control light first'. A lower L5 represents less 
activity during the night which is reflected in a decreased value for the mesor.
Few interaction effects were observed for cheerfulness and depression ratings. They
appear inconsistent and the biological meaningfulness of the findings for the mood 
data remains unclear.
5.5.5 Limitations of the study
As the analysis of the current chapter is based on the datasets from the low (chapter 3) 
and high (chapter 4) irradiance light studies, the same limitations apply. These
limitations mainly eoneem the length of the washout period, the biased sample size 
between seasons and the sample population .se.
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6 6-Sulphatoxymelatonin rhythms under different light conditions
6.1 Introduction
The neurohormone melatonin is produced by the pineal gland almost exclusively at 
night (Arendt, 1993). The rhythmic production of melatonin by the pineal is regulated 
by the master circadian clock, the SCN (section 1.2.1), and its production is acutely 
suppressed by light (section 1.3.1.5).
The specific physiological role and mode of action of melatonin on the human
circadian system has not yet been fully described. However, it seems to reinforce 
entrainment and resetting of the pacemaker. Furthermore, it appears to have sleep- 
promoting and sleep-wake regulatory effects (section 1.3.1.2) through a temporal 
relationship between the rhythms of sleep propensity and melatonin secretion (section
1.3.1.2). The onset time of melatonin synthesis coincides with the rise in sleep 
propensity, the opening of the 'sleep gate' (Lavie, 1986), in the evening. It has been 
shown that melatonin is also involved in a cascade of processes leading to the 'opening 
of the sleep gate' (Tzischinsky and Lavie, 1994; Krauehi et al, 2000), i.e. it is 
involved in physiological changes when transitioning from wake to sleep. Melatonin 
is believed to exhibit its soporific effects by promoting heat loss, which is the most 
reliable predictor for sleep propensity (Krauehi et al, 2000), and weakening the 
circadian signal for wakefulness (reviewed in Lavie, 2001). The circadian drive then 
no longer opposes the homeostatic drive for sleep and sleep can be initiated.
Melatonin, measured in plasma or saliva, and its major urinary metabolite 6 -  
sulphatoxy-melatonin (aMT6s), are highly reliable markers of the circadian timing 
system (section 1.3.1.3) and thus, can be used to determine the phase of the biological 
clock (Lewy er 1999). Light has a resetting and entraining effect on the circadian 
clock (sections 1.1.2 and 1.1.4.1) and hence on the rhythm of melatonin (i.e. onset of 
melatonin synthesis) (sections 1.3.1.2 and 1.3.1.5).
Numerous studies have reported alterations in the levels of melatonin in plasma, saliva 
and urine (aMT6s) with age (section 1.7.1.3). Studies have shown a reduction of 
melatonin amplitude of -  30% in older compared to younger adults (section 1.7.1.3). 
However, two other studies did not observe such an age-related reduction (section
1.7.1.3) and these authors suggested that this could be due, in part, to the stringent
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selection criteria applied. Alternatively, it could be due to the highly controlled light 
environment used in these studies. Animal data show again a similar age-related 
reduction in melatonin production in rodents (section 1.7.1.3). Whereas no gender 
differences in melatonin excretion were observed in some studies (section 1.7.1.3), a 
study by Zeitzer and colleagues (2007) did find differences between older women and 
men (the latter had lower levels at night). The authors suggested that this might be 
indicative o f gender differences in sleep physiology in ageing adults.
The circadian rhythms of older people are generally phase advanced compared to 
younger adults as can be seen, for example, in the earlier timing o f sleep (section
1.7.1.3). Age-related changes are proposed to also occur in the timing o f the 
melatonin rhythm, with an -1  h advance o f the melatonin rhythm compared to the 
rhythm in younger adults, and in the temporal relationship (phase angle) between the 
sleep-wake cycle and the melatonin rhythm (section 1.7.1.3). Ageing adults awaken at 
an earlier internal phase, that is, their wake-up time is closer to the melatonin 
acrophase time resulting in a reduced phase angle between the melatonin rhythm and 
sleep (section 1.7.1.3).
It has been shown that light exposure in older people is reduced (section 1.7.1.1.2) and 
light transmission (especially o f short wavelengths) through the human lens is 
compromised in older people (section 1.7.1.1.1). In addition, changes of the photic 
input signalling pathway (e.g. photoreceptor number) to the circadian pacemaker and 
deterioration of the SCN (cell loss and/or inactivation) (section 1.7.1.2) may lead to a 
reduced light sensitivity o f the clock. This might cause further alterations and 
weakening of the SCN output signalling pathway. A dampened melatonin signal and 
changes in melatonin timing are possible results o f these alterations (Van Coevorden er 
a/., 1991). Thus it has been proposed that a reduced melatonin rhythm might play a 
role in the occurrence of sleep problems as observed in older people (section 1.7.1.3). 
However, other studies could not provide evidence for such a relationship between 
melatonin production and sleep problems (Hughes, e/ a/., 1998; Lushington g/ a/., 
1998; Baskett g/ a/., 2001; 2003). It may also be that the altered melatonin rhythm is a 
marker of changes in the circadian clock and its relationship with sleep.
To date, the effects of light administration on melatonin production have not been 
investigated extensively in older, healthy adults still living in the community. In the
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current study it was of interest to investigate whether aMT6s production, amplitude 
and timing (phase position) were altered in older individuals with self-reported sleep 
problems during/following light exposure and whether these responses varied 
depending on the light condition and irradiance (chapters 3, 4 and 5).
6.2 Aim s and hypotheses
The current aim was to assess the phase and amplitude of the circadian rhythm of
aMT6s, the major urinary metabolite of melatonin, in older people with self-reported 
sleep problems before and at the end o f each light exposure period. In addition to 
assessment of phase and amplitude, the 24 h aMT6s production and the phase
relationship (phase angle W) between the aMT6s acrophase and subjective wake-up 
time were examined. The present study used a skeleton photoperiod exposure which 
aimed to boost the amplitude of the aMT6s rhythm (without inducing a phase shift).
The working hypotheses o f this study were the following:
Hypothesis] : A skeleton photoperiod exposure will strengthen the coupling of the 
circadian clock to the photic zeitgeber and thereby reinforce output signals of the 
clock. This will manifest itself in an increased amplitude of melatonin (aMT6s) 
compared to the no light conditions (baseline and washout). Furthermore it was 
hypothesised that light exposure would lead to an altered relationship (phase angle) 
between aMT6s acrophase and sleep-wake timing.
Hypothesis 2: The magnitude of the responses elicited by the blue-enriched white light 
will be greater than that of the control white light condition (spectral-sensitivity effect) 
for all markers measured.
Hypothesiss: The magnitude of the responses elicited by the two high irradiance light
conditions will be greater than those elicited by the low irradiance light conditions 
(irradiance-dependency effect).
Hypothesis4: The magnitude of the responses will be greatest with the blue-enriched
white light at the higher irradiance.
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6.3 M ethods
For a detailed description of the methods and the study design see chapter 2, General 
Methodology.
The data collected in the low (chapter 3) and high (chapter 4) irradianee light studies 
included a maximum of four urine collections from each participant, before and at the 
end of light exposure to either blue-enriched or control light. (The urine collection at 
the end of a light exposure was conducted during the last few days of the third 
exposure week.) The urine collections were used to assess time of peak production 
(acrophase time) (dec.h unless otherwise stated), amplitude (ng/min) and total 
production (pg/24 h) o f aMT6s. aMT6s levels were measured by radioimmunoassay 
analysis.
6.3.1 Participants
Demographics o f the 33 participants are presented in chapter 3, section 3.3.1 and 
chapter 4, section 4.3.1.
6.3.2 Urinary aMT6s sampling
A detailed description of the urine sampling is provided in section 2.15.1. Briefly, 
participants collected sequentially timed urine samples over a 39 h period (~ 3 h 
collection bins and a -  8 h overnight collection) before and at the end of each light 
condition. The collection periods started at 21:00 h (day 1) and ended at 12:00 h (day 
3) and were divided into 11 collection slots (with a maximum of 11 samples). The first 
and second collection of participants HLS019, HLS026, HLS029, HLS32 and HLS037 
of the low irradiance light study was only 36 h and thus this ended at 09:00 h on day 3 
with a maximum of 10 samples.
6.3.3 Data analysis
Urinary aMT6s was measured by radioimmunoassay (RIA) (section 2.15.2) and all 
samples from a participant were analysed in one assay. The limit of detection was 0.5 
ng/ml. The inter-assay coefficients o f variation (CV) for quality controls (n = 28) were 
13.4% at 4 ng/ml (low), 7.9% at 14 ng/ml (medium) and 13.7% at 26 ng/ml (high). 
Cosinor analysis (section 2.15.2.3) was used to determine aMT6s acrophase time and
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amplitude of the aMT6s rhythm (sections 6.4.2 and 6.4.3). In addition, the 24 h output 
(pg/24 h) was calculated (section 6.4.4). The data for the mesor will not be presented.
6.3.4 Statistics
Due to the low number of participants providing sufficient aMT6s data adequate for 
analysis (low irradianee [n = 8]; high irradianee [n = 16]), the data o f both light 
irradianee studies were analysed together (n = 24). Analysis was done in two steps for 
each measured marker: Firstly, the values obtained for eaeh participant before 
(baseline value = end of the week preceding a light exposure) and at the end of each 3- 
week light exposure were compared. This was done separately for each light condition 
using paired Student's t-test to test for any effect o f light (GraphPad Prism). 
Subsequently, the values obtained during the light exposure were adjusted for the 
baseline value and subjected to analysis using PROC GLM ANOVA (n = 16 out of n = 
24) to assess any carry-over effects as well as effects o f light condition and period 
(section 2.17.1). It should be noted that, due to missing data of some participants for 
certain time points, different sample sizes were used for the different calculations. The 
sample size used for each calculation is given in the relevant sections.
The phase angle between the aMT6s acrophase and subjective wake-up time (mean of 
the week preceding the urine collection) was determined and analysed as described
above. Linear regression analysis was used to analyse the relationship between 
acrophase and wake-up time.
To test for differences between the start time of the light exposure (in the morning and 
evening, respectively) o f the two periods, paired Student's t-tests were performed 
(GraphPad Prism).
6.4 Results
Individual aMT6s acrophase, amplitude, and 24 hr production before and at the end of 
each light condition for all 33 participants. These data are shown in Tables 6.2, 6.3 
and 6.4. Due to missing data and/or a non-detectable aMT6s rhythm due to low 
aMT6s production and/or non-significance of the data (percentage rhythm < 50%) 
(section 2.15.2.3) eight participants were excluded from all statistical analysis:
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HLS019, HLS037, HLS047, HLS061, HLS064, HLS070, HLS112 and HLS134. 
Another participant, HLS029, was excluded because of arrhythmicity in all the aMT6s 
data. Therefore, statistical analysis was conducted on the remaining 24 participants, 
although, due to missing data points some participants could not be included in certain 
parts of the analysis. Full data sets (values for before and at the end of each light) 
were obtained for 16 participants. Table 6.1 shows the demographics of the 24 
participants included in the statistical analysis (mean ± SEM data are presented); the 
16 participants comprising the PROC GLM analysis are marked with an asterisk (*).
Table 6.1: Demographics of the study participants included in the statistical analysis (n = 24)
Code Group Irradianee Age (years) Gender PSQI
HLS026 Oct -  Dec Low 65 F 17
HLS039 Jan -  Mar Low 73 F 15
HLS041* Jan -  Mar Low 61 F 12
HLS054 Sep -  Dec High 69 M 8
HLS058 Sep -  Dec High 69 F 15
HLS066* Sep -  Dec High 68 F 10
HLS067* Sep -  Dec High 63 F 11
HLS080* Sep -  Dec High 73 F 11
HLS120* Sep -  Dec High 75 F 16
HLS125* Sep -  Dec High 65 M 15
HLS142* Sep -  Dec High 72 F 13
HLS143* Sep -  Dec High 62 F 8
HLSOlO Jan -  Mar Low 71 M 15
HLS018* Jan -  Mar Low 60 F 11
HLS032* Oct -  Dec Low 65 F 14
HLS036 Jan -  Mar Low 60 M 14
HLS044* Jan -  Mar Low 65 M 15
HLS055 Sep -  Dec High 68 F 16
HLS078 Sep -  Dec High 61 F 7
HLS089* Feb -  Apr High 68 M 11
HLS092* Feb -  Apr High 63 F 9
HLS129* Sep -  Dec High 62 F 10
HLS130* Sep -  Dec High 67 F 11
HLS139* Sep -  Dec High 62 F 14
Mean ± SD 
N = 24
Autumn; n = 
16 High: n = 16
66.1 ±4.5 
(mean ± SD) 19 F, 5 M 12.4 ±2.9
Mean ±  SD 
N = 16 Autumn: 11 High: 12
65.7 ±4.5
(mean ± SD) 13F,3M 11.9 ±2.3
B lue font: participants w ho received the blue-enriched light first. Y e llo w  highlight: participants w ho  
received the control light first. Participants are separated by the first light condition they received. * 
indicates participants included in the PROC G LM  analysis.
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6.4.1 Individual excretion profiles
Figure 6.1 shows aMT6s excretion levels (over a -  39 h collection period) of four 
example participants. The data are plotted at the mid-point of each collection interval. 
Figure 6.1 A illustrates a typical aMT6s profile. Excretion slowly rises in the evening, 
peak excretion occurs during the night followed by a slow decline and low daytime 
levels o f aMT6s. The same pattern can be found for the second overnight collection 
illustrating the reproducibility of the melatonin profile within an individual.
An arrhythmic aMT6s excretion profile (always seen for this participant) is shown in 
Figure 6 .IB to which no statistically significant cosine curve could be fitted. Here, no 
clear excretion pattern can be seen; the peak excretion is during daytime hours.
Figure 6.1C illustrates the aMT6s excretion profile of a participant with an advanced 
aMT6s acrophase time (01:30 h) and bed- and wake-up times (mean ± SEM) of 23:14 
± 00:19 h and 05:44 ± 00:17 h, respectively, for the week of aMT6s assessment. An 
early rise in excretion on one shoulder o f the advanced peak is reflected by an early 
decrease on the other shoulder. The overall aMT6s production is low; however, the 
rhythm of aMT6s excretion is maintained.
An aMT6s excretion profile with a delayed aMT6s acrophase time (HLS120) is shown 
in Figure 6. ID. Participant HLS120 had a delayed sleep-wake timing during the week
of aMT6s assessment with a bedtime of 23:56 ± 00:11 h and wake-up time of 09:10 ± 
00:15 h (mean + SEM). In this participant, aMT6s excretion is delayed at night with 
an acrophase time at 06:48 h. Lower excretion rates occurred in the afternoon showing 
that the rhythm of aMT6s excretion is maintained in this participant.
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Figure 6.1: aMT6s excretion profiles (ng/h) over a 39 h period. The data are plotted at the 
mid-point of each collection interval. A) HLS092: before the control light exposure, normal 
profile, B) HLS029: at the end of the blue-enriched light exposure, arrhythmic profile, C) 
HLSOlO: at the end of the control light exposure, advanced profile, D) HLS120: at the end of 
the control light exposure, delayed profile.
Dotted line indicates aMT6s acrophase time (clock time h:min) as determined by cosinor 
analysis.
6.4.2 aMT6s Acrophase time
Individual aMT6s acrophase times before and at the end of eaeh light condition for 33 
participants are shown in Table 6.2. In addition. Table 6.2 eontains the calculated 
differenees in aMT6s acrophase timing between before exposure (baseline) and at the 
end of a light exposure. aMT6s rhythms with a signifieant fit to a cosine curve had 
acrophase times ranging between 0.1 h and 8.1 h, mean ± SEM: 4.0 ± 0.2 h (n= 24).
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Table 6.2: Individual aM T6s acrophase tim es (dec.h) before and at the end o f  each light 
condition____________________________________________________________________________________
aMT6s Acrophase time (dec.h)
Participant BaselincB Blue
Blue - 
Baseline Baselinec Control
Control - 
Baseline
HSL026 3.5"^ 3.5** 0.0 1.6* 0.6 ns -1.0
HSL029 18.5 ns 72.,^*** 75.9*** 12.0 *
HSL039 X 5.8* 6.9* 6.6** -0.3
HSL041 4.0*** 4.5*** 0.5 4.1** 2.8* -1.3
HSLOlO 2.5** 0.9 ns -1.6 2.7* 1.5** -1.2
HSL018 1.8*** 2.2*** 0.4 3.3*** 1.7*** -1.6
HSL019 non-detectable rhythm - low production
HSL032 6.2** 5.7** -0.5 5.0** 6.8** 1.8
HSL036 6.8 ns 4 4*** -2.4 5.2* 5.9* 0.7
HSL037 non-detectable rhythm - low production
HSL044 5.1** 5.2** 0.1 II 6.1* 4.8** -1.3
HSL047 non-detectable rhythm - low production
HSL054 3.7* X 3.7** 3.3* -0.4
HSL058 5.8** 3.5^ -2.3 X 6.5"^
HSL066 2.6*** 2.1*** -0.5 2.4*** 3.4*** 1.0
HSL067 3.6** 3.1** -0.5 2.4** 3.5** 1.1
HSL080 2.9*** 3.1** 0.2 4.7* 3.9*** -0.8
HSL112 10.3 ns 9.9 ns 8.5 ns X
HSL120 4.1*** 3.2* -0.9 5.0** 6.8** 1.8
HSL125 3.6** 2 g*** -0.7 0.1** 4.2*** 4.1
HSL142 1.7** 2 .C 0.4 3.1** 7.8** 4.7
HSL143 6.5*** 5.2** -1.3 6.0*** 8.1*** 2.1
HSL055 4.0** 3.0** -1.0 5.9 ns 3.5*** -2.4
HSL061 non-detectable rhythm - low production
HSL064 &2*** 20.,^ X 20.6^
HSL070 9.6 ns 10.1 ns 7.8 ns
HSL078 6.1 ns 5.4 ns -0.7 3.9** 2.5** -1.4
HSL089 3.8*** 4.0** 0.2 2.4* 3.8*** 1.4
HSL092 2.7*** 4.6** 1.9 ^ * * 4.0** -0.4
HSL129 3.9** 5.0** 1.1 3.9*** 4.7*** 0.8
HSL130 3.4** 4.1* 0.7 4.9* 2.4* -2.5
HSL134 23.3 ns 12.6 ns 5.5 ns 6.2 ns
HSL139 3.8* 3.8** 0.0 4.0** 4.1*** 0.1
A p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001 cosinor analysis; x: missing data; implies a 
phase advance; +: implies a phase delay. Italics indicate participants excluded from statistical 
analysis. Blue font; participants who received the blue-enriched light first. Y ellow  highlight: 
participants who received the control light first.
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Figure 6.2 shows individual aMT6s acrophase times before (mean ± SEM: 3.8 ± 0.3 h; 
n ^ 19) and at the end of the blue-enriched light (3.7 ± 0.3 h; n = 19) (Figure 6.2A) as 
well as for before (4.0 ± 0.3 h; n = 21) and at the end of the control light (4.4 ± 0.4 h; n 
= 21) (Figure 6.2B) using the maximum sample size. No significant differences were 
found in acrophase timing before and at the end of either of the two light conditions 
(paired Student’s t-test).
A)
« 7
? 5
(0 3
1 -
BAb Blue
B)
Control
Condition Condition
Figure 6.2: Individual aMT6s acrophase times: before and at the end of A) the blue-enriched 
light (n = 19) and B) the control light (n = 21).
BAg: baseline o f  the b lue-enriehed light; Blue: b lue-enriched light; B A c: baseline o f  the control light; 
Control: control light.
On the 16 participants for whom a full data set was obtained analysis using PROC 
GLM was performed. A significant period effect was found for these 16 participants 
(F (1, 14) = 6.11, p < 0.05). The baseline adjusted aMT6s acrophase time at the end of 
the second light period was on average delayed by 79 ± 30 min compared to the first 
light period. No carry-over effect was found. There was no significant effect of light 
condition or irradianee.
Figure 6.3 shows the unadjusted data (mean ± SEM) of the 16 participants used for the 
analysis of the period effect. One-way repeated measures ANOVA comparing 
baseline 1, light period 1, baseline 2 and light period 2 did show a significant 
difference (p < 0.05). Here, the aMT6s acrophase time at the end of light 2 was 
significantly later compared to the aMT6s acrophase times of light 1 and baseline 2, 
confirming the observed period effect using PROC GLM analysis.
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Figure 6.3: aMT6s acrophase time (mean ± SEM, n = 16) before and at the end of each light 
exposure period (irrespective the light condition).
Period 1: first light exposure; Period 2: second light exposure. B A l/2 ;  baseline, before the first/second  
light; Light 1/2: at the end o f  the first/second light exposure; Wk: w eek.
* p < 0.05 com pared to Light 1 and B A 2.
For the 16 participants used for the PROC GLM analysis (and who therefore 
constituted to the observed period effect) separate analysis of their subjective time 
trying to sleep and wake-up time was performed. No effect of period on these sleep 
onset and offset times was observed (as well as no effect of irradianee, light condition 
or carry-over). Comparison (paired Students’ t-test) of the start times of the light 
exposure session in the morning and evening, respectively, for period 1 and 2 did not 
reveal any statistically significant differenees.
6.4.3 aMT6s Amplitude
Individual aMT6s amplitudes before and at the end of each light condition for 33 
participants are shown in Table 6.3. For the aMT6s amplitude the difference between 
the value at the end of a light condition and before exposure (baseline) is shown. The 
significant aMT6s amplitude covered a range between 0.39 and 48.2 ng/min, mean ± 
SEM: 9.8 ± 0.6 ng/min (n = 24).
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Table 6.3: Individual aM T6s amplitude (ng/m in) before and at the end o f  each light condition
Participant Baselines Blue
Blue - 
Baseline Baselinec Control
Control - 
Baseline
HSL026 2.6A 17.9** 15.3 9.0* 2.7 ns -6.3
HSL029 0.4 ns 2^*** 3.0*** 3.7*
HSL039 X 9.0* 25.1* 11.9** -13.2
HSL041 8.7*** 8.5*** -0.2 3.7** 6.9* 3.2
HSLOlO 1.3** 1.6 ns 0.3 1.8* 1.7** -0.1
HSL018 26.8*** 17.5*** -9.3 17.3*** 10.2*** -7.1
HSL019 non-detectable rhythm - low production
HSL032 6.9** 14.6** 7.7 14.3** 9.3** -5.0
HSL036 39.2 ns 31.2*** 48.2* 26.9* -21.3
HSL037 non-detectable rhythm - low production
HSL044 7.3** 8.3** 1.0 6.8* 8.9** 2.1
HSL047 non-detectable rhythm - low production
HSL054 16.1* X 18.8** 14.9* -3.9
HSL058 3.1** 6.0A 2.9 X 3.8A
HSL066 11.8*** 8.2*** -3.6 10.3*** 3.5*** -6.8
HSL067 7.9** 10.7** 2.8 8.9** 7.2** -1.7
HSL080 30.2*** 43.0** 12.8 16.9* 37.0*** 20.1
HSL112 0.7 ns 0.1 ns 0.9 ns X
HSL120 6.6*** 8.5* 1.9 10.6** 5.6** -5.0
HSL125 3.5** 6.7*** 3.2 4.1** 3.5*** -0.6
HSL142 4.1** 0.4A -3.7 0.9** 0.8** -0.1
HSL143 3.8*** 4.1** 0.3 3.8*** 4.1*** 0.3
HSL055 9.0** 10.2** 1.2 1.1 ns 3.4
HSL061 non-detectable rhythm - low production
HSL064 &3*** 13.0 ns X 24.4A
HSL070 11.2 ns 19.1 ns 22.6 ns 16.6A
HSL078 1.5 ns 3.1 ns 1.6 2.6** 9.8** 7.2
HSL089 6.4*** 5.0** -1.4 4.9* 5.3*** 0.4
HSL092 9.3*** 5.9** -3.4 11.0*** 7.8** -3.2
HSL129 10.7** 8.9** -1.8 12.3*** 11.9*** -0.4
HSL130 3.7** 1.6* -2.1 1.5* 2.4* 0.9
HSL134 2.0 ns 0.8 ns 3.0 ns 2.8 ns
HSL139 3.2* 5.7** 2.5 5.8** 4.6*** -1.2
A p <  0.1; *p <  0.05; **p <  0.01; ***p <  0.001 cosinor analysis; x: m issing  data; im plies a phase  
advance; +: im plies a phase delay. Italics indicate participants excluded  from  statistical analysis. B lue  
font: participants w ho received the b lue-enriched light first. Y e llo w  highlight: participants w ho  
received the control light first.
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Figure 6.4A presents the mean (± SEM) aMT6s amplitude data for before (8.7 ± 1.7 
ng/min; n = 19) and at the end of the blue-enriched light (10.1 ±2.1 ng/min; n = 19). 
Figure 6.4B shows the data from before (10.9 ± 2.4 ng/min; n = 21) and at the end of 
the control light (9.2 ± 1 .9  ng/min; n = 21). No significant differenees were observed 
between the baseline and light condition. No statistically signifieant effects of light 
condition and irradianee were found (PROC GLM). Furthermore, no period and carry­
over effects were observed for the aMT6s amplitude.
B)
BAg Blue
Light condition
50-,
10 -
Control
Light condition
Figure 6.4: Individual aM T6s amplitudes: before and at the end o f  A ) the blue-enriched light 
(n =  19) and B) the control light exposure (n =  21).
BAg: baseline o f  the blue-enriched light; Blue: b lue-enriched light; BAg: baseline o f  the control light; 
Control: control light.
6.4.4 aMT6s 24 h production
Individual aMT6s 24 h production before and at the end of eaeh light condition for 33 
participants are shown in Table 6.4; this table includes the mean (± SEM) 24 h 
production of the four values obtained for each participant. Values, for which a 
signifieant 24 h production was observed ranged between 2.2 and 49.7 pg/24 h, mean 
± SEM: 12.7 ± 0.5 pg/24 h (n = 24). Five participants (HLSOlO, HLS029, HLS112, 
HLS134 and HLS142) had production levels below 5 pg/24 h.
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Table 6.4: Individual aM T6s 24 h production (pg/24  h) before and at the end o f  each light 
condition____________________________________________________________________________________
aMT6s Production (gg/24 h)
Participant Baselines Blue Baselinec Control Mean SD
HSL026 6.8 18.7 14.1 4.2 11.0 6.7
HSL029 1.9 3.9 4.6 5.9
HSL039 X 15.5 16.6 13.3 15.1 1.7
HSL041 9.0 9.2 4.9 11.7 8.7 2.8
HSLOlO 2.6 3.3 3.5 3.5 3.2 0.4
HSL018 31.6 21.4 25.1 16.8 23.7 6.3
HSL0I9 non-detectable rhythm - low production
HSL032 11.1 18.7 16.7 11.4 14.5 3.8
HSL036 41.3 45.3 49.7 34.2 42.6 6.6
HSL037 non-detectable rhythm - low production
HSL044 9.2 9.5 9.0 9.5 9.3 0.2
HSL047 non-detectable rhythm - low production
HSL054 21.2 X 21.4 22.1 21.6 0.5
HSL058 4.6 5.7 X 5.4 5.2 0.6
HSL066 16.7 11.6 11.6 8.6 12.1 3.4
HSL067 9.7 9.7 11.9 10.4 10.4 1.0
HSL080 35.7 39.9 25.4 37.7 34.7 6.4
HSL112 0.7 0.5 2.1 X
HSL120 11.9 10.4 15.2 8.9 11.6 2.7
HSL125 10.8 9.3 6.1 67.0 8.2 2.2
HSL142 4.6 2.4 2.2 2.5 2.9 1.1
HSL143 5.2 7.3 4.2 8.0 6.2 1.8
HSL055 12.6 11.0 6.3 5.2 8.8 3.6
HSL061 non-detectable rhythm - low production
HSL064 7P.P X 24.
HSL070 20.6 25.P 24.7 7&P
HSL078 5.4 4.3 5.0 9.0 5.9 2.1
HSL089 7.6 5.9 6.1 7.0 6.7 0.8
HSL092 13.2 13.4 14.4 11.8 13.2 1.1
HSL129 11.2 11.0 15.3 14.2 12.9 2.2
HSL130 7.7 3.8 5.1 4.5 5.3 1.7
HSL134 3.1 2.0 4.,ÿ 5.0
HSL139 10.0 8.3 10.8 7.7 9.2 1.4
A p < 0.1; *p <  0.05; **p <  0.01; ***p <  0 .001 cosinor analysis; x: m issing data. Italics indicate 
participants excluded from statistical analysis. B lue font: participants w ho received  the blue-enriched  
light first. Y e llo w  highlight: participants w ho received  the control light first.
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Data for the mean (± SEM) aMT6s 24 h produetion (pg/24 h) are presented in Figure 
6.5. Figure 6.5A illustrates the aMT6s 24 h produetion (pg/24 h) before (12.1 ± 1.9 
pg/24 h; n = 19) and at the end of the blue-enriehed light (12.0 ± 1.9 pg/24 h; n = 19); 
and Figure 6.5B shows the aMT6s 24 h production (pg/24 h) before (13.3 ± 2.4 pg/24 
h; n = 21) and at the end of the control light (12.4 ± 2.0 pg/24 h; n = 21) using the 
maximum sample size. No significant differenees were observed. No effect of light 
condition, irradianee, period or carry-over was observed (PROC GLM).
A)
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Figure 6.5: Individual aM T6s 24 h production; before and at the end o f  A ) the blue-enriched  
light exposure (n =  19) and B) the control light exposure (n = 21).
BAg: baseline o f  the blue-enriched light; Blue: b lue-enriched light; B A c; baseline o f  the control light; 
Control: control light.
6.4.5 Relationship between aMT6s acrophase and wake-up time
The relationship between acrophase time and wake-up time is described in section 
6.4.5.1. Analysis of the phase angle between aMT6s acrophase time and wake-up time 
is presented in section 6.4.5.2. Section 6.4.5.3 details the analysis of this phase 
relationship and the light exposure. Doubt of the subjective wake-up rating of 
participant HLS032 resulted in exclusion of this data set.
6.4.5.1 Phase angle difference between aMT6s acrophase and wake-up time
Individual and mean (± SEM) phase angles between the aMT6s acrophase and
subjective wake-up times are shown in Figures 6.6A and 6.6B. The mean (± SEM) 
phase angles before (3.5 ± 0.3 h; n = 18) and at the end of the blue-enriehed light (3.2 
+ 0.3 h; n = 18) are plotted in Figure 6.6A. Figure 6.6B shows the data before (3.2 ± 
0.3 h; n = 20) and at the end of the control light (2.5 ± 0.4 h; n = 20). Paired Student’s
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t-tests did not reveal any statistically significant differences between the phase angles 
before (baseline) and at the end of a light exposure (using matched sample size for 
each comparison.) Analysis using PROC GLM ANOVA did not reveal any significant 
effect of light condition, irradianee, period or carry-over.
A)
•  •
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Figure 6.6: Individual phase angle data between aM T6s acrophase and wake-up time: before 
and at the end o f  A ) the blue-enriched (n =  18) and B) the control (n =  20) light condition.
BAg: baseline o f  the blue-enriched light; Blue; blue-enriched light; BAc: baseline o f  the control light; 
Control: control light.
6.4.5.2 Linear regression and correlation
Figure 6.7 shows the relationship of individual aMT6s acrophase times and their 
corresponding individual wake-up times using linear regression. Figures 6.7A and 
6.7B present the data o f the end o f the blue-enriehed (n = 20) and the control light (n = 
22) exposure, respectively. Figures 6.7C and 6.7D illustrate the baseline of eaeh the 
blue-enriehed (n = 20) and control (n = 21) light exposure. A signifieant positive 
correlation was found at the end of the blue-enriched light (r  ^= 0.22, p < 0.05; Figure 
6.7A), at the end of the control light exposure (r^= 0.18, p < 0.05; Figure 6.7B) and for 
the baseline of the control light exposure (r^ = 0.30, p < 0.01; Figure 6.7D). A trend 
towards a significant correlation was observed for the baseline of the blue-enriched 
light exposure with a positive relationship between aMT6s acrophase and wake-up 
time (r^ = 0.18, p = 0.06; Figure 6.7C).
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Figure 6.7: Relationship between the aM T6s acrophase and wake-up time. A ) at the end o f  
the blue-enriched light (r^  -  0 .22, p <  0.05, n =  19) (o), B) at the end o f  the control light ( • )  (r^  
= 0 .18, p <  0 .05, n =  23) (□), C) before the blue-enriched light (r^= 0.18, p =  0.06, n =  21) and 
D ) before the control light (■) (r~= 0.30, p <  0.01, n =  22). A  significant correlation was found 
at the end o f  both light exposures and before the control light exposure.
6.4.5.3 Acrophase, wake-up and start time of the morning light exposure
The relationship between the start time of light exposure, the aMT6s acrophase and the
wake-up time was analysed (Figure 6.8). A significant positive correlation was found 
for participants’ wake-up time and the light exposure start time of the blue-enriehed 
light (r  ^= 0.4, p < 0.01, n = 19) (Figure 6.8A, solid line) and control light (r^= 0.7, p < 
0.0001, n = 20) (Figure 6.SB, solid line). A positive, but non-significant association 
was found between the aMT6s acrophase time at the end of either light condition with 
the start time of light exposure.
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Figure 6.8: Relationship between the start of morning light exposure with aMT6s acrophase
(V) and start of morning light exposure and wake-up (A) time. A) at the end of the blue- 
enriched light (r^  = 0.4, p < 0.01, n = 19) and B) at the end of the control light (r^  = 0.7, p < 
0.0001, n = 20) exposure.
6.5 Discussion
The aMT6s rhythm markers and phase angles will first be discussed with reference to 
the literature followed by interpretation of the data.
The urine collection at the end of eaeh light exposure was carried out during the last 
week of light exposure while participants were still exposed to light for 2 h morning 
and 2 h evening, respectively. It thus might be possible that aMT6s levels were 
reduced during the morning hours (am light exposure) and evening hours (pm light 
exposure). However, since no statistical signifieant changes were observed in the 
aMT6s produetion before and at the end of each light exposure, any suppressive effect 
of the light exposure is regarded negligible.
6.5.1 aMT6s rhythm markers
6.5.1.1 Altered aMT6s rhythm markers in ageing
A large inter-individual variation was observed in the measured aMT6s acrophase 
times (Table 6.2). The mean (± SEM) aMT6s acrophase time (4.0 ± 0.2 h), however, 
was similar to previous studies that have reported aMT6s acrophase times for older 
adults (mean ± SEM: 4.0 ± 0.3 h, mean + SEM age: 57 ± 5 years, Herljevic et al, 
2005; 4.0 + 0.3 h, age range: 60 -  79 years, Youngstedt et a l,  2005). These aMT6s 
acrophase times were also earlier compared to acrophase times in younger adults (5.0
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± 0.2 h, age: 24 ± 3 years, Herljevic a/., 2005; 4.1 + 0.2 h, age range: 20 -  40 years, 
Youngstedt e/ a/., 2005). Consequently, the current data confirm previous findings of 
an age-related phase advance of the melatonin rhythm (Duffy g/ a/., 1998; 2002; Yoon 
e/ a/., 2003a; Herljevic a/., 2005). However, some controversy exists as other 
studies (Monk a/., 1995; Carrier er a/., 1999; Youngsted er a/., 2001) did not 
observe such an advance. The advance o f the aMT6s acrophase time (and of other 
circadian rhythms, e.g. CBT and cortisol) has been reported to be accompanied by an 
earlier timing of the sleep-wake cycle (Duffy e/ a/., 1998). Since the circadian clock is 
a major regulator of sleep and wake (Dijk and Czeisler, 1994) a causal role o f the 
advanced circadian system in the altered timing of the sleep-wake cycle has been 
suggested (Yoon a/., 2003a). Furthermore, an earlier exposure to environmental 
light during the day (during the phase advancing part o f the light PRC) could play an 
additional role in advancing the timing of the sleep-wake cycle.
An age-related decline in melatonin production, associated with a reduced amplitude, 
has been reported numerous times in the literature (Touitou a/., 1981; Iguchi e/ a/., 
1982; Nair er c;/., 1986; Sack er a/. 1986; Waldhauser er a/., 1988; Sharma e/ a/., 1989; 
Bojkowski and Arendt, 1990; Skene e/ a/., 1990; Herljevic a/., 2005; Knoblauch e/
al, 2005; Munch et a l, 2005; reviewed in Cajochen et al, 2006). According to 
Kennaway et al. (1999) a progressive decline in aMT6s levels during lifetime might 
only occur within an earlier time span. These authors showed that aMT6s levels are 
lower in older adults, yet, the decline occurs between birth and 20 to 30 years of age, 
after which melatonin levels remain constant.
Due to the large inter-individual differences in aMT6s production, also found in the 
present study, reports on aMT6s production differ. For example, Luboshitzky et al. 
(2001) showed mean (± SD) aMT6s 24 h production levels of 19.9 ±5 .2  pg/24 h in a 
group of healthy older controls (mean ± SD age: 61.0 + 5.7 years) whereas Herljevic 
and colleagues (2005) reported mean (± SEM) levels of 12.4 ±1 .5  pg/24 h for their 
group of older woman (mean ± SEM age: 57 ± 5 years). Middleton (unpublished data) 
measured mean (± SD) aMT6s levels of 6.7 ±3.1 pg/24 h for a group of 60 -  69 year 
older men and women (n = 36). For the mean (± SD) aMT6s amplitude in healthy, 
older men and women (mean ± SD age: 66.2 ± 4.9 years) Yoon and colleagues (2003a) 
reported 338.8 ± 2.3 ng/h. The mean (± SEM) amplitude levels (588.0 ± 66.0 ng/h, n
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= 24) observed in the present study are higher probably as a result of the large inter­
individual differences.
6.5.1.2 Effects of light
The aim of this study was to assess the ability o f blue-enriched and control light to 
affect the circadian clock, i.e. strengthen (increase) the circadian amplitude, using the 
major urinary metabolite of melatonin, 6-sulphatoxymelatonin, as a marker of the 
effect. Light exposure times resembled a skeleton photoperiod in order to not phase
shift the circadian clock of the participants.
No statistically significant changes in aMT6s amplitude or 24 h production were found 
between before (baseline) and at the end o f the blue-enriched or control light. 
Moreover, there was no significant effect o f light condition, light irradianee, carry-over 
or period on any of these two parameters measured. These results clearly show that
light exposure as applied in this study did not have a significant measurable effect on 
the aMT6s rhythm as initially hypothesised. One explanation for this could be that the 
applied light irradiances were not sufficient to affect (i.e. strengthen) the circadian 
system (reviewed in Roenneberg e/ a/., 2003). This could be a result of the 
wavelength and/or the relatively low light irradiances used as well as the short duration 
o f exposure (2 x 2 h per day for 3 weeks).
It might also be that the light used here was given at a time of the circadian cycle when 
the amplitude cannot be majorly affected (Boivin a/., 1994; Jewett e/ a/., 1994). 
Another explanation could be that by using integrated urine samples and/or sample 
collection bins occurring over varying time intervals accuracy and resolution might 
have been lost. Smaller collection intervals might have provided more resolution. At 
the same time, however, this would have caused more inconvenience for the 
participants and interrupted their sleep even more.
Similarly, no statistically significant change was found for the aMT6s acrophase time 
between before (baseline) and at the end o f a light exposure; in addition, no significant 
effects of light condition, light irradianee or carry-over were observed. However, a 
statistically significant period effect was observed for the aMT6s acrophase time. The 
second period showed a significantly delayed aMT6s acrophase time compared to the 
first period, irrespective of light condition. A hypothesis that arises is that the
6-20
____________________________________________________________________Chapter 6
administration o f light may have been able to counteract the natural driA/delay of 
acrophase time (that would occur over the winter period with less morning light) 
(Bojkowski and Arendt, 1988) thereby phase locking it. During the 2-week washout 
period, no additional light was provided enabling the clock to driA to a later time and 
track the seasonal change in photoperiod. The second light exposure period would 
again provide entraining light signals and hold the clock at a ' Axed/stable % but slightly 
later, time point. However, observation of the mean aMT6s acrophase times (Figure 
6.3) shows that only in the Arst penod phase locking might have occurred as neither a 
driA during the washout nor phase locking during the second period could be seen. 
This weakens the above hypothesis.
Other possible explanations A)r the occurrence of a period effect exist and have been 
discussed in sections 4.5.2.2, 4.5.3 and 5.5.1.2 and will only be discussed brieAy here. 
Firstly, an alteration in the rest/activity behaviour, i.e. conditioning of the participants 
to the study requirements, could be involved in producing the period effect. For 
example, the time participants tried to sleep and wake up could have changed, i.e. 
delayed, across the study. Analysis (PROC GLM) of the 16 participants with complete 
data set of their aMT6s acrophase times, however, did not show any delayed sleep 
times. Furthermore, some studies have shown an effect of activity/posture on 
melatonin levels (Deacon and Arendt, 1994b). A change in behaviour, however, 
seems unlikely to have affected the aMT6s rhythm since melatonin and aMT6s 
production are relatively robust against confounding factors such as activity and stress 
(section 1.3.1.3). Additionally, the current study assessed melatonin using its aMT6s 
metabolite sampled in ~ 3 h bins which is unlikely to be suffieiently sensitive to 
changes in posture.
Secondly, although the order of receiving the two light conditions was balanced, other 
imbalances existed (e.g. number of participants receiving low or high irradianee light, 
number of participants studied during September -  December or January -  April) 
which may be involved in causing the period effect. On the premise that light 
exposure did not affect the aMT6s acrophase time, the observed delayed aMT6s 
acrophase time in the second penod (Figure 6.3) may be due to the seasonal delay of 
the body clock. Bojkowski and Arendt (1988) have shown that the phase of aMT6s 
excretion undergoes annual changes with a delay in acrophase time in winter compared 
to summer (by 1.5 h). In the current study, 69% (11 of 16 participants) were studied in
6-21
____________________________________________________________________Chapter 6
the autumn -> winter season. This imbalance might have lent more impact to the 
effects of the shorter winter photoperiod on the clock.
Of the 16 participants, 75% (12 participants) received high irradianee light; and ten of 
these participants were studied in the autumn -> winter season. Seven of these ten 
participants in turn received blue-enriched light Arst. The observed unchanged aMT6s 
acrophase time during the Arst period may therefore be due to the fact that the majority 
of the ten participants received high irradianee blue-enriched light whereas in the 
second penod a bias towards the control existed, and this latter light may have been 
insufAcient and not be able to lock the phase and consequently it delayed.
The light signal may have differentially modiAed aMT6s acrophase time by affecting
the clock whereas aMT6s amplitude and production were left unaffected. Thus, it may 
be that phase (timing) of the rhythm transmits biological and physiological information 
(Bojkowski and Arendt, 1988) for the organism to adapt to seasonal changes. Previous 
studies have shown that light has the capacity to induce a phase shift o f the circadian 
clock, with a similar magnitude between ageing and young adults (Kripke e/ a/., 2007; 
Sletten a/., 2009), but that this is not necessarily accompanied by an increase in 
amplitude (Boivin er n/., 1994; Sletten a/., 2009).
6.5.2 Phase angle data
The acrophase time o f the aMT6s rhythm served as a circadian phase marker. The 
time interval (phase angle) between the aMT6s acrophase time and subjective wake-up 
time before and at the end of each light condition was assessed.
6.5.2.1 Altered phase angle data in ageing
The phase angle between melatonin (plasma, saliva and aMT6s) acrophase and wake- 
up time varies with age and is shorter in older compared to younger adults (Youngstedt 
et al, 2001; Duffy et a l, 2002; Yoon et a l, 2003a). The phase angle in the current 
study (mean ± SEM; 3.0 ± 0.2 h) were comparable with those previously reported in 
the literature which range between 2.4 ± 0.3 h (mean ± SEM) (Youngstedt e/ a/., 
2001), 3.7 ± 0.5 h (mean + SD) (Duffy et a/., 2002) and 3.5 ± 1.4 h (mean ± SD) 
(Yoon et al, 2003a). This altered phase relationship in older people is related to the
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advanced circadian rhythm and slccp-wakc cycle that has been observed (Dnfly a/., 
2002; section 1.7.1.3). Older adults therefore do not only awake at an earlier clock 
time compared to younger people but also at an earlier phase within their intrinsic 
circadian cycle, assessed using the rhythm of core body temperature or melatonin as 
markers (Duffy a/., 1998; Duffy e/ a/., 2002). If endogenous melatonin functions as 
a signal to weaken the circadian drive, which opposes the homeostatic drive, then any 
alteration o f the melatonin rhythm will lead to a changed interaction of Process C and 
Process S. This will most likely result in increased sleep problems as observed in 
ageing adults. The cause(s) for these changes, however, remain to be investigated.
One additional explanation for the altered phase relationship between timing of sleep
and timing of the circadian rhythmicity could be a shortening of the endogenous 
circadian r, as has been observed in older rodents (Morin, 1988) and lemurs (Aujard e/ 
a/., 2006). However, based on results &om forced desynchrony experiments (Czeisler 
er a/., 1999) and the finding that the phase angle between circadian phase and wake-up
time is shorter and not longer (Duffy et al, 1998), this theory has been rejected. In 
addition, Kendall and colleagues (2001) reported a slight lengthening of the 
endogenous r in six totally blind participants (age range: 33 -  54 years).
It may also be that the earlier wake-up time o f ageing adults is a result o f a reduced 
ability to maintain sleep at that time of the circadian cycle due to changes in both the 
homeostatic (less sleep pressure and/or faster dissipation of sleep pressure) and 
circadian (strong arousal signal) processes and as well as their interaction (Duffy g/ a/., 
1998; Munch er a/., 2007; Klerman and Dijk, 2008). An earlier wake-up time might 
then result in an earlier bedtime which in turn would reinforce the advance o f the 
circadian timing system. Furthermore, earlier awakening will result in an advance of 
light exposure (light will be perceived at an earlier clock and internal time) as it has 
been observed in older individuals (Yoon et al, 2003). Light in the morning advances 
the circadian system (Czeisler er a/., 1989; Khalsa e/ a/., 2003) and thus will produce 
an even greater advance within the range of entrainment (reviewed in Roenneberg 
a/., 2003). It is not believed that the advanced light exposure of older people can 
exclusively account for the observed phase advance o f the circadian system (Kawinska 
er a/., 2005). However, the earlier light exposure might still reinforce or contribute to 
the observed phase advance (Duffy et a l, 2002; Kawinska et al, 2005). Future studies 
are warranted to elucidate the extent of this contribution.
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6.S.2.2 Effects of light exposure
The phase angles between aMT6s acrophase and wake-up time before and at the end of 
each light condition were compared. No significant changes in the magnitude of these 
intervals were observed. Furthermore, no effects o f light condition, light irradiance, 
period or carry-over were detected.
There was a significant positive correlation between aMT6s acrophase and wake-up 
time for the baseline assessment of the control light exposure as well as at the end of 
both light exposures. These findings are in accordance with the frequently observed 
phase advance and alteration of the phase angle relationship reported in the literature 
(e.g. Touitou a/., 1981; Nair e/ a/., 1986; Sack e/ a/. 1986; Waldhauser a/., 1988; 
Sharma a/., 1989; Bojkowski and Arendt, 1990; Duffy er a/., 1998; Duffy er a/., 
2002; Herljevic er a/., 2005; reviewed in Cajochen e/ üf/., 2006).
6.5.2.3 Correlation between light start time and phase angle
A significant positive correlation was identified between wake-up time and the start of
the morning light exposure for both light conditions. Participants were asked to 
commence with the exposure as soon as possible in the morning. The observed result
is therefore as expected. No significant correlation was found between aMT6s 
acrophase and start time of the light exposure, though.
6.5.3 Limitation of the study
Analysis was performed on urine samples which were collected by the participant at 
home. There is the possibility that participants made errors during the urine collection 
(confusing sample tubes, accidentally pouring away urine and/or incorrect completion 
of the collection forms) reducing the accuracy of the measured aMT6s rhythm. 
Furthermore, statistical analysis had to be performed on different subsets out of a total 
of 24 participants. For example, for the PROC GLM analysis, data from only 16 
participants could be used due to incomplete data in eight participants. The reduced 
sample number may thus be too small to observe any statistical significant differences 
(underpowered study). A fifth urine collection, i.e. at the end o f the second washout 
(week 11), may have helped to distinguish between a period or light effect.
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7 General Discussion
7.1 Introduction
A high percentage of older people suffer from sleep disturbances, disrupted rest- 
activity rhythms and compromised daytime alertness. These problems are proposed to 
originate, at least in part, from a dysfunctional circadian system which could include 
impairments of the input and/or output pathways of the central circadian clock or 
changes within the clock itself.
Numerous laboratory studies have investigated the non-visual effects of light exposure 
on physiology and behaviour including the circadian timing system and the sleep-wake
cycle, although most these studies have been conducted in young people. These 
studies have improved our understanding of the mechanisms by which light exerts its 
non-visual effects and also which characteristics of light are most important to elicit a 
response. The ability of light, particularly short wavelength blue light, to modify 
behaviour and physiology has led to its use as a therapeutic agent in situations such as 
circadian misalignment and SAD. These proposed beneficial effects of light need to 
be validated in field studies where external factors, e.g. environmental light, 
activity/behaviour and social interactions, might modify a person’s responsiveness to 
artificial light exposure. Currently, only a few field studies have evaluated the 
effectiveness of bright white light exposure on sleep, activity, daytime mood and 
alertness, and cognition in older people in care-home facilities, and even less data are 
available for community-dwelling healthy older people. To date there are no studies 
investigating the effectiveness o f blue-enriched white light exposure to ameliorate 
sleep problems in older people living in the community.
The present study aimed to investigate the impact o f a light intervention on the 
magnitude and stability of sleep/activity patterns, daytime mood and alertness, 
cognitive performance and melatonin production in older community-dwelling people. 
The light exposures were polychromatic of two different spectral compositions (4000 
K control and 17000 K blue-enriched) and of two different irradiances (~ 400 lux and 
-  1100 lux). The two lights were photon-matched in order to compare their biological 
effectiveness. During autumn/winter/early spring light was administered for 2 h in the 
morning and 2 h in the evening, respectively. Daily light exposure was designed to
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mimic a skeleton photoperiod providing a stronger lights-on and lights-off signal to the 
clock which should aid alignment to the 24 h light-dark cycle without eliciting a phase
shift. It was hypothesised that the blue-enriched white light of high irradiance would 
generate the greatest response.
The irradiance levels o f the blue-enriehed (17000 K) and control (4000 K) white light 
condition were lower than previous field studies have tested. These low irradiances 
were chosen (i) to test the efficiency of the light exposure, (ii) to allow better 
discrimination between the two light conditions and (iii) to minimise discomfort that
bright light may cause.
The first study (chapter 3) investigated the efficacy o f low irradiance blue-enriched
(17000 K) and control (4000 K) white light, of equal total photon density (~ 3.6 x lO’"^ 
photons/cm^/sec), in 12 older people (> 60 years). This study was used as a pilot study 
to test amongst other things the practicability and feasibility of the study protocol. The 
second study (chapter 4) used a slightly modified protocol with the same lights but of 
2.5-fbld higher irradiance ( -  9.1 x l O'"* photons/cm^/sec) and a larger sample size (n = 
21). Subsequently, data from the low and high irradiance light studies were pooled 
and analysed including irradiance level as a fixed effect in the analysis model (chapter 
5). Finally, the rhythm of urinary aMT6s was assessed before and at the end of the 
light exposure to examine the effects o f light exposure (low and high irradiance) on the 
circadian clock (chapter 6).
7.2 Subjective and actigraphic sleep
Both subjective (sleep diaries) and actigraphie sleep parameters from the low and high 
irradiance light studies exhibited some changes during or following exposure to blue-
enriched and/or control white light summarised in Table 3.14 and Table 4.14 and 
discussed in chapters 3 and 4. Analysis of the combined datasets (chapter 5) revealed 
few statistically significant differences between the light conditions, between the light 
irradiances and study periods. Therefore, it appears that the blue-enriched high 
irradiance light was not clearly superior to the control light or lower irradiance lights.
However, the findings do indicate that light exposure .yc had some beneficial 
effects on sleep, e.g. on sleep consolidation and timing. Unexpectedly, but
7-2
____________________________________________________________________Chapter 7
interestingly, the low irradiance light appeared to lead to more improvements in 
actigraphic sleep resulting in more consolidated sleep compared to the high irradiance 
light. Previous dose-dependency studies of non-visual light responses have shown that 
high irradiance light yielded greater phase shiAs than low irradiance light (Boivin c/ 
a/., 1996; Zeitzer cf a/., 2000; Gooley c/ a/., 2010). For the present study it was 
therefore expected that the higher irradiance light study would produce greater changes 
than the low irradiance study. The present study population, however, was older and 
not dark adapted compared to the study populations of the laboratory studies by Boivin 
cr a/. (1996), Zeitzer cr a/. (2000) and Gooley er a/. (2010). In addition, the study 
population of the current low and high irradiance light studies consisted of different 
people. Although the study participant demographics and screening scores showed no 
statistically significant differences between the two studies, the studies were conducted 
in different years and consequently participants experienced different environmental 
light conditions. Furthermore, both studies differed in sample size (low irradiance: n = 
12; high irradiance: n = 21). One explanation supporting the increased effectiveness of 
the low irradiance light is a behavioural effect and related to visual comfort. As some 
older people appear to dislike bright light due to age-related changes (e.g. light 
scattering) the participants might have found the low irradiance light easier to look at. 
In turn, for the high irradiance light it may be that participants subconsciously avoided 
looking directly at the light (at a distance of 60 cm) thereby reducing the photic input 
to their retina. Since each participant received either light of low or high irradiance, a 
direct within-subjeet comparison of the two different light irradiances in terms of 
acceptability and tolerability was not possible. The data from the semi-structured 
interview, however, do not support the idea o f avoidance of the high irradiance light, 
although participants may have been reluctant to report adverse effects to the 
researcher.
The lack o f statistically significant changes in sleep and the other parameters due to
light exposure in the present study could be related to a number of reasons that could 
operate independently or jointly to affect the sleep-wake rhythm.
(I) Alterations in the pacemaker within the SCN (section 1.7.1.2), e.g. neuronal 
degeneration, even if  only slight, might be involved in the aetiology of the reported
sleep problems. These possible alterations within the pacemaker might lead to 
changes in the amplitude of circadian oscillations and alter the pacemaker’s
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responsiveness to external stimuli, especially light, thereby changing the generation of 
output signals and rhythms (Czeisler cr a/., 1992). Thus the light signal cannot be 
translated into an effect downstream of the clock.
(II) Light exposure to the blue-enriched and eontrol light condition was for a period of 
three weeks each with a daily exposure o f 2 h in the morning and evening. Apart Aom 
all-day light exposure studies (Van Someren c/ a/., 1997a; Sloane a/., 2007; 
Riemersma-van der Lek a/., 2008; Hoof a/ a/., 2009a, b), the present study provided
more light exposure (total 84 h over three weeks) than most previous light treatment 
studies (Table 1.1). Yet, it appears that the observed changes were of a similar 
magnitude to those reported in the literature and not greater. Two striking differences, 
however, exist between the current study and most earlier studies which make 
comparisons difficult. Firstly, experimental settings: the majority of previous studies 
were conducted in care-home environments involving older adults with mixed 
cognitive levels, including a number of dementia patients, whereas the current study 
investigated sleep in older, non-demented people living in their natural home 
environment. A recent study by Meadows and colleagues (2010) has shown 
signiAcant differences in the actigraphic rest-activity rhythm between care-home 
residents and community-living older people. Furthermore, both populations may 
differ in their responsiveness to light as it has been hypothesised in studies involving 
older people with different kinds of dementia, possibly due to variable patterns of 
deterioration within the SCN with dementia (Ancoli-Israel et a l,  2002; 2003; Sloane et 
al,  2007; section 4.5.3). These differences in responsiveness could thus partly be 
explained by more pronounced alterations of the SCN clock in demented people 
(section 1.7.1.2) and/or other physiological changes (e.g. reduced mobility). Further 
differences in life-style which affect daily light exposure, social interaction, and 
cognition exist and might also inAuence study outcomes. Comparison o f the results 
obtained from these two study populations should therefore be carried out with 
caution.
Secondly, these earlier investigations have used bright polychromatic white light 
usually of > 2500 lux to improve rhythms o f sleep and rest-activity and some also have 
had a dim light control condition. In the current study, the two light irradiances used
were in the low to moderate lux range ( -  400 lux) (chapter 3) and at the lower end of 
the moderate to bright light range ( -  1100 lux) (chapter 4). The observed lack of clear
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effects might in part be attributable to the low irradiances of the lights used in the 
present study. It is possible that these levels were further modiAed and reduced by 
other factors (discussed below). In addition, it should be noted that the laboratory 
studies investigating non-visual responses to light exposure (e.g. Zeitzer c/ a/., 2000; 
Lockley c/ a/., 2003; Cajochen c/ af/., 2005; Revell c/ a/., 2005; Jung cr a/., 2010) were 
done in dark or dim light adapted participants. These laboratory participants would 
therefore have had an increased sensitivity to light and especially to low irradiance 
light.
(Ill) Previous light history, e.g. living in a dim light environment, has been shown to 
inAuence the magnitude of the non-visual responses to light (sections 1.3.1.6 and 
1.6.5). An individual’s photic history prior to an experimental light exposure can 
modulate circadian responsiveness, i.e. prior light will desensitise and prior darkness 
will increase sensitivity to a light stimulus. This phenomenon might have been an 
inAuential feature in the current study. The participants in the present studies could 
select the ambient lighting levels in their homes. In addition, they were also still very 
active and mobile and engaged in numerous social activities. Therefore, it is likely 
that, especially compared to care-home residents, they (i) received natural light with a 
varied exposure pattern, and (ii) that the received light itself would have varied in 
irradiance and spectral composition across the day. As a result the participants might 
have been less sensitive to the extra light administered in the light exposure period. 
Although it is known that melanopsin integrates photic information over a longer 
duration than the classical photoreceptors (Dacey e/ a/., 2005) and under certain 
circumstances operates alongside the classical visual photoreceptors (Belenky cr a/., 
2003; Hattar a/ a/., 2003; Lucas c/ a/., 2003; Dkhissi-Benyahya a/ a/., 2007; Lall e/ a/., 
2010), nothing is known about the spectral sensitivity o f integration o f long-term light 
exposure, i.e. light history, and the contribution of melanopsin and the classical 
photoreceptors to this. One possibility is that light history affects responses to blue- 
enriched and control light differently through differential effects on rods, cones and 
melanopsin. Prior photic history might also exhibit its modulating effect on 
melanopsin via melanopsin’s reported bistability (i.e. prior light might inAuence how 
much o f the melanopsin photopigment is available to respond) (Mure a/., 2009) as 
well as affecting the state of rod and cone adaptation.
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(IV) The environmental light could have modulated the colour temperature of the 
17000 K light source used in the current study. Van Hoof and co-workers (2009b) 
reported that natural daylight (and possibly the living environment) modiAed and 
lowered the actual colour temperature of their 17000 K light source. However, no 
reduction was seen for their 2700 K light source. It is possible that the actual colour 
temperature o f the control light condition (4000 K) in the current study might also 
have had less alteration due to daylight. If  this modifying effect of daylight brought 
the actual colour temperature of the two light sources closer together this might be one 
explanation why only very few differences were found between the two light 
conditions.
(V) With age the pupil size decreases and the opacity and density o f the lens increases. 
These ocular changes could reduce and alter the composition of the light reaching the 
light sensitive cells in the retina (section 1.7.1.1.1). This reduction in light 
transmission particularly affects short wavelength blue light. To ensure that sufAcient 
blue light would reach the retina (section 2.5.4.2.5), the age-related reduction in pupil 
size and reduced transmission of short wavelength blue light was taken into account 
when the light irradiances were calculated and chosen for the current study. The light 
conditions were photon-matched (of the same total photon density) and the 17000 K 
light therefore had an enrichment of blue photons at the cost of a reduction in the 
longer wavelengths compared to the control light (Table 2.3 and Table 4.5). For these 
calculations average estimates were used and it is possible that the actual lens density 
and pupil size of the participants were different and may have reduced the number of 
blue photons reaching the retina more than was estimated. This would have resulted in 
a lower total number of photons reaching the retina with the blue-enriched light 
compared to the control light. Cataracts further reduce light transmission of the lens. 
In the present study seven participants showed signs o f an early cataract; however, it 
was not possible to determine whether they responded less to the light exposure due to 
this low sample number.
(VI) The observed cfAcacy of the control light could be due to a contribution from the 
rod and cone visual photopigments which have been shown to provide input to the 
melanopsin-expressing ipRGCs (section 1.5.3), and to enhance non-visual light 
responses. Furthermore, recent rodent studies have shown that light detection by rods, 
cones and melanopsin play a role in directly regulating the sleep-wake state (Altimus
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e/ a/., 2008; Tsai e/ a/., 2009). These Andings might partly explain the effectiveness of  
the control light in the current study. However, rodents are nocturnal and for them 
light induces sleep whereas humans are diurnal and light enhances alertness. Results 
Aom these animal studies therefore have to be interpreted with caution.
(VII) A daily light exposure of 2 h in the morning and 2 h in the evening might not 
have been of sufficient duration, especially when considering the comparatively low 
light irradiances used in both the low and high irradiance light studies. To achieve a 
more pronounced effect on sleep (and daytime behaviour) a longer light exposure 
(increased daily duration and increased length of light exposure period) could be 
expected to be more effective. Unfortunately, an all-day light exposure was not 
feasible in our community living participants as they had active, varying daily 
schedules which required them to leave home. As mentioned before they therefore 
received varied light exposure which might have consequences for the cfAcacy of the 
supplementary light exposure. Extension o f the light exposure periods, e.g. six weeks, 
would have increased the length of the study and made it more difficult to recruit 
participants. Additionally, the study length would then be extended across seasons 
with varying photoperiods which would further complicate data interpretation. The 
current studies were restricted to autumn, winter and early spring and designed to 
commence in September and January and end in December and March/April, 
respectively.
(VIII) Study participants with self-reported sleep problems were recruited to the 
present studies. The sleep problems reported by the current study population, 
however, might rcAcct the normal age-related decline in sleep need and/or sleep ability 
(Klerman and Dijk, 2008; Duffy et al, 2009). This might impose a limit for 
improvements achieved by light exposure and as a consequence not many pronounced 
changes have been observed in the current study.
There are thus several possible reasons (working independently or synergistically) to 
explain the lack of signiAcant effects on sleep.
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7.3 Pittsburgh Sleep Q uality Index (FSQI)
Changes in self-reported sleep quality across the study period are rejected in an 
improvement of the global and certain component scores of the PSQI. Such 
improvements were observed following both light conditions in the low and high 
irradiance studies (Table 3.15 and Table 4.15). However, caution should be used when 
interpreting the PSQI results; for example, the validity of a sustained effect observed 
four weeks aAer the second light exposure (regardless of the light condition) in the low 
irradiance light study remains questionable. This could represent a placebo effect of 
the light study, however, this was not seen in the high irradiance study. It may be 
possible that participants in the low irradiance light study in some way changed their 
routine during the study and changed their attitude towards their sleep 'problems’ and 
thus the observed effect of the study was sustained.
7.4 D aytim e sleepiness, m ood and alertness
The explanations from the section above regarding the lack of pronounced changes 
during the light exposure periods can also be applied to the napping as well as the 
mood and alertness data. Additional reasons more speciAc for these parameters are 
discussed below.
No statistically signiAcant changes in subjective napping behaviour were observed 
during or aAer blue-enriched or control light exposure of low or high irradiance or 
when the pooled data were analysed. From this it can be concluded that any effect of 
light exposure on sleep at night did not directly impact on the number and duration of 
subjective daytime naps. Data by Dijk er a/. (2010) have shown no increase in 
daytime sleepiness following experimental disruption o f SWS in middle-aged and 
older adults (despite these populations reporting more disrupted sleep) compared to 
young adults. Similarly, Andings by Duffy and colleagues (2009) have shown that 
under a 26 h constant routine protocol healthy older people do not have increased 
daytime sleepiness (compared to young adults) contrary to the conventional belief that 
older adults experience more daytime sleepiness. These authors attributed the reported 
daytime sleepiness in some older adults to impaired health and/or (mis-)use of 
medication rather than a direct consequence o f ageing. The current study population 
was healthy with overall only some mild impairment of nighttime sleep and daytime
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sleepiness according to their PSQI scores and thus daytime sleepiness might not have 
been problematic. The data Aom Duffy cr a/. (2009) and Dijk and colleagues (2010) 
would support the observation that the participants in the current study did not suffer 
Aom an increase in daytime sleep propensity and therefore no changes in napping 
behaviour were possible during and aAer the light exposure.
Although napping Aequency was unaltered in the present study, there were statistically 
signiAcant changes in subjective mood and alertness. The magnitude of these changes, 
however, was small, i.e. mainly by < 1 point (on 9-point scales), and variable (sections 
3.4.10, 4.4.8 and 5.4.8). This finding is in agreement with other studies which have 
shown similar changes (Dowling c/ a/., 2007). Whether these statistically signiAcant 
results arc clinically meaningful is doubtful.
The Andings for the mood and alertness data might be further explained in three ways 
on the premise that the participants received the light, i.e. the light reached the retina. 
Firstly, assessments were carried out during the subjective day contrary to the majority 
of laboratory studies assessing the impact of light on alertness and mood which were 
conducted at night (mainly with young adults as a study population). The human light 
PRC demonstrates that the circadian system is most sensitive to light during the 
biological night and less so during the daytime which could also be the case for non­
visual effects on alertness and mood (although some studies have shown 
improvements in alertness with daytime light [Phipps-Nelson er a/., 2003]). Secondly, 
mood and alertness assessments were done immediately aAer getting-up, before 
lunchtimc and before going to bed in the evening. Thus in the present protocol the 
acute effects of light were not assessed. Rather it was of interest what effect an 
extended photopcriod might have on mood and alertness. Thirdly, the baseline (no 
light) levels of alertness and mood in the here studied population might have been 
sufficient, leaving no room for improvement during the light exposure. Results from a 
study by Philip cr a/. (2004) suggest that older people show a higher resistance to the 
detrimental effects of sleep deprivation. Reaction times and alertness levels seem less 
impaired in older people compared to younger people (Bonnet, 1989; reviewed in 
Bonnet and Arand, 1989; Duffy cr a/., 2009). The low level of daytime sleepiness 
observed in healthy older people (Duffy cr a/., 2009; Dijk e/ a/., 2010) as well as the 
nap data obtained in the present study population further support the view that there
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was little impairment of daytime mood and alertness in the current study population
making it difficult to detect any effect of light supplementation.
7.5 Characteristics of the study population
None of the participants in the current study suffered Aom severe health conditions 
and participants had no or very little cognitive impairment as identiAed by the MMSE 
scores. The high cognitive status of the study population might in part explain why 
few improvements were observed during the light administration period. The 
observed improvement in MMSE scores Aom week 1 to week 11 in the low irradiance 
light study is likely due to participants getting used to the MMSE test (practice effect). 
Previous studies which have reported an improvement of cognitive deAcits with light 
treatment have investigated demented or otherwise cognitively impaired older people 
(Yamadcra et al, 2000; Proust-Lima et a l, 2007). Some studies further reported a 
positive correlation between the level of cognitive impairment and the degree of 
sleep/rest-activity disturbances (reviewed in Vitiello c/ a/., 1992; Dowling 6f/., 2005; 
Oostcrman et al., 2009). The recent study by Meadows et al (2010) compared 
different NPCRA parameters obtained from older people living in carc-homcs (non- 
demented) to those obtained Aom older, healthy community-dwelling adults with self- 
reported sleep problems (PSQI score > 5). The authors reported significant differences 
between both populations; care-home residents had a greater impairment of NPCRA 
parameters and a more severely disturbed rest-activity rhythm. This might in part 
explain the lack of effects of light exposure on the rest-activity rhythm measured with 
parametric (cosinor) and non-paramctric (NPCRA) methods in the present study in that 
the baseline rest-activity rhythms of the current study population were not signiAcantly 
impaired.
The current study population consisted of older people suffering Aom self-reported 
and subjectively assessed sleep problems (PSQI > 5 as an inclusion criterion). 
However, no clinical diagnosis of their sleep was performed. It might be that the study 
participants did not suffer sufAcient sleep impairment for light supplementation to 
produce pronounced changes in their sleep. Ohayon and Vecchierini (2005) found 
that, in addition to cognitive difAculties, poor health has a negative inAuence on sleep.
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Participants in the present study did not have any major medical conditions which 
could have affected their sleep negatively.
Results Aom the SRM assessments show high lifestyle regularity, i.e. structured daily 
routines and activities, for the entire study population during the baseline, no light 
condition. Social factors and behaviour may also affect sleep-wake timing (reviewed 
in Dijk and Schantz, 2005). Although the study participants were no longer in full- 
time employment, most of them had other social commitments and some did part-time 
work (24.2%) or were self-employed (6.1%). These social commitments miglit have 
acted as additional zeitgebers and inAuenced sleep-wake times independently o f the 
circadian pacemaker and homeostatic processes. The consistency of the lifestyle 
regularity in older adults might be viewed as an “adaptive response” (Monk et al, 
1997b) using zeitgebers o f the daily routine to keep the circadian system entrained. 
With such high lifestyle regularity at baseline, it is not surprising that SRM scores did 
not change during the entire study period and thus it was not possible to detect any 
effect of light supplementation on these participants.
The highly regular lifestyle and the high level of cognitive status of the study 
participants may further explain why only a few changes in the actigraphic rest-activity 
rhythm were observed. As mentioned before, studies showing light-induced 
improvements in the rest-activity rhythm have been carried out mostly in the care- 
home environment (e.g. Van Someren a/., 1997a; Mishima e/ a/., 1998; Sakakibara 
er a/., 1999; Yamadera a/., 2000; Ancoli-Israel er a/., 2002; 2003; Fetveit cr a/., 
2003; Fetveit and Bjorvatn, 2004; 2005) where people lead a more sedentary, inactive 
life (Van Someren a/., 1996) with increased daytime sleep propensity. By contrast, 
the current study participants already had an active lifestyle shown by high positive 
values for theA rest-activity rhythms during the baseline, no light condition (sections 
3.4.8 and 3.4.9; sections 4.4.6 and 4.4.7). There was no evidence that the present 
study population had rest-activity rhythm disturbances. The few changes in activity 
patterns observed during the light administration period could be due to changes in 
participant behaviour, for example, sitting in Aont o f the light box in the morning 
delayed the onset of activity as assessed by the MIO.
Furthermore, the observed high lifestyle regularity agrees with the observation of the 
participants’ good compliance with the current protocol. This view o f good
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compliance is based on personal communications from the participants and their 
general attitude and commitment (“Once I have started something I will carry it 
through”). Furthermore, participants were asked to complete time sheets for each light 
session and were visited by a researcher during each study week, not only making it 
easier to solve any arising problems/questions but also to reinforce the importance of 
each individual light session. It is therefore unlikely that the observed lack of effects 
o f light exposure arc due to the participants’ non-compliance with the protocol. Both 
the low and high irradiance light study populations received the same amount of 
attention Aom the investigating researchers during their weekly visits. This might 
have had an additional positive effect on the compliance rate of the participants. In 
addition, previous research indicates that non-cognitively impaired older people are a 
reliable study group (Matousck, 1988).
7.6 aM T6s rhythm s
One o f the study hypotheses was that the light exposure would strengthen the circadian 
amplitude, assessed using the urinary aMT6s rhythm. Furthermore, the relationship 
(phase angle) between the aMT6s acrophase time and habitual wake-up time was 
assessed. The skeleton photopcriod light administration was not designed to phase 
shiA the timing of the aMT6s melatonin rhythm.
The aMT6s acrophase times Aom the present study agree with other aMT6s studies 
(Herljevic er a/., 2005; Youngstedt a/ a/., 2005) (section 6.5.1.1) confirming the 
previously reported age-related advance of the timing of the melatonin rhythm. In 
addition, the shorter phase angle between melatonin acrophase and wake-up times 
observed in the current study, was in agreement with that reported in the literature 
(Youngstedt e/ a/., 2001; Duffy e/ a/., 2002; Yoon a/., 2003a). A signiAcant 
positive relationship between aMT6s acrophase and wake-up time was observed for 
after each light exposure and the baseline (no light) of the control light measurement. 
Duffy and co-workers (1998; 2002) reported that compared to younger people older 
adults wake up at an earlier internal phase, i.e. closer to the CBT minimum while 
melatonin levels are still high. Since the current data is similar to the results reported 
by Duffy er a/. (1998; 2002) it may be hypothesised that the same situation occurred in 
the present study population. The age-related advance and altered phase-relationship
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between the cAcadian clock and the sleep-wake cycle might be further compounded 
and reinforced by early light exposure (during the phase advancing portion of the PRC 
[Czeisler a/., 1989; Khalsa c/ a/., 2003]) in the morning caused by earlier wake-up 
times (Duffy eZ a/., 1998; reviewd in Van Someren cr a/., 2002; Yoon cr a/., 2003a; 
Kawinska a/ a/., 2005). Together, these changes might lead to an altered circadian 
timing system and contribute to reported sleep problems in older people.
For the aMT6s acrophase time a period effect was observed; the second period had a 
delayed aMT6s acrophase time compared to the Arst period. Several explanations for 
this have been discussed in chapter 6 (section 6.5.1.2). One plausible explanation 
might be the imbalance in the number of participants receiving low and high irradiance 
light as well as the uneven number o f participants studied in the autumn -> winter 
season compared to the winter —> spring season.
Compared to baseline, no increase in aMT6s amplitude or in the 24 h aMT6s 
production was observed at the end of either light exposure as was hypothesised for 
the current study. Likewise, no changes in aMT6s rhythm parameters between the two 
light conditions were found. As discussed in section 6.5.1.2, this lack of effect on the 
aMT6s rhythm could be due to the light (irradiance, wavelength, duration and time of 
exposure) being insufficient to produce a measurable effect. Age-related changes in 
lens transmission may further reduce the light signal reaching the retina as discussed in 
section 7.2. Environmental light and light history might also had an inAuence by 
modifying the irradiance and colour temperature as well as the light sensitivity of the 
participants as previously discussed (section 7.2).
7.7 Comparison of the blue-enriched and control light
It was hypothesised for the current study that blue-enriched light would elicit a greater 
magnitude o f responses compared to the conAol light exposure. The two light 
conditions were photon-matched but differed in theA amount of blue photons and thus, 
it was thought that the 17000 K light would stimulate melanopsin to a greater degree. 
This hypothesis, however, was not conArmed by the observed Andings. Both lights 
had a high green photon content (lO'"* photons/cm^/sec) and, although melanopsin is 
less sensitive to these longer wavelengths, it is plausible that these photon levels may 
have been sufficient to elicit a response. Moreover, it has recently been demonstrated
7-13
____________________________________________________________________Chapter 7
that the longer wavelength cones 555 nm) can conAibnte to non-visnal responses 
in humans (Gooley cr a;/., 2010) and thus, the high photon density in the longer green 
wavelengths could have stimulated the cone photopigments.
The lack o f statistically signiAcant differences between the blue-enriched and control 
light in the current study is in accordance with the few studies published in the 
literature. Previous studies companng the efAciency and effectiveness of blue- 
enriehed with control light failed to And any major differences between the two lights 
(Scheuermaier cf ûr/., 2008; Smith, o7, 2009; Smith and Eastman 2009; Van Hoof c/ 
a/., 2009b; section 3.5.1.3).
7.8 Limitations of the study and recommendations 
LzwAaAoM."
The fact that the current study was designed as a Aeld study and therefore had not been 
conducted in a more controllable laboratory environment limits some of the 
interpretation of the results. Participants had to administer the light themselves 
without the help of a researcher controlling the correct set-up of the light box for every 
light session. Inter-individual differences in gaze and in the distance, angle and height 
Aom the light source and the duration of the light exposure can therefore not be 
excluded completely. Furthermore, the amount of light actually reaching the eye of 
the participants may have differed and could not be measured exactly. Although 
methods of objectively measuring the light from the light boxes and light environment 
were put in place (e.g. neck-worn AWL and HOBO light monitor near the light), these 
were unable to determine the exact amount of light reaching the participants’ retina.
.y/zow/ùZ wear a Zzg/z^  zMO/zAorzMg z7evzce a/ eye ZeveZ /o 
meoyzzre /^ze azMozzzz^  Zzg/z/ .y/ze/Tze zj^  e;ç?oje(/ /o. TTzea^ e z)ye^ 6/evzee.y are ezzrre»//y 
ZzezMg (/eveZqqeù  ^ e.g. Lzg/z^-IFare/zer.yf/ze EfA^We^Z/?rq/eef EUCZOCW.
LzzMZ/aAazz." farAezqazz/ ae/zvzfy (Zwrzzzg /Zze Zzg/z^  jej.yza»j^
In order to make the protocol acceptable, participants were allowed to eat, read, write 
and watch TV during the light exposure sessions. Engaging in these behaviours may 
have meant that the participants diverted their gaze Aom the light box, and in turn, 
reducing the amount of light perceived.
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RecozMmezz&zAoM.' qarAc^azz/ fo a zzzzzzzzzzzz/M q/^ ac/zvz/zg.y azzaf 6gAavzozzr.y w/zz/g
zzzyrozz^  q/^ Z^zg /zgA^  (z<7ga/Zy qarAc^azzf j/zozz/z7 ozzZy ZooA: a/ /Ag ZzgA^ j)).
Zzzzzzfa/zozz." 5"azzzq/g .yzzg
The overall sample size of 33 participants was small and was further divided between 
the low (n = 12) and high irradiance (n = 21) light studies. In addition, for the low 
irradiance light study the sample size of the order o f the light conditions was 
unbalanced. This might have had an effect on the measurement outcomes. 
Rggozzz/zzgzzc/cz/zozz.' Ezzj^ zzrg gqzzaZ .yazzzq/g .yzzg zzz gac/z Zzg/z^  gozz^ /zAozz; gacZz j^ zz6-j^ zzo[y 
j^ /zozz/(/ 6g gozzzz/gz"6aZazzgg(//bz" //zg orz/gz" q /  ^ /zg Zzg/z^  cozzûZzAozz. /zz oz-^ /gz- /o zzzoxzzzzzj^ g 
r/zg zzzzzzzbgz- q / " qaz"rzgÿ?azz^ .y A wow/üZ bg Zzg(q^/ /o Zzovg a qz-q/g.yjzozzaZ z"ggz^ z/zzzgzz/ 
aggzzcy.
Lzzzzz/a/zozz. Lzg/z^  gxqoj^ zzz-g 6/zzz-a/zozz
The irradiances used throughout the study can be considered low in comparison to 
previous of light Aeatment studies. Thus, it is possible that a longer light exposure 
(increased daily duration and number of weeks of light exposure) could have produced 
a greater effect with more significant changes in sleep and daytime behaviour. A 
longer washout period might also have been better to prevent any carry-over effect 
since some of the data, e.g. subjective get-up time (low irradiance study) and DSST 
performance (low irradiance study), had to be excluded Aom statistical analysis 
because of the carry-over eAects. Some o f the observed period effects, mainly Ar the 
activity data (NPCRA and cosinor analysis), might also be related to a short washout 
penod. Although there was no statistical difference between week 1 and week 6 
(which served as the baseline week Ar the second light exposure), it is still possible 
that small changes existed which might have added to Ae observed period effect. 
However, extending Ae light exposure and/or washout periods would have increased 
Ae lengA of the sAdy and made it more difficult to recruit participants. Additionally, 
the expanded sAdy length would then have made it even more difAcult to conAne the 
study to a constant photopcriod.
RgcozzzzzzgzzùZo/zozz." Lozzggz" wa^ /^zozz/ /zgz"zo6/ azzûf Zzg/zAzzg ybc/zzz-gj^  zzz gvgzy z-oozzz. AAz-g 
j^ A<7zg.y az"g zzgg(/g(/ A qq/zzzz^g /^zg z7zzz-a/zozz q//zg/z^ gjçzoj^ zzz-g azzz7 //zg /zg/zZ zz"z"az7zazzgg.
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ZzzMAarzoM." iS'ga.yowa/ g;(/gc^
The sAdy was conducted between September and April in 2006/2007 and 2007/2008, 
with groups commencing in eiAer September or January. A  the September group the 
photoperiod would have shortened across the sAdy whilst Ar the January group the 
photoperiod would have lengthened across Ae sAdy. The m^ority of participants 
(69.7%) were sAdied between September and December and Aus, there was an 
imbalance in the number of individuals sAdied in the two photoperiods. These 
photoperiodic changes may also have had an impact on the daA.
/(gc'OZMZMgzzùkzqozz. TTzc .y/zozz/z7 be A ozze q/zo/qqcrzo^/ Z^o avozz7 j^ ga^ o^zza/
goz^zzzzdk üüy /gzzgZ/z.
Lzzzzz/a^ zozz." /zz/gz"zza/ czz'gaùfzazz p/zaj^g a/ /zg/zZ gjcqo.yzzz'g
There is the possibility that participants received the light exposure at different time 
points o f their individual light PRCs and therefore responded differently to the light, 
/(ggozzzzzzgzz^ /a^ zozz." C r^zzzzMg //zg g/^c^ q/^  /zg/zZ zzzz7zvz(/zza/Azzzg //zg Z^zzzzzzzg q/  ^/zg/z^  
gxpOm^zzz-g azza^  //zg /zg/zZ zzrWzazzgg. v4A/zozzg/z zzzzyzvz^ Aza/Mzzzg //zg Zzzzzzzzg q/" /zg/zZ 
gxqo.yzzz"g wozz/ /^ 6g z(/ga/, //zM cazzzzo^yg  ^6g Jbzzg aggzzz"a/g(y zzz /zg/z^ j/zz6/zg.y. TTzg /^zzz-g 
z7gvg/qqzzzgzz/ q/^ azz azzzbzz/aAzy 6zo.ygzz.yoz' Zo oy.yg.y.y czz-go^ /zozz /z/zo.yg wz// zzzoA:g 6^z.y zzzoz'g 
ygoj z^6/g.
Lzzzzz^ o^ zozz.' 7zzz7zvzz7zza/ /zg6^ zz-z-Wzozzcg /zz-g/gz-gzzcg
There could have been inter-individual differences in the preference for the brightness 
of the light and Ais might have led to participants avoiding Ae light Aom time to time. 
A  particular Ais might have been the case in the high irradiance light sAdy leadmg to
the observed lack of effectiveness. No light irradiance cross-over was applied in the 
present study.
/(ggozzzzzzgzzù^ /zozz. 7zzz7zvzz7zza/za^ g^ / /6g z^zzzzzzg q/^ /zg/zZ gxqoj^ zzz-g ozzo^  zzz6/zvzz7zza//y qqZzzzzMg 
Z6g /zgAz zzToe/zazzgg. Dgj^ zgzz q/  ^ o cz'Oj^ .y-ovgz' .yZzzc;^  Zo oya^ gj^ j^  Z/zg g^cZ q/^  /zg/zZ
irradiance within participants.
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Z,z/MzZaZzoM.' TVio /zg6zq/acg6o
It is well recognised in the light therapy research Aeld that no effective placebo Ar
light intervention sAdies exists. This is a limitation o f all these sAdies including the 
current sAdy. In order to overcome this limitation Terman eZ a/. (1998) employed a 
negative ion generator in SAD which also proved effective.
/(gcozMZMCZz^/aZzozz.' D e v g /q q /z z c z z Z  a  Zz^zg q / a g g 6 o  cozzz/zZ zozz/b z"  /zg/zZ  jZzzz7zg.y.
LzzzzzZaZzozz. 7zz/7zzgzzgg q/^Z/zg .vZz^z^ q z " o Z o c o /
For Ae light exposure participants had to sit Ar 2 x 2 hours each day whereas during 
baseline and washout (no light condition) they were free to undertake their normal 
daily activities. This change in behaviour and posAre during Ae no light condition 
could have inAuenced the parameters measured. For example, A e signiAcant 
improvements in mood during the washout may support this view.
Rggozzzzzzgzzz/aZzozz." Dzzz"zzzg zzo  /zg /zZ  cozzz/zZzozz Z/zg ^az"ZzczqazzZ  j^/zozz/z7 b g  z"gqzzzz"gz7 Zo j^ zZ 
zzz ^ o z z Z  q /^ a  zzozz^/zzzzcZzozzzzzg /zg /zZ  g a c / z  z /q y  wzZ/z j^zzzzz/az" gozzjZz-azzz.y a y  z7zzz"zzzg Z/zg /zg/zZ  
g x q o y z z z -g  y g y y z o z z y .
ZzzzzzZaZzozz. 5 " zz^ g g Z zv g  z"aZzzzgy
Subjective assessment o f  sleep and daytime behaviour despite the proven validity o f 
the questionnaires and diaries might raise some problems. For example, some 
participants might not have been precise enough in judging Aeir sleep and 
mood/alerAess or accurate enough in completing the necessary Arms. Ater-mdividual 
difArences m making Aese judgements and self-assessments might add Airther 
variation to the data. To overcome these possible biases between participants, each 
participant served as his/her own control in A e present sAdy. A  addition, objective 
measurements, e.g. actigraphy and circadian phase assessment using urinary aMT6s, 
had been utilised.
/^ggozzzzzzgzzüüZ zozz. y4üK(/zZzozza/ zzyg q/^ o /y g c Z z v g  zzzgoyzzz-gzzzgzzZy ybz" oyygyyzzzgzzZ  q / '  zzzooz7  
azz(7  a/gz"Zzzgyy.
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Z/ZZMzZaZzoM." Cozzzq/zazzcg
Participant compliance wiA Ae light exposure sessions and Ae sAdy protocol also 
remams an open question. However as previously discussed, lack o f compliance is not 
believed to be a major shortcoming o f the study protocol (section 7.2.4). 
RgcozzzzzzgzzfZaZzozz." fa z 'Z z c z q a z z Z  y/zozz/zZ  w e a z "  a  z Z e v z c e  aZ  g y g  / g v g /  Zo zzzcoyzzz-g Z/zg 
azzzozzzzZ /zg/zZ  y /z g /7 z g  zy g x q o y g z Z  Zo Z /zgz'gb y  g o z ^ z-zzzzzzg  c o z z z q /z a z z c g  Zo Z/zg /zg/zZ  gxq oy zzz" g  
y g y y z o z z y , g . g .  z z y g q / ' lz g /z Z - lP a Z c /z g z - y .
Z/ZzzzzZaZzozz." Paz^Zzc^izazzZy ' g xq g g Z a Z zo zzy
It is possible that some o f  the observed effects were simply due to an effect o f  the
participants’ expectations. Most participants took part in the study in the hope that this 
might improve their sleep problems. They would thus view the light exposure in a 
positive way. The balanced design o f  directly testing one light condition compared to
the other was chosen to minimise the influence o f participants’ expectations.
Not necessarily a shortcoming but a point to raise are the sometimes small, though 
statistically significant, changes observed. This was especially apparent for 
actigraphic mean wake-up time and the mood and alertness data o f the low and high 
irradiance light sAdies. The clinical validity and biological meanmgAAess o f Aese 
findings for sleep and mood remains questionable. The mood and alertness scales (9- 
point scales) might not have been sensitive enough to be used in A e current field 
study. Visual analogue scales marking a point on a 10-em line may have been more 
sensitive to assess changes in mood and alertness in this population.
7.9 Conclusions
A  major strength o f A e protocol design was matching the photon density o f  the two
light conditions, i.e. the blue-enriched and control light, for both the low and high 
irradiance lights. Thus it was possible to compare the biological effectiveness o f the 
two light conditions.
This sAdy presents new insights into the sleep-wake behaviour o f healthy, older
people living in the community. It Arther provides important information about the
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Aasibility o f  conducting a light intervention sAdy in the home environment to reduce 
self-reported sleep problems. Avestigating the effects o f two polycAomatic light 
conditions on sleep in older independently living people makes this study unique.
This sAdy has shown that timed light exposure, administered as a skeleton 
photoperiod, in Ae home environment (during auAmn/wmter/spring) has measurable 
effects on several parameters o f sleep, activity and daytime Anctioning. For a number 
o f reasons discussed in Ae previous chapters, the observed effects o f  the lights were 
not pronounced. Increasing the light irradiance, optimising spectral composition and 
increasmg the duration o f light exposure per day and per session may achieve a greater 
magnitude o f responses.
Laboratory sAdies in animals have shown that the contribution o f melanopsin to non­
visual responses varies in a circadian manner (Tsai cZ a/., 2009). Two recent sAdies
from our laboratory have shown that it is not possible to predict the human non-visual 
response to a polychromatic light on the basis o f m elanopsin sensitivity alone (Revell 
and Skene, 2007; Revell cZ a/., 2010). These findings highlight the importance o f  
Ature laboratory and field sAdies to determine how a polycAomatic light signal is 
received, including A e temporal dynamics, and how A e different photoreceptors 
contribute to these processes. This knowledge will help to manipulate the spectral 
composition and the temporal pattern o f polychromatic light in order to optimise light 
irradiance, duration and timing for non-visual light responses.
Once optimised, it is hoped that light exposure will provide a non-invasive, low-cost 
alternative to Ae standard pharmacological treatment o f sleep problems A  older
people. Not only will costs o f health-care be reduced but also instiAtionalisation o f an 
older person with disturbed sleep-wake/rest-activity rhythms might be delayed. 
FurAermore, amelioration o f sleep problems will improve Ae overall quality o f  liA  o f  
the older person.
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Appendix A
GENERAL HEALTH QUESTIONNAIRE
Identification Code:.................................... Date:
Date o f  Birth:
Age:
Are you a Smoker/Non Smoker?
If yes, how many cigarettes do you smoke per day:
H ow  much alcohol (units) do you drink on average per w eek (units per week)?
(1 pint = 2 units; 1 measure of alcohol = 1 unit)
None 1-4 units 5-14 15 or more
H ow  many cups o f  tea/coffee do you drink a day?
Any known eve conditions (wear glasses, glaucoma, cataract)? 
Eve Colour:
Are vou colour blind?
Do vou take anv regular medication? tPlease specify name, dose, time of administration.
frequency)
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D o vou have anv major health problems?
Psychiatric conditions (i.e. depression/schizophrenia) Y es/N o
Migraine Yes/No
Epilepsy Yes/No
Heart disease Y es/N o
Vascular disease Y es/N o
B lood Pressure Yes/No
Gastrointestinal disorders Yes/No
Endocrine disorders Yes/No
Asthma Yes/No
Retinal disease Yes/No
Kidney disease Yes/No
Autoimmune disease Yes/No
Liver disease Y es/N o
Arthritis Y es/N o
Diabetes Yes/No
Cancer Y es/N o
Hernia Yes/No
Tuberculosis Yes/No
Lung problems Y es/N o
Anaem ia Yes/No
Thyroid disorders Y es/N o
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Appendix B
PITTSBURGH SLEEP QUALITY INDEX 
Identification Code:................................ Date:
Instructions:
The following questions relate to your usual sleep habits during the past month ow/y. Your 
answers should indicate the most accurate reply for the mq/onfy of days and nights in the past 
month. Please answer all the questions.
1) During the past month, when have you usually gone to bed at night?
Usual bed time:_____________________
2) During the past month, how long (in minutes) has it usually take you to fall asleep 
each night?
Num ber o f  minutes;__________________________
3) During the past month, when have you usually got up in the morning?
Usual getting up time:__________________________
4) During the past month, how many hours of actual sleep did you get at night? (This 
may be different from the number of hours spent in bed.)
Hours o f  sleep per night
For each of the remaining questions, check the one best response. Please answer all questions.
5) During the past month, how often have you had trouble sleeping because you.....
a) Cannot get to sleep within 30 minutes 
Not during the Less than
past month  once a week____
O nce or tw ice  
a w eek
3 or more 
times a week
b) Wake up in the middle of the night or early morning
Not during the Less than Once or twice 3 or more
past month  once a week  a week  times a week
c) Have to get up to use the bathroom 
Not during the Less than
past month  once a week 
d) Cannot breathe comfortably 
Not during the Less than
past month  once a week
O nce or twice 
a week
Once or tw ice  
a w eek
3 or more 
tim es a w eek
3 or more 
tim es a w eek
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e) Cough or snore loudly
Not during the Less than
past month once a week
Once or tw ice  
a week
3 or more 
times a week
f) Feel too cold 
Not during the
past month_____
Less than 
once a week
Once or twice 
a week
3 or more 
times a week
g) Feel too hot
N ot during the 
past month___
Less than 
once a week
O nce or tw ice 
a week
3 or more 
times a week
h) Had bad dreams
N ot during the 
past month_____
L ess than 
once a w eek
Once or tw ice 
a week
3 or more
tim es a w eek
i) Have pain
N ot during the 
past month____
Less than
once a w eek
Once or twice 
a w eek
3 or more 
times a week
j) Other reason(s), please describe
H ow  often during the past month have you had trouble sleeping because o f  this?
Not during the 
past month___
Less than 
once a w eek
Once or tw ice 
a w eek
3 or more 
tim es a w eek
6) During the past month, how would you rate your sleep quality overall?
Very good_____________
Fairly good___________
Fairly bad____________
Very bad_____________
7) During the past month, how often have you taken medicine (prescribed or “over the 
counter”) to help you sleep?
N ot during the Less than O nce or tw ice 3 or more
past month  once a w eek   a w eek  tim es a w eek 
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8) During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity?
N ot during the 
past month___
Less than 
once a w eek
Once or tw ice  
a week
3 or more 
tim es a w eek
9) During the past month, how much of a problem has it been for you to show 
enthusiasm to get things done?
No problem at all_________
Only a very slight problem
Som ewhat o f  a problem___
A  very big problem_______
10) Do you have a bed partner or roommate?
No bed partner or roommate?
Partner/roommate in other room
Partner in same room, but not sam e bed 
Partner in same bed
If you have a roommate or bed partner, ask him/her how often in the past month you 
have had)...
a) Loud snoring 
Not during the
past month______
Less than
once a w eek
Once or tw ice  
a w eek
3 or more 
tim es a w eek
b) Long pauses between breaths while asleep
Not during the Less than Once or twice 3 or more
past month  once a week  a week  times a week
c) Legs twitching or jerking while you sleep
Not during the Less than Once or twice 3 or more
past month  once a week  a week  times a week
d) Episodes of disorientation or confusion during sleep?
Not during the Less than Once or twice 3 or more
past month  once a week  a week  times a week
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e) Other restlessness while you sleep; please describe
N ot during the Less than Once or tw ice 3 or more
past month  once a week  a week  times a week
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Appendix C
GENERAL SLEEP QUESTIONNAIRE
Identification Code:..................................... Date:
1. On a normal day how  many tim es do you go outside?
< 1/day 1/day > 1/day
2. W ould you regard your m obility as:
good fair poor
3. What time do you normally go to bed (h:min)?______________
4. H ow  m any hours per night do you sleep on average?
5. H ow  long does it take you to fall asleep?
< 10 min 10-30 min > 30 min
6. H ow  often do you wake up during the n igh t?_________________
7. H ow  often do you get up during the night?
8. Why do you get up during the night?
9. What time do you norm ally wake up (h:min)?
10. Do you go through phases of getting to sleep earlier and earlier or later and later each 
night?
xc
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11. Do you have any difficulty getting up in the morning? ü  Yes O No 
If yes, what kind of difficulty?
12. Do you fall asleep during the day? H Yes O No 
If yes, how often and for how long?
13. Do you feel you have any problems sleeping? □  Yes □  No 
If yes - What kind of problems?
14. Does it occur regularly?
15. Do you do anything to try and overcome this problem?
(i.e. sleeping pills, relaxation techniques, herbal remedies, routine)
16. Are these strategies effective?
17. How long have you had this sleep problem?
< 6 months 6-12 months >12 months
18. Do you ever skip a night’s sleep? □  Yes □  No
19. Is your sleep pattern different during work fi-ee periods (e.g. holidays, weekends)?
If yes, how is it different?
20. Does your sleep pattern affect your social or occupational life? □  Yes □  No 
If yes, in what way?
21. Do you live alone? □  Yes □  No
xci
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Appendix D
HORNE-OSTBERG QUESTIONNAIRE
Identification Code:.................................... DATE:...........................
This questionnaire will used to assess whether you are a “morning” type (i.e. a lark) or an 
“evening” type (i.e. an owl) person.
a) Please read each question very carefully before answering.
b) Answer all questions
c) Answer questions in numerical order
d) Each question should be answered independently of others. Do NOT go back and check 
your answers.
e) For some questions you are required to respond by placing a cross alongside your answer. 
In such cases, select ONE answer only.
f) Please answer each question as honestly as possible. Both your answers and results will 
be kept in strict confidence.
QUESTION 1
Considering only your own “feeling best” rhythm, at what time would you get up if you were 
entirely free to plan your day?
Time:
QUESTION 2
Considering only your own “feeling best” rhythm, at what time would you go to bed if you 
were entirely free to plan your evening?
Time:
QUESTION 3
If there is a specific time you have to get up in the morning, to what extent are you dependent 
on being woken up by an alarm clock?
a. Not at all dependent [ ]
b. Slightly dependent [ ]
c. Fairly dependent [ ]
d. Very dependent [ ]
xcii
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QUESTION 4
Assuming adequate environmental conditions, how easy do you find getting up in the 
morning?
& [ ]
b. Not very easy [ ]
c . [ ]
d. [ ]
QUESTION 5
How alert do you feel during the first half hour after having woken in the morning?
a. Not at all alert [ ]
b. Slightly alert [ ]
c. Fairly alert [ ]
d. [ ]
QUESTION 6
How is your appetite during the first half hour after having woken in the morning?
a. Ve^pŒM [ ]
b. FæHypMM [ ]
c. Fairly good [ ]
d. Very good [ ]
QUESTION 7
During the first half hour after having woken in the morning, how tired do you feel?
a. Very tired [ ]
b. Fairly tired [ ]
c. Fairly refreshed [ ]
d. Very refreshed [ ]
xcni
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QUESTION 8
When you have no commitments the next day, at what time do you go to bed compared to your 
usual bedtime?
a. Seldom or never later [ ]
b. Less than one hour later [ ]
c. l-2lioursl(üer [ ]
d. More than 2 hours later [ ]
QUESTION 9
You have decided to engage in some physical exercise. A friend suggests that you do this one 
hour twice a week and the best time for him is between 0700 and OSOOh. Bearing in mind 
nothing else but your own inclinations, how do you think you would perform?
a. \Vcnfhit#ongcKxiihTm [ ]
b. Would be on reasonable form [ ]
c. Would find it difficult [ ]
d. Would find it very difficult [ ]
QUESTION 10
At what time in the evening do you feel tired and as a result in need of sleep?
Time:
QUESTION 11
You wish to be at your peak for a test which you know is going to be mentally exhausting and 
lasting for two hours. You are entirely free to plan your day and considering only your own 
"feeling best" rhythm, which ONE of the four testing times would you choose?
a. 0800- 1000 [ ]
b. 1100- 1300 [ ]
c. 1500- 1700 [ ]
d. 1900-2100 [ ]
XCIV
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QUESTION 12
If you went to bed at 2300b at what level of tiredness would you be?
a. Not at all tired [ ]
b. A little tired [ ]
c. Fairly tired [ ]
d. Very tired [ ]
QUESTION 13
For some reason you have gone to bed several hours later than usual, but there is no need to 
get up at any particular time the next morning. Which ONE of the following events are you
most likely to experience:
a. Wake up at the usual time and not go back to sleep [ ]
b. Wake up at the usual time and doze [ ]
c. Wake up at the usual time and go back to sleep [ ]
d. Wake up later than usual [ ]
QUESTION 14
One night you have to remain awake between 0400 and 0600h. You have no commitments the 
next day. Which ONE of the following suits you best:
a. Not to go to bed until 0600h [ ]
b. Nap before 0400h and sleep after 0600h [ ]
c. Sleep before 0400h and nap after 0600h [ ]
d. Sleep before 0400h and remain awake after 0600h [ ]
QUESTION 15
You have to do two hours of hard physical work. You are entirely free to plan your day and 
considering only your own "feeling best" rhythm which ONE of the following times would 
you choose?
a. 0800- 1000 [ ]
b. 1100- 1300 [ ]
c. 1500- 1700 [ ]
d. 1900- 2100 [ ]
xcv
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QUESTION 16
You have decided to engage in some physical exercise. A friend suggests that you do this 
between 2200 and 2300h twice a week. Bearing in mind nothing else but your own "feeling 
best" rhythm how well do you think you would perform?
a. Would be on good form [ ]
b. Would be on reasonable form [ ]
c. Would find it difficult [ ]
d. Would find it very difficult [ ]
QUESTION 17
Suppose that you can choose your own work hours. Assume that you worked a FIVE hour day
(including breaks)) and that your job was interesting and paid by results. Which FIVE 
CONSECUTIVE HOURS would you select:
Hours:
QUESTION 18
At what time of day do you think that you reach your “feeling best” peak? 
Time:.........................................
QUESTION 19
One hears of “morning” and “evening” types. Which do you consider yourself to be?
a. Morning type [ ]
b. More morning than evening [ ]
c. More evening than morning [ ]
d. Evening type [ ]
xcvi
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Appendix E
BECK DEPRESSION INVENTORY
Identification Code: Date:
Choose one statement from among the group of four statements in each question that best 
describes how you have been feeling during the past few days. Circle the number beside your 
choice.
1 0 I do not feel sad.
11 feel sad.
2 I am sad all the tim e and I can't snap out 
o f  it.
3 I am so sad or unhappy that 1 can't stand
it.
8 0 I don't feel I am any w orse than anybody  
else.
1 1 am critical o f  m yself for my 
weaknesses or mistakes.
2 I blam e m y se lf  all the tim e for m y faults.
3 I blam e m y se lf  for everything bad that 
happens.
2 0 I am not particularly discouraged about 
the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel that the future is hop eless and that 
things cannot improve.
9 0 1 don't have any thoughts o f  killing
m yself.
1 1 have thoughts o f  k illing m yself, but I 
w ould  not carry them  out.
2 I w ould  like to kill m yself.
3 I w ou ld  kill m y se lf  i f  I had the chance.
3 0 I do not feel like a failure.
1 I feel I have failed more than the average 
person.
2 A s I look  back on m y life, all 1 can see  is 
a lot o f  failure.
3 I feel I am  a com plete failure as a person.
10 0 I don't cry any more than usual.
1 1 cry m ore now  than I used to.
2 I cry all the tim e now .
3 1 used to be able to cry, but now  I can't 
cry even  though I want to.
4 0 I get as m uch satisfaction out o f  things as
1 used to.
1 I don't enjoy things the w ay I used to.
2 I don't get any real satisfaction out o f  
anything anym ore.
3 I am dissatisfied  or bored with  
everything.
11 0 I am no more irritated by  things than I 
ever am.
1 I am slightly  m ore irritated n ow  than 
usual.
2 I am quite annoyed or irritated a good  
deal o f  the time.
3 I feel irritated all the tim e now .
5 0 I don't feel particularly guilty.
1 I feel gu ilty  a good  part o f  the time.
2 I feel quite gu ilty  m ost o f  the tim e.
3 I feel gu ilty  all o f  the time.
12 0 I have not lost interest in other people.
1 1 am less interested in other peop le  than I 
used to be.
2 I have lost m ost o f  m y interest in other 
people.
3 I have lost all o f  m y interest in other 
people.
6 0 I don't feel I am  being punished.
1 I feel 1 m ay be punished.
2 I expect to be punished.
3 I feel I am  being punished.
13 0 I m ake decision s about as w ell as I ever  
could.
1 I put o f f  m aking d ecision s m ore than I 
used to.
2 I have greater d ifficu lty in m aking  
decision s than before.
3 I can't m ake decision s at all anymore.
7 0 I don't feel disappointed in m yself.
1 I am disappointed in m yself.
2 I am disgusted with myself.
3 I hate myself.
14 0 I don't feel that I look  any w orse than I 
used to.
1 I am worried that 1 am  looking  o ld  or 
unattractive.
2 I feel that there are perm anent changes in 
m y appearance that m ake m e look  
unattractive.
3 I b e lieve  that 1 look ugly.
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15 0 I can work about as w ell as before.
1 It takes an extra effort to get started at 
doing something.
2 1 have to push m y se lf  very hard to do 
anything.
3 1 can't do any work at all.
19 0 I haven't lost m uch w eight, i f  any, lately.
1 I have lost m ore than five pounds.
2 I have lost m ore than ten pounds.
3 I have lost m ore than fifteen  pounds. 
(Score 0 i f  you have been purposely trying 
to lose weight.)
16 0 I can sleep  as w ell as usual.
1 I don't sleep as w ell as 1 used to.
2 I wake up 1 -2 hours earlier than usual 
and find it hard to get back to sleep.
3 I wake up several hours earlier than I 
used to and cannot get back to sleep.
20 0 I am no more worried about m y health  
than usual.
1 I am worried about physical problem s 
such as aches and pains, or upset stom ach, 
or constipation.
2 I am very worried about physical 
problems, and it's hard to think o f  m uch  
else.
3 I am so worried about m y physical 
problem s that I  cannot think about 
anything else.
17 0 I don't get more tired than usual.
1 I get tired more easily  than I used to.
2 I get tired from doing alm ost anything.
3 I am too tired to do anything.
2 1 0 I have not noticed any recent change in 
m y interest in sex.
1 I  am less interested in sex  than I  used to 
be.
2 I am m uch less interested in sex now .
3 I have lost interested in sex  com pletely.
18 0 M y appetite is no w orse than usual.
1 M y appetite is not as good  as it used to 
be.
2 M y appetite is m uch w orse now.
3 I have no appetite at all anymore.
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Appendix F
EPWORTH SLEEPINESS SCALE
Identification Code:..................................... Date:
Use the following scale to choose the most appropriate number for each situation:
0 = would /zevgr doze or sleep.
1 = chance of dozing or sleeping
2 = moderate chance of dozing or sleeping
3 = high chance of dozing or sleeping
Situation Chance of Dozing or Sleeping
Sitting and reading
Watching TV
Sitting inactive in a public place
Being a passenger in a motor vehicle for an hour
or more
Lying down in the afternoon
Sitting and talking to someone
Sitting quietly after lunch (no alcohol)
Stopped for a few minutes in traffic while driving
Total score
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Appendix H-I
Time table for putting on/olÏ  AWL fneck-worn) Participant’s co d e :................
Week Date Time off Time on Reason
Appendix H-II
Time table for putting on/oJff AWL fwrist-worn) Participant’s code:................
Week Date Time off Time on Reason
Cl
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Appendix I
SLEEP DIARY
Participant’s code:............................................................
Date 0 « m . Day of week-
This form is to be completed in the morning EACH DAY throughout the entire study.
What time did you go to bed? (hh:mm)
At what time did you try  to sleep? (if 
different to above answer)
How long  did it take you to fall asleep? 
(minutes)
How many times did you wake up?
How long were you awake for? (minutes) 
Please estimate the time & duration of each 
night awakening!
For what reason? Please state for each 
awakening a single word description!
Woke up
1 .
Fell asleep Reason
What time did you wake up? (hh:mm)
What was the reason for waking up?
Alarm Noise Person Just
awoke
What time did you turn on the light? (hh:mm)
What time did you get up? (hh:mm)
Would you describe this as a typical night? □  Yes □  No
If permitted, could you have slept longer? □  Yes □  No
How would you rate your quality of sleep? (circle one)
best ever 1 2 3 4 5 6 7
worst ever
cn
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NAP DIARY
Appendix J
Participant’s code:............................................................
Date:............................  Day of w eek:............................
Please complete one column of this table after each day-time nap.
Nap 1 Nap 2 Nap 3 Nap 4 Nap 5
What time did the nap start?
What time did the nap end?
How long was the nap? 
(min)
Please record any times you would have liked to nap but were unable to for
whatever reason,
e.g. wanted a nap 1 6 :0 0 -
V7/30.....................................................................................................
Instructions for completing sleep and nap
Please complete a sleep diary every day for the entire study. Questions need to be 
answered as accurately as possible. But don’t worry too much if you don’t remember 
the exact times, an approximation is fine. It is more important that you sleep as 
naturally as possible.
cm
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Appendix K
ALERTNESS AND MOOD SCALES
Participant’s code: 
D ate:......................... Day of week:
These will be recorded (a) 15 min after getting out of bed, (b) before lunch, and (c) 
after evening light exposure. Each completion will take -1 0  min.
Time of rating:
How would you rate your alertness? (circle one)
1 2 3 4 5 6
1 = very alert
8 9
9 = very sleepy
How would you rate your mood? (circle one)
1 2 3 4 5 6 7 8 9  
1 = very cheerful 9 = very miserable
How would you rate your mood? (circle one)
1 2 3 4 5 6 7 8 9  
1 = very calm 9 = very tense
How would you rate your mood? (circle one)
1 2 3 4 5 6
1 = very depressed
7 8 9
9 = very elated
CIV
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Karolinska Sleepiness Scale
Please indicate your sleepiness during the 10 minutes before this rating.
Very alert 1
2
Alert -  normal level 3
4
Neither alert nor sleepy 5
6
Sleepy, but no effort to keep awake 7
8
Very sleepy, great effort to keep awake 9
cv
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Appendix L
Digital Symbol Substitution Test -  DSST
Participant’s code:............................................................
D ate:.............................. Day of w eek:....................  T im e:...........
1 2 3 4 5 6 7 8 9 0
tx n A 4 X
9 6 2 7 4 8 5 0 3 1 8 9 5 3 4 2 6 7 1 0
3 5 8 1 6 0 7 9 2 4 3 6 1 7 5 0 8 9 2 4
2 4 9 3 2 9 5 8 6 8 2 9 8 5 7 0 1 5 7 4
8 2 3 9 0 4 1 6 5 7 4 3 9 2 6 7 1 5 8 0
1 9 4 8 2 5 3 7 0 6 9 0 8 3 1 7 4 5 6 5
2 3 6 4 5 1 0 8 7 9 0 4 8 6 2 5 9 3 7 1
7 4 9 6 3 2 8 5 1 0 2 7 4 1 8 6 0 5 9 3
5 1 0 6 3 2 8 4 7 9 1 6 8 0 4 7 9 2 6 9
0 7 5 9 8 3 2 1 6 2 1 0 6 5 7 8 4 2 3 9
6 8 1 3 0 7 9 5 4 5 7 8 5 2 0 9 3 2 1 4
cvi
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DIGITAL SYMBOL SUBSTITUTION TEST (DSST)
Training: please complete before starting the study.
1. Starting at the top left hand side, write the symbol corresponding to the digit in 
the space provided. Complete each line in turn, working down the page. DO 
NOT attempt to complete all the substitutions for number 1 followed by those 
for number 2 etc.
2. Work as quickly and accurately as possible.
3. Turn over the page and repeat the process for the second side.
4. Please try to complete 5 sheets in total.
When you have completed 10 sides (5 sheets):
1. Set the timer for 2 min and complete as many substitutions as possible in this 
time. Turn over the page and repeat the process for the second side.
2. Try to do this for 5 times before the study if possible.
evil
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THE MINI MENTAL STATE EXAMINATION (MMSE)
Identification Code: Date:
Section 1 : Orientation
The first 10 points are gained for giving the correct date and
location.
What is the day of the week?
What year was last year?
What is the street name?
What building are we in?
Maximum
10
Score
Section 2: Memory (part 1)
The first part of the memory test tests the ability to remember
immediately three words.
You will be given the names of three objects to remember - table, 
ball and pen, for example.
You will then be asked to repeat the three names, scoring 1 point 
for each object correctly recalled (3 points maximum).
If you can't remember all three objects, the person testing you will
repeat the words. However, you only score points on the first 
attempt.
You should try to remember the three items as you will be asked to 
recall them later in the test.
Maximum
3
Score
Section 3: Attention and Calculation
The next part of the MMSE tests the ability to concentrate on a 
tricky task.
Two different tests are used, and the best of the two scores is 
included in the final score.
You will be asked to count backwards. For example, start at 50 and 
count backwards by 5. One point is given for each correct 
subtraction, with a maximum of 5 points.
You may also be asked to spell a word backwards such as 'lunch'. 
Again, the maximum score is 5.
Maximum
5
Score
Section 4: Memory (part 2)
You will now be asked to recall the three items from Section 2. 
The attention and calculation section may have been quite a 
stressful experience, so this can be tricky.
One point is given for each correctly recalled object. Sometimes 
the person doing the testing will drop hints!
Maximum
3
Score
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Appendix O
EXAMPLE OF THE SEMI-STRUCTURED INTERVIEW
Identification Code: Date:
Short summary of where participant is in the 
study
General well-being Make them feel at ease.
How did you like it? 
Light
Administration
Timing
Duration
Convenience/practicability of 
administration.
Problems since last visit?
any modifications 
or suggestions
Possible ac^ustments.
Any changes to well-being? 
Influence on 
sleep
mood
daytime activity 
social interactions
Part of assessment of treatment.
cx
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Appendix P-I
Instructions for Urine Collection
Please find enclosed:
1 urine collection bottle
1 measuring cylinder 
11 small plastic vials
2 grip seal bag 
some pasteur pipettes 
1 urine collection diary 
1 funnel 
Ijug
Instructions:
Please collect all urine passed for 39 consecutive hours. Please ensure that two nights are
included. The 39 hour period will be divided into collection periods that will each last for 
selected hours, e.g. 21:00 - bedtime, bedtime - wake-time.
For example:
Day 1 Collect fi"om 21:00h on to wake-up on
Day 2 From wake-up on Wednesday to wake-up on Thursday.
Day 3 From wake-up on Thursday until 12:00 h.
To make it easier, it is a good idea to do your urine collection during three days of the week
when it is likely that you will be mostly at home. If you are leaving the house during a 
collection period then you will need to make sure that you take the collection bottle with you. 
If it is near the end of a collection period you will also need to take the measuring cylinder and 
relevant labelled plastic vial with you. If it is not possible to freeze the sample straight away
e.g. you are at work or out shopping, then please fi-eeze once you return home. The urine is 
stable for up to five days so it is not essential that it is frozen straight away and the samples 
collected over the 39-hour period can be posted immediately the last sample has been taken. 
Urine samples should be double contained if placed in a freezer near food.
CXI
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Urine Collection Instructions
You are asked to collect all urine passed for approximately 39 consecutive hours which 
includes two overnight periods.
It is very important that BEFORE you start the 39 hour urine collection you empty your 
bladder first and record the time on the urine collection diary (under "time Bladder emptied"). 
You do not need to collect this urine but it is essential to record the time your bladder was 
emptied. For example, if you intend to begin the urine collection at 21:00 h then vou must 
completelV emptv vour bladder before 21:00 h but do NOT collect that urine. The 39 hour 
collection period is divided into 11 collection periods.
During each collection period, collect all urine passed in the bottle, using the funnel if 
necessary.
At the end of each collection period record the total volume of all the urine in the bottle.
Put about 5ml (a teaspoonful) of it into the small labelled vial (Tube).
Push the top of the tube on carefully and place in the grip seal bag in your freezer. The rest of
the urine can be discarded.
Bottles and measuring cylinder should be rinsed with tap water (but do not use any detergent).
All small vials are labelled with your participant’s code, Day 1 or 2 or 3, the sample number
(e.g. SI) and the approximate time of the collection period. For example, your first urine 
collection should be placed into the vial labelled Day 1 and SI and the time. You have 2 small
vials for Day 1, 7 for Day 2 and 2 for Day 3. Also, some spare ones will be provided.
It is very important that you record the time and volume of each urine collection.
exit
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Before 21:00 h you should completely empty your bladder.
Sanq)ling:
Vials labelled Day 1
Vial SI: 21:00 h -  bedtime
Vial S2: bedtime -  wake/get-up -  overnight
Vials labelled Day 2 
Vial S3: wake/get-up -  09:00 h 
VialS4: 09:00 h - 12:00 h 
VailS5: 12:00 h - 15:00 h.
VialS6: 15:00 h - 18:00 h 
VialS7: 18:00 h - 21:00 h 
Vial S8: 21:00 h -  bedtime 
Vial S9: bedtime -  wake/get-up -  overnight
Vials labelled Day 3
Vial SIO: wake/get-up -  09:00 h
Vial SI 1: 09:00-12:00 h
Please record vial number and matching collection period on the urine collection sheet diary. 
When all urine for 39 hours is collected you can keep it in the fridge or freezer until a research 
collects it. Please keep the collection sheet in the booklet.
The box with the rest of the equipment will be collected at the end of the study.
CX ll l
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Appendix P-II
Participant’s code: 
TIME BLADDER EMPTIED:
URINE COLLECTION DIARY
DATE:
Actual
Period
Sample
Number
Total volume of urine 
collected for
time period (ml)
5ml sample 
into vial
5ml sample 
frozen (V )
Day 1
21:00 -  bedtime 
Viall
bedtime -  
wake/get up 
Vial 2
Day 2
wake/get up -  
09:00 
Vial 3
09:00-12:00 
Vial 4
12:00-15:00 
Vial 5
15:00-18:00 
Vial 6
18:00-21:00
Vial?
21:00-bedtime 
Vial 8
bedtime -  
wake/get up 
Vial 9
Day 3
wake/get up -  
09:00 
Vial 10
09:00-12:00 
Vial 11
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Appendix R
Appetite Scales 1 -  everyday before lunch
Participant code: Date:
Answer the following questions by placing a vertical mark through the line for each
question. Mark the line according to how you feel at this moment. Regard both the ends of 
the lines as indicating the most extreme sensations vou have ever felt.
Time:
How hungry do you feel?
I am not hungry at all 1 have never been more hungry
Not at all thirsty
How thirsty do you feel?
Extremely thirsty
No, not at all
Would you like to eat something sweet?
Yes, very much
No, not at all
Would you like to eat something salty?
Yes, very much
No, not at all
Would you like to eat something fatty?
Yes, very much
No, not full at all
How full do you feel?
Extremely full
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Appetite Scales 2 -after lunch
Participant code: Date:
Answer the following questions by placing a vertical mark through the line for each 
question. Mark the line according to how you feel at this moment. Regard both the ends of 
the lines as indicating the most extreme sensations you have ever felt.
Time:
How hungry do you feel?
1 am not hungry at all 1 have never been more hungry
How thirsty do you feel?
Not at all thirsty Extremely thirsty
No, not at all
Would you like to eat something sweet?
Yes, very much
No, not at all
Would you like to eat something salty?
Yes, very much
No, not at all
Would you like to eat something fatty?
Yes, very much
How full do you feel?
No, not full at all Extremely full
cxvii
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Aûpendix S
Ehtical Approval
Unis
Ethics Com m ittee
19 June 2006
Ivis Katharine Lederle
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Dear Ms Lederle
Evaluation of blue-enriched' white light vs. control ordinary room llaht on improving 
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